,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,690362,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,79682,CENPU,https://ctdbase.org/detail.go?type=gene&acc=79682,,,79682.0,CENPU,10090.0,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of CENPU mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,
1,807847,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,2621,GAS6,https://ctdbase.org/detail.go?type=gene&acc=2621,,,2621.0,GAS6,10090.0,Mus musculus (house mouse),Testosterone deficiency results in increased expression of GAS6 mRNA,,,PMID:33848595,https://www.ncbi.nlm.nih.gov/pubmed/33848595,33848595,,
2,807848,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,8522,GAS7,https://ctdbase.org/detail.go?type=gene&acc=8522,,,8522.0,GAS7,9606.0,Homo sapiens (human),Testosterone results in increased expression of GAS7 mRNA,,,PMID:33359661,https://www.ncbi.nlm.nih.gov/pubmed/33359661,33359661,,
3,807849,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,8522,GAS7,https://ctdbase.org/detail.go?type=gene&acc=8522,,,8522.0,GAS7,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of GAS7 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
4,807850,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,51313,GASK1B,https://ctdbase.org/detail.go?type=gene&acc=51313,,,51313.0,GASK1B,9606.0,Homo sapiens (human),[testosterone co-treated with calcitriol] results in increased expression of GASK1B mrna|testosterone results in decreased expression of GASK1B mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
5,807851,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,2625,GATA3,https://ctdbase.org/detail.go?type=gene&acc=2625,,,2625.0,GATA3,9986.0,Oryctolagus cuniculus (rabbit),Testosterone inhibits the reaction [dietary fats results in increased expression of GATA3 mrna],,,PMID:22010203,https://www.ncbi.nlm.nih.gov/pubmed/22010203,22010203,,
6,807852,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,2625,GATA3,https://ctdbase.org/detail.go?type=gene&acc=2625,,,2625.0,GATA3,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with testosterone] results in decreased expression of GATA3 mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
7,807853,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,2627,GATA6,https://ctdbase.org/detail.go?type=gene&acc=2627,,,2627.0,GATA6,9606.0,Homo sapiens (human),Testosterone results in decreased expression of GATA6 mRNA,,,PMID:33359661,https://www.ncbi.nlm.nih.gov/pubmed/33359661,33359661,,
8,807854,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,2628,GATM,https://ctdbase.org/detail.go?type=gene&acc=2628,,,2628.0,GATM,9606.0,Homo sapiens (human),Testosterone results in decreased expression of GATM mRNA,,,PMID:33359661,https://www.ncbi.nlm.nih.gov/pubmed/33359661,33359661,,
9,814688,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,641654,HEPN1,https://ctdbase.org/detail.go?type=gene&acc=641654,,,641654.0,HEPN1,9606.0,Homo sapiens (human),[testosterone co-treated with calcitriol] results in decreased expression of HEPN1 mrna|testosterone results in decreased expression of HEPN1 mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
10,814689,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,26091,HERC4,https://ctdbase.org/detail.go?type=gene&acc=26091,,,26091.0,HERC4,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with testosterone] results in increased expression of HERC4 mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
11,814690,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,55008,HERC6,https://ctdbase.org/detail.go?type=gene&acc=55008,,,55008.0,HERC6,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of HERC6 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
12,814691,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,9709,HERPUD1,https://ctdbase.org/detail.go?type=gene&acc=9709,,,9709.0,HERPUD1,10090.0,Mus musculus (house mouse),"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [testosterone deficiency results in decreased expression of HERPUD1 mrna]|testosterone deficiency results in decreased expression of HERPUD1 mRNA",,,PMID:33848595,https://www.ncbi.nlm.nih.gov/pubmed/33848595,33848595,,
13,814692,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,3280,HES1,https://ctdbase.org/detail.go?type=gene&acc=3280,,,3280.0,HES1,9606.0,Homo sapiens (human),Testosterone results in increased expression of HES1 mrna|[testosterone co-treated with calcitriol] results in increased expression of HES1 mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
14,814693,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,3280,HES1,https://ctdbase.org/detail.go?type=gene&acc=3280,,,3280.0,HES1,9606.0,Homo sapiens (human),Testosterone results in decreased expression of HES1 mRNA,,,PMID:33359661,https://www.ncbi.nlm.nih.gov/pubmed/33359661,33359661,,
15,814694,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,54626,HES2,https://ctdbase.org/detail.go?type=gene&acc=54626,,,54626.0,HES2,9606.0,Homo sapiens (human),Testosterone results in increased expression of HES2 mrna|[testosterone co-treated with calcitriol] results in increased expression of HES2 mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
16,814695,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,55502,HES6,https://ctdbase.org/detail.go?type=gene&acc=55502,,,55502.0,HES6,9606.0,Homo sapiens (human),Testosterone results in decreased expression of HES6 mRNA,,,PMID:33359661,https://www.ncbi.nlm.nih.gov/pubmed/33359661,33359661,,
17,814696,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,26508,HEYL,https://ctdbase.org/detail.go?type=gene&acc=26508,,,26508.0,HEYL,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of HEYL mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
18,817164,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,84263,HSDL2,https://ctdbase.org/detail.go?type=gene&acc=84263,,,84263.0,HSDL2,9606.0,Homo sapiens (human),Testosterone results in decreased expression of HSDL2 mRNA,,,PMID:33359661,https://www.ncbi.nlm.nih.gov/pubmed/33359661,33359661,,
19,817165,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,84941,HSH2D,https://ctdbase.org/detail.go?type=gene&acc=84941,,,84941.0,HSH2D,9606.0,Homo sapiens (human),[testosterone co-treated with calcitriol] results in increased expression of HSH2D mrna|testosterone results in increased expression of HSH2D mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
20,817166,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,84941,HSH2D,https://ctdbase.org/detail.go?type=gene&acc=84941,,,84941.0,HSH2D,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of HSH2D mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
21,818477,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,9606.0,Homo sapiens (human),Testosterone results in increased expression of IGF1 protein,,,PMID:16002536,https://www.ncbi.nlm.nih.gov/pubmed/16002536,16002536,,
22,818478,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,10090.0,Mus musculus (house mouse),Testosterone affects the expression of IGF1 mRNA,,,PMID:20403060,https://www.ncbi.nlm.nih.gov/pubmed/20403060,20403060,,
23,818479,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,10090.0,Mus musculus (house mouse),Testosterone inhibits the reaction [testosterone deficiency results in decreased expression of IGF1 mrna]|testosterone deficiency results in decreased expression of IGF1 mRNA,,,PMID:21045173,https://www.ncbi.nlm.nih.gov/pubmed/21045173,21045173,,
24,818480,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,10090.0,Mus musculus (house mouse),Testosterone results in decreased expression of IGF1 mRNA,,,PMID:22138414,https://www.ncbi.nlm.nih.gov/pubmed/22138414,22138414,,
25,818481,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,8022.0,Oncorhynchus mykiss (rainbow trout),Testosterone results in increased expression of IGF1 protein|testosterone results in increased expression of IGF1 mRNA,,,PMID:21703268,https://www.ncbi.nlm.nih.gov/pubmed/21703268,21703268,,
26,818482,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,10116.0,Rattus norvegicus (Norway rat),Chrysin inhibits the reaction [testosterone results in increased expression of IGF1 mrna],,,PMID:29247772,https://www.ncbi.nlm.nih.gov/pubmed/29247772,29247772,,
27,818483,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,10116.0,Rattus norvegicus (Norway rat),Metformin inhibits the reaction [testosterone results in increased expression of IGF1 mrna],,,PMID:26492952,https://www.ncbi.nlm.nih.gov/pubmed/26492952,26492952,,
28,818484,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,10116.0,Rattus norvegicus (Norway rat),Testosterone results in increased expression of IGF1 mRNA,,,PMID:15917159|PMID:26492952|PMID:29247772,https://www.ncbi.nlm.nih.gov/pubmed/15917159|https://www.ncbi.nlm.nih.gov/pubmed/26492952|https://www.ncbi.nlm.nih.gov/pubmed/29247772,15917159|26492952|29247772,,
29,818485,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,10116.0,Rattus norvegicus (Norway rat),Testosterone results in increased expression of IGF1 protein,,,PMID:10100480,https://www.ncbi.nlm.nih.gov/pubmed/10100480,10100480,,
30,808013,6137,Comparative Toxicogenomics Database (CTD),Methionine,D008715,Methionine,https://ctdbase.org/detail.go?type=chem&acc=D008715,574434,MIR410,https://ctdbase.org/detail.go?type=gene&acc=574434,,,574434.0,MIR410,10116.0,Rattus norvegicus (Norway rat),[methionine deficiency co-treated with choline deficiency] results in decreased expression of MIR410 mRNA,,,PMID:22363424,https://www.ncbi.nlm.nih.gov/pubmed/22363424,22363424,,
31,808014,6137,Comparative Toxicogenomics Database (CTD),Methionine,D008715,Methionine,https://ctdbase.org/detail.go?type=chem&acc=D008715,693121,MIR411,https://ctdbase.org/detail.go?type=gene&acc=693121,,,693121.0,MIR411,10090.0,Mus musculus (house mouse),Methionine results in increased expression of MIR411 mRNA,,,PMID:35314295,https://www.ncbi.nlm.nih.gov/pubmed/35314295,35314295,,
32,808015,6137,Comparative Toxicogenomics Database (CTD),Methionine,D008715,Methionine,https://ctdbase.org/detail.go?type=chem&acc=D008715,693122,MIR421,https://ctdbase.org/detail.go?type=gene&acc=693122,,,693122.0,MIR421,10090.0,Mus musculus (house mouse),[methionine deficiency co-treated with choline deficiency co-treated with folic acid deficiency] results in increased expression of MIR421 mRNA,,,PMID:20548288,https://www.ncbi.nlm.nih.gov/pubmed/20548288,20548288,,
33,808016,6137,Comparative Toxicogenomics Database (CTD),Methionine,D008715,Methionine,https://ctdbase.org/detail.go?type=chem&acc=D008715,494337,MIR425,https://ctdbase.org/detail.go?type=gene&acc=494337,,,494337.0,MIR425,10090.0,Mus musculus (house mouse),[methionine deficiency co-treated with choline deficiency co-treated with folic acid deficiency] results in decreased expression of MIR425 mRNA,,,PMID:20548288,https://www.ncbi.nlm.nih.gov/pubmed/20548288,20548288,,
34,813488,6137,Comparative Toxicogenomics Database (CTD),Methionine,D008715,Methionine,https://ctdbase.org/detail.go?type=chem&acc=D008715,7080,NKX2-1,https://ctdbase.org/detail.go?type=gene&acc=7080,,,7080.0,NKX2-1,10090.0,Mus musculus (house mouse),[methionine deficiency co-treated with choline deficiency co-treated with folic acid deficiency] results in increased methylation of NKX2-1 gene,,,PMID:20938992,https://www.ncbi.nlm.nih.gov/pubmed/20938992,20938992,,
35,813489,6137,Comparative Toxicogenomics Database (CTD),Methionine,D008715,Methionine,https://ctdbase.org/detail.go?type=chem&acc=D008715,18094,NKX2-9,https://ctdbase.org/detail.go?type=gene&acc=18094,,,18094.0,Nkx2-9,10090.0,Mus musculus (house mouse),[methionine deficiency co-treated with choline deficiency co-treated with folic acid deficiency] results in decreased methylation of NKX2-9 gene,,,PMID:20938992,https://www.ncbi.nlm.nih.gov/pubmed/20938992,20938992,,
36,813490,6137,Comparative Toxicogenomics Database (CTD),Methionine,D008715,Methionine,https://ctdbase.org/detail.go?type=chem&acc=D008715,4825,NKX6-1,https://ctdbase.org/detail.go?type=gene&acc=4825,,,4825.0,NKX6-1,10090.0,Mus musculus (house mouse),[methionine deficiency co-treated with choline deficiency co-treated with folic acid deficiency] results in increased methylation of NKX6-1 gene,,,PMID:20938992,https://www.ncbi.nlm.nih.gov/pubmed/20938992,20938992,,
37,813491,6137,Comparative Toxicogenomics Database (CTD),Methionine,D008715,Methionine,https://ctdbase.org/detail.go?type=chem&acc=D008715,84504,NKX6-2,https://ctdbase.org/detail.go?type=gene&acc=84504,,,84504.0,NKX6-2,10090.0,Mus musculus (house mouse),[methionine deficiency co-treated with choline deficiency co-treated with folic acid deficiency] results in decreased methylation of NKX6-2 gene,,,PMID:20938992,https://www.ncbi.nlm.nih.gov/pubmed/20938992,20938992,,
38,814345,6251,Comparative Toxicogenomics Database (CTD),Mannitol,D008353,Mannitol,https://ctdbase.org/detail.go?type=chem&acc=D008353,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116.0,Rattus norvegicus (Norway rat),Mannitol results in increased expression of BCL2 protein,,,PMID:15786717,https://www.ncbi.nlm.nih.gov/pubmed/15786717,15786717,,
39,814346,6251,Comparative Toxicogenomics Database (CTD),Mannitol,D008353,Mannitol,https://ctdbase.org/detail.go?type=chem&acc=D008353,81928,CABLES2,https://ctdbase.org/detail.go?type=gene&acc=81928,,,81928.0,CABLES2,10090.0,Mus musculus (house mouse),Mannitol results in decreased expression of CABLES2 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
40,814347,6251,Comparative Toxicogenomics Database (CTD),Mannitol,D008353,Mannitol,https://ctdbase.org/detail.go?type=chem&acc=D008353,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),IGF1 inhibits the reaction [mannitol results in increased activity of CASP3 protein],,,PMID:10567913,https://www.ncbi.nlm.nih.gov/pubmed/10567913,10567913,,
41,814348,6251,Comparative Toxicogenomics Database (CTD),Mannitol,D008353,Mannitol,https://ctdbase.org/detail.go?type=chem&acc=D008353,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Mannitol inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased activity of CASP3 protein],,,PMID:29803612,https://www.ncbi.nlm.nih.gov/pubmed/29803612,29803612,,
42,814349,6251,Comparative Toxicogenomics Database (CTD),Mannitol,D008353,Mannitol,https://ctdbase.org/detail.go?type=chem&acc=D008353,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Mannitol results in increased activity of CASP3 protein,,,PMID:10567913|PMID:12011046,https://www.ncbi.nlm.nih.gov/pubmed/10567913|https://www.ncbi.nlm.nih.gov/pubmed/12011046,10567913|12011046,,
43,814992,6251,Comparative Toxicogenomics Database (CTD),Mannitol,D008353,Mannitol,https://ctdbase.org/detail.go?type=chem&acc=D008353,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606.0,Homo sapiens (human),Mannitol inhibits the reaction [glucose results in increased expression of ICAM1 mrna]|mannitol inhibits the reaction [glucose results in increased expression of ICAM1 protein],,,PMID:16285992,https://www.ncbi.nlm.nih.gov/pubmed/16285992,16285992,,
44,814993,6251,Comparative Toxicogenomics Database (CTD),Mannitol,D008353,Mannitol,https://ctdbase.org/detail.go?type=chem&acc=D008353,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,9606.0,Homo sapiens (human),IGF1 inhibits the reaction [mannitol results in increased activity of CASP3 protein],,,PMID:10567913,https://www.ncbi.nlm.nih.gov/pubmed/10567913,10567913,,
45,814994,6251,Comparative Toxicogenomics Database (CTD),Mannitol,D008353,Mannitol,https://ctdbase.org/detail.go?type=chem&acc=D008353,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),Rotenone inhibits the reaction [mannitol inhibits the reaction [lipopolysaccharides results in increased expression of IL6 protein]]|mannitol inhibits the reaction [lipopolysaccharides results in increased expression of IL6 protein],,,PMID:23867654,https://www.ncbi.nlm.nih.gov/pubmed/23867654,23867654,,
46,815694,6251,Comparative Toxicogenomics Database (CTD),Mannitol,D008353,Mannitol,https://ctdbase.org/detail.go?type=chem&acc=D008353,5251,PHEX,https://ctdbase.org/detail.go?type=gene&acc=5251,,,5251.0,PHEX,10116.0,Rattus norvegicus (Norway rat),Mannitol results in increased expression of PHEX mRNA,,,PMID:37992803,https://www.ncbi.nlm.nih.gov/pubmed/37992803,37992803,,
47,815695,6251,Comparative Toxicogenomics Database (CTD),Mannitol,D008353,Mannitol,https://ctdbase.org/detail.go?type=chem&acc=D008353,23228,PLCL2,https://ctdbase.org/detail.go?type=gene&acc=23228,,,23228.0,PLCL2,10090.0,Mus musculus (house mouse),Mannitol results in decreased expression of PLCL2 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
48,815696,6251,Comparative Toxicogenomics Database (CTD),Mannitol,D008353,Mannitol,https://ctdbase.org/detail.go?type=chem&acc=D008353,51177,PLEKHO1,https://ctdbase.org/detail.go?type=gene&acc=51177,,,51177.0,PLEKHO1,10090.0,Mus musculus (house mouse),Mannitol results in increased expression of PLEKHO1 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
49,815697,6251,Comparative Toxicogenomics Database (CTD),Mannitol,D008353,Mannitol,https://ctdbase.org/detail.go?type=chem&acc=D008353,5447,POR,https://ctdbase.org/detail.go?type=gene&acc=5447,,,5447.0,POR,9606.0,Homo sapiens (human),Mannitol inhibits the reaction [oxygen inhibits the reaction [[fe(iii)-EDTA co-treated with NADP co-treated with POR protein] results in increased reduction of sodium chromate(vi)]],,,PMID:7741258,https://www.ncbi.nlm.nih.gov/pubmed/7741258,7741258,,
50,815698,6251,Comparative Toxicogenomics Database (CTD),Mannitol,D008353,Mannitol,https://ctdbase.org/detail.go?type=chem&acc=D008353,5449,POU1F1,https://ctdbase.org/detail.go?type=gene&acc=5449,,,5449.0,POU1F1,10090.0,Mus musculus (house mouse),Mannitol results in increased expression of POU1F1 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
51,815699,6251,Comparative Toxicogenomics Database (CTD),Mannitol,D008353,Mannitol,https://ctdbase.org/detail.go?type=chem&acc=D008353,5514,PPP1R10,https://ctdbase.org/detail.go?type=gene&acc=5514,,,5514.0,PPP1R10,10090.0,Mus musculus (house mouse),Mannitol results in decreased expression of PPP1R10 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
52,815700,6251,Comparative Toxicogenomics Database (CTD),Mannitol,D008353,Mannitol,https://ctdbase.org/detail.go?type=chem&acc=D008353,5531,PPP4C,https://ctdbase.org/detail.go?type=gene&acc=5531,,,5531.0,PPP4C,10090.0,Mus musculus (house mouse),Mannitol results in increased expression of PPP4C mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
53,815701,6251,Comparative Toxicogenomics Database (CTD),Mannitol,D008353,Mannitol,https://ctdbase.org/detail.go?type=chem&acc=D008353,5579,PRKCB,https://ctdbase.org/detail.go?type=gene&acc=5579,,,5579.0,PRKCB,9606.0,Homo sapiens (human),Mannitol inhibits the reaction [glucose results in increased expression of PRKCB protein alternative form]|mannitol inhibits the reaction [glucose results in increased expression of PRKCB protein],,,PMID:16285992,https://www.ncbi.nlm.nih.gov/pubmed/16285992,16285992,,
54,815702,6251,Comparative Toxicogenomics Database (CTD),Mannitol,D008353,Mannitol,https://ctdbase.org/detail.go?type=chem&acc=D008353,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,9606.0,Homo sapiens (human),Mannitol inhibits the reaction [glucose results in increased expression of PRKCD protein],,,PMID:16285992,https://www.ncbi.nlm.nih.gov/pubmed/16285992,16285992,,
55,805884,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,54763,ROPN1,https://ctdbase.org/detail.go?type=gene&acc=54763,,,54763.0,ROPN1,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in decreased expression of ROPN1 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
56,805885,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,4919,ROR1,https://ctdbase.org/detail.go?type=gene&acc=4919,,,4919.0,ROR1,9606.0,Homo sapiens (human),Acrylamide results in decreased expression of ROR1 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
57,805886,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,4919,ROR1,https://ctdbase.org/detail.go?type=gene&acc=4919,,,4919.0,ROR1,10090.0,Mus musculus (house mouse),Acrylamide results in decreased expression of ROR1 mRNA,,,PMID:30807115,https://www.ncbi.nlm.nih.gov/pubmed/30807115,30807115,,
58,805887,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,6095,RORA,https://ctdbase.org/detail.go?type=gene&acc=6095,,,6095.0,RORA,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in decreased expression of RORA mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
59,805888,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,441212,RP9P,https://ctdbase.org/detail.go?type=gene&acc=441212,,,441212.0,RP9P,9606.0,Homo sapiens (human),Acrylamide results in increased expression of RP9P mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
60,805889,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,6118,RPA2,https://ctdbase.org/detail.go?type=gene&acc=6118,,,6118.0,RPA2,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of RPA2 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
61,806763,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,22800,RRAS2,https://ctdbase.org/detail.go?type=gene&acc=22800,,,22800.0,RRAS2,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in decreased expression of RRAS2 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
62,806764,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,6241,RRM2,https://ctdbase.org/detail.go?type=gene&acc=6241,,,6241.0,RRM2,9606.0,Homo sapiens (human),Acrylamide results in decreased expression of RRM2 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
63,806765,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,6241,RRM2,https://ctdbase.org/detail.go?type=gene&acc=6241,,,6241.0,RRM2,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of RRM2 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
64,806766,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,23076,RRP1B,https://ctdbase.org/detail.go?type=gene&acc=23076,,,23076.0,RRP1B,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of RRP1B mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
65,806767,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,23212,RRS1,https://ctdbase.org/detail.go?type=gene&acc=23212,,,23212.0,RRS1,9606.0,Homo sapiens (human),Acrylamide results in decreased expression of RRS1 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
66,806768,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,55316,RSAD1,https://ctdbase.org/detail.go?type=gene&acc=55316,,,55316.0,RSAD1,9606.0,Homo sapiens (human),Acrylamide results in decreased expression of RSAD1 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
67,806769,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,91543,RSAD2,https://ctdbase.org/detail.go?type=gene&acc=91543,,,91543.0,RSAD2,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in decreased expression of RSAD2 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
68,806770,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,222194,RSBN1L,https://ctdbase.org/detail.go?type=gene&acc=222194,,,222194.0,RSBN1L,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in decreased expression of RSBN1L mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
69,808487,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,57466,SCAF4,https://ctdbase.org/detail.go?type=gene&acc=57466,,,57466.0,SCAF4,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in decreased expression of SCAF4 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
70,808488,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,286205,SCAI,https://ctdbase.org/detail.go?type=gene&acc=286205,,,286205.0,SCAI,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in decreased expression of SCAI mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
71,808489,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,728769,SCAMP1-AS1,https://ctdbase.org/detail.go?type=gene&acc=728769,,,728769.0,SCAMP1-AS1,9606.0,Homo sapiens (human),Acrylamide results in decreased expression of SCAMP1-AS1 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
72,808490,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,10066,SCAMP2,https://ctdbase.org/detail.go?type=gene&acc=10066,,,10066.0,SCAMP2,7955.0,Danio rerio (zebrafish),Acrylamide results in decreased expression of SCAMP2 protein,,,PMID:29784925,https://www.ncbi.nlm.nih.gov/pubmed/29784925,29784925,,
73,809190,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,6329,SCN4A,https://ctdbase.org/detail.go?type=gene&acc=6329,,,6329.0,SCN4A,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in decreased expression of SCN4A mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
74,809191,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,6330,SCN4B,https://ctdbase.org/detail.go?type=gene&acc=6330,,,6330.0,SCN4B,9606.0,Homo sapiens (human),Acrylamide results in decreased expression of SCN4B mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
75,809192,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,6330,SCN4B,https://ctdbase.org/detail.go?type=gene&acc=6330,,,6330.0,SCN4B,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in decreased expression of SCN4B mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
76,809193,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,6337,SCNN1A,https://ctdbase.org/detail.go?type=gene&acc=6337,,,6337.0,SCNN1A,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of SCNN1A mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
77,810008,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,10512,SEMA3C,https://ctdbase.org/detail.go?type=gene&acc=10512,,,10512.0,SEMA3C,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in decreased expression of SEMA3C mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
78,812477,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,10280,SIGMAR1,https://ctdbase.org/detail.go?type=gene&acc=10280,,,10280.0,SIGMAR1,9606.0,Homo sapiens (human),Acrylamide results in decreased expression of SIGMAR1 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
79,812478,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,64374,SIL1,https://ctdbase.org/detail.go?type=gene&acc=64374,,,64374.0,SIL1,10116.0,Rattus norvegicus (Norway rat),Acrylamide affects the expression of SIL1 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
80,813143,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,23539,SLC16A8,https://ctdbase.org/detail.go?type=gene&acc=23539,,,23539.0,SLC16A8,10090.0,Mus musculus (house mouse),Acrylamide results in decreased expression of SLC16A8 mRNA,,,PMID:35032568,https://www.ncbi.nlm.nih.gov/pubmed/35032568,35032568,,
81,813862,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,10165,SLC25A13,https://ctdbase.org/detail.go?type=gene&acc=10165,,,10165.0,SLC25A13,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of SLC25A13 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
82,813863,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,10166,SLC25A15,https://ctdbase.org/detail.go?type=gene&acc=10166,,,10166.0,SLC25A15,9606.0,Homo sapiens (human),Acrylamide results in decreased expression of SLC25A15 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
83,813864,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,8034,SLC25A16,https://ctdbase.org/detail.go?type=gene&acc=8034,,,8034.0,SLC25A16,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in decreased expression of SLC25A16 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
84,817636,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,26952,SMR3A,https://ctdbase.org/detail.go?type=gene&acc=26952,,,26952.0,SMR3A,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in decreased expression of SMR3A mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
85,817637,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,6525,SMTN,https://ctdbase.org/detail.go?type=gene&acc=6525,,,6525.0,SMTN,10116.0,Rattus norvegicus (Norway rat),Acrylamide affects the expression of SMTN mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
86,817638,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,342527,SMTNL2,https://ctdbase.org/detail.go?type=gene&acc=342527,,,342527.0,SMTNL2,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of SMTNL2 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
87,817639,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,23583,SMUG1,https://ctdbase.org/detail.go?type=gene&acc=23583,,,23583.0,SMUG1,9606.0,Homo sapiens (human),Acrylamide results in decreased expression of SMUG1 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
88,817640,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,56950,SMYD2,https://ctdbase.org/detail.go?type=gene&acc=56950,,,56950.0,SMYD2,9606.0,Homo sapiens (human),Acrylamide results in decreased expression of SMYD2 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
89,817641,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,114826,SMYD4,https://ctdbase.org/detail.go?type=gene&acc=114826,,,114826.0,SMYD4,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of SMYD4 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
90,817642,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,10322,SMYD5,https://ctdbase.org/detail.go?type=gene&acc=10322,,,10322.0,SMYD5,9606.0,Homo sapiens (human),Acrylamide results in decreased expression of SMYD5 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
91,817643,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,8773,SNAP23,https://ctdbase.org/detail.go?type=gene&acc=8773,,,8773.0,SNAP23,9606.0,Homo sapiens (human),Acrylamide results in increased expression of SNAP23 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
92,818486,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,9655,SOCS5,https://ctdbase.org/detail.go?type=gene&acc=9655,,,9655.0,SOCS5,9606.0,Homo sapiens (human),Acrylamide results in increased expression of SOCS5 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
93,818487,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,30837,SOCS7,https://ctdbase.org/detail.go?type=gene&acc=30837,,,30837.0,SOCS7,10116.0,Rattus norvegicus (Norway rat),Acrylamide affects the expression of SOCS7 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
94,818985,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,6659,SOX4,https://ctdbase.org/detail.go?type=gene&acc=6659,,,6659.0,SOX4,9606.0,Homo sapiens (human),Acrylamide results in decreased expression of SOX4 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
95,818986,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,6659,SOX4,https://ctdbase.org/detail.go?type=gene&acc=6659,,,6659.0,SOX4,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in decreased expression of SOX4 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
96,818987,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,6660,SOX5,https://ctdbase.org/detail.go?type=gene&acc=6660,,,6660.0,SOX5,9606.0,Homo sapiens (human),Acrylamide results in decreased expression of SOX5 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
97,818988,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,55553,SOX6,https://ctdbase.org/detail.go?type=gene&acc=55553,,,55553.0,SOX6,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in decreased expression of SOX6 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
98,818989,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,30812,SOX8,https://ctdbase.org/detail.go?type=gene&acc=30812,,,30812.0,SOX8,9606.0,Homo sapiens (human),Acrylamide results in increased expression of SOX8 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
99,818990,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,30812,SOX8,https://ctdbase.org/detail.go?type=gene&acc=30812,,,30812.0,SOX8,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in decreased expression of SOX8 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
100,818991,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,6662,SOX9,https://ctdbase.org/detail.go?type=gene&acc=6662,,,6662.0,SOX9,9606.0,Homo sapiens (human),Acrylamide results in decreased expression of SOX9 protein|acrylamide results in decreased expression of SOX9 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
101,818992,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,400618,SOX9-AS1,https://ctdbase.org/detail.go?type=gene&acc=400618,,,400618.0,SOX9-AS1,9606.0,Homo sapiens (human),Acrylamide results in decreased expression of SOX9-AS1 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
102,732151,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,55011,PIH1D1,https://ctdbase.org/detail.go?type=gene&acc=55011,,,55011.0,PIH1D1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of PIH1D1 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
103,732292,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,143686,SESN3,https://ctdbase.org/detail.go?type=gene&acc=143686,,,143686.0,SESN3,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of SESN3 mRNA,,,PMID:29275510,https://www.ncbi.nlm.nih.gov/pubmed/29275510,29275510,,
104,732293,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,143686,SESN3,https://ctdbase.org/detail.go?type=gene&acc=143686,,,143686.0,SESN3,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of SESN3 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
105,732355,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,5286,PIK3C2A,https://ctdbase.org/detail.go?type=gene&acc=5286,,,5286.0,PIK3C2A,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of PIK3C2A mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
106,732356,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,5286,PIK3C2A,https://ctdbase.org/detail.go?type=gene&acc=5286,,,5286.0,PIK3C2A,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of PIK3C2A mRNA,,,PMID:25181051|PMID:30816183,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/30816183,25181051|30816183,,
107,732435,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,136853,SSC4D,https://ctdbase.org/detail.go?type=gene&acc=136853,,,136853.0,SSC4D,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of SSC4D mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
108,732436,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,284297,SSC5D,https://ctdbase.org/detail.go?type=gene&acc=284297,,,284297.0,SSC5D,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased expression of SSC5D mRNA,,,PMID:38074096,https://www.ncbi.nlm.nih.gov/pubmed/38074096,38074096,,
109,806570,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,259173,ALS2CL,https://ctdbase.org/detail.go?type=gene&acc=259173,,,259173.0,ALS2CL,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of ALS2CL mRNA,,,PMID:25181051|PMID:34947998|PMID:35192832,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/34947998|https://www.ncbi.nlm.nih.gov/pubmed/35192832,25181051|34947998|35192832,,
110,806571,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,42127,ALT,https://ctdbase.org/detail.go?type=gene&acc=42127,,,42127.0,alt,7227.0,Drosophila melanogaster (fruit fly),Bisphenol A results in decreased expression of ALT mRNA,,,PMID:35041872,https://www.ncbi.nlm.nih.gov/pubmed/35041872,35041872,,
111,806572,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,42127,ALT,https://ctdbase.org/detail.go?type=gene&acc=42127,,,42127.0,alt,10116.0,Rattus norvegicus (Norway rat),Dietary fats promotes the reaction [bisphenol A results in increased activity of ALT protein]|bisphenol A promotes the reaction [dietary fats results in increased activity of ALT protein]|bisphenol A results in increased activity of ALT protein,,,PMID:25112833,https://www.ncbi.nlm.nih.gov/pubmed/25112833,25112833,,
112,806573,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,8092,ALX1,https://ctdbase.org/detail.go?type=gene&acc=8092,,,8092.0,ALX1,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of ALX1 mRNA,,,PMID:23557687,https://www.ncbi.nlm.nih.gov/pubmed/23557687,23557687,,
113,806574,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,8092,ALX1,https://ctdbase.org/detail.go?type=gene&acc=8092,,,8092.0,ALX1,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of ALX1 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
114,806575,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,8092,ALX1,https://ctdbase.org/detail.go?type=gene&acc=8092,,,8092.0,ALX1,10090.0,Mus musculus (house mouse),Bisphenol A results in increased methylation of ALX1 promoter,,,PMID:27312807,https://www.ncbi.nlm.nih.gov/pubmed/27312807,27312807,,
115,806576,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,8092,ALX1,https://ctdbase.org/detail.go?type=gene&acc=8092,,,8092.0,ALX1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of ALX1 mRNA,,,PMID:25181051|PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/34947998,25181051|34947998,,
116,806577,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,257,ALX3,https://ctdbase.org/detail.go?type=gene&acc=257,,,257.0,ALX3,10090.0,Mus musculus (house mouse),Bisphenol A affects the methylation of ALX3 promoter,,,PMID:27334623,https://www.ncbi.nlm.nih.gov/pubmed/27334623,27334623,,
117,806578,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,257,ALX3,https://ctdbase.org/detail.go?type=gene&acc=257,,,257.0,ALX3,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of ALX3 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
118,806579,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,257,ALX3,https://ctdbase.org/detail.go?type=gene&acc=257,,,257.0,ALX3,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of ALX3 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
119,806580,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3597,IL13RA1,https://ctdbase.org/detail.go?type=gene&acc=3597,,,3597.0,IL13RA1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of IL13RA1 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
120,806771,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,60529,ALX4,https://ctdbase.org/detail.go?type=gene&acc=60529,,,60529.0,ALX4,9606.0,Homo sapiens (human),Bisphenol A results in decreased methylation of ALX4 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
121,806772,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,60529,ALX4,https://ctdbase.org/detail.go?type=gene&acc=60529,,,60529.0,ALX4,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of ALX4 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
122,806773,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,60529,ALX4,https://ctdbase.org/detail.go?type=gene&acc=60529,,,60529.0,ALX4,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of ALX4 mRNA,,,PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/32528016|https://www.ncbi.nlm.nih.gov/pubmed/34947998,25181051|30816183|32528016|34947998,,
123,806962,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,102465787,MIR126B,https://ctdbase.org/detail.go?type=gene&acc=102465787,,,102465787.0,Mir126b,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of MIR126B mRNA,,,PMID:32701268,https://www.ncbi.nlm.nih.gov/pubmed/32701268,32701268,,
124,806963,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,406914,MIR127,https://ctdbase.org/detail.go?type=gene&acc=406914,,,406914.0,MIR127,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with genistein] results in increased methylation of MIR127 gene|bisphenol A results in increased methylation of MIR127 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
125,806964,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,100302123,MIR1275,https://ctdbase.org/detail.go?type=gene&acc=100302123,,,100302123.0,MIR1275,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of MIR1275 mRNA,,,PMID:22403704,https://www.ncbi.nlm.nih.gov/pubmed/22403704,22403704,,
126,806965,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,100302205,MIR1283-2,https://ctdbase.org/detail.go?type=gene&acc=100302205,,,100302205.0,MIR1283-2,9606.0,Homo sapiens (human),Bisphenol A results in increased methylation of MIR1283-2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
127,806966,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,100302218,MIR1285-1,https://ctdbase.org/detail.go?type=gene&acc=100302218,,,100302218.0,MIR1285-1,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of MIR1285-1 mRNA,,,PMID:33670352,https://www.ncbi.nlm.nih.gov/pubmed/33670352,33670352,,
128,806967,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,100302187,MIR1297,https://ctdbase.org/detail.go?type=gene&acc=100302187,,,100302187.0,MIR1297,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of MIR1297 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
129,806968,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,100302153,MIR1298,https://ctdbase.org/detail.go?type=gene&acc=100302153,,,100302153.0,MIR1298,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of MIR1298 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
130,806969,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,102465170,MIR133C,https://ctdbase.org/detail.go?type=gene&acc=102465170,,,102465170.0,Mir133c,9544.0,Macaca mulatta (Rhesus monkey),Bisphenol A results in decreased expression of MIR133C mRNA,,,PMID:24586524,https://www.ncbi.nlm.nih.gov/pubmed/24586524,24586524,,
131,806970,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,406924,MIR134,https://ctdbase.org/detail.go?type=gene&acc=406924,,,406924.0,MIR134,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of MIR134 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
132,807506,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,406938,MIR146A,https://ctdbase.org/detail.go?type=gene&acc=406938,,,406938.0,MIR146A,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of MIR146A mRNA,,,PMID:20417706|PMID:22949852,https://www.ncbi.nlm.nih.gov/pubmed/20417706|https://www.ncbi.nlm.nih.gov/pubmed/22949852,20417706|22949852,,
133,807507,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,387165,MIR147,https://ctdbase.org/detail.go?type=gene&acc=387165,,,387165.0,Mir147,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of MIR147 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
134,807508,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,100302126,MIR1471,https://ctdbase.org/detail.go?type=gene&acc=100302126,,,100302126.0,MIR1471,9940.0,Ovis aries (sheep),Bisphenol A results in decreased expression of MIR1471 mRNA,,,PMID:23525218,https://www.ncbi.nlm.nih.gov/pubmed/23525218,23525218,,
135,807509,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,442892,MIR148B,https://ctdbase.org/detail.go?type=gene&acc=442892,,,442892.0,MIR148B,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of MIR148B gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
136,807510,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,406941,MIR149,https://ctdbase.org/detail.go?type=gene&acc=406941,,,406941.0,MIR149,9606.0,Homo sapiens (human),MIR149 mRNA inhibits the reaction [bisphenol A results in decreased expression of ARF6 mrna]|bisphenol A results in decreased expression of MIR149 mrna|mir149 mRNA inhibits the reaction [bisphenol A results in decreased expression of TP53 mrna]|mir149 mRNA inhibits the reaction [bisphenol A results in increased expression of CCNE2 mrna],,,PMID:28238728,https://www.ncbi.nlm.nih.gov/pubmed/28238728,28238728,,
137,807511,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,406941,MIR149,https://ctdbase.org/detail.go?type=gene&acc=406941,,,406941.0,MIR149,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of MIR149 mRNA,,,PMID:22403704,https://www.ncbi.nlm.nih.gov/pubmed/22403704,22403704,,
138,807512,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,406942,MIR150,https://ctdbase.org/detail.go?type=gene&acc=406942,,,406942.0,MIR150,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of MIR150 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
139,808324,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,406968,MIR193A,https://ctdbase.org/detail.go?type=gene&acc=406968,,,406968.0,MIR193A,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased expression of MIR193A mRNA,,,PMID:36656826,https://www.ncbi.nlm.nih.gov/pubmed/36656826,36656826,,
140,808325,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,574455,MIR193B,https://ctdbase.org/detail.go?type=gene&acc=574455,,,574455.0,MIR193B,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of MIR193B mRNA,,,PMID:28238728,https://www.ncbi.nlm.nih.gov/pubmed/28238728,28238728,,
141,808326,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,574455,MIR193B,https://ctdbase.org/detail.go?type=gene&acc=574455,,,574455.0,MIR193B,9940.0,Ovis aries (sheep),Bisphenol A results in decreased expression of MIR193B mRNA,,,PMID:23525218,https://www.ncbi.nlm.nih.gov/pubmed/23525218,23525218,,
142,808327,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,574455,MIR193B,https://ctdbase.org/detail.go?type=gene&acc=574455,,,574455.0,MIR193B,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of MIR193B mRNA,,,PMID:32701268,https://www.ncbi.nlm.nih.gov/pubmed/32701268,32701268,,
143,808328,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,406969,MIR194-1,https://ctdbase.org/detail.go?type=gene&acc=406969,,,406969.0,MIR194-1,9544.0,Macaca mulatta (Rhesus monkey),Bisphenol A results in increased expression of MIR194-1 mRNA,,,PMID:24586524,https://www.ncbi.nlm.nih.gov/pubmed/24586524,24586524,,
144,808329,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,406969,MIR194-1,https://ctdbase.org/detail.go?type=gene&acc=406969,,,406969.0,MIR194-1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of MIR194-1 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
145,808330,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,100316695,MIR1943,https://ctdbase.org/detail.go?type=gene&acc=100316695,,,100316695.0,Mir1943,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased expression of MIR1943 mRNA,,,PMID:32156529,https://www.ncbi.nlm.nih.gov/pubmed/32156529,32156529,,
146,808331,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,406971,MIR195,https://ctdbase.org/detail.go?type=gene&acc=406971,,,406971.0,MIR195,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of MIR195 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
147,808332,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,387191,MIR196A-1,https://ctdbase.org/detail.go?type=gene&acc=387191,,,387191.0,Mir196a-1,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased expression of MIR196A-1 mRNA,,,PMID:32156529|PMID:38074096,https://www.ncbi.nlm.nih.gov/pubmed/32156529|https://www.ncbi.nlm.nih.gov/pubmed/38074096,32156529|38074096,,
148,808333,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,387191,MIR196A-1,https://ctdbase.org/detail.go?type=gene&acc=387191,,,387191.0,Mir196a-1,10090.0,Mus musculus (house mouse),[NR1H4 gene mutant form affects the susceptibility to bisphenol A] which results in increased expression of MIR196A-1 mRNA,,,PMID:30245210,https://www.ncbi.nlm.nih.gov/pubmed/30245210,30245210,,
149,809683,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2041,EPHA1,https://ctdbase.org/detail.go?type=gene&acc=2041,,,2041.0,EPHA1,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of EPHA1 mRNA,,,PMID:32156529|PMID:34585602,https://www.ncbi.nlm.nih.gov/pubmed/32156529|https://www.ncbi.nlm.nih.gov/pubmed/34585602,32156529|34585602,,
150,809684,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2041,EPHA1,https://ctdbase.org/detail.go?type=gene&acc=2041,,,2041.0,EPHA1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of EPHA1 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
151,809685,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2041,EPHA1,https://ctdbase.org/detail.go?type=gene&acc=2041,,,2041.0,EPHA1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of EPHA1 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
152,809686,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,284656,EPHA10,https://ctdbase.org/detail.go?type=gene&acc=284656,,,284656.0,EPHA10,9606.0,Homo sapiens (human),Bisphenol A results in decreased expression of EPHA10 mRNA,,,PMID:32756504,https://www.ncbi.nlm.nih.gov/pubmed/32756504,32756504,,
153,809687,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,284656,EPHA10,https://ctdbase.org/detail.go?type=gene&acc=284656,,,284656.0,EPHA10,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased methylation of EPHA10 promoter,,,PMID:27312807,https://www.ncbi.nlm.nih.gov/pubmed/27312807,27312807,,
154,809688,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,284656,EPHA10,https://ctdbase.org/detail.go?type=gene&acc=284656,,,284656.0,EPHA10,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of EPHA10 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
155,809689,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,1969,EPHA2,https://ctdbase.org/detail.go?type=gene&acc=1969,,,1969.0,EPHA2,9606.0,Homo sapiens (human),Bisphenol A results in decreased expression of EPHA2 mRNA,,,PMID:29275510|PMID:36126549,https://www.ncbi.nlm.nih.gov/pubmed/29275510|https://www.ncbi.nlm.nih.gov/pubmed/36126549,29275510|36126549,,
156,809690,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,1969,EPHA2,https://ctdbase.org/detail.go?type=gene&acc=1969,,,1969.0,EPHA2,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased methylation of EPHA2 promoter,,,PMID:27312807,https://www.ncbi.nlm.nih.gov/pubmed/27312807,27312807,,
157,809835,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,11141,IL1RAPL1,https://ctdbase.org/detail.go?type=gene&acc=11141,,,11141.0,IL1RAPL1,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of IL1RAPL1 mRNA,,,PMID:35598803,https://www.ncbi.nlm.nih.gov/pubmed/35598803,35598803,,
158,809836,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,11141,IL1RAPL1,https://ctdbase.org/detail.go?type=gene&acc=11141,,,11141.0,IL1RAPL1,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with androgen antagonists co-treated with acetaminophen] results in decreased expression of IL1RAPL1 mRNA,,,PMID:25607892,https://www.ncbi.nlm.nih.gov/pubmed/25607892,25607892,,
159,809837,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,11141,IL1RAPL1,https://ctdbase.org/detail.go?type=gene&acc=11141,,,11141.0,IL1RAPL1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of IL1RAPL1 mRNA,,,PMID:25181051|PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/34947998,25181051|34947998,,
160,809838,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,568868,IL1RAPL1A,https://ctdbase.org/detail.go?type=gene&acc=568868,,,568868.0,il1rapl1a,7955.0,Danio rerio (zebrafish),Bisphenol A results in increased methylation of IL1RAPL1A intron|bisphenol A results in decreased methylation of IL1RAPL1A intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
161,809839,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,568868,IL1RAPL1A,https://ctdbase.org/detail.go?type=gene&acc=568868,,,568868.0,il1rapl1a,90988.0,Pimephales promelas (fathead minnow),Bisphenol A affects the expression of IL1RAPL1A mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
162,809840,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,557801,IL1RAPL1B,https://ctdbase.org/detail.go?type=gene&acc=557801,,,557801.0,il1rapl1b,7955.0,Danio rerio (zebrafish),Bisphenol A results in increased methylation of IL1RAPL1B intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
163,809841,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,26280,IL1RAPL2,https://ctdbase.org/detail.go?type=gene&acc=26280,,,26280.0,IL1RAPL2,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of IL1RAPL2 mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
164,809842,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,26280,IL1RAPL2,https://ctdbase.org/detail.go?type=gene&acc=26280,,,26280.0,IL1RAPL2,7955.0,Danio rerio (zebrafish),Bisphenol A results in decreased methylation of IL1RAPL2 intron|bisphenol A results in increased methylation of IL1RAPL2 intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
165,809843,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,26280,IL1RAPL2,https://ctdbase.org/detail.go?type=gene&acc=26280,,,26280.0,IL1RAPL2,10090.0,Mus musculus (house mouse),Bisphenol A results in increased methylation of IL1RAPL2 promoter,,,PMID:27312807,https://www.ncbi.nlm.nih.gov/pubmed/27312807,27312807,,
166,809844,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,26280,IL1RAPL2,https://ctdbase.org/detail.go?type=gene&acc=26280,,,26280.0,IL1RAPL2,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of IL1RAPL2 mRNA,,,PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/32528016|https://www.ncbi.nlm.nih.gov/pubmed/34947998,25181051|30816183|32528016|34947998,,
167,810337,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3557,IL1RN,https://ctdbase.org/detail.go?type=gene&acc=3557,,,3557.0,IL1RN,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of IL1RN mRNA,,,PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/34947998,34947998,,
168,810338,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3558,IL2,https://ctdbase.org/detail.go?type=gene&acc=3558,,,3558.0,IL2,9606.0,Homo sapiens (human),Bisphenol A affects the reaction [[ionomycin co-treated with tetradecanoylphorbol acetate] results in increased secretion of IL2 protein],,,PMID:29777833,https://www.ncbi.nlm.nih.gov/pubmed/29777833,29777833,,
169,810339,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3558,IL2,https://ctdbase.org/detail.go?type=gene&acc=3558,,,3558.0,IL2,10090.0,Mus musculus (house mouse),Bisphenol A promotes the reaction [lipopolysaccharides results in increased secretion of IL2 protein],,,PMID:24189131,https://www.ncbi.nlm.nih.gov/pubmed/24189131,24189131,,
170,810340,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3558,IL2,https://ctdbase.org/detail.go?type=gene&acc=3558,,,3558.0,IL2,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of IL2 mRNA,,,PMID:26063408,https://www.ncbi.nlm.nih.gov/pubmed/26063408,26063408,,
171,810341,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3558,IL2,https://ctdbase.org/detail.go?type=gene&acc=3558,,,3558.0,IL2,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of IL2 mRNA,,,PMID:18569609|PMID:19267065,https://www.ncbi.nlm.nih.gov/pubmed/18569609|https://www.ncbi.nlm.nih.gov/pubmed/19267065,18569609|19267065,,
172,810342,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,53832,IL20RA,https://ctdbase.org/detail.go?type=gene&acc=53832,,,53832.0,IL20RA,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of IL20RA mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
173,810343,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,53832,IL20RA,https://ctdbase.org/detail.go?type=gene&acc=53832,,,53832.0,IL20RA,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of IL20RA gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
174,810344,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,53832,IL20RA,https://ctdbase.org/detail.go?type=gene&acc=53832,,,53832.0,IL20RA,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of IL20RA mRNA,,,PMID:32156529,https://www.ncbi.nlm.nih.gov/pubmed/32156529,32156529,,
175,810345,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,285220,EPHA6,https://ctdbase.org/detail.go?type=gene&acc=285220,,,285220.0,EPHA6,7955.0,Danio rerio (zebrafish),Bisphenol A results in decreased expression of EPHA6 mRNA,,,PMID:33243503,https://www.ncbi.nlm.nih.gov/pubmed/33243503,33243503,,
176,810346,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,285220,EPHA6,https://ctdbase.org/detail.go?type=gene&acc=285220,,,285220.0,EPHA6,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of EPHA6 mRNA,,,PMID:35598803,https://www.ncbi.nlm.nih.gov/pubmed/35598803,35598803,,
177,810347,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,285220,EPHA6,https://ctdbase.org/detail.go?type=gene&acc=285220,,,285220.0,EPHA6,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of EPHA6 mRNA,,,PMID:25181051|PMID:30816183|PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/34947998,25181051|30816183|34947998,,
178,810984,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,30313,EPHB3A,https://ctdbase.org/detail.go?type=gene&acc=30313,,,30313.0,ephb3a,7955.0,Danio rerio (zebrafish),Bisphenol A results in decreased methylation of EPHB3A intron|bisphenol A results in increased methylation of EPHB3A intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
179,810985,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2050,EPHB4,https://ctdbase.org/detail.go?type=gene&acc=2050,,,2050.0,EPHB4,9606.0,Homo sapiens (human),Bisphenol A binds to EPHB4 protein,,,PMID:34706627,https://www.ncbi.nlm.nih.gov/pubmed/34706627,34706627,,
180,810986,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2050,EPHB4,https://ctdbase.org/detail.go?type=gene&acc=2050,,,2050.0,EPHB4,9606.0,Homo sapiens (human),Bisphenol A results in increased methylation of EPHB4 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
181,810987,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2050,EPHB4,https://ctdbase.org/detail.go?type=gene&acc=2050,,,2050.0,EPHB4,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of EPHB4 mRNA,,,PMID:32156529,https://www.ncbi.nlm.nih.gov/pubmed/32156529,32156529,,
182,810988,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2050,EPHB4,https://ctdbase.org/detail.go?type=gene&acc=2050,,,2050.0,EPHB4,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of EPHB4 mRNA,,,PMID:30816183|PMID:32528016|PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/32528016|https://www.ncbi.nlm.nih.gov/pubmed/34947998,30816183|32528016|34947998,,
183,810989,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,30688,EPHB4A,https://ctdbase.org/detail.go?type=gene&acc=30688,,,30688.0,ephb4a,7955.0,Danio rerio (zebrafish),Bisphenol A affects the methylation of EPHB4A intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
184,810990,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,30691,EPHB4B,https://ctdbase.org/detail.go?type=gene&acc=30691,,,30691.0,ephb4b,90988.0,Pimephales promelas (fathead minnow),Bisphenol A affects the expression of EPHB4B mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
185,810991,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2051,EPHB6,https://ctdbase.org/detail.go?type=gene&acc=2051,,,2051.0,EPHB6,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of EPHB6 mRNA,,,PMID:30248606,https://www.ncbi.nlm.nih.gov/pubmed/30248606,30248606,,
186,811133,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,574412,MIR452,https://ctdbase.org/detail.go?type=gene&acc=574412,,,574412.0,MIR452,9544.0,Macaca mulatta (Rhesus monkey),Bisphenol A results in decreased expression of MIR452 mRNA,,,PMID:24586524,https://www.ncbi.nlm.nih.gov/pubmed/24586524,24586524,,
187,811134,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,100033791,MIR454B,https://ctdbase.org/detail.go?type=gene&acc=100033791,,,100033791.0,mir454b,7955.0,Danio rerio (zebrafish),Bisphenol A results in increased methylation of MIR454B promoter,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
188,811135,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,619556,MIR455,https://ctdbase.org/detail.go?type=gene&acc=619556,,,619556.0,MIR455,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of MIR455 mRNA,,,PMID:32701268,https://www.ncbi.nlm.nih.gov/pubmed/32701268,32701268,,
189,811136,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,100033525,MIR456,https://ctdbase.org/detail.go?type=gene&acc=100033525,,,100033525.0,mir456,7955.0,Danio rerio (zebrafish),Bisphenol A results in decreased methylation of MIR456 promoter,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
190,811137,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,100033528,MIR458,https://ctdbase.org/detail.go?type=gene&acc=100033528,,,100033528.0,mir458,7955.0,Danio rerio (zebrafish),Bisphenol A results in increased expression of MIR458 mRNA,,,PMID:29027980,https://www.ncbi.nlm.nih.gov/pubmed/29027980,29027980,,
191,811138,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,723887,MIR463,https://ctdbase.org/detail.go?type=gene&acc=723887,,,723887.0,Mir463,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of MIR463 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
192,811139,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,723888,MIR465,https://ctdbase.org/detail.go?type=gene&acc=723888,,,723888.0,Mir465,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of MIR465 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
193,811140,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,100124465,MIR466D,https://ctdbase.org/detail.go?type=gene&acc=100124465,,,100124465.0,Mir466d,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of MIR466D gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
194,811141,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,100316665,MIR466I,https://ctdbase.org/detail.go?type=gene&acc=100316665,,,100316665.0,Mir466i,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased expression of MIR466I mRNA,,,PMID:32156529,https://www.ncbi.nlm.nih.gov/pubmed/32156529,32156529,,
195,811142,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,100616242,MIR4673,https://ctdbase.org/detail.go?type=gene&acc=100616242,,,100616242.0,MIR4673,9606.0,Homo sapiens (human),Bisphenol A results in decreased methylation of MIR4673 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
196,811460,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2052,EPHX1,https://ctdbase.org/detail.go?type=gene&acc=2052,,,2052.0,EPHX1,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of EPHX1 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
197,811461,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2052,EPHX1,https://ctdbase.org/detail.go?type=gene&acc=2052,,,2052.0,EPHX1,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with estradiol] results in decreased expression of EPHX1 mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
198,811462,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2052,EPHX1,https://ctdbase.org/detail.go?type=gene&acc=2052,,,2052.0,EPHX1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of EPHX1 mRNA,,,PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/32145629|https://www.ncbi.nlm.nih.gov/pubmed/32528016|https://www.ncbi.nlm.nih.gov/pubmed/34947998,30816183|32145629|32528016|34947998,,
199,812306,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of IL4 protein,,,PMID:12709020|PMID:29737898|PMID:35278557,https://www.ncbi.nlm.nih.gov/pubmed/12709020|https://www.ncbi.nlm.nih.gov/pubmed/29737898|https://www.ncbi.nlm.nih.gov/pubmed/35278557,12709020|29737898|35278557,,
200,812307,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10090.0,Mus musculus (house mouse),Bisphenol A results in increased secretion of IL4 protein,,,PMID:12711627,https://www.ncbi.nlm.nih.gov/pubmed/12711627,12711627,,
201,812308,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10090.0,Mus musculus (house mouse),[bisphenol A results in increased susceptibility to ovalbumin] which results in increased expression of IL4 mRNA,,,PMID:32012983,https://www.ncbi.nlm.nih.gov/pubmed/32012983,32012983,,
202,812309,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10090.0,Mus musculus (house mouse),Phytochemicals inhibits the reaction [bisphenol A results in increased expression of IL4 mrna],,,PMID:20553123,https://www.ncbi.nlm.nih.gov/pubmed/20553123,20553123,,
203,812310,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of IL4 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
204,812311,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10116.0,Rattus norvegicus (Norway rat),[phytochemicals co-treated with bisphenol A] results in decreased expression of IL4,,,PMID:20136622,https://www.ncbi.nlm.nih.gov/pubmed/20136622,20136622,,
205,812312,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,259307,IL4I1,https://ctdbase.org/detail.go?type=gene&acc=259307,,,259307.0,IL4I1,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of IL4I1 mRNA,,,PMID:27685785,https://www.ncbi.nlm.nih.gov/pubmed/27685785,27685785,,
206,812313,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,259307,IL4I1,https://ctdbase.org/detail.go?type=gene&acc=259307,,,259307.0,IL4I1,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased expression of IL4I1 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
207,812314,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3566,IL4R,https://ctdbase.org/detail.go?type=gene&acc=3566,,,3566.0,IL4R,9606.0,Homo sapiens (human),Bisphenol A affects the expression of IL4R mRNA,,,PMID:30903817,https://www.ncbi.nlm.nih.gov/pubmed/30903817,30903817,,
208,812315,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3566,IL4R,https://ctdbase.org/detail.go?type=gene&acc=3566,,,3566.0,IL4R,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of IL4R mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
209,812479,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,693175,MIR590,https://ctdbase.org/detail.go?type=gene&acc=693175,,,693175.0,MIR590,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of MIR590 mRNA,,,PMID:36828454,https://www.ncbi.nlm.nih.gov/pubmed/36828454,36828454,,
210,812480,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,693182,MIR597,https://ctdbase.org/detail.go?type=gene&acc=693182,,,693182.0,MIR597,9606.0,Homo sapiens (human),Bisphenol A results in decreased expression of MIR597 mRNA,,,PMID:36828454,https://www.ncbi.nlm.nih.gov/pubmed/36828454,36828454,,
211,812481,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,693182,MIR597,https://ctdbase.org/detail.go?type=gene&acc=693182,,,693182.0,MIR597,9606.0,Homo sapiens (human),Bisphenol A results in increased methylation of MIR597 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
212,812482,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,693190,MIR605,https://ctdbase.org/detail.go?type=gene&acc=693190,,,693190.0,MIR605,9940.0,Ovis aries (sheep),Bisphenol A results in decreased expression of MIR605 mRNA,,,PMID:23525218,https://www.ncbi.nlm.nih.gov/pubmed/23525218,23525218,,
213,812483,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,693193,MIR608,https://ctdbase.org/detail.go?type=gene&acc=693193,,,693193.0,MIR608,9606.0,Homo sapiens (human),Bisphenol A results in decreased methylation of MIR608 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
214,812484,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,693197,MIR612,https://ctdbase.org/detail.go?type=gene&acc=693197,,,693197.0,MIR612,9606.0,Homo sapiens (human),Bisphenol A affects the expression of MIR612 mRNA,,,PMID:30903817,https://www.ncbi.nlm.nih.gov/pubmed/30903817,30903817,,
215,812485,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,693197,MIR612,https://ctdbase.org/detail.go?type=gene&acc=693197,,,693197.0,MIR612,9544.0,Macaca mulatta (Rhesus monkey),Bisphenol A results in increased expression of MIR612 mRNA,,,PMID:24586524,https://www.ncbi.nlm.nih.gov/pubmed/24586524,24586524,,
216,812486,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,693200,MIR615,https://ctdbase.org/detail.go?type=gene&acc=693200,,,693200.0,MIR615,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of MIR615 mRNA,,,PMID:36656826,https://www.ncbi.nlm.nih.gov/pubmed/36656826,36656826,,
217,812487,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,102465147,MIR6216,https://ctdbase.org/detail.go?type=gene&acc=102465147,,,102465147.0,Mir6216,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of MIR6216 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
218,813144,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,150709,ANKAR,https://ctdbase.org/detail.go?type=gene&acc=150709,,,150709.0,ANKAR,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of ANKAR mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
219,813145,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,348094,ANKDD1A,https://ctdbase.org/detail.go?type=gene&acc=348094,,,348094.0,ANKDD1A,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of ANKDD1A mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
220,813146,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,348094,ANKDD1A,https://ctdbase.org/detail.go?type=gene&acc=348094,,,348094.0,ANKDD1A,9606.0,Homo sapiens (human),Bisphenol A results in decreased expression of ANKDD1A mrna|bisphenol A results in increased methylation of ANKDD1A gene,,,PMID:22576693,https://www.ncbi.nlm.nih.gov/pubmed/22576693,22576693,,
221,813147,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,348094,ANKDD1A,https://ctdbase.org/detail.go?type=gene&acc=348094,,,348094.0,ANKDD1A,9606.0,Homo sapiens (human),Bisphenol A results in decreased methylation of ANKDD1A gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
222,813148,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,348094,ANKDD1A,https://ctdbase.org/detail.go?type=gene&acc=348094,,,348094.0,ANKDD1A,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of ANKDD1A mRNA,,,PMID:30816183,https://www.ncbi.nlm.nih.gov/pubmed/30816183,30816183,,
223,813149,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,728780,ANKDD1B,https://ctdbase.org/detail.go?type=gene&acc=728780,,,728780.0,ANKDD1B,9606.0,Homo sapiens (human),Bisphenol A results in decreased methylation of ANKDD1B gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
224,813150,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,63926,ANKEF1,https://ctdbase.org/detail.go?type=gene&acc=63926,,,63926.0,ANKEF1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of ANKEF1 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
225,813151,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,566413,ANKEF1A,https://ctdbase.org/detail.go?type=gene&acc=566413,,,566413.0,ankef1a,7955.0,Danio rerio (zebrafish),Bisphenol A affects the methylation of ANKEF1A intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
226,813152,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,51479,ANKFY1,https://ctdbase.org/detail.go?type=gene&acc=51479,,,51479.0,ANKFY1,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of ANKFY1 mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
227,813668,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),[dietary fats co-treated with bisphenol A co-treated with cholesterol] results in increased secretion of IL6 protein,,,PMID:33239236,https://www.ncbi.nlm.nih.gov/pubmed/33239236,33239236,,
228,813669,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),Fulvestrant inhibits the reaction [bisphenol A results in increased expression of IL6 mrna],,,PMID:28500084,https://www.ncbi.nlm.nih.gov/pubmed/28500084,28500084,,
229,813670,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),Pyrazolanthrone inhibits the reaction [bisphenol A results in increased expression of IL6 mrna]|fulvestrant inhibits the reaction [bisphenol A results in increased secretion of IL6 protein],,,PMID:25047101,https://www.ncbi.nlm.nih.gov/pubmed/25047101,25047101,,
230,813671,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),PS1145 inhibits the reaction [bisphenol A results in increased expression of IL6 mrna]|t 0070907 inhibits the reaction [bisphenol A results in increased expression of IL6 mrna]|gnrh1 protein inhibits the reaction [bisphenol A results in increased expression of IL6 mrna],,,PMID:30149043,https://www.ncbi.nlm.nih.gov/pubmed/30149043,30149043,,
231,813672,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),GSR protein affects the reaction [bisphenol A results in increased expression of IL6 mrna],,,PMID:37510359,https://www.ncbi.nlm.nih.gov/pubmed/37510359,37510359,,
232,813865,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,23141,ANKLE2,https://ctdbase.org/detail.go?type=gene&acc=23141,,,23141.0,ANKLE2,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of ANKLE2 mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
233,813866,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,23141,ANKLE2,https://ctdbase.org/detail.go?type=gene&acc=23141,,,23141.0,ANKLE2,7955.0,Danio rerio (zebrafish),Bisphenol A results in decreased expression of ANKLE2 mRNA,,,PMID:33243503,https://www.ncbi.nlm.nih.gov/pubmed/33243503,33243503,,
234,813867,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,23141,ANKLE2,https://ctdbase.org/detail.go?type=gene&acc=23141,,,23141.0,ANKLE2,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of ANKLE2 mRNA,,,PMID:33221593,https://www.ncbi.nlm.nih.gov/pubmed/33221593,33221593,,
235,813868,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,23141,ANKLE2,https://ctdbase.org/detail.go?type=gene&acc=23141,,,23141.0,ANKLE2,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of ANKLE2 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
236,813869,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,23141,ANKLE2,https://ctdbase.org/detail.go?type=gene&acc=23141,,,23141.0,ANKLE2,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of ANKLE2 mRNA,,,PMID:30816183,https://www.ncbi.nlm.nih.gov/pubmed/30816183,30816183,,
237,813870,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,23141,ANKLE2,https://ctdbase.org/detail.go?type=gene&acc=23141,,,23141.0,ANKLE2,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of ANKLE2 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
238,813871,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,51281,ANKMY1,https://ctdbase.org/detail.go?type=gene&acc=51281,,,51281.0,ANKMY1,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of ANKMY1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
239,813872,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,57037,ANKMY2,https://ctdbase.org/detail.go?type=gene&acc=57037,,,57037.0,ANKMY2,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased expression of ANKMY2 mRNA,,,PMID:33221593,https://www.ncbi.nlm.nih.gov/pubmed/33221593,33221593,,
240,814523,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3581,IL9R,https://ctdbase.org/detail.go?type=gene&acc=3581,,,3581.0,IL9R,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of IL9R mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
241,814524,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,286676,ILDR1,https://ctdbase.org/detail.go?type=gene&acc=286676,,,286676.0,ILDR1,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of ILDR1 mRNA,,,PMID:36232920,https://www.ncbi.nlm.nih.gov/pubmed/36232920,36232920,,
242,814525,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,286676,ILDR1,https://ctdbase.org/detail.go?type=gene&acc=286676,,,286676.0,ILDR1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of ILDR1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
243,814526,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,286676,ILDR1,https://ctdbase.org/detail.go?type=gene&acc=286676,,,286676.0,ILDR1,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of ILDR1 mRNA,,,PMID:32156529,https://www.ncbi.nlm.nih.gov/pubmed/32156529,32156529,,
244,814527,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,286676,ILDR1,https://ctdbase.org/detail.go?type=gene&acc=286676,,,286676.0,ILDR1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of ILDR1 mRNA,,,PMID:25181051|PMID:30816183|PMID:32528016,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/32528016,25181051|30816183|32528016,,
245,814528,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,393364,ILDR1A,https://ctdbase.org/detail.go?type=gene&acc=393364,,,393364.0,ildr1a,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of ILDR1A mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
246,814529,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,447904,ILDR1B,https://ctdbase.org/detail.go?type=gene&acc=447904,,,447904.0,ildr1b,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of ILDR1B mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
247,814530,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,387597,ILDR2,https://ctdbase.org/detail.go?type=gene&acc=387597,,,387597.0,ILDR2,7955.0,Danio rerio (zebrafish),Bisphenol A results in decreased methylation of ILDR2 intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
248,814531,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2065,ERBB3,https://ctdbase.org/detail.go?type=gene&acc=2065,,,2065.0,ERBB3,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of ERBB3 protein,,,PMID:19590682,https://www.ncbi.nlm.nih.gov/pubmed/19590682,19590682,,
249,814532,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,386635,ERBB3A,https://ctdbase.org/detail.go?type=gene&acc=386635,,,386635.0,erbb3a,90988.0,Pimephales promelas (fathead minnow),Bisphenol A affects the expression of ERBB3A mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
250,814533,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,544664,ERBB3B,https://ctdbase.org/detail.go?type=gene&acc=544664,,,544664.0,erbb3b,7955.0,Danio rerio (zebrafish),Bisphenol A results in increased methylation of ERBB3B intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
251,815180,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2072,ERCC4,https://ctdbase.org/detail.go?type=gene&acc=2072,,,2072.0,ERCC4,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of ERCC4 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
252,815348,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,84248,FYTTD1,https://ctdbase.org/detail.go?type=gene&acc=84248,,,84248.0,FYTTD1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of FYTTD1 mRNA,,,PMID:29097150,https://www.ncbi.nlm.nih.gov/pubmed/29097150,29097150,,
253,815349,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,31659,FZ4,https://ctdbase.org/detail.go?type=gene&acc=31659,,,31659.0,fz4,7227.0,Drosophila melanogaster (fruit fly),Bisphenol A results in decreased expression of FZ4 mRNA,,,PMID:35041872,https://www.ncbi.nlm.nih.gov/pubmed/35041872,35041872,,
254,815350,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,8321,FZD1,https://ctdbase.org/detail.go?type=gene&acc=8321,,,8321.0,FZD1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of FZD1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
255,815351,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,8321,FZD1,https://ctdbase.org/detail.go?type=gene&acc=8321,,,8321.0,FZD1,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of FZD1 mRNA,,,PMID:32156529|PMID:32370801,https://www.ncbi.nlm.nih.gov/pubmed/32156529|https://www.ncbi.nlm.nih.gov/pubmed/32370801,32156529|32370801,,
256,815352,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,8321,FZD1,https://ctdbase.org/detail.go?type=gene&acc=8321,,,8321.0,FZD1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of FZD1 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
257,815353,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,8321,FZD1,https://ctdbase.org/detail.go?type=gene&acc=8321,,,8321.0,FZD1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of FZD1 mRNA,,,PMID:12075121,https://www.ncbi.nlm.nih.gov/pubmed/12075121,12075121,,
258,815354,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,11211,FZD10,https://ctdbase.org/detail.go?type=gene&acc=11211,,,11211.0,FZD10,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of FZD10 mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
259,815355,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,11211,FZD10,https://ctdbase.org/detail.go?type=gene&acc=11211,,,11211.0,FZD10,7955.0,Danio rerio (zebrafish),Bisphenol A results in increased expression of FZD10 mRNA,,,PMID:26562050,https://www.ncbi.nlm.nih.gov/pubmed/26562050,26562050,,
260,815356,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,11211,FZD10,https://ctdbase.org/detail.go?type=gene&acc=11211,,,11211.0,FZD10,9606.0,Homo sapiens (human),Bisphenol A results in decreased methylation of FZD10 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
261,815357,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,11211,FZD10,https://ctdbase.org/detail.go?type=gene&acc=11211,,,11211.0,FZD10,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of FZD10 mRNA,,,PMID:26063408|PMID:32156529,https://www.ncbi.nlm.nih.gov/pubmed/26063408|https://www.ncbi.nlm.nih.gov/pubmed/32156529,26063408|32156529,,
262,816028,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,9761,MLEC,https://ctdbase.org/detail.go?type=gene&acc=9761,,,9761.0,MLEC,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of MLEC mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
263,816029,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,9761,MLEC,https://ctdbase.org/detail.go?type=gene&acc=9761,,,9761.0,MLEC,7955.0,Danio rerio (zebrafish),Bisphenol A results in decreased expression of MLEC mRNA,,,PMID:33243503,https://www.ncbi.nlm.nih.gov/pubmed/33243503,33243503,,
264,816030,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,9761,MLEC,https://ctdbase.org/detail.go?type=gene&acc=9761,,,9761.0,MLEC,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of MLEC mRNA,,,PMID:29275510,https://www.ncbi.nlm.nih.gov/pubmed/29275510,29275510,,
265,816031,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,9761,MLEC,https://ctdbase.org/detail.go?type=gene&acc=9761,,,9761.0,MLEC,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of MLEC protein,,,PMID:37567409,https://www.ncbi.nlm.nih.gov/pubmed/37567409,37567409,,
266,816032,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,9761,MLEC,https://ctdbase.org/detail.go?type=gene&acc=9761,,,9761.0,MLEC,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of MLEC mRNA,,,PMID:30816183|PMID:32528016|PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/32528016|https://www.ncbi.nlm.nih.gov/pubmed/34947998,30816183|32528016|34947998,,
267,816033,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,4291,MLF1,https://ctdbase.org/detail.go?type=gene&acc=4291,,,4291.0,MLF1,7955.0,Danio rerio (zebrafish),Bisphenol A results in decreased methylation of MLF1 intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
268,816034,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,4291,MLF1,https://ctdbase.org/detail.go?type=gene&acc=4291,,,4291.0,MLF1,143606.0,Gobiocypris rarus,Bisphenol A results in increased expression of MLF1 mRNA,,,PMID:26364221,https://www.ncbi.nlm.nih.gov/pubmed/26364221,26364221,,
269,816035,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,4291,MLF1,https://ctdbase.org/detail.go?type=gene&acc=4291,,,4291.0,MLF1,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of MLF1 mRNA,,,PMID:16474171,https://www.ncbi.nlm.nih.gov/pubmed/16474171,16474171,,
270,816036,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,4291,MLF1,https://ctdbase.org/detail.go?type=gene&acc=4291,,,4291.0,MLF1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of MLF1 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
271,816037,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,4291,MLF1,https://ctdbase.org/detail.go?type=gene&acc=4291,,,4291.0,MLF1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of MLF1 mRNA,,,PMID:25181051|PMID:27178563|PMID:29097150|PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/27178563|https://www.ncbi.nlm.nih.gov/pubmed/29097150|https://www.ncbi.nlm.nih.gov/pubmed/34947998,25181051|27178563|29097150|34947998,,
272,816985,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10084,PQBP1,https://ctdbase.org/detail.go?type=gene&acc=10084,,,10084.0,PQBP1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of PQBP1 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
273,816986,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,101883969,PQLC1,https://ctdbase.org/detail.go?type=gene&acc=101883969,,,101883969.0,pqlc1,7955.0,Danio rerio (zebrafish),Bisphenol A results in increased methylation of PQLC1 intron|bisphenol A results in decreased methylation of PQLC1 intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
274,816987,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,419472,PQLC2,https://ctdbase.org/detail.go?type=gene&acc=419472,,,419472.0,PQLC2,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of PQLC2 mRNA,,,PMID:36232920,https://www.ncbi.nlm.nih.gov/pubmed/36232920,36232920,,
275,816988,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,19066,PR,https://ctdbase.org/detail.go?type=gene&acc=19066,,,19066.0,pr,7227.0,Drosophila melanogaster (fruit fly),Bisphenol A results in decreased expression of PR mRNA,,,PMID:35041872,https://www.ncbi.nlm.nih.gov/pubmed/35041872,35041872,,
276,817294,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,445118,G6PC1A.1,https://ctdbase.org/detail.go?type=gene&acc=445118,,,445118.0,g6pc1a.1,7955.0,Danio rerio (zebrafish),Bisphenol A results in decreased expression of G6PC1A.1 mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
277,817295,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,563180,G6PC1A.2,https://ctdbase.org/detail.go?type=gene&acc=563180,,,563180.0,g6pc1a.2,7955.0,Danio rerio (zebrafish),Bisphenol A results in decreased expression of G6PC1A.2 mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
278,817296,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,563180,G6PC1A.2,https://ctdbase.org/detail.go?type=gene&acc=563180,,,563180.0,g6pc1a.2,7955.0,Danio rerio (zebrafish),Bisphenol A results in increased expression of G6PC1A.2 mRNA,,,PMID:30248606|PMID:32208220|PMID:32836160,https://www.ncbi.nlm.nih.gov/pubmed/30248606|https://www.ncbi.nlm.nih.gov/pubmed/32208220|https://www.ncbi.nlm.nih.gov/pubmed/32836160,30248606|32208220|32836160,,
279,817297,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,92579,G6PC3,https://ctdbase.org/detail.go?type=gene&acc=92579,,,92579.0,G6PC3,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of G6PC3 mRNA,,,PMID:20678512|PMID:29275510,https://www.ncbi.nlm.nih.gov/pubmed/20678512|https://www.ncbi.nlm.nih.gov/pubmed/29275510,20678512|29275510,,
280,817298,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,92579,G6PC3,https://ctdbase.org/detail.go?type=gene&acc=92579,,,92579.0,G6PC3,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of G6PC3 mRNA,,,PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/32528016|https://www.ncbi.nlm.nih.gov/pubmed/34947998,25181051|30816183|32528016|34947998,,
281,817299,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2539,G6PD,https://ctdbase.org/detail.go?type=gene&acc=2539,,,2539.0,G6PD,8478.0,Chrysemys picta bellii (western painted turtle),Bisphenol A results in increased expression of G6PD mRNA,,,PMID:28159858,https://www.ncbi.nlm.nih.gov/pubmed/28159858,28159858,,
282,817471,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,100170765,ERICH4,https://ctdbase.org/detail.go?type=gene&acc=100170765,,,100170765.0,ERICH4,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of ERICH4 mRNA,,,PMID:30816183|PMID:32528016,https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/32528016,30816183|32528016,,
283,817472,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,203111,ERICH5,https://ctdbase.org/detail.go?type=gene&acc=203111,,,203111.0,ERICH5,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased expression of ERICH5 mRNA,,,PMID:32156529,https://www.ncbi.nlm.nih.gov/pubmed/32156529,32156529,,
284,817473,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,203111,ERICH5,https://ctdbase.org/detail.go?type=gene&acc=203111,,,203111.0,ERICH5,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of ERICH5 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
285,817474,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,131831,ERICH6,https://ctdbase.org/detail.go?type=gene&acc=131831,,,131831.0,ERICH6,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of ERICH6 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
286,817475,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,131831,ERICH6,https://ctdbase.org/detail.go?type=gene&acc=131831,,,131831.0,ERICH6,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of ERICH6 mRNA,,,PMID:31129395,https://www.ncbi.nlm.nih.gov/pubmed/31129395,31129395,,
287,817476,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,220081,ERICH6B,https://ctdbase.org/detail.go?type=gene&acc=220081,,,220081.0,ERICH6B,9606.0,Homo sapiens (human),Bisphenol A results in increased methylation of ERICH6B gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
288,817477,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,27248,ERLEC1,https://ctdbase.org/detail.go?type=gene&acc=27248,,,27248.0,ERLEC1,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of ERLEC1 mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
289,817478,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,27248,ERLEC1,https://ctdbase.org/detail.go?type=gene&acc=27248,,,27248.0,ERLEC1,7955.0,Danio rerio (zebrafish),Bisphenol A results in increased expression of ERLEC1 mRNA,,,PMID:30248606,https://www.ncbi.nlm.nih.gov/pubmed/30248606,30248606,,
290,817479,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,27248,ERLEC1,https://ctdbase.org/detail.go?type=gene&acc=27248,,,27248.0,ERLEC1,9606.0,Homo sapiens (human),Bisphenol A affects the expression of ERLEC1 mRNA,,,PMID:30903817,https://www.ncbi.nlm.nih.gov/pubmed/30903817,30903817,,
291,817969,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,55780,ERMARD,https://ctdbase.org/detail.go?type=gene&acc=55780,,,55780.0,ERMARD,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of ERMARD mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
292,817970,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,55780,ERMARD,https://ctdbase.org/detail.go?type=gene&acc=55780,,,55780.0,ERMARD,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with tributyltin] results in decreased expression of ERMARD mRNA,,,PMID:31129395,https://www.ncbi.nlm.nih.gov/pubmed/31129395,31129395,,
293,817971,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,57471,ERMN,https://ctdbase.org/detail.go?type=gene&acc=57471,,,57471.0,ERMN,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of ERMN mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
294,818799,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,64781,CERK,https://ctdbase.org/detail.go?type=gene&acc=64781,,,64781.0,CERK,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of CERK mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
295,818800,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,375298,CERKL,https://ctdbase.org/detail.go?type=gene&acc=375298,,,375298.0,CERKL,7955.0,Danio rerio (zebrafish),Bisphenol A results in increased methylation of CERKL intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
296,818801,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10715,CERS1,https://ctdbase.org/detail.go?type=gene&acc=10715,,,10715.0,CERS1,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of CERS1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
297,818802,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10715,CERS1,https://ctdbase.org/detail.go?type=gene&acc=10715,,,10715.0,CERS1,10090.0,Mus musculus (house mouse),[bisphenol A co-treated with tretinoin] results in decreased expression of CERS1 mrna|bisphenol A affects the expression of CERS1 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
298,818982,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,327065,RTN1B,https://ctdbase.org/detail.go?type=gene&acc=327065,,,327065.0,rtn1b,7955.0,Danio rerio (zebrafish),Bisphenol A results in increased methylation of RTN1B intron|bisphenol A results in decreased methylation of RTN1B intron|bisphenol A results in increased methylation of RTN1B exon,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
299,818983,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,6253,RTN2,https://ctdbase.org/detail.go?type=gene&acc=6253,,,6253.0,RTN2,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of RTN2 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
300,818984,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,6253,RTN2,https://ctdbase.org/detail.go?type=gene&acc=6253,,,6253.0,RTN2,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of RTN2 mRNA,,,PMID:25181051|PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/32145629,25181051|32145629,,
301,819158,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,6253,RTN2,https://ctdbase.org/detail.go?type=gene&acc=6253,,,6253.0,RTN2,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of RTN2 mRNA,,,PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/34947998,34947998,,
302,819159,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10313,RTN3,https://ctdbase.org/detail.go?type=gene&acc=10313,,,10313.0,RTN3,9606.0,Homo sapiens (human),Bisphenol A affects the expression of RTN3 mRNA,,,PMID:30903817,https://www.ncbi.nlm.nih.gov/pubmed/30903817,30903817,,
303,819160,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10313,RTN3,https://ctdbase.org/detail.go?type=gene&acc=10313,,,10313.0,RTN3,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of RTN3 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
304,819161,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10313,RTN3,https://ctdbase.org/detail.go?type=gene&acc=10313,,,10313.0,RTN3,9606.0,Homo sapiens (human),Bisphenol A results in decreased expression of RTN3 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
305,819162,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10313,RTN3,https://ctdbase.org/detail.go?type=gene&acc=10313,,,10313.0,RTN3,9606.0,Homo sapiens (human),"[[ginger extract results in increased abundance of oils, volatile] which co-treated with bisphenol A] affects the expression of RTN3 protein",,,PMID:33376534,https://www.ncbi.nlm.nih.gov/pubmed/33376534,33376534,,
306,819163,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10313,RTN3,https://ctdbase.org/detail.go?type=gene&acc=10313,,,10313.0,RTN3,10090.0,Mus musculus (house mouse),Bisphenol A affects the expression of RTN3 mRNA,,,PMID:26063408,https://www.ncbi.nlm.nih.gov/pubmed/26063408,26063408,,
307,819164,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10313,RTN3,https://ctdbase.org/detail.go?type=gene&acc=10313,,,10313.0,RTN3,10090.0,Mus musculus (house mouse),Bisphenol A affects the splicing of RTN3 mRNA,,,PMID:37894381,https://www.ncbi.nlm.nih.gov/pubmed/37894381,37894381,,
308,819165,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10313,RTN3,https://ctdbase.org/detail.go?type=gene&acc=10313,,,10313.0,RTN3,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of RTN3 mRNA,,,PMID:33221593,https://www.ncbi.nlm.nih.gov/pubmed/33221593,33221593,,
309,819166,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10313,RTN3,https://ctdbase.org/detail.go?type=gene&acc=10313,,,10313.0,RTN3,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of RTN3 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
310,819167,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10313,RTN3,https://ctdbase.org/detail.go?type=gene&acc=10313,,,10313.0,RTN3,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of RTN3 mRNA,,,PMID:25181051|PMID:30816183,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/30816183,25181051|30816183,,
311,819632,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,244595,CES1A,https://ctdbase.org/detail.go?type=gene&acc=244595,,,244595.0,Ces1a,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of CES1A mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
312,819633,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,244595,CES1A,https://ctdbase.org/detail.go?type=gene&acc=244595,,,244595.0,Ces1a,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of CES1A mRNA,,,PMID:30816183|PMID:32528016,https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/32528016,30816183|32528016,,
313,819634,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,382044,CES1B,https://ctdbase.org/detail.go?type=gene&acc=382044,,,382044.0,Ces1b,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of CES1B mRNA,,,PMID:33221593,https://www.ncbi.nlm.nih.gov/pubmed/33221593,33221593,,
314,819635,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,13884,CES1C,https://ctdbase.org/detail.go?type=gene&acc=13884,,,13884.0,Ces1c,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of CES1C mRNA,,,PMID:30245210|PMID:33221593,https://www.ncbi.nlm.nih.gov/pubmed/30245210|https://www.ncbi.nlm.nih.gov/pubmed/33221593,30245210|33221593,,
315,819636,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,13884,CES1C,https://ctdbase.org/detail.go?type=gene&acc=13884,,,13884.0,Ces1c,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of CES1C mRNA,,,PMID:25181051|PMID:30903817,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/30903817,25181051|30903817,,
316,819970,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,51637,RTRAF,https://ctdbase.org/detail.go?type=gene&acc=51637,,,51637.0,RTRAF,9606.0,Homo sapiens (human),Bisphenol A results in decreased expression of RTRAF protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
317,819971,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,51637,RTRAF,https://ctdbase.org/detail.go?type=gene&acc=51637,,,51637.0,RTRAF,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased expression of RTRAF mRNA,,,PMID:33221593,https://www.ncbi.nlm.nih.gov/pubmed/33221593,33221593,,
318,819972,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,51637,RTRAF,https://ctdbase.org/detail.go?type=gene&acc=51637,,,51637.0,RTRAF,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of RTRAF mRNA,,,PMID:25181051|PMID:30816183|PMID:32528016,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/32528016,25181051|30816183|32528016,,
319,819973,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,25914,RTTN,https://ctdbase.org/detail.go?type=gene&acc=25914,,,25914.0,RTTN,7955.0,Danio rerio (zebrafish),Bisphenol A results in decreased methylation of RTTN exon|bisphenol A results in decreased methylation of RTTN intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
320,819974,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,25914,RTTN,https://ctdbase.org/detail.go?type=gene&acc=25914,,,25914.0,RTTN,9606.0,Homo sapiens (human),Bisphenol A results in decreased methylation of RTTN gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
321,819975,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,25914,RTTN,https://ctdbase.org/detail.go?type=gene&acc=25914,,,25914.0,RTTN,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of RTTN mRNA,,,PMID:25181051|PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/34947998,25181051|34947998,,
322,819976,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,25914,RTTN,https://ctdbase.org/detail.go?type=gene&acc=25914,,,25914.0,RTTN,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of RTTN mRNA,,,PMID:33296240,https://www.ncbi.nlm.nih.gov/pubmed/33296240,33296240,,
323,820147,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,80183,RUBCNL,https://ctdbase.org/detail.go?type=gene&acc=80183,,,80183.0,RUBCNL,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of RUBCNL mRNA,,,PMID:36828454,https://www.ncbi.nlm.nih.gov/pubmed/36828454,36828454,,
324,820148,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,80183,RUBCNL,https://ctdbase.org/detail.go?type=gene&acc=80183,,,80183.0,RUBCNL,9606.0,Homo sapiens (human),Bisphenol A results in increased methylation of RUBCNL gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
325,820149,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,80183,RUBCNL,https://ctdbase.org/detail.go?type=gene&acc=80183,,,80183.0,RUBCNL,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of RUBCNL mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
326,820150,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,80230,RUFY1,https://ctdbase.org/detail.go?type=gene&acc=80230,,,80230.0,RUFY1,7955.0,Danio rerio (zebrafish),Bisphenol A results in increased methylation of RUFY1 intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
327,820151,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,80230,RUFY1,https://ctdbase.org/detail.go?type=gene&acc=80230,,,80230.0,RUFY1,9606.0,Homo sapiens (human),Bisphenol A results in decreased expression of RUFY1 mrna|bisphenol A results in increased methylation of RUFY1 gene,,,PMID:22576693,https://www.ncbi.nlm.nih.gov/pubmed/22576693,22576693,,
328,820152,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,80230,RUFY1,https://ctdbase.org/detail.go?type=gene&acc=80230,,,80230.0,RUFY1,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased expression of RUFY1 mRNA,,,PMID:33221593,https://www.ncbi.nlm.nih.gov/pubmed/33221593,33221593,,
329,820153,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,80230,RUFY1,https://ctdbase.org/detail.go?type=gene&acc=80230,,,80230.0,RUFY1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of RUFY1 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
330,820154,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,80230,RUFY1,https://ctdbase.org/detail.go?type=gene&acc=80230,,,80230.0,RUFY1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of RUFY1 gene|bisphenol A results in decreased methylation of RUFY1 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
331,820362,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10549,PRDX4,https://ctdbase.org/detail.go?type=gene&acc=10549,,,10549.0,PRDX4,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased methylation of PRDX4 promoter,,,PMID:27312807,https://www.ncbi.nlm.nih.gov/pubmed/27312807,27312807,,
332,820363,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10549,PRDX4,https://ctdbase.org/detail.go?type=gene&acc=10549,,,10549.0,PRDX4,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of PRDX4 mRNA,,,PMID:32156529|PMID:33221593,https://www.ncbi.nlm.nih.gov/pubmed/32156529|https://www.ncbi.nlm.nih.gov/pubmed/33221593,32156529|33221593,,
333,820364,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10549,PRDX4,https://ctdbase.org/detail.go?type=gene&acc=10549,,,10549.0,PRDX4,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of PRDX4 mRNA,,,PMID:30816183|PMID:32528016,https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/32528016,30816183|32528016,,
334,820365,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10549,PRDX4,https://ctdbase.org/detail.go?type=gene&acc=10549,,,10549.0,PRDX4,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of PRDX4 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
335,820366,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,25824,PRDX5,https://ctdbase.org/detail.go?type=gene&acc=25824,,,25824.0,PRDX5,9606.0,Homo sapiens (human),Bisphenol A results in decreased expression of PRDX5 mRNA,,,PMID:33670352,https://www.ncbi.nlm.nih.gov/pubmed/33670352,33670352,,
336,820367,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,25824,PRDX5,https://ctdbase.org/detail.go?type=gene&acc=25824,,,25824.0,PRDX5,9606.0,Homo sapiens (human),Bisphenol A results in decreased expression of PRDX5 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
337,820368,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,25824,PRDX5,https://ctdbase.org/detail.go?type=gene&acc=25824,,,25824.0,PRDX5,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of PRDX5 protein,,,PMID:34186270|PMID:37567409,https://www.ncbi.nlm.nih.gov/pubmed/34186270|https://www.ncbi.nlm.nih.gov/pubmed/37567409,34186270|37567409,,
338,820369,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,25824,PRDX5,https://ctdbase.org/detail.go?type=gene&acc=25824,,,25824.0,PRDX5,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased expression of PRDX5 protein,,,PMID:35999755,https://www.ncbi.nlm.nih.gov/pubmed/35999755,35999755,,
339,820370,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,25824,PRDX5,https://ctdbase.org/detail.go?type=gene&acc=25824,,,25824.0,PRDX5,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of PRDX5 mRNA,,,PMID:32156529,https://www.ncbi.nlm.nih.gov/pubmed/32156529,32156529,,
340,820476,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,501232,CESL1,https://ctdbase.org/detail.go?type=gene&acc=501232,,,501232.0,Cesl1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of CESL1 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
341,806248,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,4882,NPR2,https://ctdbase.org/detail.go?type=gene&acc=4882,,,4882.0,NPR2,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone affects the methylation of NPR2 gene,,,PMID:31683443,https://www.ncbi.nlm.nih.gov/pubmed/31683443,31683443,,
342,806249,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,4882,NPR2,https://ctdbase.org/detail.go?type=gene&acc=4882,,,4882.0,NPR2,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of NPR2 exon,,,PMID:33297965,https://www.ncbi.nlm.nih.gov/pubmed/33297965,33297965,,
343,806250,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,4882,NPR2,https://ctdbase.org/detail.go?type=gene&acc=4882,,,4882.0,NPR2,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of NPR2 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
344,806251,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,4883,NPR3,https://ctdbase.org/detail.go?type=gene&acc=4883,,,4883.0,NPR3,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in increased expression of NPR3 mRNA,,,PMID:25912373,https://www.ncbi.nlm.nih.gov/pubmed/25912373,25912373,,
345,808166,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,9775,EIF4A3,https://ctdbase.org/detail.go?type=gene&acc=9775,,,9775.0,EIF4A3,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of EIF4A3 exon,,,PMID:33297965,https://www.ncbi.nlm.nih.gov/pubmed/33297965,33297965,,
346,808167,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,9775,EIF4A3,https://ctdbase.org/detail.go?type=gene&acc=9775,,,9775.0,EIF4A3,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of EIF4A3 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
347,808168,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,1975,EIF4B,https://ctdbase.org/detail.go?type=gene&acc=1975,,,1975.0,EIF4B,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of EIF4B exon,,,PMID:33297965,https://www.ncbi.nlm.nih.gov/pubmed/33297965,33297965,,
348,808169,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,1977,EIF4E,https://ctdbase.org/detail.go?type=gene&acc=1977,,,1977.0,EIF4E,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of EIF4E gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
349,808170,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,253314,EIF4E1B,https://ctdbase.org/detail.go?type=gene&acc=253314,,,253314.0,EIF4E1B,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in decreased expression of EIF4E1B mRNA,,,PMID:33297965,https://www.ncbi.nlm.nih.gov/pubmed/33297965,33297965,,
350,808663,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,197370,NSMCE1,https://ctdbase.org/detail.go?type=gene&acc=197370,,,197370.0,NSMCE1,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of NSMCE1 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
351,808664,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,286053,NSMCE2,https://ctdbase.org/detail.go?type=gene&acc=286053,,,286053.0,NSMCE2,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of NSMCE2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
352,808665,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,26012,NSMF,https://ctdbase.org/detail.go?type=gene&acc=26012,,,26012.0,NSMF,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone affects the methylation of NSMF gene,,,PMID:31683443,https://www.ncbi.nlm.nih.gov/pubmed/31683443,31683443,,
353,808666,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,177878,NSPH-3.2,https://ctdbase.org/detail.go?type=gene&acc=177878,,,177878.0,nsph-3.2,6239.0,Caenorhabditis elegans,Bis(4-hydroxyphenyl)sulfone results in decreased expression of NSPH-3.2 mRNA,,,PMID:27472198,https://www.ncbi.nlm.nih.gov/pubmed/27472198,27472198,,
354,808667,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,54888,NSUN2,https://ctdbase.org/detail.go?type=gene&acc=54888,,,54888.0,NSUN2,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone affects the expression of NSUN2 protein,,,PMID:31945527,https://www.ncbi.nlm.nih.gov/pubmed/31945527,31945527,,
355,808867,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,22978,NT5C2,https://ctdbase.org/detail.go?type=gene&acc=22978,,,22978.0,NT5C2,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of NT5C2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
356,808868,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,22978,NT5C2,https://ctdbase.org/detail.go?type=gene&acc=22978,,,22978.0,NT5C2,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of NT5C2 exon,,,PMID:33297965,https://www.ncbi.nlm.nih.gov/pubmed/33297965,33297965,,
357,808869,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,4907,NT5E,https://ctdbase.org/detail.go?type=gene&acc=4907,,,4907.0,NT5E,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in increased expression of NT5E mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
358,809332,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,442075,EMC3-AS1,https://ctdbase.org/detail.go?type=gene&acc=442075,,,442075.0,EMC3-AS1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of EMC3-AS1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
359,809333,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,51234,EMC4,https://ctdbase.org/detail.go?type=gene&acc=51234,,,51234.0,EMC4,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in increased expression of EMC4 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
360,809334,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,10328,EMC8,https://ctdbase.org/detail.go?type=gene&acc=10328,,,10328.0,EMC8,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone affects the methylation of EMC8 gene,,,PMID:31683443,https://www.ncbi.nlm.nih.gov/pubmed/31683443,31683443,,
361,809335,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,51016,EMC9,https://ctdbase.org/detail.go?type=gene&acc=51016,,,51016.0,EMC9,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of EMC9 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
362,809336,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,51705,EMCN,https://ctdbase.org/detail.go?type=gene&acc=51705,,,51705.0,EMCN,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in increased expression of EMCN mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
363,809337,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,10436,EMG1,https://ctdbase.org/detail.go?type=gene&acc=10436,,,10436.0,EMG1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of EMG1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
364,809512,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,80224,NUBPL,https://ctdbase.org/detail.go?type=gene&acc=80224,,,80224.0,NUBPL,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone affects the expression of NUBPL protein,,,PMID:31945527,https://www.ncbi.nlm.nih.gov/pubmed/31945527,31945527,,
365,809513,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,80224,NUBPL,https://ctdbase.org/detail.go?type=gene&acc=80224,,,80224.0,NUBPL,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of NUBPL gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
366,809514,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,64710,NUCKS1,https://ctdbase.org/detail.go?type=gene&acc=64710,,,64710.0,NUCKS1,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased expression of NUCKS1 mRNA,,,PMID:25912373,https://www.ncbi.nlm.nih.gov/pubmed/25912373,25912373,,
367,809515,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,23386,NUDCD3,https://ctdbase.org/detail.go?type=gene&acc=23386,,,23386.0,NUDCD3,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in decreased expression of NUDCD3 mRNA,,,PMID:33297965,https://www.ncbi.nlm.nih.gov/pubmed/33297965,33297965,,
368,809516,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,4521,NUDT1,https://ctdbase.org/detail.go?type=gene&acc=4521,,,4521.0,NUDT1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of NUDT1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
369,809517,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,256281,NUDT14,https://ctdbase.org/detail.go?type=gene&acc=256281,,,256281.0,NUDT14,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of NUDT14 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
370,809518,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,390916,NUDT19,https://ctdbase.org/detail.go?type=gene&acc=390916,,,390916.0,NUDT19,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in increased expression of NUDT19 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
371,809680,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,2018,EMX2,https://ctdbase.org/detail.go?type=gene&acc=2018,,,2018.0,EMX2,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in decreased expression of EMX2 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
372,809681,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,196047,EMX2OS,https://ctdbase.org/detail.go?type=gene&acc=196047,,,196047.0,EMX2OS,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of EMX2OS gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
373,809682,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,30536,EMX3,https://ctdbase.org/detail.go?type=gene&acc=30536,,,30536.0,emx3,7955.0,Danio rerio (zebrafish),Bis(4-hydroxyphenyl)sulfone results in decreased expression of EMX3 mRNA,,,PMID:30265984,https://www.ncbi.nlm.nih.gov/pubmed/30265984,30265984,,
374,812646,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9940.0,Ovis aries (sheep),Bis(4-hydroxyphenyl)sulfone results in increased expression of ESR1 mRNA,,,PMID:28938450|PMID:32092037,https://www.ncbi.nlm.nih.gov/pubmed/28938450|https://www.ncbi.nlm.nih.gov/pubmed/32092037,28938450|32092037,,
375,812647,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10116.0,Rattus norvegicus (Norway rat),"[1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole results in decreased activity of ESR1 protein] which results in increased susceptibility to bis(4-hydroxyphenyl)sulfone",,,PMID:25723814,https://www.ncbi.nlm.nih.gov/pubmed/25723814,25723814,,
376,812648,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9823.0,Sus scrofa (pig),Bis(4-hydroxyphenyl)sulfone results in decreased expression of ESR1 mrna|bis(4-hydroxyphenyl)sulfone results in increased expression of ESR1 protein,,,PMID:28352085,https://www.ncbi.nlm.nih.gov/pubmed/28352085,28352085,,
377,812649,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,398734,ESR1.L,https://ctdbase.org/detail.go?type=gene&acc=398734,,,398734.0,esr1.L,8355.0,Xenopus laevis (African clawed frog),Bis(4-hydroxyphenyl)sulfone binds to and results in increased activity of ESR1.L protein,,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
378,812650,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone binds to and results in increased activity of ESR2 protein,,,PMID:27633901|PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/27633901|https://www.ncbi.nlm.nih.gov/pubmed/33049310,27633901|33049310,,
379,812651,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased expression of ESR2 protein,,,PMID:34831106,https://www.ncbi.nlm.nih.gov/pubmed/34831106,34831106,,
380,812652,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in increased activity of [ESR1 protein co-treated with ESR2 protein],,,PMID:22507746,https://www.ncbi.nlm.nih.gov/pubmed/22507746,22507746,,
381,812653,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in increased activity of ESR2 protein,,,PMID:23714657|PMID:30582956,https://www.ncbi.nlm.nih.gov/pubmed/23714657|https://www.ncbi.nlm.nih.gov/pubmed/30582956,23714657|30582956,,
382,812654,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in increased expression of ESR2 mRNA,,,PMID:37234927,https://www.ncbi.nlm.nih.gov/pubmed/37234927,37234927,,
383,812655,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,26696,OR2T1,https://ctdbase.org/detail.go?type=gene&acc=26696,,,26696.0,OR2T1,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of OR2T1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
384,812979,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,317733,ESR2B,https://ctdbase.org/detail.go?type=gene&acc=317733,,,317733.0,esr2b,7955.0,Danio rerio (zebrafish),Bis(4-hydroxyphenyl)sulfone binds to and results in increased activity of ESR2B protein,,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
385,812980,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,317733,ESR2B,https://ctdbase.org/detail.go?type=gene&acc=317733,,,317733.0,esr2b,7955.0,Danio rerio (zebrafish),Bis(4-hydroxyphenyl)sulfone binds to ESR2B protein,,,PMID:29397701,https://www.ncbi.nlm.nih.gov/pubmed/29397701,29397701,,
386,812981,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,317733,ESR2B,https://ctdbase.org/detail.go?type=gene&acc=317733,,,317733.0,esr2b,7955.0,Danio rerio (zebrafish),Bis(4-hydroxyphenyl)sulfone results in decreased expression of ESR2B mRNA,,,PMID:34299453|PMID:34808222,https://www.ncbi.nlm.nih.gov/pubmed/34299453|https://www.ncbi.nlm.nih.gov/pubmed/34808222,34299453|34808222,,
387,812982,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,317733,ESR2B,https://ctdbase.org/detail.go?type=gene&acc=317733,,,317733.0,esr2b,7955.0,Danio rerio (zebrafish),Bis(4-hydroxyphenyl)sulfone results in increased expression of ESR2B mRNA,,,PMID:28407500|PMID:30893755|PMID:32045791|PMID:35595038,https://www.ncbi.nlm.nih.gov/pubmed/28407500|https://www.ncbi.nlm.nih.gov/pubmed/30893755|https://www.ncbi.nlm.nih.gov/pubmed/32045791|https://www.ncbi.nlm.nih.gov/pubmed/35595038,28407500|30893755|32045791|35595038,,
388,813312,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,23762,OSBP2,https://ctdbase.org/detail.go?type=gene&acc=23762,,,23762.0,OSBP2,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of OSBP2 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
389,813313,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,114885,OSBPL11,https://ctdbase.org/detail.go?type=gene&acc=114885,,,114885.0,OSBPL11,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone affects the methylation of OSBPL11 gene,,,PMID:31683443,https://www.ncbi.nlm.nih.gov/pubmed/31683443,31683443,,
390,813314,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,114879,OSBPL5,https://ctdbase.org/detail.go?type=gene&acc=114879,,,114879.0,OSBPL5,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of OSBPL5 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
391,813315,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,114880,OSBPL6,https://ctdbase.org/detail.go?type=gene&acc=114880,,,114880.0,OSBPL6,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of OSBPL6 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
392,813316,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,114882,OSBPL8,https://ctdbase.org/detail.go?type=gene&acc=114882,,,114882.0,OSBPL8,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of OSBPL8 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
393,813317,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,114882,OSBPL8,https://ctdbase.org/detail.go?type=gene&acc=114882,,,114882.0,OSBPL8,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of OSBPL8 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
394,813318,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,114883,OSBPL9,https://ctdbase.org/detail.go?type=gene&acc=114883,,,114883.0,OSBPL9,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in increased expression of OSBPL9 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
395,813319,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,127700,OSCP1,https://ctdbase.org/detail.go?type=gene&acc=127700,,,127700.0,OSCP1,9606.0,Homo sapiens (human),[bis(4-hydroxyphenyl)sulfone co-treated with fulvestrant] results in decreased methylation of OSCP1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
396,813320,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,55214,P3H2,https://ctdbase.org/detail.go?type=gene&acc=55214,,,55214.0,P3H2,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone affects the expression of P3H2 protein,,,PMID:31945527,https://www.ncbi.nlm.nih.gov/pubmed/31945527,31945527,,
397,814850,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,8106,PABPN1,https://ctdbase.org/detail.go?type=gene&acc=8106,,,8106.0,PABPN1,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of PABPN1 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
398,814851,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,135138,PACRG,https://ctdbase.org/detail.go?type=gene&acc=135138,,,135138.0,PACRG,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone affects the methylation of PACRG gene,,,PMID:31683443,https://www.ncbi.nlm.nih.gov/pubmed/31683443,31683443,,
399,814852,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,29993,PACSIN1,https://ctdbase.org/detail.go?type=gene&acc=29993,,,29993.0,PACSIN1,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in increased methylation of PACSIN1 gene|[bis(4-hydroxyphenyl)sulfone co-treated with fulvestrant] results in decreased methylation of PACSIN1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
400,815525,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,54873,PALMD,https://ctdbase.org/detail.go?type=gene&acc=54873,,,54873.0,PALMD,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in increased expression of PALMD protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
401,815526,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,64398,PALS1,https://ctdbase.org/detail.go?type=gene&acc=64398,,,64398.0,PALS1,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of PALS1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
402,816672,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,5079,PAX5,https://ctdbase.org/detail.go?type=gene&acc=5079,,,5079.0,PAX5,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of PAX5 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
403,816673,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,5079,PAX5,https://ctdbase.org/detail.go?type=gene&acc=5079,,,5079.0,PAX5,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in decreased expression of PAX5 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
404,816674,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,5080,PAX6,https://ctdbase.org/detail.go?type=gene&acc=5080,,,5080.0,PAX6,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of PAX6 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
405,816675,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,5080,PAX6,https://ctdbase.org/detail.go?type=gene&acc=5080,,,5080.0,PAX6,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone affects the methylation of PAX6 gene,,,PMID:31683443,https://www.ncbi.nlm.nih.gov/pubmed/31683443,31683443,,
406,816676,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,5080,PAX6,https://ctdbase.org/detail.go?type=gene&acc=5080,,,5080.0,PAX6,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in decreased expression of PAX6 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
407,816677,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,5080,PAX6,https://ctdbase.org/detail.go?type=gene&acc=5080,,,5080.0,PAX6,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in increased methylation of PAX6 promoter,,,PMID:33297965,https://www.ncbi.nlm.nih.gov/pubmed/33297965,33297965,,
408,816678,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,5081,PAX7,https://ctdbase.org/detail.go?type=gene&acc=5081,,,5081.0,PAX7,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of PAX7 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
409,817817,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,56142,PCDHA6,https://ctdbase.org/detail.go?type=gene&acc=56142,,,56142.0,PCDHA6,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in decreased expression of PCDHA6 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
410,817818,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,56141,PCDHA7,https://ctdbase.org/detail.go?type=gene&acc=56141,,,56141.0,PCDHA7,10090.0,Mus musculus (house mouse),[bis(4-hydroxyphenyl)sulfone co-treated with tretinoin] results in decreased expression of PCDHA7 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
411,818132,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,130888,FBXO36,https://ctdbase.org/detail.go?type=gene&acc=130888,,,130888.0,FBXO36,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of FBXO36 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
412,818133,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,51725,FBXO40,https://ctdbase.org/detail.go?type=gene&acc=51725,,,51725.0,FBXO40,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone affects the methylation of FBXO40 gene,,,PMID:31683443,https://www.ncbi.nlm.nih.gov/pubmed/31683443,31683443,,
413,818134,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,150726,FBXO41,https://ctdbase.org/detail.go?type=gene&acc=150726,,,150726.0,FBXO41,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone affects the methylation of FBXO41 gene,,,PMID:31683443,https://www.ncbi.nlm.nih.gov/pubmed/31683443,31683443,,
414,819794,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,201626,PDE12,https://ctdbase.org/detail.go?type=gene&acc=201626,,,201626.0,PDE12,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in increased expression of PDE12 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
415,819795,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,5136,PDE1A,https://ctdbase.org/detail.go?type=gene&acc=5136,,,5136.0,PDE1A,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in increased expression of PDE1A mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
416,819796,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,5153,PDE1B,https://ctdbase.org/detail.go?type=gene&acc=5153,,,5153.0,PDE1B,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in increased expression of PDE1B mRNA,,,PMID:27685785,https://www.ncbi.nlm.nih.gov/pubmed/27685785,27685785,,
417,819797,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,5153,PDE1B,https://ctdbase.org/detail.go?type=gene&acc=5153,,,5153.0,PDE1B,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in decreased expression of PDE1B mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
418,819798,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,5138,PDE2A,https://ctdbase.org/detail.go?type=gene&acc=5138,,,5138.0,PDE2A,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased expression of PDE2A mRNA,,,PMID:27685785,https://www.ncbi.nlm.nih.gov/pubmed/27685785,27685785,,
419,819799,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,5138,PDE2A,https://ctdbase.org/detail.go?type=gene&acc=5138,,,5138.0,PDE2A,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in decreased expression of PDE2A mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
420,819800,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,5139,PDE3A,https://ctdbase.org/detail.go?type=gene&acc=5139,,,5139.0,PDE3A,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in increased expression of PDE3A mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
421,819801,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,5140,PDE3B,https://ctdbase.org/detail.go?type=gene&acc=5140,,,5140.0,PDE3B,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in increased expression of PDE3B protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
422,806252,6741,Drug Gene Interaction database (DGIdb),Methylprednisolone,,METHYLPREDNISOLONE,https://www.dgidb.org/drugs/rxcui:6902,,IL2RA,https://www.dgidb.org/genes/hgnc:6008,,,3559.0,IL2RA,9606.0,Homo sapiens (human),,,,,,,,
423,806253,6741,Drug Gene Interaction database (DGIdb),Methylprednisolone,,METHYLPREDNISOLONE,https://www.dgidb.org/drugs/rxcui:6902,,CXCL10,https://www.dgidb.org/genes/hgnc:10637,,,3627.0,CXCL10,9606.0,Homo sapiens (human),,,,,,,,
424,806254,6741,Drug Gene Interaction database (DGIdb),Methylprednisolone,,METHYLPREDNISOLONE,https://www.dgidb.org/drugs/rxcui:6902,,CD80,https://www.dgidb.org/genes/hgnc:1700,,,941.0,CD80,9606.0,Homo sapiens (human),,,,,,,,
425,806255,6741,Drug Gene Interaction database (DGIdb),Methylprednisolone,,METHYLPREDNISOLONE,https://www.dgidb.org/drugs/rxcui:6902,,ABCB1,https://www.dgidb.org/genes/hgnc:40,,,5243.0,ABCB1,9606.0,Homo sapiens (human),,,,,,,,
426,806256,6763,Drug Gene Interaction database (DGIdb),"9,10-Phenanthrenequinone",,"9,10-PHENANTHRENEQUINONE",https://www.dgidb.org/drugs/chembl:CHEMBL51931,,USP1,https://www.dgidb.org/genes/hgnc:12607,,,7398.0,USP1,9606.0,Homo sapiens (human),,,,,,,,
427,806257,6763,Drug Gene Interaction database (DGIdb),"9,10-Phenanthrenequinone",,"9,10-PHENANTHRENEQUINONE",https://www.dgidb.org/drugs/chembl:CHEMBL51931,,POLH,https://www.dgidb.org/genes/hgnc:9181,,,5429.0,POLH,9606.0,Homo sapiens (human),,,,,,,,
428,806258,6763,Drug Gene Interaction database (DGIdb),"9,10-Phenanthrenequinone",,"9,10-PHENANTHRENEQUINONE",https://www.dgidb.org/drugs/chembl:CHEMBL51931,,GALK1,https://www.dgidb.org/genes/hgnc:4118,,,2584.0,GALK1,9606.0,Homo sapiens (human),,,,,,,,
429,807161,6786,Comparative Toxicogenomics Database (CTD),Dihexyl phthalate,C027387,di-n-hexyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C027387,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606.0,Homo sapiens (human),Di-n-hexyl phthalate results in increased expression of CASP8 mRNA,,,PMID:33043605,https://www.ncbi.nlm.nih.gov/pubmed/33043605,33043605,,
430,807162,6786,Comparative Toxicogenomics Database (CTD),Dihexyl phthalate,C027387,di-n-hexyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C027387,1375,CPT1B,https://ctdbase.org/detail.go?type=gene&acc=1375,,,1375.0,CPT1B,9606.0,Homo sapiens (human),Di-n-hexyl phthalate results in decreased expression of CPT1B mRNA,,,PMID:33043605,https://www.ncbi.nlm.nih.gov/pubmed/33043605,33043605,,
431,807163,6786,Comparative Toxicogenomics Database (CTD),Dihexyl phthalate,C027387,di-n-hexyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C027387,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10116.0,Rattus norvegicus (Norway rat),Di-n-hexyl phthalate results in decreased expression of CYP11A1 mRNA,,,PMID:22112501|PMID:23754470|PMID:26934186|PMID:33983380,https://www.ncbi.nlm.nih.gov/pubmed/22112501|https://www.ncbi.nlm.nih.gov/pubmed/23754470|https://www.ncbi.nlm.nih.gov/pubmed/26934186|https://www.ncbi.nlm.nih.gov/pubmed/33983380,22112501|23754470|26934186|33983380,,
432,807164,6786,Comparative Toxicogenomics Database (CTD),Dihexyl phthalate,C027387,di-n-hexyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C027387,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10116.0,Rattus norvegicus (Norway rat),Di-n-hexyl phthalate results in decreased expression of CYP11A1 protein,,,PMID:26934186,https://www.ncbi.nlm.nih.gov/pubmed/26934186,26934186,,
433,807165,6786,Comparative Toxicogenomics Database (CTD),Dihexyl phthalate,C027387,di-n-hexyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C027387,1584,CYP11B1,https://ctdbase.org/detail.go?type=gene&acc=1584,,,1584.0,CYP11B1,10116.0,Rattus norvegicus (Norway rat),Di-n-hexyl phthalate results in decreased expression of CYP11B1 mRNA,,,PMID:22112501|PMID:33983380,https://www.ncbi.nlm.nih.gov/pubmed/22112501|https://www.ncbi.nlm.nih.gov/pubmed/33983380,22112501|33983380,,
434,808334,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,10286,BCAS2,https://ctdbase.org/detail.go?type=gene&acc=10286,,,10286.0,BCAS2,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of BCAS2 protein,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
435,810170,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,29105,CFAP20,https://ctdbase.org/detail.go?type=gene&acc=29105,,,29105.0,CFAP20,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of CFAP20 protein,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
436,810171,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,118491,CFAP70,https://ctdbase.org/detail.go?type=gene&acc=118491,,,118491.0,CFAP70,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of CFAP70 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
437,810172,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,629,CFB,https://ctdbase.org/detail.go?type=gene&acc=629,,,629.0,CFB,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of CFB mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
438,810173,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,3075,CFH,https://ctdbase.org/detail.go?type=gene&acc=3075,,,3075.0,CFH,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of CFH mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
439,810174,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,118487,CHCHD1,https://ctdbase.org/detail.go?type=gene&acc=118487,,,118487.0,CHCHD1,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of CHCHD1 protein,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
440,810175,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,400916,CHCHD10,https://ctdbase.org/detail.go?type=gene&acc=400916,,,400916.0,CHCHD10,10090.0,Mus musculus (house mouse),Diquat results in increased expression of CHCHD10 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
441,810176,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,51142,CHCHD2,https://ctdbase.org/detail.go?type=gene&acc=51142,,,51142.0,CHCHD2,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of CHCHD2 protein,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
442,810177,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,12655,CHIL3,https://ctdbase.org/detail.go?type=gene&acc=12655,,,12655.0,Chil3,10090.0,Mus musculus (house mouse),Diquat results in increased expression of CHIL3 protein,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
443,810178,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,11261,CHP1,https://ctdbase.org/detail.go?type=gene&acc=11261,,,11261.0,CHP1,10090.0,Mus musculus (house mouse),Diquat results in increased expression of CHP1 protein,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
444,810179,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,25884,CHRDL2,https://ctdbase.org/detail.go?type=gene&acc=25884,,,25884.0,CHRDL2,10090.0,Mus musculus (house mouse),Diquat results in increased expression of CHRDL2 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
445,810495,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,23562,CLDN14,https://ctdbase.org/detail.go?type=gene&acc=23562,,,23562.0,CLDN14,10090.0,Mus musculus (house mouse),Diquat results in increased expression of CLDN14 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
446,810496,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,51208,CLDN18,https://ctdbase.org/detail.go?type=gene&acc=51208,,,51208.0,CLDN18,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of CLDN18 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
447,810497,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,1365,CLDN3,https://ctdbase.org/detail.go?type=gene&acc=1365,,,1365.0,CLDN3,9823.0,Sus scrofa (pig),Diquat results in decreased expression of CLDN3 protein|amino acids inhibits the reaction [diquat results in decreased expression of CLDN3 protein],,,PMID:26338884,https://www.ncbi.nlm.nih.gov/pubmed/26338884,26338884,,
448,811796,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,56448,CYP2D22,https://ctdbase.org/detail.go?type=gene&acc=56448,,,56448.0,Cyp2d22,10090.0,Mus musculus (house mouse),Diquat results in increased expression of CYP2D22 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
449,811797,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,13105,CYP2D9,https://ctdbase.org/detail.go?type=gene&acc=13105,,,13105.0,Cyp2d9,10090.0,Mus musculus (house mouse),Diquat results in increased expression of CYP2D9 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
450,811798,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,13107,CYP2F2,https://ctdbase.org/detail.go?type=gene&acc=13107,,,13107.0,Cyp2f2,10090.0,Mus musculus (house mouse),Diquat results in increased expression of CYP2F2 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
451,811799,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,230459,CYP2J13,https://ctdbase.org/detail.go?type=gene&acc=230459,,,230459.0,Cyp2j13,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of CYP2J13 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
452,811800,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,266682,CYP3A2,https://ctdbase.org/detail.go?type=gene&acc=266682,,,266682.0,Cyp3a2,10116.0,Rattus norvegicus (Norway rat),Diquat results in decreased expression of CYP3A2 mRNA,,,PMID:7676460,https://www.ncbi.nlm.nih.gov/pubmed/7676460,7676460,,
453,811801,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,50549,CYP4A1,https://ctdbase.org/detail.go?type=gene&acc=50549,,,50549.0,Cyp4a1,10116.0,Rattus norvegicus (Norway rat),Diquat results in increased expression of CYP4A1 mRNA,,,PMID:7676460,https://www.ncbi.nlm.nih.gov/pubmed/7676460,7676460,,
454,811802,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,13117,CYP4A10,https://ctdbase.org/detail.go?type=gene&acc=13117,,,13117.0,Cyp4a10,10090.0,Mus musculus (house mouse),Diquat results in increased expression of CYP4A10 mrna|diquat results in increased expression of CYP4A10 protein,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
455,811803,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,13118,CYP4A12B,https://ctdbase.org/detail.go?type=gene&acc=13118,,,13118.0,Cyp4a12b,10090.0,Mus musculus (house mouse),Diquat results in increased expression of CYP4A12B mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
456,811990,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,10671,DCTN6,https://ctdbase.org/detail.go?type=gene&acc=10671,,,10671.0,DCTN6,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of DCTN6 protein,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
457,811991,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,1644,DDC,https://ctdbase.org/detail.go?type=gene&acc=1644,,,1644.0,DDC,10090.0,Mus musculus (house mouse),Diquat results in increased expression of DDC mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
458,811992,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,10090.0,Mus musculus (house mouse),Diquat results in increased expression of DDIT3 mRNA,,,PMID:20826540|PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/20826540|https://www.ncbi.nlm.nih.gov/pubmed/36851058,20826540|36851058,,
459,812179,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,10090.0,Mus musculus (house mouse),Diquat results in increased expression of DDIT3 protein|prop1 protein affects the reaction [diquat results in increased expression of DDIT3 mrna]|prop1 protein affects the reaction [diquat results in increased expression of DDIT3 protein],,,PMID:20826540,https://www.ncbi.nlm.nih.gov/pubmed/20826540,20826540,,
460,812180,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,4921,DDR2,https://ctdbase.org/detail.go?type=gene&acc=4921,,,4921.0,DDR2,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of DDR2 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
461,812181,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,8886,DDX18,https://ctdbase.org/detail.go?type=gene&acc=8886,,,8886.0,DDX18,6523.0,Lymnaea stagnalis (great pond snail),Diquat affects the expression of DDX18 mRNA,,,PMID:22814884,https://www.ncbi.nlm.nih.gov/pubmed/22814884,22814884,,
462,812182,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,54514,DDX4,https://ctdbase.org/detail.go?type=gene&acc=54514,,,54514.0,DDX4,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of DDX4 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
463,812183,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,54555,DDX49,https://ctdbase.org/detail.go?type=gene&acc=54555,,,54555.0,DDX49,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of DDX49 protein,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
464,814686,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,236573,GBP9,https://ctdbase.org/detail.go?type=gene&acc=236573,,,236573.0,Gbp9,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of GBP9 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
465,814687,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,2638,GC,https://ctdbase.org/detail.go?type=gene&acc=2638,,,2638.0,GC,10090.0,Mus musculus (house mouse),Diquat results in increased expression of GC mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
466,816333,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,57817,HAMP,https://ctdbase.org/detail.go?type=gene&acc=57817,,,57817.0,HAMP,10116.0,Rattus norvegicus (Norway rat),Diquat results in increased expression of HAMP mRNA,,,PMID:21698372,https://www.ncbi.nlm.nih.gov/pubmed/21698372,21698372,,
467,816334,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,1404,HAPLN1,https://ctdbase.org/detail.go?type=gene&acc=1404,,,1404.0,HAPLN1,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of HAPLN1 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
468,816335,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,84868,HAVCR2,https://ctdbase.org/detail.go?type=gene&acc=84868,,,84868.0,HAVCR2,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of HAVCR2 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
469,816336,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,27198,HCAR1,https://ctdbase.org/detail.go?type=gene&acc=27198,,,27198.0,HCAR1,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of HCAR1 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
470,816337,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,55027,HEATR3,https://ctdbase.org/detail.go?type=gene&acc=55027,,,55027.0,HEATR3,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of HEATR3 protein,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
471,816338,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,50865,HEBP1,https://ctdbase.org/detail.go?type=gene&acc=50865,,,50865.0,HEBP1,10090.0,Mus musculus (house mouse),Diquat results in increased expression of HEBP1 protein,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
472,816339,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,113802,HENMT1,https://ctdbase.org/detail.go?type=gene&acc=113802,,,113802.0,HENMT1,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of HENMT1 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
473,816340,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,3077,HFE,https://ctdbase.org/detail.go?type=gene&acc=3077,,,3077.0,HFE,10090.0,Mus musculus (house mouse),Diquat results in increased expression of HFE mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
474,816506,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,3082,HGF,https://ctdbase.org/detail.go?type=gene&acc=3082,,,3082.0,HGF,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of HGF mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
475,816507,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,138050,HGSNAT,https://ctdbase.org/detail.go?type=gene&acc=138050,,,138050.0,HGSNAT,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of HGSNAT protein,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
476,816508,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,3090,HIC1,https://ctdbase.org/detail.go?type=gene&acc=3090,,,3090.0,HIC1,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of HIC1 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
477,816509,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,283987,HID1,https://ctdbase.org/detail.go?type=gene&acc=283987,,,283987.0,HID1,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of HID1 protein,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
478,816510,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,64344,HIF3A,https://ctdbase.org/detail.go?type=gene&acc=64344,,,64344.0,HIF3A,10090.0,Mus musculus (house mouse),Diquat results in increased expression of HIF3A mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
479,816511,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,83872,HMCN1,https://ctdbase.org/detail.go?type=gene&acc=83872,,,83872.0,HMCN1,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of HMCN1 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
480,816679,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),Diquat results in increased expression of HMOX1 mrna|diquat results in increased expression of HMOX1 protein|diquat results in increased activity of HMOX1 protein,,,PMID:21172416,https://www.ncbi.nlm.nih.gov/pubmed/21172416,21172416,,
481,816680,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090.0,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [diquat results in decreased expression of HMOX1 protein]|diquat results in decreased expression of HMOX1 protein,,,PMID:33475796,https://www.ncbi.nlm.nih.gov/pubmed/33475796,33475796,,
482,816681,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of HMOX1 mrna|ellagic acid inhibits the reaction [diquat results in decreased expression of HMOX1 mrna],,,PMID:35268077,https://www.ncbi.nlm.nih.gov/pubmed/35268077,35268077,,
483,818135,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,3791,KDR,https://ctdbase.org/detail.go?type=gene&acc=3791,,,3791.0,KDR,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of KDR mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
484,818136,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,9817,KEAP1,https://ctdbase.org/detail.go?type=gene&acc=9817,,,9817.0,KEAP1,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of KEAP1 protein,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
485,818137,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,9817,KEAP1,https://ctdbase.org/detail.go?type=gene&acc=9817,,,9817.0,KEAP1,10090.0,Mus musculus (house mouse),KEAP1 gene mutant form inhibits the reaction [diquat results in decreased abundance of glutathione]|keap1 gene mutant form inhibits the reaction [NFE2L2 gene mutant form results in increased susceptibility to diquat]|[keap1 gene mutant form inhibits the reaction [diquat results in decreased abundance of glutathione]] which results in increased expression of GCLC mRNA,,,PMID:22762311,https://www.ncbi.nlm.nih.gov/pubmed/22762311,22762311,,
486,818138,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,22889,KHDC4,https://ctdbase.org/detail.go?type=gene&acc=22889,,,22889.0,KHDC4,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of KHDC4 protein,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
487,818139,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,3832,KIF11,https://ctdbase.org/detail.go?type=gene&acc=3832,,,3832.0,KIF11,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of KIF11 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
488,818140,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,9585,KIF20B,https://ctdbase.org/detail.go?type=gene&acc=9585,,,9585.0,KIF20B,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of KIF20B mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
489,818141,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,16571,KIF4,https://ctdbase.org/detail.go?type=gene&acc=16571,,,16571.0,Kif4,10090.0,Mus musculus (house mouse),Diquat results in increased expression of KIF4 protein,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
490,818142,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,3798,KIF5A,https://ctdbase.org/detail.go?type=gene&acc=3798,,,3798.0,KIF5A,10090.0,Mus musculus (house mouse),Diquat results in increased expression of KIF5A mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
491,818324,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,16619,KLK1B27,https://ctdbase.org/detail.go?type=gene&acc=16619,,,16619.0,Klk1b27,10090.0,Mus musculus (house mouse),Diquat results in increased expression of KLK1B27 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
492,818325,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,9622,KLK4,https://ctdbase.org/detail.go?type=gene&acc=9622,,,9622.0,KLK4,6523.0,Lymnaea stagnalis (great pond snail),Diquat affects the expression of KLK4 mRNA,,,PMID:22814884,https://www.ncbi.nlm.nih.gov/pubmed/22814884,22814884,,
493,818326,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,3875,KRT18,https://ctdbase.org/detail.go?type=gene&acc=3875,,,3875.0,KRT18,10090.0,Mus musculus (house mouse),Diquat results in increased expression of KRT18 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
494,818327,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,54474,KRT20,https://ctdbase.org/detail.go?type=gene&acc=54474,,,54474.0,KRT20,10090.0,Mus musculus (house mouse),Diquat results in increased expression of KRT20 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
495,818328,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,3853,KRT6A,https://ctdbase.org/detail.go?type=gene&acc=3853,,,3853.0,KRT6A,10090.0,Mus musculus (house mouse),Diquat results in increased expression of KRT6A protein,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
496,818329,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,3856,KRT8,https://ctdbase.org/detail.go?type=gene&acc=3856,,,3856.0,KRT8,10090.0,Mus musculus (house mouse),Diquat results in increased expression of KRT8 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
497,818330,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,8942,KYNU,https://ctdbase.org/detail.go?type=gene&acc=8942,,,8942.0,KYNU,9606.0,Homo sapiens (human),Diquat results in increased expression of KYNU mRNA,,,PMID:21172416,https://www.ncbi.nlm.nih.gov/pubmed/21172416,21172416,,
498,818331,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,8942,KYNU,https://ctdbase.org/detail.go?type=gene&acc=8942,,,8942.0,KYNU,10090.0,Mus musculus (house mouse),Diquat results in increased expression of KYNU mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
499,818332,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,3897,L1CAM,https://ctdbase.org/detail.go?type=gene&acc=3897,,,3897.0,L1CAM,6523.0,Lymnaea stagnalis (great pond snail),Diquat affects the expression of L1CAM mRNA,,,PMID:22814884,https://www.ncbi.nlm.nih.gov/pubmed/22814884,22814884,,
500,818333,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,3908,LAMA2,https://ctdbase.org/detail.go?type=gene&acc=3908,,,3908.0,LAMA2,10090.0,Mus musculus (house mouse),Diquat results in decreased expression of LAMA2 mRNA,,,PMID:36851058,https://www.ncbi.nlm.nih.gov/pubmed/36851058,36851058,,
501,807166,6883,ChEMBL,Isosorbide Dinitrate,CHEMBL6622,ISOSORBIDE DINITRATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6622/,CHEMBL2111348,Soluble guanylate cyclase,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2111348/,O75343,Guanylate cyclase soluble subunit beta-2,2977.0,GUCY1A2,9606.0,Homo sapiens (human),Soluble guanylate cyclase activator,,,,,,,
502,807167,6883,ChEMBL,Isosorbide Dinitrate,CHEMBL6622,ISOSORBIDE DINITRATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6622/,CHEMBL2111348,Soluble guanylate cyclase,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2111348/,P33402,Guanylate cyclase soluble subunit alpha-2,2982.0,GUCY1A1,9606.0,Homo sapiens (human),Soluble guanylate cyclase activator,,,,,,,
503,808017,6889,BindingDB,5-Bromoisatin,22814,"5-bromo-2,3-dihydro-1H-indole-2,3-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22814,8446,Coagulation factor XII,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8446,P00748,Coagulation factor XII,2161.0,F12,9606.0,Homo sapiens (human),,Ki (nM),13300,PMID:17378546|DOI:10.1021/jm061471k,https://www.ncbi.nlm.nih.gov/pubmed/17378546|https://doi.org/10.1021/jm061471k,17378546,10.1021/jm061471k,
504,808018,6889,BindingDB,5-Bromoisatin,22814,"5-bromo-2,3-dihydro-1H-indole-2,3-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22814,7016,Liver carboxylesterase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7016,P23141,Liver carboxylesterase 1,1066.0,CES1,9606.0,Homo sapiens (human),,Ki (nM),31700,PMID:17378546|DOI:10.1021/jm061471k,https://www.ncbi.nlm.nih.gov/pubmed/17378546|https://doi.org/10.1021/jm061471k,17378546,10.1021/jm061471k,
505,808019,6890,Drug Gene Interaction database (DGIdb),Gramine,,GRAMINE,https://www.dgidb.org/drugs/ncit:C64181,,TSHR,https://www.dgidb.org/genes/hgnc:12373,,,7253.0,TSHR,9606.0,Homo sapiens (human),,,,,,,,
506,808020,6950,Comparative Toxicogenomics Database (CTD),Dinoseb,C018527,dinoseb,https://ctdbase.org/detail.go?type=chem&acc=C018527,1327,COX4I1,https://ctdbase.org/detail.go?type=gene&acc=1327,,,1327.0,COX4I1,7955.0,Danio rerio (zebrafish),Dinoseb results in decreased expression of COX4I1 mRNA,,,PMID:35500749,https://www.ncbi.nlm.nih.gov/pubmed/35500749,35500749,,
507,808021,6950,Comparative Toxicogenomics Database (CTD),Dinoseb,C018527,dinoseb,https://ctdbase.org/detail.go?type=chem&acc=C018527,2919,CXCL1,https://ctdbase.org/detail.go?type=gene&acc=2919,,,2919.0,CXCL1,7955.0,Danio rerio (zebrafish),Dinoseb results in decreased expression of CXCL1 mRNA,,,PMID:35500749,https://www.ncbi.nlm.nih.gov/pubmed/35500749,35500749,,
508,808022,6950,Comparative Toxicogenomics Database (CTD),Dinoseb,C018527,dinoseb,https://ctdbase.org/detail.go?type=chem&acc=C018527,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,10090.0,Mus musculus (house mouse),Dinoseb results in increased expression of GCLC mRNA,,,PMID:30547568,https://www.ncbi.nlm.nih.gov/pubmed/30547568,30547568,,
509,808023,6950,Comparative Toxicogenomics Database (CTD),Dinoseb,C018527,dinoseb,https://ctdbase.org/detail.go?type=chem&acc=C018527,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730.0,GCLM,10090.0,Mus musculus (house mouse),Dinoseb results in increased expression of GCLM mRNA,,,PMID:30547568,https://www.ncbi.nlm.nih.gov/pubmed/30547568,30547568,,
510,819966,7042,Toxin and Toxin Target Database (T3DB),Phthalonitrile,T3D1707,Phthalonitrile,http://www.t3db.ca/toxins/T3D1707,BE0000648,"Glutathione reductase, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000648,P00390,"Glutathione reductase, mitochondrial",2936.0,GSR,9606.0,Homo sapiens (human),Cyanide inhibits glutathione reductase. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
511,819967,7042,Toxin and Toxin Target Database (T3DB),Phthalonitrile,T3D1707,Phthalonitrile,http://www.t3db.ca/toxins/T3D1707,BE0000896,"Alkaline phosphatase, placental-like",http://www.t3db.ca/biodb/bio_entities/BE0000896,P10696,"Alkaline phosphatase, germ cell type",251.0,ALPG,9606.0,Homo sapiens (human),Cyanide inhibits alkaline phosphatases. (A73),,,PMID:924371,https://www.ncbi.nlm.nih.gov/pubmed/924371,924371,,
512,819968,7042,Toxin and Toxin Target Database (T3DB),Phthalonitrile,T3D1707,Phthalonitrile,http://www.t3db.ca/toxins/T3D1707,BE0003546,"Alkaline phosphatase, tissue-nonspecific isozyme",http://www.t3db.ca/biodb/bio_entities/BE0003546,P05186,"Alkaline phosphatase, tissue-nonspecific isozyme",249.0,ALPL,9606.0,Homo sapiens (human),Cyanide inhibits alkaline phosphatases. (A73),,,PMID:924371,https://www.ncbi.nlm.nih.gov/pubmed/924371,924371,,
513,819969,7042,Toxin and Toxin Target Database (T3DB),Phthalonitrile,T3D1707,Phthalonitrile,http://www.t3db.ca/toxins/T3D1707,BE0001207,Catalase,http://www.t3db.ca/biodb/bio_entities/BE0001207,P04040,Catalase,847.0,CAT,9606.0,Homo sapiens (human),Cyanide inhibits catalase. (A74),,,PMID:16728955,https://www.ncbi.nlm.nih.gov/pubmed/16728955,16728955,,
514,820361,7042,Toxin and Toxin Target Database (T3DB),Phthalonitrile,T3D1707,Phthalonitrile,http://www.t3db.ca/toxins/T3D1707,BE0003993,"Cytochrome c oxidase subunit 8A, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0003993,P10176,"Cytochrome c oxidase subunit 8A, mitochondrial",1351.0,COX8A,9606.0,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
515,813321,7261,Comparative Toxicogenomics Database (CTD),"2,4-Diaminotoluene",C010914,"2,4-diaminotoluene",https://ctdbase.org/detail.go?type=chem&acc=C010914,15122,HBA-A1,https://ctdbase.org/detail.go?type=gene&acc=15122,,,15122.0,Hba-a1,10090.0,Mus musculus (house mouse),"2,4-diaminotoluene results in increased expression of HBA-A1 mRNA",,,PMID:20713471,https://www.ncbi.nlm.nih.gov/pubmed/20713471,20713471,,
516,813322,7261,Comparative Toxicogenomics Database (CTD),"2,4-Diaminotoluene",C010914,"2,4-diaminotoluene",https://ctdbase.org/detail.go?type=chem&acc=C010914,25994,HIGD1A,https://ctdbase.org/detail.go?type=gene&acc=25994,,,25994.0,HIGD1A,10090.0,Mus musculus (house mouse),"2,4-diaminotoluene results in increased expression of HIGD1A mRNA",,,PMID:20713471,https://www.ncbi.nlm.nih.gov/pubmed/20713471,20713471,,
517,814182,7261,Comparative Toxicogenomics Database (CTD),"2,4-Diaminotoluene",C010914,"2,4-diaminotoluene",https://ctdbase.org/detail.go?type=chem&acc=C010914,4641,MYO1C,https://ctdbase.org/detail.go?type=gene&acc=4641,,,4641.0,MYO1C,10090.0,Mus musculus (house mouse),"2,4-diaminotoluene results in increased expression of MYO1C mRNA",,,PMID:20713471,https://www.ncbi.nlm.nih.gov/pubmed/20713471,20713471,,
518,814183,7261,Comparative Toxicogenomics Database (CTD),"2,4-Diaminotoluene",C010914,"2,4-diaminotoluene",https://ctdbase.org/detail.go?type=chem&acc=C010914,54892,NCAPG2,https://ctdbase.org/detail.go?type=gene&acc=54892,,,54892.0,NCAPG2,10090.0,Mus musculus (house mouse),"2,4-diaminotoluene results in increased expression of NCAPG2 mRNA",,,PMID:20713471,https://www.ncbi.nlm.nih.gov/pubmed/20713471,20713471,,
519,814184,7261,Comparative Toxicogenomics Database (CTD),"2,4-Diaminotoluene",C010914,"2,4-diaminotoluene",https://ctdbase.org/detail.go?type=chem&acc=C010914,4689,NCF4,https://ctdbase.org/detail.go?type=gene&acc=4689,,,4689.0,NCF4,10090.0,Mus musculus (house mouse),"2,4-diaminotoluene results in increased expression of NCF4 mRNA",,,PMID:20713471,https://www.ncbi.nlm.nih.gov/pubmed/20713471,20713471,,
520,814185,7261,Comparative Toxicogenomics Database (CTD),"2,4-Diaminotoluene",C010914,"2,4-diaminotoluene",https://ctdbase.org/detail.go?type=chem&acc=C010914,10403,NDC80,https://ctdbase.org/detail.go?type=gene&acc=10403,,,10403.0,NDC80,10090.0,Mus musculus (house mouse),"2,4-diaminotoluene results in increased expression of NDC80 mRNA",,,PMID:20713471,https://www.ncbi.nlm.nih.gov/pubmed/20713471,20713471,,
521,814186,7261,Comparative Toxicogenomics Database (CTD),"2,4-Diaminotoluene",C010914,"2,4-diaminotoluene",https://ctdbase.org/detail.go?type=chem&acc=C010914,55247,NEIL3,https://ctdbase.org/detail.go?type=gene&acc=55247,,,55247.0,NEIL3,10090.0,Mus musculus (house mouse),"2,4-diaminotoluene results in increased expression of NEIL3 mRNA",,,PMID:20713471,https://www.ncbi.nlm.nih.gov/pubmed/20713471,20713471,,
522,814187,7261,Comparative Toxicogenomics Database (CTD),"2,4-Diaminotoluene",C010914,"2,4-diaminotoluene",https://ctdbase.org/detail.go?type=chem&acc=C010914,116496,NIBAN1,https://ctdbase.org/detail.go?type=gene&acc=116496,,,116496.0,NIBAN1,10090.0,Mus musculus (house mouse),"2,4-diaminotoluene results in increased expression of NIBAN1 mRNA",,,PMID:20713471,https://www.ncbi.nlm.nih.gov/pubmed/20713471,20713471,,
523,814188,7261,Comparative Toxicogenomics Database (CTD),"2,4-Diaminotoluene",C010914,"2,4-diaminotoluene",https://ctdbase.org/detail.go?type=chem&acc=C010914,9221,NOLC1,https://ctdbase.org/detail.go?type=gene&acc=9221,,,9221.0,NOLC1,10090.0,Mus musculus (house mouse),"2,4-diaminotoluene results in increased expression of NOLC1 mRNA",,,PMID:20713471,https://www.ncbi.nlm.nih.gov/pubmed/20713471,20713471,,
524,815517,7261,Comparative Toxicogenomics Database (CTD),"2,4-Diaminotoluene",C010914,"2,4-diaminotoluene",https://ctdbase.org/detail.go?type=chem&acc=C010914,6462,SHBG,https://ctdbase.org/detail.go?type=gene&acc=6462,,,6462.0,SHBG,10116.0,Rattus norvegicus (Norway rat),"2,4-diaminotoluene results in increased expression of SHBG protein",,,PMID:3199457,https://www.ncbi.nlm.nih.gov/pubmed/3199457,3199457,,
525,815518,7261,Comparative Toxicogenomics Database (CTD),"2,4-Diaminotoluene",C010914,"2,4-diaminotoluene",https://ctdbase.org/detail.go?type=chem&acc=C010914,79801,SHCBP1,https://ctdbase.org/detail.go?type=gene&acc=79801,,,79801.0,SHCBP1,10090.0,Mus musculus (house mouse),"2,4-diaminotoluene results in increased expression of SHCBP1 mRNA",,,PMID:20713471,https://www.ncbi.nlm.nih.gov/pubmed/20713471,20713471,,
526,815519,7261,Comparative Toxicogenomics Database (CTD),"2,4-Diaminotoluene",C010914,"2,4-diaminotoluene",https://ctdbase.org/detail.go?type=chem&acc=C010914,80349,SKIC8,https://ctdbase.org/detail.go?type=gene&acc=80349,,,80349.0,SKIC8,10090.0,Mus musculus (house mouse),"2,4-diaminotoluene results in increased expression of SKIC8 mRNA",,,PMID:20713471,https://www.ncbi.nlm.nih.gov/pubmed/20713471,20713471,,
527,815520,7261,Comparative Toxicogenomics Database (CTD),"2,4-Diaminotoluene",C010914,"2,4-diaminotoluene",https://ctdbase.org/detail.go?type=chem&acc=C010914,117247,SLC16A10,https://ctdbase.org/detail.go?type=gene&acc=117247,,,117247.0,SLC16A10,10116.0,Rattus norvegicus (Norway rat),"2,4-diaminotoluene results in decreased expression of SLC16A10 mRNA",,,PMID:17070881,https://www.ncbi.nlm.nih.gov/pubmed/17070881,17070881,,
528,815521,7261,Comparative Toxicogenomics Database (CTD),"2,4-Diaminotoluene",C010914,"2,4-diaminotoluene",https://ctdbase.org/detail.go?type=chem&acc=C010914,9120,SLC16A6,https://ctdbase.org/detail.go?type=gene&acc=9120,,,9120.0,SLC16A6,10090.0,Mus musculus (house mouse),"2,4-diaminotoluene results in increased expression of SLC16A6 mRNA",,,PMID:20713471,https://www.ncbi.nlm.nih.gov/pubmed/20713471,20713471,,
529,815522,7261,Comparative Toxicogenomics Database (CTD),"2,4-Diaminotoluene",C010914,"2,4-diaminotoluene",https://ctdbase.org/detail.go?type=chem&acc=C010914,20556,SLFN2,https://ctdbase.org/detail.go?type=gene&acc=20556,,,20556.0,Slfn2,10090.0,Mus musculus (house mouse),"2,4-diaminotoluene results in increased expression of SLFN2 mRNA",,,PMID:20713471,https://www.ncbi.nlm.nih.gov/pubmed/20713471,20713471,,
530,815523,7261,Comparative Toxicogenomics Database (CTD),"2,4-Diaminotoluene",C010914,"2,4-diaminotoluene",https://ctdbase.org/detail.go?type=chem&acc=C010914,237886,SLFN9,https://ctdbase.org/detail.go?type=gene&acc=237886,,,237886.0,Slfn9,10090.0,Mus musculus (house mouse),"2,4-diaminotoluene results in increased expression of SLFN9 mRNA",,,PMID:20713471,https://www.ncbi.nlm.nih.gov/pubmed/20713471,20713471,,
531,815524,7261,Comparative Toxicogenomics Database (CTD),"2,4-Diaminotoluene",C010914,"2,4-diaminotoluene",https://ctdbase.org/detail.go?type=chem&acc=C010914,6590,SLPI,https://ctdbase.org/detail.go?type=gene&acc=6590,,,6590.0,SLPI,10090.0,Mus musculus (house mouse),"2,4-diaminotoluene results in increased expression of SLPI mRNA",,,PMID:20713471,https://www.ncbi.nlm.nih.gov/pubmed/20713471,20713471,,
532,808860,7276,Comparative Toxicogenomics Database (CTD),Styrene oxide,C013690,styrene oxide,https://ctdbase.org/detail.go?type=chem&acc=C013690,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Styrene oxide results in increased activity of CASP3 protein,,,PMID:11929631,https://www.ncbi.nlm.nih.gov/pubmed/11929631,11929631,,
533,808861,7276,Comparative Toxicogenomics Database (CTD),Styrene oxide,C013690,styrene oxide,https://ctdbase.org/detail.go?type=chem&acc=C013690,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090.0,Mus musculus (house mouse),Styrene oxide results in increased activity of CASP3 protein,,,PMID:17662326|PMID:19666080,https://www.ncbi.nlm.nih.gov/pubmed/17662326|https://www.ncbi.nlm.nih.gov/pubmed/19666080,17662326|19666080,,
534,808862,7276,Comparative Toxicogenomics Database (CTD),Styrene oxide,C013690,styrene oxide,https://ctdbase.org/detail.go?type=chem&acc=C013690,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Styrene oxide results in increased activity of CASP3 protein,,,PMID:11929631|PMID:12663515,https://www.ncbi.nlm.nih.gov/pubmed/11929631|https://www.ncbi.nlm.nih.gov/pubmed/12663515,11929631|12663515,,
535,808863,7276,Comparative Toxicogenomics Database (CTD),Styrene oxide,C013690,styrene oxide,https://ctdbase.org/detail.go?type=chem&acc=C013690,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),Styrene oxide affects the expression of CDKN1A mRNA,,,PMID:11230554,https://www.ncbi.nlm.nih.gov/pubmed/11230554,11230554,,
536,808864,7276,Comparative Toxicogenomics Database (CTD),Styrene oxide,C013690,styrene oxide,https://ctdbase.org/detail.go?type=chem&acc=C013690,1111,CHEK1,https://ctdbase.org/detail.go?type=gene&acc=1111,,,1111.0,CHEK1,10090.0,Mus musculus (house mouse),Styrene oxide results in increased expression of CHEK1 protein,,,PMID:20025956,https://www.ncbi.nlm.nih.gov/pubmed/20025956,20025956,,
537,808865,7276,Comparative Toxicogenomics Database (CTD),Styrene oxide,C013690,styrene oxide,https://ctdbase.org/detail.go?type=chem&acc=C013690,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10116.0,Rattus norvegicus (Norway rat),CYP1A1 protein promotes the reaction [EPHX1 protein affects the hydrolysis of styrene oxide],,,PMID:12051674,https://www.ncbi.nlm.nih.gov/pubmed/12051674,12051674,,
538,808866,7276,Comparative Toxicogenomics Database (CTD),Styrene oxide,C013690,styrene oxide,https://ctdbase.org/detail.go?type=chem&acc=C013690,24300,CYP2B1,https://ctdbase.org/detail.go?type=gene&acc=24300,,,24300.0,Cyp2b1,10116.0,Rattus norvegicus (Norway rat),CYP2B1 protein promotes the reaction [EPHX1 protein affects the hydrolysis of styrene oxide],,,PMID:12051674,https://www.ncbi.nlm.nih.gov/pubmed/12051674,12051674,,
539,809058,7276,Comparative Toxicogenomics Database (CTD),Styrene oxide,C013690,styrene oxide,https://ctdbase.org/detail.go?type=chem&acc=C013690,29277,CYP2C11,https://ctdbase.org/detail.go?type=gene&acc=29277,,,29277.0,Cyp2c11,10116.0,Rattus norvegicus (Norway rat),CYP2C11 protein promotes the reaction [EPHX1 protein affects the hydrolysis of styrene oxide],,,PMID:12051674,https://www.ncbi.nlm.nih.gov/pubmed/12051674,12051674,,
540,817808,7289,Comparative Toxicogenomics Database (CTD),"1,3-Dichloro-2-propanol",C033489,"1,3-dichloro-2-propanol",https://ctdbase.org/detail.go?type=chem&acc=C033489,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288.0,MKI67,10116.0,Rattus norvegicus (Norway rat),"1,3-dichloro-2-propanol results in increased expression of MKI67 protein",,,PMID:34269859,https://www.ncbi.nlm.nih.gov/pubmed/34269859,34269859,,
541,817809,7289,Comparative Toxicogenomics Database (CTD),"1,3-Dichloro-2-propanol",C033489,"1,3-dichloro-2-propanol",https://ctdbase.org/detail.go?type=chem&acc=C033489,197259,MLKL,https://ctdbase.org/detail.go?type=gene&acc=197259,,,197259.0,MLKL,10090.0,Mus musculus (house mouse),"1,3-dichloro-2-propanol results in increased expression of MLKL protein|gsk872 inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of MLKL protein]|1,3-dichloro-2-propanol results in increased expression of and results in increased phosphorylation of MLKL protein|acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of MLKL protein]|ripk3 protein promotes the reaction [1,3-dichloro-2-propanol results in increased expression of MLKL protein]",,,PMID:36000575,https://www.ncbi.nlm.nih.gov/pubmed/36000575,36000575,,
542,817810,7289,Comparative Toxicogenomics Database (CTD),"1,3-Dichloro-2-propanol",C033489,"1,3-dichloro-2-propanol",https://ctdbase.org/detail.go?type=chem&acc=C033489,2475,MTOR,https://ctdbase.org/detail.go?type=gene&acc=2475,,,2475.0,MTOR,9606.0,Homo sapiens (human),"1,3-dichloro-2-propanol results in increased phosphorylation of MTOR protein|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [1,3-dichloro-2-propanol results in increased phosphorylation of MTOR protein]",,,PMID:33581215,https://www.ncbi.nlm.nih.gov/pubmed/33581215,33581215,,
543,817811,7289,Comparative Toxicogenomics Database (CTD),"1,3-Dichloro-2-propanol",C033489,"1,3-dichloro-2-propanol",https://ctdbase.org/detail.go?type=chem&acc=C033489,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),"1,3-dichloro-2-propanol binds to NFE2L2 protein",,,PMID:35870111,https://www.ncbi.nlm.nih.gov/pubmed/35870111,35870111,,
544,817812,7289,Comparative Toxicogenomics Database (CTD),"1,3-Dichloro-2-propanol",C033489,"1,3-dichloro-2-propanol",https://ctdbase.org/detail.go?type=chem&acc=C033489,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116.0,Rattus norvegicus (Norway rat),"Dimethyl fumarate inhibits the reaction [1,3-dichloro-2-propanol results in decreased expression of NFE2L2 protein]|1,3-dichloro-2-propanol results in decreased expression of NFE2L2 protein",,,PMID:36000575,https://www.ncbi.nlm.nih.gov/pubmed/36000575,36000575,,
545,817813,7289,Comparative Toxicogenomics Database (CTD),"1,3-Dichloro-2-propanol",C033489,"1,3-dichloro-2-propanol",https://ctdbase.org/detail.go?type=chem&acc=C033489,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090.0,Mus musculus (house mouse),"Pyrrolidine dithiocarbamic acid inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of NOS2 protein]|1,3-dichloro-2-propanol results in increased expression of NOS2 protein",,,PMID:29248572,https://www.ncbi.nlm.nih.gov/pubmed/29248572,29248572,,
546,817814,7289,Comparative Toxicogenomics Database (CTD),"1,3-Dichloro-2-propanol",C033489,"1,3-dichloro-2-propanol",https://ctdbase.org/detail.go?type=chem&acc=C033489,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10116.0,Rattus norvegicus (Norway rat),"1,3-dichloro-2-propanol results in increased expression of NQO1 mRNA",,,PMID:26143167,https://www.ncbi.nlm.nih.gov/pubmed/26143167,26143167,,
547,817815,7289,Comparative Toxicogenomics Database (CTD),"1,3-Dichloro-2-propanol",C033489,"1,3-dichloro-2-propanol",https://ctdbase.org/detail.go?type=chem&acc=C033489,9572,NR1D1,https://ctdbase.org/detail.go?type=gene&acc=9572,,,9572.0,NR1D1,10090.0,Mus musculus (house mouse),"1,3-dichloro-2-propanol results in decreased expression of NR1D1 protein",,,PMID:36805544,https://www.ncbi.nlm.nih.gov/pubmed/36805544,36805544,,
548,817816,7289,Comparative Toxicogenomics Database (CTD),"1,3-Dichloro-2-propanol",C033489,"1,3-dichloro-2-propanol",https://ctdbase.org/detail.go?type=chem&acc=C033489,40336,PARK,https://ctdbase.org/detail.go?type=gene&acc=40336,,,40336.0,park,10116.0,Rattus norvegicus (Norway rat),"1,3-dichloro-2-propanol results in decreased expression of PARK protein",,,PMID:36000575,https://www.ncbi.nlm.nih.gov/pubmed/36000575,36000575,,
549,818658,7305,Comparative Toxicogenomics Database (CTD),Soman,D012999,Soman,https://ctdbase.org/detail.go?type=chem&acc=D012999,1410,CRYAB,https://ctdbase.org/detail.go?type=gene&acc=1410,,,1410.0,CRYAB,10116.0,Rattus norvegicus (Norway rat),Soman results in increased expression of CRYAB mRNA,,,PMID:19281266,https://www.ncbi.nlm.nih.gov/pubmed/19281266,19281266,,
550,818659,7305,Comparative Toxicogenomics Database (CTD),Soman,D012999,Soman,https://ctdbase.org/detail.go?type=chem&acc=D012999,1418,CRYGA,https://ctdbase.org/detail.go?type=gene&acc=1418,,,1418.0,CRYGA,10116.0,Rattus norvegicus (Norway rat),Soman results in decreased expression of CRYGA mRNA,,,PMID:19281266,https://www.ncbi.nlm.nih.gov/pubmed/19281266,19281266,,
551,818660,7305,Comparative Toxicogenomics Database (CTD),Soman,D012999,Soman,https://ctdbase.org/detail.go?type=chem&acc=D012999,1428,CRYM,https://ctdbase.org/detail.go?type=gene&acc=1428,,,1428.0,CRYM,10116.0,Rattus norvegicus (Norway rat),Soman results in decreased expression of CRYM mRNA,,,PMID:19281266,https://www.ncbi.nlm.nih.gov/pubmed/19281266,19281266,,
552,818661,7305,Comparative Toxicogenomics Database (CTD),Soman,D012999,Soman,https://ctdbase.org/detail.go?type=chem&acc=D012999,9946,CRYZL1,https://ctdbase.org/detail.go?type=gene&acc=9946,,,9946.0,CRYZL1,10116.0,Rattus norvegicus (Norway rat),Soman results in decreased expression of CRYZL1 mRNA,,,PMID:19281266,https://www.ncbi.nlm.nih.gov/pubmed/19281266,19281266,,
553,818662,7305,Comparative Toxicogenomics Database (CTD),Soman,D012999,Soman,https://ctdbase.org/detail.go?type=chem&acc=D012999,1435,CSF1,https://ctdbase.org/detail.go?type=gene&acc=1435,,,1435.0,CSF1,10116.0,Rattus norvegicus (Norway rat),Soman results in increased expression of CSF1 mRNA,,,PMID:19281266,https://www.ncbi.nlm.nih.gov/pubmed/19281266,19281266,,
554,818663,7305,Comparative Toxicogenomics Database (CTD),Soman,D012999,Soman,https://ctdbase.org/detail.go?type=chem&acc=D012999,1436,CSF1R,https://ctdbase.org/detail.go?type=gene&acc=1436,,,1436.0,CSF1R,10116.0,Rattus norvegicus (Norway rat),Soman results in increased expression of CSF1R mRNA,,,PMID:19281266,https://www.ncbi.nlm.nih.gov/pubmed/19281266,19281266,,
555,818664,7305,Comparative Toxicogenomics Database (CTD),Soman,D012999,Soman,https://ctdbase.org/detail.go?type=chem&acc=D012999,1441,CSF3R,https://ctdbase.org/detail.go?type=gene&acc=1441,,,1441.0,CSF3R,10116.0,Rattus norvegicus (Norway rat),Soman results in increased expression of CSF3R mRNA,,,PMID:19281266,https://www.ncbi.nlm.nih.gov/pubmed/19281266,19281266,,
556,818665,7305,Comparative Toxicogenomics Database (CTD),Soman,D012999,Soman,https://ctdbase.org/detail.go?type=chem&acc=D012999,55790,CSGALNACT1,https://ctdbase.org/detail.go?type=gene&acc=55790,,,55790.0,CSGALNACT1,10116.0,Rattus norvegicus (Norway rat),Soman results in decreased expression of CSGALNACT1 mRNA,,,PMID:19281266,https://www.ncbi.nlm.nih.gov/pubmed/19281266,19281266,,
557,818666,7305,Comparative Toxicogenomics Database (CTD),Soman,D012999,Soman,https://ctdbase.org/detail.go?type=chem&acc=D012999,1445,CSK,https://ctdbase.org/detail.go?type=gene&acc=1445,,,1445.0,CSK,10116.0,Rattus norvegicus (Norway rat),Soman results in increased expression of CSK mRNA,,,PMID:19281266,https://www.ncbi.nlm.nih.gov/pubmed/19281266,19281266,,
558,818667,7305,Comparative Toxicogenomics Database (CTD),Soman,D012999,Soman,https://ctdbase.org/detail.go?type=chem&acc=D012999,1452,CSNK1A1,https://ctdbase.org/detail.go?type=gene&acc=1452,,,1452.0,CSNK1A1,10116.0,Rattus norvegicus (Norway rat),Soman results in increased expression of CSNK1A1 mRNA,,,PMID:19281266,https://www.ncbi.nlm.nih.gov/pubmed/19281266,19281266,,
559,818668,7305,Comparative Toxicogenomics Database (CTD),Soman,D012999,Soman,https://ctdbase.org/detail.go?type=chem&acc=D012999,64651,CSRNP1,https://ctdbase.org/detail.go?type=gene&acc=64651,,,64651.0,CSRNP1,10116.0,Rattus norvegicus (Norway rat),Soman results in increased expression of CSRNP1 mRNA,,,PMID:19281266,https://www.ncbi.nlm.nih.gov/pubmed/19281266,19281266,,
560,831500,7305,Comparative Toxicogenomics Database (CTD),Soman,D012999,Soman,https://ctdbase.org/detail.go?type=chem&acc=D012999,4016,LOXL1,https://ctdbase.org/detail.go?type=gene&acc=4016,,,4016.0,LOXL1,10116.0,Rattus norvegicus (Norway rat),Soman results in increased expression of LOXL1 mRNA,,,PMID:19281266,https://www.ncbi.nlm.nih.gov/pubmed/19281266,19281266,,
561,732586,7471,Comparative Toxicogenomics Database (CTD),"N,N-Dimethyl-p-toluidine",C015835,dimethyl-4-toluidine,https://ctdbase.org/detail.go?type=chem&acc=C015835,79814,AGMAT,https://ctdbase.org/detail.go?type=gene&acc=79814,,,79814.0,AGMAT,10116.0,Rattus norvegicus (Norway rat),Dimethyl-4-toluidine results in decreased expression of AGMAT mRNA,,,PMID:27638505,https://www.ncbi.nlm.nih.gov/pubmed/27638505,27638505,,
562,732587,7471,Comparative Toxicogenomics Database (CTD),"N,N-Dimethyl-p-toluidine",C015835,dimethyl-4-toluidine,https://ctdbase.org/detail.go?type=chem&acc=C015835,23287,AGTPBP1,https://ctdbase.org/detail.go?type=gene&acc=23287,,,23287.0,AGTPBP1,10116.0,Rattus norvegicus (Norway rat),Dimethyl-4-toluidine results in increased expression of AGTPBP1 mRNA,,,PMID:27638505,https://www.ncbi.nlm.nih.gov/pubmed/27638505,27638505,,
563,811291,7474,Comparative Toxicogenomics Database (CTD),1-Chloro-4-nitrobenzene,C010407,4-chloronitrobenzene,https://ctdbase.org/detail.go?type=chem&acc=C010407,2944,GSTM1,https://ctdbase.org/detail.go?type=gene&acc=2944,,,2944.0,GSTM1,10114.0,Rattus,GSTM1 protein affects the metabolism of [4-chloronitrobenzene analog co-treated with glutathione],,,PMID:8867999,https://www.ncbi.nlm.nih.gov/pubmed/8867999,8867999,,
564,811292,7474,Comparative Toxicogenomics Database (CTD),1-Chloro-4-nitrobenzene,C010407,4-chloronitrobenzene,https://ctdbase.org/detail.go?type=chem&acc=C010407,2944,GSTM1,https://ctdbase.org/detail.go?type=gene&acc=2944,,,2944.0,GSTM1,10116.0,Rattus norvegicus (Norway rat),GSTM1 protein affects the metabolism of [4-chloronitrobenzene analog co-treated with glutathione],,,PMID:8973562,https://www.ncbi.nlm.nih.gov/pubmed/8973562,8973562,,
565,811293,7474,Comparative Toxicogenomics Database (CTD),1-Chloro-4-nitrobenzene,C010407,4-chloronitrobenzene,https://ctdbase.org/detail.go?type=chem&acc=C010407,2946,GSTM2,https://ctdbase.org/detail.go?type=gene&acc=2946,,,2946.0,GSTM2,10116.0,Rattus norvegicus (Norway rat),GSTM2 protein affects the metabolism of [4-chloronitrobenzene analog co-treated with glutathione],,,PMID:8973562,https://www.ncbi.nlm.nih.gov/pubmed/8973562,8973562,,
566,811294,7474,Comparative Toxicogenomics Database (CTD),1-Chloro-4-nitrobenzene,C010407,4-chloronitrobenzene,https://ctdbase.org/detail.go?type=chem&acc=C010407,2950,GSTP1,https://ctdbase.org/detail.go?type=gene&acc=2950,,,2950.0,GSTP1,10116.0,Rattus norvegicus (Norway rat),GSTP1 protein affects the metabolism of [4-chloronitrobenzene analog co-treated with glutathione],,,PMID:8973562,https://www.ncbi.nlm.nih.gov/pubmed/8973562,8973562,,
567,811295,7501,Comparative Toxicogenomics Database (CTD),Styrene,C024075,styrofoam,https://ctdbase.org/detail.go?type=chem&acc=C024075,718,C3,https://ctdbase.org/detail.go?type=gene&acc=718,,,718.0,C3,9606.0,Homo sapiens (human),Styrofoam analog results in increased expression of C3 protein,,,PMID:19428933,https://www.ncbi.nlm.nih.gov/pubmed/19428933,19428933,,
568,811296,7501,Comparative Toxicogenomics Database (CTD),Styrene,C024075,styrofoam,https://ctdbase.org/detail.go?type=chem&acc=C024075,727,C5,https://ctdbase.org/detail.go?type=gene&acc=727,,,727.0,C5,9606.0,Homo sapiens (human),Styrofoam analog results in increased expression of C5 protein,,,PMID:19428933,https://www.ncbi.nlm.nih.gov/pubmed/19428933,19428933,,
569,811297,7501,Comparative Toxicogenomics Database (CTD),Styrene,C024075,styrofoam,https://ctdbase.org/detail.go?type=chem&acc=C024075,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),Styrofoam analog affects the activity of CYP1A2 protein|styrofoam analog promotes the reaction [cimetidine results in decreased activity of CYP1A2 protein],,,PMID:19909766,https://www.ncbi.nlm.nih.gov/pubmed/19909766,19909766,,
570,811298,7501,Comparative Toxicogenomics Database (CTD),Styrene,C024075,styrofoam,https://ctdbase.org/detail.go?type=chem&acc=C024075,1559,CYP2C9,https://ctdbase.org/detail.go?type=gene&acc=1559,,,1559.0,CYP2C9,9606.0,Homo sapiens (human),Styrofoam analog promotes the reaction [cimetidine results in decreased activity of CYP2C9 protein]|styrofoam analog results in decreased activity of CYP2C9 protein,,,PMID:19909766,https://www.ncbi.nlm.nih.gov/pubmed/19909766,19909766,,
571,811299,7501,Comparative Toxicogenomics Database (CTD),Styrene,C024075,styrofoam,https://ctdbase.org/detail.go?type=chem&acc=C024075,1565,CYP2D6,https://ctdbase.org/detail.go?type=gene&acc=1565,,,1565.0,CYP2D6,9606.0,Homo sapiens (human),Styrofoam analog results in decreased activity of CYP2D6 protein|styrofoam analog promotes the reaction [cimetidine results in decreased activity of CYP2D6 protein],,,PMID:19909766,https://www.ncbi.nlm.nih.gov/pubmed/19909766,19909766,,
572,816845,7577,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenedianiline",C009505,"4,4'-diaminodiphenylmethane",https://ctdbase.org/detail.go?type=chem&acc=C009505,2919,CXCL1,https://ctdbase.org/detail.go?type=gene&acc=2919,,,2919.0,CXCL1,10116.0,Rattus norvegicus (Norway rat),"4,4'-diaminodiphenylmethane results in increased expression of CXCL1 mRNA",,,PMID:25380136,https://www.ncbi.nlm.nih.gov/pubmed/25380136,25380136,,
573,816846,7577,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenedianiline",C009505,"4,4'-diaminodiphenylmethane",https://ctdbase.org/detail.go?type=chem&acc=C009505,3627,CXCL10,https://ctdbase.org/detail.go?type=gene&acc=3627,,,3627.0,CXCL10,10116.0,Rattus norvegicus (Norway rat),"4,4'-diaminodiphenylmethane results in increased expression of CXCL10 mRNA",,,PMID:25380136,https://www.ncbi.nlm.nih.gov/pubmed/25380136,25380136,,
574,816847,7577,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenedianiline",C009505,"4,4'-diaminodiphenylmethane",https://ctdbase.org/detail.go?type=chem&acc=C009505,6387,CXCL12,https://ctdbase.org/detail.go?type=gene&acc=6387,,,6387.0,CXCL12,10116.0,Rattus norvegicus (Norway rat),"4,4'-diaminodiphenylmethane affects the expression of CXCL12 mRNA",,,PMID:25380136,https://www.ncbi.nlm.nih.gov/pubmed/25380136,25380136,,
575,816848,7577,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenedianiline",C009505,"4,4'-diaminodiphenylmethane",https://ctdbase.org/detail.go?type=chem&acc=C009505,10563,CXCL13,https://ctdbase.org/detail.go?type=gene&acc=10563,,,10563.0,CXCL13,10116.0,Rattus norvegicus (Norway rat),"4,4'-diaminodiphenylmethane results in decreased expression of CXCL13 mRNA",,,PMID:25380136,https://www.ncbi.nlm.nih.gov/pubmed/25380136,25380136,,
576,817300,7577,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenedianiline",C009505,"4,4'-diaminodiphenylmethane",https://ctdbase.org/detail.go?type=chem&acc=C009505,24895,CYP2A2,https://ctdbase.org/detail.go?type=gene&acc=24895,,,24895.0,Cyp2a2,10116.0,Rattus norvegicus (Norway rat),"4,4'-diaminodiphenylmethane results in decreased expression of CYP2A2 mRNA",,,PMID:25380136|PMID:30723492,https://www.ncbi.nlm.nih.gov/pubmed/25380136|https://www.ncbi.nlm.nih.gov/pubmed/30723492,25380136|30723492,,
577,817301,7577,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenedianiline",C009505,"4,4'-diaminodiphenylmethane",https://ctdbase.org/detail.go?type=chem&acc=C009505,24300,CYP2B1,https://ctdbase.org/detail.go?type=gene&acc=24300,,,24300.0,Cyp2b1,10116.0,Rattus norvegicus (Norway rat),"4,4'-diaminodiphenylmethane results in increased expression of CYP2B1 mRNA",,,PMID:30723492,https://www.ncbi.nlm.nih.gov/pubmed/30723492,30723492,,
578,817302,7577,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenedianiline",C009505,"4,4'-diaminodiphenylmethane",https://ctdbase.org/detail.go?type=chem&acc=C009505,13094,CYP2B9,https://ctdbase.org/detail.go?type=gene&acc=13094,,,13094.0,Cyp2b9,10090.0,Mus musculus (house mouse),"4,4'-diaminodiphenylmethane results in increased expression of CYP2B9 mRNA",,,PMID:18648102,https://www.ncbi.nlm.nih.gov/pubmed/18648102,18648102,,
579,819791,7577,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenedianiline",C009505,"4,4'-diaminodiphenylmethane",https://ctdbase.org/detail.go?type=chem&acc=C009505,1849,DUSP7,https://ctdbase.org/detail.go?type=gene&acc=1849,,,1849.0,DUSP7,10090.0,Mus musculus (house mouse),"4,4'-diaminodiphenylmethane results in decreased expression of DUSP7 mRNA",,,PMID:18648102,https://www.ncbi.nlm.nih.gov/pubmed/18648102,18648102,,
580,819792,7577,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenedianiline",C009505,"4,4'-diaminodiphenylmethane",https://ctdbase.org/detail.go?type=chem&acc=C009505,1854,DUT,https://ctdbase.org/detail.go?type=gene&acc=1854,,,1854.0,DUT,10090.0,Mus musculus (house mouse),"4,4'-diaminodiphenylmethane affects the expression of DUT mRNA",,,PMID:18648102,https://www.ncbi.nlm.nih.gov/pubmed/18648102,18648102,,
581,819793,7577,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenedianiline",C009505,"4,4'-diaminodiphenylmethane",https://ctdbase.org/detail.go?type=chem&acc=C009505,1855,DVL1,https://ctdbase.org/detail.go?type=gene&acc=1855,,,1855.0,DVL1,10116.0,Rattus norvegicus (Norway rat),"4,4'-diaminodiphenylmethane results in decreased expression of DVL1 mRNA",,,PMID:30723492,https://www.ncbi.nlm.nih.gov/pubmed/30723492,30723492,,
582,732520,7961,Comparative Toxicogenomics Database (CTD),Bromobenzene,C032036,bromobenzene,https://ctdbase.org/detail.go?type=chem&acc=C032036,7534,YWHAZ,https://ctdbase.org/detail.go?type=gene&acc=7534,,,7534.0,YWHAZ,10116.0,Rattus norvegicus (Norway rat),Bromobenzene results in decreased expression of YWHAZ mRNA,,,PMID:12628495,https://www.ncbi.nlm.nih.gov/pubmed/12628495,12628495,,
583,732521,7961,Comparative Toxicogenomics Database (CTD),Bromobenzene,C032036,bromobenzene,https://ctdbase.org/detail.go?type=chem&acc=C032036,81030,ZBP1,https://ctdbase.org/detail.go?type=gene&acc=81030,,,81030.0,ZBP1,10116.0,Rattus norvegicus (Norway rat),Bromobenzene results in decreased expression of ZBP1 mRNA,,,PMID:32479839,https://www.ncbi.nlm.nih.gov/pubmed/32479839,32479839,,
584,793828,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,7462,LAT2,https://ctdbase.org/detail.go?type=gene&acc=7462,,,7462.0,LAT2,9606.0,Homo sapiens (human),Pentanal results in increased expression of LAT2 mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
585,806067,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,84958,SYTL1,https://ctdbase.org/detail.go?type=gene&acc=84958,,,84958.0,SYTL1,9606.0,Homo sapiens (human),Pentanal results in increased expression of SYTL1 mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
586,806068,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,23435,TARDBP,https://ctdbase.org/detail.go?type=gene&acc=23435,,,23435.0,TARDBP,9606.0,Homo sapiens (human),Pentanal results in decreased expression of TARDBP mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
587,808480,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,80328,ULBP2,https://ctdbase.org/detail.go?type=gene&acc=80328,,,80328.0,ULBP2,9606.0,Homo sapiens (human),Pentanal results in increased expression of ULBP2 mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
588,808481,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,219699,UNC5B,https://ctdbase.org/detail.go?type=gene&acc=219699,,,219699.0,UNC5B,9606.0,Homo sapiens (human),Pentanal results in increased expression of UNC5B mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
589,808482,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,124590,USH1G,https://ctdbase.org/detail.go?type=gene&acc=124590,,,124590.0,USH1G,9606.0,Homo sapiens (human),Pentanal results in increased expression of USH1G mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
590,808483,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,392197,USP17L7,https://ctdbase.org/detail.go?type=gene&acc=392197,,,392197.0,USP17L7,9606.0,Homo sapiens (human),Pentanal results in increased expression of USP17L7 mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
591,808484,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,158572,USP27X-DT,https://ctdbase.org/detail.go?type=gene&acc=158572,,,158572.0,USP27X-DT,9606.0,Homo sapiens (human),Pentanal results in decreased expression of USP27X-DT mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
592,808485,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,25862,USP49,https://ctdbase.org/detail.go?type=gene&acc=25862,,,25862.0,USP49,9606.0,Homo sapiens (human),Pentanal results in decreased expression of USP49 mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
593,808486,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,7402,UTRN,https://ctdbase.org/detail.go?type=gene&acc=7402,,,7402.0,UTRN,9606.0,Homo sapiens (human),Pentanal results in decreased expression of UTRN mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
594,809183,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,170626,XAGE3,https://ctdbase.org/detail.go?type=gene&acc=170626,,,170626.0,XAGE3,9606.0,Homo sapiens (human),Pentanal results in decreased expression of XAGE3 mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
595,809184,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,7498,XDH,https://ctdbase.org/detail.go?type=gene&acc=7498,,,7498.0,XDH,9606.0,Homo sapiens (human),Pentanal results in increased expression of XDH mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
596,809185,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,143570,XRRA1,https://ctdbase.org/detail.go?type=gene&acc=143570,,,143570.0,XRRA1,9606.0,Homo sapiens (human),Pentanal results in decreased expression of XRRA1 mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
597,809186,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,51087,YBX2,https://ctdbase.org/detail.go?type=gene&acc=51087,,,51087.0,YBX2,9606.0,Homo sapiens (human),Pentanal results in increased expression of YBX2 mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
598,809187,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,29799,YPEL1,https://ctdbase.org/detail.go?type=gene&acc=29799,,,29799.0,YPEL1,9606.0,Homo sapiens (human),Pentanal results in decreased expression of YPEL1 mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
599,809188,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,79413,ZBED2,https://ctdbase.org/detail.go?type=gene&acc=79413,,,79413.0,ZBED2,9606.0,Homo sapiens (human),Pentanal results in increased expression of ZBED2 mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
600,809189,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,57684,ZBTB26,https://ctdbase.org/detail.go?type=gene&acc=57684,,,57684.0,ZBTB26,9606.0,Homo sapiens (human),Pentanal results in decreased expression of ZBTB26 mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
601,809998,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,22834,ZNF652,https://ctdbase.org/detail.go?type=gene&acc=22834,,,22834.0,ZNF652,9606.0,Homo sapiens (human),Pentanal results in decreased expression of ZNF652 mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
602,809999,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,7617,ZNF66,https://ctdbase.org/detail.go?type=gene&acc=7617,,,7617.0,ZNF66,9606.0,Homo sapiens (human),Pentanal results in decreased expression of ZNF66 mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
603,810000,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,163223,ZNF676,https://ctdbase.org/detail.go?type=gene&acc=163223,,,163223.0,ZNF676,9606.0,Homo sapiens (human),Pentanal results in decreased expression of ZNF676 mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
604,810001,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,51123,ZNF706,https://ctdbase.org/detail.go?type=gene&acc=51123,,,51123.0,ZNF706,9606.0,Homo sapiens (human),Pentanal results in decreased expression of ZNF706 mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
605,810002,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,349075,ZNF713,https://ctdbase.org/detail.go?type=gene&acc=349075,,,349075.0,ZNF713,9606.0,Homo sapiens (human),Pentanal results in decreased expression of ZNF713 mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
606,810003,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,100131827,ZNF717,https://ctdbase.org/detail.go?type=gene&acc=100131827,,,100131827.0,ZNF717,9606.0,Homo sapiens (human),Pentanal results in increased expression of ZNF717 mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
607,810004,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,7629,ZNF76,https://ctdbase.org/detail.go?type=gene&acc=7629,,,7629.0,ZNF76,9606.0,Homo sapiens (human),Pentanal results in decreased expression of ZNF76 mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
608,810005,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,388558,ZNF808,https://ctdbase.org/detail.go?type=gene&acc=388558,,,388558.0,ZNF808,9606.0,Homo sapiens (human),Pentanal results in increased expression of ZNF808 mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
609,810006,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,125893,ZNF816,https://ctdbase.org/detail.go?type=gene&acc=125893,,,125893.0,ZNF816,9606.0,Homo sapiens (human),Pentanal results in increased expression of ZNF816 mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
610,810007,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,152485,ZNF827,https://ctdbase.org/detail.go?type=gene&acc=152485,,,152485.0,ZNF827,9606.0,Homo sapiens (human),Pentanal results in decreased expression of ZNF827 mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
611,811289,8110,Toxin and Toxin Target Database (T3DB),Butyl isocyanate,T3D1666,n-Butyl isocyanate,http://www.t3db.ca/toxins/T3D1666,BE0005057,Extracellular superoxide dismutase [Cu-Zn],http://www.t3db.ca/biodb/bio_entities/BE0005057,P08294,Extracellular superoxide dismutase [Cu-Zn],6649.0,SOD3,9606.0,Homo sapiens (human),Cyanide inhibits superoxide dismutase [cu-zn]. (A72),,,PMID:15856906,https://www.ncbi.nlm.nih.gov/pubmed/15856906,15856906,,
612,811290,8110,Toxin and Toxin Target Database (T3DB),Butyl isocyanate,T3D1666,n-Butyl isocyanate,http://www.t3db.ca/toxins/T3D1666,BE0001135,"Phospholipid hydroperoxide glutathione peroxidase, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0001135,P36969,Phospholipid hydroperoxide glutathione peroxidase,2879.0,GPX4,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
613,811463,8110,Toxin and Toxin Target Database (T3DB),Butyl isocyanate,T3D1666,n-Butyl isocyanate,http://www.t3db.ca/toxins/T3D1666,BE0002288,Probable glutathione peroxidase 8,http://www.t3db.ca/biodb/bio_entities/BE0002288,Q8TED1,Probable glutathione peroxidase 8,493869.0,GPX8,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
614,811464,8110,Toxin and Toxin Target Database (T3DB),Butyl isocyanate,T3D1666,n-Butyl isocyanate,http://www.t3db.ca/toxins/T3D1666,BE0005082,"Putative cytochrome c oxidase subunit 7A3, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0005082,O60397,"Putative cytochrome c oxidase subunit 7A3, mitochondrial",,,9606.0,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
615,811465,8110,Toxin and Toxin Target Database (T3DB),Butyl isocyanate,T3D1666,n-Butyl isocyanate,http://www.t3db.ca/toxins/T3D1666,BE0002252,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0002252,O14521,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",6392.0,SDHD,9606.0,Homo sapiens (human),Cyanide inhibits succinate dehydrogenases. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
616,811466,8110,Toxin and Toxin Target Database (T3DB),Butyl isocyanate,T3D1666,n-Butyl isocyanate,http://www.t3db.ca/toxins/T3D1666,BE0000176,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000176,P31040,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",6389.0,SDHA,9606.0,Homo sapiens (human),Cyanide inhibits succinate dehydrogenases. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
617,811467,8110,Toxin and Toxin Target Database (T3DB),Butyl isocyanate,T3D1666,n-Butyl isocyanate,http://www.t3db.ca/toxins/T3D1666,BE0002254,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0002254,P21912,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",6390.0,SDHB,9606.0,Homo sapiens (human),Cyanide inhibits succinate dehydrogenases. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
618,811468,8110,Toxin and Toxin Target Database (T3DB),Butyl isocyanate,T3D1666,n-Butyl isocyanate,http://www.t3db.ca/toxins/T3D1666,BE0002257,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0002257,Q99643,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",6391.0,SDHC,9606.0,Homo sapiens (human),Cyanide inhibits succinate dehydrogenases. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
619,811469,8110,Toxin and Toxin Target Database (T3DB),Butyl isocyanate,T3D1666,n-Butyl isocyanate,http://www.t3db.ca/toxins/T3D1666,BE0002390,Superoxide dismutase [Cu-Zn],http://www.t3db.ca/biodb/bio_entities/BE0002390,P00441,Superoxide dismutase [Cu-Zn],6647.0,SOD1,9606.0,Homo sapiens (human),Cyanide inhibits superoxide dismutase [cu-zn]. (A72),,,PMID:15856906,https://www.ncbi.nlm.nih.gov/pubmed/15856906,15856906,,
620,811470,8110,Toxin and Toxin Target Database (T3DB),Butyl isocyanate,T3D1666,n-Butyl isocyanate,http://www.t3db.ca/toxins/T3D1666,BE0000252,Tyrosinase,http://www.t3db.ca/biodb/bio_entities/BE0000252,P14679,Tyrosinase,7299.0,TYR,9606.0,Homo sapiens (human),Cyanide inhibits tyrosinase. (A77),,,PMID:16950829,https://www.ncbi.nlm.nih.gov/pubmed/16950829,16950829,,
621,806069,8371,Comparative Toxicogenomics Database (CTD),Chloranil,C000591600,tetrachlorobenzoquinone,https://ctdbase.org/detail.go?type=chem&acc=C000591600,7514,XPO1,https://ctdbase.org/detail.go?type=gene&acc=7514,,,7514.0,XPO1,9606.0,Homo sapiens (human),Tetrachlorobenzoquinone promotes the reaction [BACH1 protein binds to XPO1 protein],,,PMID:27393035,https://www.ncbi.nlm.nih.gov/pubmed/27393035,27393035,,
622,806070,8371,Comparative Toxicogenomics Database (CTD),Chloranil,C000591600,tetrachlorobenzoquinone,https://ctdbase.org/detail.go?type=chem&acc=C000591600,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606.0,Homo sapiens (human),Acetovanillone inhibits the reaction [tetrachlorobenzoquinone results in increased expression of ICAM1 protein]|benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane analog inhibits the reaction [tetrachlorobenzoquinone results in increased expression of ICAM1 protein]|mitotempo inhibits the reaction [tetrachlorobenzoquinone results in increased expression of ICAM1 protein]|tetrachlorobenzoquinone results in increased expression of ICAM1 protein|acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of ICAM1 protein]|l 709049 inhibits the reaction [tetrachlorobenzoquinone results in increased expression of ICAM1 protein]|nlrp3 protein promotes the reaction [tetrachlorobenzoquinone results in increased expression of ICAM1 protein],,,PMID:26901245,https://www.ncbi.nlm.nih.gov/pubmed/26901245,26901245,,
623,806071,8371,Comparative Toxicogenomics Database (CTD),Chloranil,C000591600,tetrachlorobenzoquinone,https://ctdbase.org/detail.go?type=chem&acc=C000591600,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),"Potassium inhibits the reaction [tetrachlorobenzoquinone results in increased secretion of IL1B protein modified form]|acetovanillone inhibits the reaction [tetrachlorobenzoquinone results in increased secretion of IL1B protein modified form]|l 709049 inhibits the reaction [tetrachlorobenzoquinone results in increased expression of IL1B protein]|tetrachlorobenzoquinone results in increased expression of IL1B mrna|tetrachlorobenzoquinone results in increased expression of and results in increased cleavage of IL1B protein|2,6-diaminopyridine-3,5-bis(thiocyanate) inhibits the reaction [tetrachlorobenzoquinone results in increased secretion of IL1B protein modified form]|benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane analog inhibits the reaction [tetrachlorobenzoquinone results in increased secretion of IL1B protein modified form]|cycloheximide inhibits the reaction [tetrachlorobenzoquinone results in increased expression of IL1B protein]|acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased secretion of IL1B protein modified form]|l 709049 inhibits the reaction [tetrachlorobenzoquinone results in increased secretion of IL1B protein modified form]|benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane analog inhibits the reaction [tetrachlorobenzoquinone results in increased expression of IL1B protein]|mitotempo inhibits the reaction [tetrachlorobenzoquinone results in increased expression of IL1B protein]|mitotempo inhibits the reaction [tetrachlorobenzoquinone results in increased secretion of IL1B protein modified form]|nlrp3 protein promotes the reaction [tetrachlorobenzoquinone results in increased secretion of IL1B protein modified form]|acetovanillone inhibits the reaction [tetrachlorobenzoquinone results in increased expression of IL1B protein]|acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of IL1B protein]|tetrachlorobenzoquinone results in increased secretion of IL1B protein modified form|cycloheximide inhibits the reaction [tetrachlorobenzoquinone results in increased secretion of IL1B protein modified form]",,,PMID:26901245,https://www.ncbi.nlm.nih.gov/pubmed/26901245,26901245,,
624,806072,8371,Comparative Toxicogenomics Database (CTD),Chloranil,C000591600,tetrachlorobenzoquinone,https://ctdbase.org/detail.go?type=chem&acc=C000591600,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),Polyethylene glycol 1000 inhibits the reaction [tetrachlorobenzoquinone results in increased secretion of IL1B protein]|gsdmd protein affects the reaction [tetrachlorobenzoquinone results in increased secretion of IL1B protein]|tetrachlorobenzoquinone results in increased secretion of IL1B protein|polyethylene glycol 6000 inhibits the reaction [tetrachlorobenzoquinone results in increased secretion of IL1B protein],,,PMID:30378427,https://www.ncbi.nlm.nih.gov/pubmed/30378427,30378427,,
625,806073,8371,Comparative Toxicogenomics Database (CTD),Chloranil,C000591600,tetrachlorobenzoquinone,https://ctdbase.org/detail.go?type=chem&acc=C000591600,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),Tetrachlorobenzoquinone results in increased expression of IL1B mrna|tetrachlorobenzoquinone results in increased expression of and results in increased secretion of IL1B protein|melatonin inhibits the reaction [tetrachlorobenzoquinone results in increased expression of and results in increased secretion of IL1B protein]|tlr4 gene mutant form inhibits the reaction [tetrachlorobenzoquinone results in increased expression of IL1B mrna]|tetrachlorobenzoquinone results in increased expression of IL1B protein|hmgb1 affects the reaction [tetrachlorobenzoquinone results in increased expression of and results in increased secretion of IL1B protein],,,PMID:27413111,https://www.ncbi.nlm.nih.gov/pubmed/27413111,27413111,,
626,807503,8378,Comparative Toxicogenomics Database (CTD),Framycetin,D009355,Neomycin,https://ctdbase.org/detail.go?type=chem&acc=D009355,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,10090.0,Mus musculus (house mouse),[vancomycin co-treated with neomycin co-treated with ampicillin co-treated with metronidazole co-treated with amphotericin B] results in decreased expression of ABCA1 mRNA,,,PMID:36464106,https://www.ncbi.nlm.nih.gov/pubmed/36464106,36464106,,
627,807504,8378,Comparative Toxicogenomics Database (CTD),Framycetin,D009355,Neomycin,https://ctdbase.org/detail.go?type=chem&acc=D009355,8647,ABCB11,https://ctdbase.org/detail.go?type=gene&acc=8647,,,8647.0,ABCB11,10090.0,Mus musculus (house mouse),[vancomycin co-treated with neomycin co-treated with ampicillin co-treated with metronidazole co-treated with amphotericin B] results in increased expression of ABCB11 mRNA,,,PMID:36464106,https://www.ncbi.nlm.nih.gov/pubmed/36464106,36464106,,
628,807505,8378,Comparative Toxicogenomics Database (CTD),Framycetin,D009355,Neomycin,https://ctdbase.org/detail.go?type=chem&acc=D009355,18671,ABCB1A,https://ctdbase.org/detail.go?type=gene&acc=18671,,,18671.0,Abcb1a,10090.0,Mus musculus (house mouse),[vancomycin co-treated with neomycin co-treated with ampicillin co-treated with metronidazole co-treated with amphotericin B] results in increased expression of ABCB1A mRNA,,,PMID:36464106,https://www.ncbi.nlm.nih.gov/pubmed/36464106,36464106,,
629,809508,8378,Comparative Toxicogenomics Database (CTD),Framycetin,D009355,Neomycin,https://ctdbase.org/detail.go?type=chem&acc=D009355,3360,HTR4,https://ctdbase.org/detail.go?type=gene&acc=3360,,,3360.0,HTR4,10090.0,Mus musculus (house mouse),[vancomycin co-treated with neomycin co-treated with metronidazole] promotes the reaction [zinc oxide results in increased expression of HTR4 mrna]|[vancomycin co-treated with neomycin co-treated with metronidazole] results in increased expression of HTR4 mRNA,,,PMID:36535435,https://www.ncbi.nlm.nih.gov/pubmed/36535435,36535435,,
630,809509,8378,Comparative Toxicogenomics Database (CTD),Framycetin,D009355,Neomycin,https://ctdbase.org/detail.go?type=chem&acc=D009355,3507,IGHM,https://ctdbase.org/detail.go?type=gene&acc=3507,,,3507.0,IGHM,10116.0,Rattus norvegicus (Norway rat),[ampicillin co-treated with neomycin co-treated with gentamicins co-treated with metronidazole co-treated with vancomycin] results in increased expression of IGHM protein,,,PMID:30545405,https://www.ncbi.nlm.nih.gov/pubmed/30545405,30545405,,
631,809510,8378,Comparative Toxicogenomics Database (CTD),Framycetin,D009355,Neomycin,https://ctdbase.org/detail.go?type=chem&acc=D009355,3606,IL18,https://ctdbase.org/detail.go?type=gene&acc=3606,,,3606.0,IL18,10090.0,Mus musculus (house mouse),[neomycin co-treated with metronidazole co-treated with ampicillin co-treated with vancomycin] inhibits the reaction [methamphetamine results in increased secretion of IL18 protein],,,PMID:35390362,https://www.ncbi.nlm.nih.gov/pubmed/35390362,35390362,,
632,809511,8378,Comparative Toxicogenomics Database (CTD),Framycetin,D009355,Neomycin,https://ctdbase.org/detail.go?type=chem&acc=D009355,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),[neomycin co-treated with metronidazole co-treated with ampicillin co-treated with vancomycin] inhibits the reaction [methamphetamine results in increased expression of IL1B mrna]|[neomycin co-treated with metronidazole co-treated with ampicillin co-treated with vancomycin] inhibits the reaction [methamphetamine results in increased expression of and results in increased secretion of IL1B protein],,,PMID:35390362,https://www.ncbi.nlm.nih.gov/pubmed/35390362,35390362,,
633,813482,8490,Comparative Toxicogenomics Database (CTD),Cyclonite,C009160,cyclonite,https://ctdbase.org/detail.go?type=chem&acc=C009160,7979,SEM1,https://ctdbase.org/detail.go?type=gene&acc=7979,,,7979.0,SEM1,6396.0,Eisenia fetida (common brandling worm),Cyclonite affects the expression of SEM1 mRNA,,,PMID:21060837,https://www.ncbi.nlm.nih.gov/pubmed/21060837,21060837,,
634,813483,8490,Comparative Toxicogenomics Database (CTD),Cyclonite,C009160,cyclonite,https://ctdbase.org/detail.go?type=chem&acc=C009160,9467,SH3BP5,https://ctdbase.org/detail.go?type=gene&acc=9467,,,9467.0,SH3BP5,10116.0,Rattus norvegicus (Norway rat),Cyclonite results in decreased expression of SH3BP5 mRNA,,,PMID:25559034,https://www.ncbi.nlm.nih.gov/pubmed/25559034,25559034,,
635,813484,8490,Comparative Toxicogenomics Database (CTD),Cyclonite,C009160,cyclonite,https://ctdbase.org/detail.go?type=chem&acc=C009160,51310,SLC22A17,https://ctdbase.org/detail.go?type=gene&acc=51310,,,51310.0,SLC22A17,10116.0,Rattus norvegicus (Norway rat),Cyclonite results in decreased expression of SLC22A17 mRNA,,,PMID:25559034,https://www.ncbi.nlm.nih.gov/pubmed/25559034,25559034,,
636,813485,8490,Comparative Toxicogenomics Database (CTD),Cyclonite,C009160,cyclonite,https://ctdbase.org/detail.go?type=chem&acc=C009160,339665,SLC35E4,https://ctdbase.org/detail.go?type=gene&acc=339665,,,339665.0,SLC35E4,10116.0,Rattus norvegicus (Norway rat),Cyclonite results in decreased expression of SLC35E4 mRNA,,,PMID:25559034,https://www.ncbi.nlm.nih.gov/pubmed/25559034,25559034,,
637,813486,8490,Comparative Toxicogenomics Database (CTD),Cyclonite,C009160,cyclonite,https://ctdbase.org/detail.go?type=chem&acc=C009160,222553,SLC35F1,https://ctdbase.org/detail.go?type=gene&acc=222553,,,222553.0,SLC35F1,9014.0,Colinus virginianus (northern bobwhite),Cyclonite results in decreased expression of SLC35F1 mRNA,,,PMID:19417177,https://www.ncbi.nlm.nih.gov/pubmed/19417177,19417177,,
638,813487,8490,Comparative Toxicogenomics Database (CTD),Cyclonite,C009160,cyclonite,https://ctdbase.org/detail.go?type=chem&acc=C009160,54407,SLC38A2,https://ctdbase.org/detail.go?type=gene&acc=54407,,,54407.0,SLC38A2,10116.0,Rattus norvegicus (Norway rat),Cyclonite results in increased expression of SLC38A2 mRNA,,,PMID:25559034,https://www.ncbi.nlm.nih.gov/pubmed/25559034,25559034,,
639,814339,8515,Comparative Toxicogenomics Database (CTD),"1,9-Pyrazoloanthrone",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [oxygen deficiency results in increased expression of ABCB1 mrna]|pyrazolanthrone inhibits the reaction [MAP3K1 protein results in increased expression of ABCB1 mrna],,,PMID:15604272,https://www.ncbi.nlm.nih.gov/pubmed/15604272,15604272,,
640,814340,8515,Comparative Toxicogenomics Database (CTD),"1,9-Pyrazoloanthrone",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,10116.0,Rattus norvegicus (Norway rat),Pyrazolanthrone inhibits the reaction [particulate matter results in increased expression of and results in increased activity of ABCB1 protein]|pyrazolanthrone inhibits the reaction [vehicle emissions results in increased expression of and results in increased activity of ABCB1 protein],,,PMID:18474546,https://www.ncbi.nlm.nih.gov/pubmed/18474546,18474546,,
641,814341,8515,Comparative Toxicogenomics Database (CTD),"1,9-Pyrazoloanthrone",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,59272,ACE2,https://ctdbase.org/detail.go?type=gene&acc=59272,,,59272.0,ACE2,10116.0,Rattus norvegicus (Norway rat),"Pyrazolanthrone inhibits the reaction [2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid inhibits the reaction [ACE2 protein inhibits the reaction [lipopolysaccharides results in increased expression of TNF protein]]]|pyrazolanthrone inhibits the reaction [7-ala-angiotensin (1-7) inhibits the reaction [ACE2 protein inhibits the reaction [lipopolysaccharides results in increased expression of IL1B protein]]]|pyrazolanthrone inhibits the reaction [7-ala-angiotensin (1-7) inhibits the reaction [ACE2 protein inhibits the reaction [lipopolysaccharides results in increased expression of TNF protein]]]|pyrazolanthrone inhibits the reaction [2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid inhibits the reaction [ACE2 protein inhibits the reaction [lipopolysaccharides results in increased expression of IL1B protein]]]",,,PMID:27302421,https://www.ncbi.nlm.nih.gov/pubmed/27302421,27302421,,
642,814342,8515,Comparative Toxicogenomics Database (CTD),"1,9-Pyrazoloanthrone",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116.0,Rattus norvegicus (Norway rat),Pyrazolanthrone inhibits the reaction [streptozocin results in increased activity of ACHE protein],,,PMID:20600246,https://www.ncbi.nlm.nih.gov/pubmed/20600246,20600246,,
643,814343,8515,Comparative Toxicogenomics Database (CTD),"1,9-Pyrazoloanthrone",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,54,ACP5,https://ctdbase.org/detail.go?type=gene&acc=54,,,54.0,ACP5,10090.0,Mus musculus (house mouse),Pyrazolanthrone inhibits the reaction [TNFSF11 protein results in increased activity of ACP5 protein]|crocin promotes the reaction [pyrazolanthrone inhibits the reaction [TNFSF11 protein results in increased activity of ACP5 protein]],,,PMID:30580027,https://www.ncbi.nlm.nih.gov/pubmed/30580027,30580027,,
644,814344,8515,Comparative Toxicogenomics Database (CTD),"1,9-Pyrazoloanthrone",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,10090.0,Mus musculus (house mouse),"Pyrazolanthrone promotes the reaction [6,7-dimethyl-2-(2E)-3-(1-methyl-2-phenyl-1H-pyrrolo(2,3-b)pyridin-3-yl-prop-2-enoyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride inhibits the reaction [folic acid results in increased expression of ACTA2 protein]]|pyrazolanthrone inhibits the reaction [folic acid results in increased expression of ACTA2 protein]|6,7-dimethyl-2-(2E)-3-(1-methyl-2-phenyl-1H-pyrrolo(2,3-b)pyridin-3-yl-prop-2-enoyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride promotes the reaction [pyrazolanthrone inhibits the reaction [folic acid results in increased expression of ACTA2 protein]]",,,PMID:31447676,https://www.ncbi.nlm.nih.gov/pubmed/31447676,31447676,,
645,815181,8515,Comparative Toxicogenomics Database (CTD),"1,9-Pyrazoloanthrone",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606.0,Homo sapiens (human),Pyrazolanthrone affects the reaction [quercetin inhibits the reaction [mibolerone results in increased expression of AR protein]],,,PMID:20148354,https://www.ncbi.nlm.nih.gov/pubmed/20148354,20148354,,
646,815182,8515,Comparative Toxicogenomics Database (CTD),"1,9-Pyrazoloanthrone",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,1386,ATF2,https://ctdbase.org/detail.go?type=gene&acc=1386,,,1386.0,ATF2,9606.0,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased phosphorylation of ATF2 protein]|pyrazolanthrone inhibits the reaction [tetrachlorodibenzodioxin results in increased phosphorylation of ATF2 protein],,,PMID:24469321,https://www.ncbi.nlm.nih.gov/pubmed/24469321,24469321,,
647,815183,8515,Comparative Toxicogenomics Database (CTD),"1,9-Pyrazoloanthrone",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,1386,ATF2,https://ctdbase.org/detail.go?type=gene&acc=1386,,,1386.0,ATF2,9606.0,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [2-aminodiphenyl results in increased expression of and results in increased phosphorylation of ATF2 protein],,,PMID:23836369,https://www.ncbi.nlm.nih.gov/pubmed/23836369,23836369,,
648,815184,8515,Comparative Toxicogenomics Database (CTD),"1,9-Pyrazoloanthrone",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,1386,ATF2,https://ctdbase.org/detail.go?type=gene&acc=1386,,,1386.0,ATF2,9606.0,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [cisplatin results in increased activity of ATF2 protein]|pyrazolanthrone inhibits the reaction [cisplatin results in increased phosphorylation of and results in increased activity of ATF2 protein]|pyrazolanthrone inhibits the reaction [ATF2 protein results in decreased susceptibility to cisplatin],,,PMID:12663670,https://www.ncbi.nlm.nih.gov/pubmed/12663670,12663670,,
649,815185,8515,Comparative Toxicogenomics Database (CTD),"1,9-Pyrazoloanthrone",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,1386,ATF2,https://ctdbase.org/detail.go?type=gene&acc=1386,,,1386.0,ATF2,9606.0,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [bortezomib results in increased phosphorylation of ATF2 protein],,,PMID:12393500,https://www.ncbi.nlm.nih.gov/pubmed/12393500,12393500,,
650,815186,8515,Comparative Toxicogenomics Database (CTD),"1,9-Pyrazoloanthrone",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,1386,ATF2,https://ctdbase.org/detail.go?type=gene&acc=1386,,,1386.0,ATF2,9606.0,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [hydroquinone results in increased phosphorylation of ATF2 protein],,,PMID:23791922,https://www.ncbi.nlm.nih.gov/pubmed/23791922,23791922,,
651,815187,8515,Comparative Toxicogenomics Database (CTD),"1,9-Pyrazoloanthrone",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,1386,ATF2,https://ctdbase.org/detail.go?type=gene&acc=1386,,,1386.0,ATF2,9606.0,Homo sapiens (human),"Pyrazolanthrone inhibits the reaction [O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate results in increased phosphorylation of ATF2 protein]",,,PMID:22003962,https://www.ncbi.nlm.nih.gov/pubmed/22003962,22003962,,
652,815188,8515,Comparative Toxicogenomics Database (CTD),"1,9-Pyrazoloanthrone",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,1386,ATF2,https://ctdbase.org/detail.go?type=gene&acc=1386,,,1386.0,ATF2,9606.0,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [sodium arsenite results in increased expression of ATF2 protein modified form]|pyrazolanthrone inhibits the reaction [sodium arsenite results in increased expression of ATF2 protein]|pyrazolanthrone inhibits the reaction [sodium arsenite results in increased expression of ATF2 mrna],,,PMID:23591579,https://www.ncbi.nlm.nih.gov/pubmed/23591579,23591579,,
653,815189,8515,Comparative Toxicogenomics Database (CTD),"1,9-Pyrazoloanthrone",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,1386,ATF2,https://ctdbase.org/detail.go?type=gene&acc=1386,,,1386.0,ATF2,10090.0,Mus musculus (house mouse),Pyrazolanthrone inhibits the reaction [anisomycin results in increased phosphorylation of ATF2 protein],,,PMID:28975372,https://www.ncbi.nlm.nih.gov/pubmed/28975372,28975372,,
654,817469,8515,Comparative Toxicogenomics Database (CTD),"1,9-Pyrazoloanthrone",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [biological products results in increased expression of CASP3 mrna],,,PMID:22654482,https://www.ncbi.nlm.nih.gov/pubmed/22654482,22654482,,
655,817470,8515,Comparative Toxicogenomics Database (CTD),"1,9-Pyrazoloanthrone",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [bortezomib results in increased activity of CASP3 protein],,,PMID:16357177,https://www.ncbi.nlm.nih.gov/pubmed/16357177,16357177,,
656,818803,8566,Comparative Toxicogenomics Database (CTD),Diatrizoate Meglumine,D003974,Diatrizoate Meglumine,https://ctdbase.org/detail.go?type=chem&acc=D003974,7184,HSP90B1,https://ctdbase.org/detail.go?type=gene&acc=7184,,,7184.0,HSP90B1,10116.0,Rattus norvegicus (Norway rat),Diatrizoate meglumine results in increased expression of HSP90B1 protein,,,PMID:20071420,https://www.ncbi.nlm.nih.gov/pubmed/20071420,20071420,,
657,818804,8566,Comparative Toxicogenomics Database (CTD),Diatrizoate Meglumine,D003974,Diatrizoate Meglumine,https://ctdbase.org/detail.go?type=chem&acc=D003974,3309,HSPA5,https://ctdbase.org/detail.go?type=gene&acc=3309,,,3309.0,HSPA5,10116.0,Rattus norvegicus (Norway rat),Diatrizoate meglumine results in increased expression of HSPA5 protein,,,PMID:20071420,https://www.ncbi.nlm.nih.gov/pubmed/20071420,20071420,,
658,818805,8566,Comparative Toxicogenomics Database (CTD),Diatrizoate Meglumine,D003974,Diatrizoate Meglumine,https://ctdbase.org/detail.go?type=chem&acc=D003974,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),Lansoprazole inhibits the reaction [diatrizoate meglumine results in increased expression of IL6 mrna]|diatrizoate meglumine results in increased expression of IL6 mRNA,,,PMID:28412091,https://www.ncbi.nlm.nih.gov/pubmed/28412091,28412091,,
659,818806,8566,Comparative Toxicogenomics Database (CTD),Diatrizoate Meglumine,D003974,Diatrizoate Meglumine,https://ctdbase.org/detail.go?type=chem&acc=D003974,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),NFE2L2 protein affects the reaction [sulforaphane inhibits the reaction [diatrizoate meglumine results in increased expression of IL6 protein]]|sulforaphane inhibits the reaction [diatrizoate meglumine results in increased expression of IL6 protein]|diatrizoate meglumine results in increased expression of IL6 protein,,,PMID:31173751,https://www.ncbi.nlm.nih.gov/pubmed/31173751,31173751,,
660,818807,8566,Comparative Toxicogenomics Database (CTD),Diatrizoate Meglumine,D003974,Diatrizoate Meglumine,https://ctdbase.org/detail.go?type=chem&acc=D003974,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116.0,Rattus norvegicus (Norway rat),Diatrizoate meglumine results in decreased expression of NFE2L2 protein|nfe2l2 protein affects the reaction [[sulforaphane co-treated with diatrizoate meglumine] results in increased activity of CASP3 protein]|nfe2l2 protein affects the reaction [sulforaphane inhibits the reaction [diatrizoate meglumine results in increased expression of IL6 protein]],,,PMID:31173751,https://www.ncbi.nlm.nih.gov/pubmed/31173751,31173751,,
661,818808,8566,Comparative Toxicogenomics Database (CTD),Diatrizoate Meglumine,D003974,Diatrizoate Meglumine,https://ctdbase.org/detail.go?type=chem&acc=D003974,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116.0,Rattus norvegicus (Norway rat),Diatrizoate meglumine results in increased expression of NFE2L2 mrna|lansoprazole inhibits the reaction [diatrizoate meglumine results in increased expression of NFE2L2 mrna],,,PMID:28412091,https://www.ncbi.nlm.nih.gov/pubmed/28412091,28412091,,
662,811793,8607,Comparative Toxicogenomics Database (CTD),Folpet,C005020,folpet,https://ctdbase.org/detail.go?type=chem&acc=C005020,112,ADCY6,https://ctdbase.org/detail.go?type=gene&acc=112,,,112.0,ADCY6,10090.0,Mus musculus (house mouse),Folpet results in decreased expression of ADCY6 mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
663,811794,8607,Comparative Toxicogenomics Database (CTD),Folpet,C005020,folpet,https://ctdbase.org/detail.go?type=chem&acc=C005020,128,ADH5,https://ctdbase.org/detail.go?type=gene&acc=128,,,128.0,ADH5,10090.0,Mus musculus (house mouse),Folpet results in increased expression of ADH5 mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
664,811795,8607,Comparative Toxicogenomics Database (CTD),Folpet,C005020,folpet,https://ctdbase.org/detail.go?type=chem&acc=C005020,79814,AGMAT,https://ctdbase.org/detail.go?type=gene&acc=79814,,,79814.0,AGMAT,10090.0,Mus musculus (house mouse),Folpet results in decreased expression of AGMAT mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
665,812173,8607,Comparative Toxicogenomics Database (CTD),Folpet,C005020,folpet,https://ctdbase.org/detail.go?type=chem&acc=C005020,345,APOC3,https://ctdbase.org/detail.go?type=gene&acc=345,,,345.0,APOC3,10090.0,Mus musculus (house mouse),Folpet results in increased expression of APOC3 mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
666,812174,8607,Comparative Toxicogenomics Database (CTD),Folpet,C005020,folpet,https://ctdbase.org/detail.go?type=chem&acc=C005020,348,APOE,https://ctdbase.org/detail.go?type=gene&acc=348,,,348.0,APOE,10090.0,Mus musculus (house mouse),Folpet results in decreased expression of APOE mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
667,812175,8607,Comparative Toxicogenomics Database (CTD),Folpet,C005020,folpet,https://ctdbase.org/detail.go?type=chem&acc=C005020,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,10090.0,Mus musculus (house mouse),Folpet results in decreased expression of APP mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
668,812176,8607,Comparative Toxicogenomics Database (CTD),Folpet,C005020,folpet,https://ctdbase.org/detail.go?type=chem&acc=C005020,358,AQP1,https://ctdbase.org/detail.go?type=gene&acc=358,,,358.0,AQP1,10090.0,Mus musculus (house mouse),Folpet results in decreased expression of AQP1 mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
669,812177,8607,Comparative Toxicogenomics Database (CTD),Folpet,C005020,folpet,https://ctdbase.org/detail.go?type=chem&acc=C005020,375,ARF1,https://ctdbase.org/detail.go?type=gene&acc=375,,,375.0,ARF1,10090.0,Mus musculus (house mouse),Folpet results in increased expression of ARF1 mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
670,812178,8607,Comparative Toxicogenomics Database (CTD),Folpet,C005020,folpet,https://ctdbase.org/detail.go?type=chem&acc=C005020,64333,ARHGAP9,https://ctdbase.org/detail.go?type=gene&acc=64333,,,64333.0,ARHGAP9,10090.0,Mus musculus (house mouse),Folpet results in decreased expression of ARHGAP9 mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
671,814995,8607,Comparative Toxicogenomics Database (CTD),Folpet,C005020,folpet,https://ctdbase.org/detail.go?type=chem&acc=C005020,8666,EIF3G,https://ctdbase.org/detail.go?type=gene&acc=8666,,,8666.0,EIF3G,10090.0,Mus musculus (house mouse),Folpet results in decreased expression of EIF3G mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
672,814996,8607,Comparative Toxicogenomics Database (CTD),Folpet,C005020,folpet,https://ctdbase.org/detail.go?type=chem&acc=C005020,8668,EIF3I,https://ctdbase.org/detail.go?type=gene&acc=8668,,,8668.0,EIF3I,10090.0,Mus musculus (house mouse),Folpet results in decreased expression of EIF3I mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
673,814997,8607,Comparative Toxicogenomics Database (CTD),Folpet,C005020,folpet,https://ctdbase.org/detail.go?type=chem&acc=C005020,1975,EIF4B,https://ctdbase.org/detail.go?type=gene&acc=1975,,,1975.0,EIF4B,10090.0,Mus musculus (house mouse),Folpet results in increased expression of EIF4B mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
674,814998,8607,Comparative Toxicogenomics Database (CTD),Folpet,C005020,folpet,https://ctdbase.org/detail.go?type=chem&acc=C005020,1978,EIF4EBP1,https://ctdbase.org/detail.go?type=gene&acc=1978,,,1978.0,EIF4EBP1,10090.0,Mus musculus (house mouse),Folpet results in increased expression of EIF4EBP1 mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
675,814999,8607,Comparative Toxicogenomics Database (CTD),Folpet,C005020,folpet,https://ctdbase.org/detail.go?type=chem&acc=C005020,1981,EIF4G1,https://ctdbase.org/detail.go?type=gene&acc=1981,,,1981.0,EIF4G1,10090.0,Mus musculus (house mouse),Folpet results in decreased expression of EIF4G1 mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
676,815000,8607,Comparative Toxicogenomics Database (CTD),Folpet,C005020,folpet,https://ctdbase.org/detail.go?type=chem&acc=C005020,1994,ELAVL1,https://ctdbase.org/detail.go?type=gene&acc=1994,,,1994.0,ELAVL1,10090.0,Mus musculus (house mouse),Folpet results in decreased expression of ELAVL1 mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
677,815001,8607,Comparative Toxicogenomics Database (CTD),Folpet,C005020,folpet,https://ctdbase.org/detail.go?type=chem&acc=C005020,60481,ELOVL5,https://ctdbase.org/detail.go?type=gene&acc=60481,,,60481.0,ELOVL5,10090.0,Mus musculus (house mouse),Folpet results in decreased expression of ELOVL5 mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
678,815190,8607,Comparative Toxicogenomics Database (CTD),Folpet,C005020,folpet,https://ctdbase.org/detail.go?type=chem&acc=C005020,2052,EPHX1,https://ctdbase.org/detail.go?type=gene&acc=2052,,,2052.0,EPHX1,10090.0,Mus musculus (house mouse),Folpet results in increased expression of EPHX1 mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
679,816341,8607,Comparative Toxicogenomics Database (CTD),Folpet,C005020,folpet,https://ctdbase.org/detail.go?type=chem&acc=C005020,283464,GXYLT1,https://ctdbase.org/detail.go?type=gene&acc=283464,,,283464.0,GXYLT1,10090.0,Mus musculus (house mouse),Folpet results in increased expression of GXYLT1 mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
680,816342,8607,Comparative Toxicogenomics Database (CTD),Folpet,C005020,folpet,https://ctdbase.org/detail.go?type=chem&acc=C005020,3001,GZMA,https://ctdbase.org/detail.go?type=gene&acc=3001,,,3001.0,GZMA,10090.0,Mus musculus (house mouse),Folpet results in decreased expression of GZMA mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
681,819490,8607,Comparative Toxicogenomics Database (CTD),Folpet,C005020,folpet,https://ctdbase.org/detail.go?type=chem&acc=C005020,5723,PSPH,https://ctdbase.org/detail.go?type=gene&acc=5723,,,5723.0,PSPH,10090.0,Mus musculus (house mouse),Folpet results in increased expression of PSPH mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
682,819491,8607,Comparative Toxicogenomics Database (CTD),Folpet,C005020,folpet,https://ctdbase.org/detail.go?type=chem&acc=C005020,5734,PTGER4,https://ctdbase.org/detail.go?type=gene&acc=5734,,,5734.0,PTGER4,10090.0,Mus musculus (house mouse),Folpet results in increased expression of PTGER4 mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
683,819637,8691,Drug Gene Interaction database (DGIdb),Phenazopyridine hydrochloride,,PHENAZOPYRIDINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203197,,NR1H4,https://www.dgidb.org/genes/hgnc:7967,,,9971.0,NR1H4,9606.0,Homo sapiens (human),,,,,,,,
684,819638,8691,Drug Gene Interaction database (DGIdb),Phenazopyridine hydrochloride,,PHENAZOPYRIDINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203197,,ESR1,https://www.dgidb.org/genes/hgnc:3467,,,2099.0,ESR1,9606.0,Homo sapiens (human),,,,,,,,
685,819639,8691,Drug Gene Interaction database (DGIdb),Phenazopyridine hydrochloride,,PHENAZOPYRIDINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203197,,AHR,https://www.dgidb.org/genes/hgnc:348,,,196.0,AHR,9606.0,Homo sapiens (human),,,,,,,,
686,819640,8747,Therapeutic Target Database (TTD),Mercuribenzoic acid,D06CGS,Mercuribenzoic Acid,https://idrblab.net/ttd/data/drug/details/D06CGS,T20401,Carbonic anhydrase II (CA-II),https://idrblab.net/ttd/data/target/details/T20401,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
687,819641,8753,Drug Gene Interaction database (DGIdb),Benzododecinium chloride,,BENZODODECINIUM CHLORIDE,https://www.dgidb.org/drugs/rxcui:1311592,,AR,https://www.dgidb.org/genes/hgnc:644,,,367.0,AR,9606.0,Homo sapiens (human),,,,,,,,
688,819642,8758,Therapeutic Target Database (TTD),Nitrilotriacetic acid,D03ZSY,Nitrilotriacetic Acid,https://idrblab.net/ttd/data/drug/details/D03ZSY,T67801,Lactotransferrin (LTF),https://idrblab.net/ttd/data/target/details/T67801,P02788,Lactotransferrin,4057.0,LTF,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
689,810487,8969,IUPHAR/BPS Guide to PHARMACOLOGY,Yohimbine,102,yohimbine,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102,4,5-ht1e receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=4,P28566,5-hydroxytryptamine receptor 1E,3354.0,HTR1E,9606.0,Homo sapiens (human),Antagonist,pKi,5.9,PMID:8380639,https://www.ncbi.nlm.nih.gov/pubmed/8380639,8380639,,
690,810488,8982,Comparative Toxicogenomics Database (CTD),Nafcillin,D009254,Nafcillin,https://ctdbase.org/detail.go?type=chem&acc=D009254,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),[nafcillin co-treated with IL1B protein] results in increased activity of CASP3 protein|[nafcillin co-treated with IL6 protein] results in increased activity of CASP3 protein|[nafcillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein|[nafcillin co-treated with TNF protein] results in increased activity of CASP3 protein|[tnf protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [nafcillin results in increased activity of CASP3 protein]|nafcillin results in increased activity of CASP3 protein,,,PMID:30876886,https://www.ncbi.nlm.nih.gov/pubmed/30876886,30876886,,
691,810489,8982,Comparative Toxicogenomics Database (CTD),Nafcillin,D009254,Nafcillin,https://ctdbase.org/detail.go?type=chem&acc=D009254,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Nafcillin results in increased expression of CYP3A4 mrna|nafcillin results in increased expression of CYP3A4 protein,,,PMID:18505790,https://www.ncbi.nlm.nih.gov/pubmed/18505790,18505790,,
692,810490,8982,Comparative Toxicogenomics Database (CTD),Nafcillin,D009254,Nafcillin,https://ctdbase.org/detail.go?type=chem&acc=D009254,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),[TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [nafcillin results in increased activity of CASP3 protein]|[nafcillin co-treated with IL1B protein] results in increased activity of CASP3 protein|[nafcillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein,,,PMID:30876886,https://www.ncbi.nlm.nih.gov/pubmed/30876886,30876886,,
693,810491,8982,Comparative Toxicogenomics Database (CTD),Nafcillin,D009254,Nafcillin,https://ctdbase.org/detail.go?type=chem&acc=D009254,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),[TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [nafcillin results in increased activity of CASP3 protein]|[nafcillin co-treated with IL6 protein] results in increased activity of CASP3 protein|[nafcillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein,,,PMID:30876886,https://www.ncbi.nlm.nih.gov/pubmed/30876886,30876886,,
694,810492,8982,Comparative Toxicogenomics Database (CTD),Nafcillin,D009254,Nafcillin,https://ctdbase.org/detail.go?type=chem&acc=D009254,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,9606.0,Homo sapiens (human),Nafcillin results in increased activity of NR1I2 protein,,,PMID:25455453,https://www.ncbi.nlm.nih.gov/pubmed/25455453,25455453,,
695,810493,8982,Comparative Toxicogenomics Database (CTD),Nafcillin,D009254,Nafcillin,https://ctdbase.org/detail.go?type=chem&acc=D009254,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),[TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [nafcillin results in increased activity of CASP3 protein]|[nafcillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein|[nafcillin co-treated with TNF protein] results in increased activity of CASP3 protein,,,PMID:30876886,https://www.ncbi.nlm.nih.gov/pubmed/30876886,30876886,,
696,810494,9015,Comparative Toxicogenomics Database (CTD),Mequinol,C009760,mequinol,https://ctdbase.org/detail.go?type=chem&acc=C009760,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),[mequinol co-treated with ESR1 protein] results in increased expression of HSP90B1 protein|[mequinol co-treated with ESR1 protein] results in increased expression of HSPA5 protein,,,PMID:19269315,https://www.ncbi.nlm.nih.gov/pubmed/19269315,19269315,,
697,810668,9015,Comparative Toxicogenomics Database (CTD),Mequinol,C009760,mequinol,https://ctdbase.org/detail.go?type=chem&acc=C009760,7299,TYR,https://ctdbase.org/detail.go?type=gene&acc=7299,,,7299.0,TYR,9606.0,Homo sapiens (human),TYR protein results in increased oxidation of mequinol,,,PMID:19944085,https://www.ncbi.nlm.nih.gov/pubmed/19944085,19944085,,
698,810669,9015,Comparative Toxicogenomics Database (CTD),Mequinol,C009760,mequinol,https://ctdbase.org/detail.go?type=chem&acc=C009760,3309,HSPA5,https://ctdbase.org/detail.go?type=gene&acc=3309,,,3309.0,HSPA5,9606.0,Homo sapiens (human),[mequinol co-treated with ESR1 protein] results in increased expression of HSPA5 protein,,,PMID:19269315,https://www.ncbi.nlm.nih.gov/pubmed/19269315,19269315,,
699,810670,9046,Toxin and Toxin Target Database (T3DB),Quinestrol,T3D3063,Quinestrol,http://www.t3db.ca/toxins/T3D3063,BE0000123,Estrogen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000123,P03372,Estrogen receptor,2099.0,ESR1,9606.0,Homo sapiens (human),"Estrogens diffuse into their target cells and interact with a protein receptor. target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. estrogens increase the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary. the combination of an estrogen with a progestin suppresses the hypothalamic-pituitary system, decreasing the secretion of gonadotropin-releasing hormone (gnrh).",,,,,,,
700,811638,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,59271,EVA1C,https://ctdbase.org/detail.go?type=gene&acc=59271,,,59271.0,EVA1C,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of EVA1C intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
701,811639,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,51466,EVL,https://ctdbase.org/detail.go?type=gene&acc=51466,,,51466.0,EVL,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of EVL polya tail,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
702,812793,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,83706,FERMT3,https://ctdbase.org/detail.go?type=gene&acc=83706,,,83706.0,FERMT3,9606.0,Homo sapiens (human),Benzo(e)pyrene results in decreased methylation of FERMT3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
703,812794,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,338557,FFAR4,https://ctdbase.org/detail.go?type=gene&acc=338557,,,338557.0,FFAR4,9606.0,Homo sapiens (human),Benzo(e)pyrene results in decreased methylation of FFAR4 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
704,812795,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,121512,FGD4,https://ctdbase.org/detail.go?type=gene&acc=121512,,,121512.0,FGD4,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of FGD4 promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
705,812796,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,152273,FGD5,https://ctdbase.org/detail.go?type=gene&acc=152273,,,152273.0,FGD5,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of FGD5 intron|benzo(e)pyrene results in increased methylation of FGD5 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
706,812797,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,2246,FGF1,https://ctdbase.org/detail.go?type=gene&acc=2246,,,2246.0,FGF1,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of FGF1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
707,812798,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,2257,FGF12,https://ctdbase.org/detail.go?type=gene&acc=2257,,,2257.0,FGF12,9606.0,Homo sapiens (human),Benzo(e)pyrene affects the methylation of FGF12 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
708,812799,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,2259,FGF14,https://ctdbase.org/detail.go?type=gene&acc=2259,,,2259.0,FGF14,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of FGF14 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
709,812800,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,55277,FGGY,https://ctdbase.org/detail.go?type=gene&acc=55277,,,55277.0,FGGY,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of FGGY intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
710,812801,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,114827,FHAD1,https://ctdbase.org/detail.go?type=gene&acc=114827,,,114827.0,FHAD1,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of FHAD1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
711,812972,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,11259,FILIP1L,https://ctdbase.org/detail.go?type=gene&acc=11259,,,11259.0,FILIP1L,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of FILIP1L intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
712,812973,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,201163,FLCN,https://ctdbase.org/detail.go?type=gene&acc=201163,,,201163.0,FLCN,9606.0,Homo sapiens (human),Benzo(e)pyrene results in decreased methylation of FLCN intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
713,812974,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,2313,FLI1,https://ctdbase.org/detail.go?type=gene&acc=2313,,,2313.0,FLI1,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of FLI1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
714,812975,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,2316,FLNA,https://ctdbase.org/detail.go?type=gene&acc=2316,,,2316.0,FLNA,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of FLNA exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
715,812976,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,2321,FLT1,https://ctdbase.org/detail.go?type=gene&acc=2321,,,2321.0,FLT1,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of FLT1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
716,812977,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,2322,FLT3,https://ctdbase.org/detail.go?type=gene&acc=2322,,,2322.0,FLT3,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of FLT3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
717,812978,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,55640,FLVCR2,https://ctdbase.org/detail.go?type=gene&acc=55640,,,55640.0,FLVCR2,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of FLVCR2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
718,814013,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,2624,GATA2,https://ctdbase.org/detail.go?type=gene&acc=2624,,,2624.0,GATA2,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of GATA2 polya tail|benzo(e)pyrene results in increased methylation of GATA2 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
719,814014,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,54815,GATAD2A,https://ctdbase.org/detail.go?type=gene&acc=54815,,,54815.0,GATAD2A,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of GATAD2A intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
720,814015,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,347862,GATD1,https://ctdbase.org/detail.go?type=gene&acc=347862,,,347862.0,GATD1,9606.0,Homo sapiens (human),Benzo(e)pyrene results in decreased methylation of GATD1 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
721,814016,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,57733,GBA3,https://ctdbase.org/detail.go?type=gene&acc=57733,,,57733.0,GBA3,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of GBA3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
722,814017,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,2632,GBE1,https://ctdbase.org/detail.go?type=gene&acc=2632,,,2632.0,GBE1,9606.0,Homo sapiens (human),Benzo(e)pyrene results in decreased methylation of GBE1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
723,814018,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,26301,GBGT1,https://ctdbase.org/detail.go?type=gene&acc=26301,,,26301.0,GBGT1,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of GBGT1 5' UTR,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
724,814019,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,2642,GCGR,https://ctdbase.org/detail.go?type=gene&acc=2642,,,2642.0,GCGR,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of GCGR intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
725,814020,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,8521,GCM1,https://ctdbase.org/detail.go?type=gene&acc=8521,,,8521.0,GCM1,9606.0,Homo sapiens (human),Benzo(e)pyrene results in decreased methylation of GCM1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
726,814021,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,140687,GCNT7,https://ctdbase.org/detail.go?type=gene&acc=140687,,,140687.0,GCNT7,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of GCNT7 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
727,814022,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,9615,GDA,https://ctdbase.org/detail.go?type=gene&acc=9615,,,9615.0,GDA,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of GDA intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
728,815851,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,93323,HAUS8,https://ctdbase.org/detail.go?type=gene&acc=93323,,,93323.0,HAUS8,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of HAUS8 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
729,815852,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,10021,HCN4,https://ctdbase.org/detail.go?type=gene&acc=10021,,,10021.0,HCN4,9606.0,Homo sapiens (human),Benzo(e)pyrene affects the methylation of HCN4 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
730,815853,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,9759,HDAC4,https://ctdbase.org/detail.go?type=gene&acc=9759,,,9759.0,HDAC4,9606.0,Homo sapiens (human),Benzo(e)pyrene results in decreased methylation of HDAC4 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
731,815854,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,9734,HDAC9,https://ctdbase.org/detail.go?type=gene&acc=9734,,,9734.0,HDAC9,9606.0,Homo sapiens (human),Benzo(e)pyrene results in decreased methylation of HDAC9 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
732,815855,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,54497,HEATR5B,https://ctdbase.org/detail.go?type=gene&acc=54497,,,54497.0,HEATR5B,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of HEATR5B exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
733,815856,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,100188947,HECTD2-AS1,https://ctdbase.org/detail.go?type=gene&acc=100188947,,,100188947.0,HECTD2-AS1,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of HECTD2-AS1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
734,815857,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,23072,HECW1,https://ctdbase.org/detail.go?type=gene&acc=23072,,,23072.0,HECW1,9606.0,Homo sapiens (human),Benzo(e)pyrene results in decreased methylation of HECW1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
735,815858,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,9931,HELZ,https://ctdbase.org/detail.go?type=gene&acc=9931,,,9931.0,HELZ,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of HELZ intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
736,815859,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,85441,HELZ2,https://ctdbase.org/detail.go?type=gene&acc=85441,,,85441.0,HELZ2,9606.0,Homo sapiens (human),Benzo(e)pyrene results in decreased methylation of HELZ2 promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
737,815860,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,8916,HERC3,https://ctdbase.org/detail.go?type=gene&acc=8916,,,8916.0,HERC3,9606.0,Homo sapiens (human),Benzo(e)pyrene results in decreased methylation of HERC3 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
738,815861,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,124790,HEXIM2,https://ctdbase.org/detail.go?type=gene&acc=124790,,,124790.0,HEXIM2,9606.0,Homo sapiens (human),Benzo(e)pyrene results in decreased methylation of HEXIM2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
739,817157,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,10527,IPO7,https://ctdbase.org/detail.go?type=gene&acc=10527,,,10527.0,IPO7,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of IPO7 promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
740,817158,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,64768,IPPK,https://ctdbase.org/detail.go?type=gene&acc=64768,,,64768.0,IPPK,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of IPPK promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
741,817159,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,79781,IQCA1,https://ctdbase.org/detail.go?type=gene&acc=79781,,,79781.0,IQCA1,9606.0,Homo sapiens (human),Benzo(e)pyrene results in decreased methylation of IQCA1 intron|benzo(e)pyrene results in increased methylation of IQCA1 promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
742,817160,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,23288,IQCE,https://ctdbase.org/detail.go?type=gene&acc=23288,,,23288.0,IQCE,9606.0,Homo sapiens (human),Benzo(e)pyrene results in decreased methylation of IQCE intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
743,817161,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,84223,IQCG,https://ctdbase.org/detail.go?type=gene&acc=84223,,,84223.0,IQCG,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of IQCG intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
744,817162,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,654502,IQCJ,https://ctdbase.org/detail.go?type=gene&acc=654502,,,654502.0,IQCJ,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of IQCJ intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
745,817163,9128,Comparative Toxicogenomics Database (CTD),Benzo[e]pyrene,C026487,benzo(e)pyrene,https://ctdbase.org/detail.go?type=chem&acc=C026487,128239,IQGAP3,https://ctdbase.org/detail.go?type=gene&acc=128239,,,128239.0,IQGAP3,9606.0,Homo sapiens (human),Benzo(e)pyrene results in increased methylation of IQGAP3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
746,806413,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,1395,CRHR2,https://ctdbase.org/detail.go?type=gene&acc=1395,,,1395.0,CRHR2,10090.0,Mus musculus (house mouse),Lead acetate results in increased expression of CRHR2 mRNA,,,PMID:22613225,https://www.ncbi.nlm.nih.gov/pubmed/22613225,22613225,,
747,806414,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,1397,CRIP2,https://ctdbase.org/detail.go?type=gene&acc=1397,,,1397.0,CRIP2,10116.0,Rattus norvegicus (Norway rat),Lead acetate affects the expression of CRIP2 protein,,,PMID:36539177,https://www.ncbi.nlm.nih.gov/pubmed/36539177,36539177,,
748,809048,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,1734,DIO2,https://ctdbase.org/detail.go?type=gene&acc=1734,,,1734.0,DIO2,9031.0,Gallus gallus (chicken),[sodium selenite co-treated with lead acetate] results in increased expression of DIO2 mrna|lead acetate results in increased expression of DIO2 mRNA,,,PMID:28213321,https://www.ncbi.nlm.nih.gov/pubmed/28213321,28213321,,
749,809049,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,1734,DIO2,https://ctdbase.org/detail.go?type=gene&acc=1734,,,1734.0,DIO2,10116.0,Rattus norvegicus (Norway rat),Lead acetate results in increased expression of DIO2 mRNA,,,PMID:22641619,https://www.ncbi.nlm.nih.gov/pubmed/22641619,22641619,,
750,809050,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,1735,DIO3,https://ctdbase.org/detail.go?type=gene&acc=1735,,,1735.0,DIO3,9031.0,Gallus gallus (chicken),[sodium selenite co-treated with lead acetate] results in increased expression of DIO3 mrna|lead acetate results in increased expression of DIO3 mRNA,,,PMID:28213321,https://www.ncbi.nlm.nih.gov/pubmed/28213321,28213321,,
751,809051,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,64150,DIO3OS,https://ctdbase.org/detail.go?type=gene&acc=64150,,,64150.0,DIO3OS,9606.0,Homo sapiens (human),Lead acetate results in decreased expression of DIO3OS mRNA,,,PMID:27562236,https://www.ncbi.nlm.nih.gov/pubmed/27562236,27562236,,
752,809052,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,27185,DISC1,https://ctdbase.org/detail.go?type=gene&acc=27185,,,27185.0,DISC1,10116.0,Rattus norvegicus (Norway rat),Lead acetate results in increased expression of DISC1 mRNA,,,PMID:11578147,https://www.ncbi.nlm.nih.gov/pubmed/11578147,11578147,,
753,809053,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,57540,DISP3,https://ctdbase.org/detail.go?type=gene&acc=57540,,,57540.0,DISP3,10090.0,Mus musculus (house mouse),Lead acetate results in increased expression of DISP3 mRNA,,,PMID:20542052,https://www.ncbi.nlm.nih.gov/pubmed/20542052,20542052,,
754,809054,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,1738,DLD,https://ctdbase.org/detail.go?type=gene&acc=1738,,,1738.0,DLD,10116.0,Rattus norvegicus (Norway rat),Lead acetate results in decreased expression of DLD protein,,,PMID:25981801,https://www.ncbi.nlm.nih.gov/pubmed/25981801,25981801,,
755,809055,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,220107,DLEU7,https://ctdbase.org/detail.go?type=gene&acc=220107,,,220107.0,DLEU7,10090.0,Mus musculus (house mouse),Lead acetate results in increased expression of DLEU7 mRNA,,,PMID:20542052,https://www.ncbi.nlm.nih.gov/pubmed/20542052,20542052,,
756,809056,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,1739,DLG1,https://ctdbase.org/detail.go?type=gene&acc=1739,,,1739.0,DLG1,7227.0,Drosophila melanogaster (fruit fly),Lead acetate results in decreased expression of DLG1 mRNA,,,PMID:19737576,https://www.ncbi.nlm.nih.gov/pubmed/19737576,19737576,,
757,809057,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,1739,DLG1,https://ctdbase.org/detail.go?type=gene&acc=1739,,,1739.0,DLG1,9606.0,Homo sapiens (human),BACH1 gene mutant form inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased expression of DLG1 protein]|hemin inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased expression of DLG1 protein]|[lead acetate results in increased abundance of lead] which results in decreased expression of DLG1 protein,,,PMID:36096218,https://www.ncbi.nlm.nih.gov/pubmed/36096218,36096218,,
758,815703,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,59345,GNB4,https://ctdbase.org/detail.go?type=gene&acc=59345,,,59345.0,GNB4,10090.0,Mus musculus (house mouse),Lead acetate results in increased expression of GNB4 mRNA,,,PMID:21829687,https://www.ncbi.nlm.nih.gov/pubmed/21829687,21829687,,
759,815704,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,55970,GNG12,https://ctdbase.org/detail.go?type=gene&acc=55970,,,55970.0,GNG12,10090.0,Mus musculus (house mouse),Lead acetate results in decreased expression of GNG12 mRNA,,,PMID:22613225,https://www.ncbi.nlm.nih.gov/pubmed/22613225,22613225,,
760,816839,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,2904,GRIN2B,https://ctdbase.org/detail.go?type=gene&acc=2904,,,2904.0,GRIN2B,10090.0,Mus musculus (house mouse),Lead acetate results in decreased expression of GRIN2B protein,,,PMID:25242007,https://www.ncbi.nlm.nih.gov/pubmed/25242007,25242007,,
761,816840,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,2904,GRIN2B,https://ctdbase.org/detail.go?type=gene&acc=2904,,,2904.0,GRIN2B,10090.0,Mus musculus (house mouse),Lead acetate results in increased expression of GRIN2B mRNA,,,PMID:24260418,https://www.ncbi.nlm.nih.gov/pubmed/24260418,24260418,,
762,816841,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,2904,GRIN2B,https://ctdbase.org/detail.go?type=gene&acc=2904,,,2904.0,GRIN2B,10116.0,Rattus norvegicus (Norway rat),Asarone inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased expression of GRIN2B protein]|[lead acetate results in increased abundance of lead] which results in decreased expression of GRIN2B protein,,,PMID:27936013,https://www.ncbi.nlm.nih.gov/pubmed/27936013,27936013,,
763,816842,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,2904,GRIN2B,https://ctdbase.org/detail.go?type=gene&acc=2904,,,2904.0,GRIN2B,10116.0,Rattus norvegicus (Norway rat),Choline analog affects the reaction [lead acetate results in decreased expression of GRIN2B mrna],,,PMID:20381573,https://www.ncbi.nlm.nih.gov/pubmed/20381573,20381573,,
764,816843,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,2904,GRIN2B,https://ctdbase.org/detail.go?type=gene&acc=2904,,,2904.0,GRIN2B,10116.0,Rattus norvegicus (Norway rat),[lead acetate promotes the reaction [GRIN1 protein binds to GRIN2B protein]] which results in decreased phosphorylation of CREB1 protein|lead acetate promotes the reaction [GRIN1 protein binds to GRIN2B protein],,,PMID:12480136,https://www.ncbi.nlm.nih.gov/pubmed/12480136,12480136,,
765,816844,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,2904,GRIN2B,https://ctdbase.org/detail.go?type=gene&acc=2904,,,2904.0,GRIN2B,10116.0,Rattus norvegicus (Norway rat),Lead acetate results in decreased expression of GRIN2B mRNA,,,PMID:20381573|PMID:22160880|PMID:22362014,https://www.ncbi.nlm.nih.gov/pubmed/20381573|https://www.ncbi.nlm.nih.gov/pubmed/22160880|https://www.ncbi.nlm.nih.gov/pubmed/22362014,20381573|22160880|22362014,,
766,817972,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,373156,GSTK1,https://ctdbase.org/detail.go?type=gene&acc=373156,,,373156.0,GSTK1,10090.0,Mus musculus (house mouse),Lead acetate results in decreased expression of GSTK1 mRNA,,,PMID:29746905,https://www.ncbi.nlm.nih.gov/pubmed/29746905,29746905,,
767,817973,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,2944,GSTM1,https://ctdbase.org/detail.go?type=gene&acc=2944,,,2944.0,GSTM1,10116.0,Rattus norvegicus (Norway rat),Lead acetate affects the localization of GSTM1 protein|lead acetate results in increased expression of GSTM1 mRNA,,,PMID:9750042,https://www.ncbi.nlm.nih.gov/pubmed/9750042,9750042,,
768,817974,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,2944,GSTM1,https://ctdbase.org/detail.go?type=gene&acc=2944,,,2944.0,GSTM1,10116.0,Rattus norvegicus (Norway rat),Lead acetate results in increased expression of GSTM1 protein,,,PMID:7878682|PMID:9750042,https://www.ncbi.nlm.nih.gov/pubmed/7878682|https://www.ncbi.nlm.nih.gov/pubmed/9750042,7878682|9750042,,
769,817975,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,2946,GSTM2,https://ctdbase.org/detail.go?type=gene&acc=2946,,,2946.0,GSTM2,10116.0,Rattus norvegicus (Norway rat),Lead acetate results in decreased expression of GSTM2 protein|lead acetate results in increased expression of GSTM2 protein,,,PMID:9750042,https://www.ncbi.nlm.nih.gov/pubmed/9750042,9750042,,
770,817976,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,9446,GSTO1,https://ctdbase.org/detail.go?type=gene&acc=9446,,,9446.0,GSTO1,9606.0,Homo sapiens (human),Ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased expression of GSTO1 mrna]|rosmarinic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased expression of GSTO1 mrna]|[lead acetate results in increased abundance of lead] which results in decreased expression of GSTO1 mRNA,,,PMID:31610155,https://www.ncbi.nlm.nih.gov/pubmed/31610155,31610155,,
771,817977,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,9446,GSTO1,https://ctdbase.org/detail.go?type=gene&acc=9446,,,9446.0,GSTO1,10116.0,Rattus norvegicus (Norway rat),Lead acetate results in increased expression of GSTO1 mRNA,,,PMID:11578147,https://www.ncbi.nlm.nih.gov/pubmed/11578147,11578147,,
772,817978,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,2950,GSTP1,https://ctdbase.org/detail.go?type=gene&acc=2950,,,2950.0,GSTP1,10090.0,Mus musculus (house mouse),Lead acetate results in increased expression of GSTP1 mRNA,,,PMID:29746905,https://www.ncbi.nlm.nih.gov/pubmed/29746905,29746905,,
773,817979,9317,Comparative Toxicogenomics Database (CTD),lead acetate anhydrous,C008261,lead acetate,https://ctdbase.org/detail.go?type=chem&acc=C008261,2950,GSTP1,https://ctdbase.org/detail.go?type=gene&acc=2950,,,2950.0,GSTP1,10116.0,Rattus norvegicus (Norway rat),Lead acetate affects the localization of GSTP1 protein|lead acetate results in increased expression of GSTP1 mRNA,,,PMID:9750042,https://www.ncbi.nlm.nih.gov/pubmed/9750042,9750042,,
774,806404,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,2184,FAH,https://ctdbase.org/detail.go?type=gene&acc=2184,,,2184.0,FAH,10116.0,Rattus norvegicus (Norway rat),Methamphetamine results in decreased expression of FAH mRNA,,,PMID:19564919,https://www.ncbi.nlm.nih.gov/pubmed/19564919,19564919,,
775,806405,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,55179,FAIM,https://ctdbase.org/detail.go?type=gene&acc=55179,,,55179.0,FAIM,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine results in decreased expression of FAIM mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
776,806406,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,23017,FAIM2,https://ctdbase.org/detail.go?type=gene&acc=23017,,,23017.0,FAIM2,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine results in decreased expression of FAIM2 mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
777,806407,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,11170,FAM107A,https://ctdbase.org/detail.go?type=gene&acc=11170,,,11170.0,FAM107A,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine results in decreased expression of FAM107A mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
778,806408,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,83541,FAM110A,https://ctdbase.org/detail.go?type=gene&acc=83541,,,83541.0,FAM110A,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine results in increased expression of FAM110A mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
779,806409,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,83541,FAM110A,https://ctdbase.org/detail.go?type=gene&acc=83541,,,83541.0,FAM110A,10116.0,Rattus norvegicus (Norway rat),Methamphetamine results in decreased expression of FAM110A mRNA,,,PMID:19564919,https://www.ncbi.nlm.nih.gov/pubmed/19564919,19564919,,
780,806410,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,131408,FAM131A,https://ctdbase.org/detail.go?type=gene&acc=131408,,,131408.0,FAM131A,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine results in decreased expression of FAM131A mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
781,806411,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,10144,FAM13A,https://ctdbase.org/detail.go?type=gene&acc=10144,,,10144.0,FAM13A,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine results in decreased expression of FAM13A mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
782,806412,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,51306,FAM13B,https://ctdbase.org/detail.go?type=gene&acc=51306,,,51306.0,FAM13B,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine results in decreased expression of FAM13B mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
783,811640,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,2670,GFAP,https://ctdbase.org/detail.go?type=gene&acc=2670,,,2670.0,GFAP,10116.0,Rattus norvegicus (Norway rat),Methamphetamine results in increased expression of GFAP protein,,,PMID:10773198|PMID:9427479|PMID:9739098,https://www.ncbi.nlm.nih.gov/pubmed/10773198|https://www.ncbi.nlm.nih.gov/pubmed/9427479|https://www.ncbi.nlm.nih.gov/pubmed/9739098,10773198|9427479|9739098,,
784,811641,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,84340,GFM2,https://ctdbase.org/detail.go?type=gene&acc=84340,,,84340.0,GFM2,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine affects the expression of GFM2 mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
785,811642,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,2675,GFRA2,https://ctdbase.org/detail.go?type=gene&acc=2675,,,2675.0,GFRA2,10116.0,Rattus norvegicus (Norway rat),Methamphetamine results in increased expression of GFRA2 mRNA,,,PMID:15644446,https://www.ncbi.nlm.nih.gov/pubmed/15644446,15644446,,
786,811643,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,64096,GFRA4,https://ctdbase.org/detail.go?type=gene&acc=64096,,,64096.0,GFRA4,10116.0,Rattus norvegicus (Norway rat),Methamphetamine results in decreased expression of GFRA4 mrna|[methamphetamine co-treated with SCH 23390] results in decreased expression of GFRA4 mRNA,,,PMID:19564919,https://www.ncbi.nlm.nih.gov/pubmed/19564919,19564919,,
787,811644,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,26088,GGA1,https://ctdbase.org/detail.go?type=gene&acc=26088,,,26088.0,GGA1,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine affects the expression of GGA1 mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
788,811645,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,23163,GGA3,https://ctdbase.org/detail.go?type=gene&acc=23163,,,23163.0,GGA3,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine affects the expression of GGA3 mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
789,811646,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,79017,GGCT,https://ctdbase.org/detail.go?type=gene&acc=79017,,,79017.0,GGCT,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine results in increased expression of GGCT mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
790,811647,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,2677,GGCX,https://ctdbase.org/detail.go?type=gene&acc=2677,,,2677.0,GGCX,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine results in increased expression of GGCX mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
791,812305,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,2778,GNAS,https://ctdbase.org/detail.go?type=gene&acc=2778,,,2778.0,GNAS,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine results in decreased expression of GNAS mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
792,813663,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,2878,GPX3,https://ctdbase.org/detail.go?type=gene&acc=2878,,,2878.0,GPX3,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine results in decreased expression of GPX3 mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
793,813664,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,493869,GPX8,https://ctdbase.org/detail.go?type=gene&acc=493869,,,493869.0,GPX8,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine results in increased expression of GPX8 mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
794,813665,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,57655,GRAMD1A,https://ctdbase.org/detail.go?type=gene&acc=57655,,,57655.0,GRAMD1A,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine results in increased expression of GRAMD1A mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
795,813666,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,65983,GRAMD2B,https://ctdbase.org/detail.go?type=gene&acc=65983,,,65983.0,GRAMD2B,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine results in increased expression of GRAMD2B mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
796,813667,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,2887,GRB10,https://ctdbase.org/detail.go?type=gene&acc=2887,,,2887.0,GRB10,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine affects the expression of GRB10 mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
797,815358,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,64412,GZF1,https://ctdbase.org/detail.go?type=gene&acc=64412,,,64412.0,GZF1,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine results in decreased expression of GZF1 mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
798,816501,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,3096,HIVEP1,https://ctdbase.org/detail.go?type=gene&acc=3096,,,3096.0,HIVEP1,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine affects the expression of HIVEP1 mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
799,816502,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,55355,HJURP,https://ctdbase.org/detail.go?type=gene&acc=55355,,,55355.0,HJURP,9606.0,Homo sapiens (human),Methamphetamine results in decreased expression of HJURP mRNA,,,PMID:25290377,https://www.ncbi.nlm.nih.gov/pubmed/25290377,25290377,,
800,816503,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,3098,HK1,https://ctdbase.org/detail.go?type=gene&acc=3098,,,3098.0,HK1,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine affects the expression of HK1 mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
801,816504,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,3098,HK1,https://ctdbase.org/detail.go?type=gene&acc=3098,,,3098.0,HK1,10090.0,Mus musculus (house mouse),Methamphetamine results in increased expression of HK1 mRNA,,,PMID:26307267|PMID:36914120,https://www.ncbi.nlm.nih.gov/pubmed/26307267|https://www.ncbi.nlm.nih.gov/pubmed/36914120,26307267|36914120,,
802,816505,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,6596,HLTF,https://ctdbase.org/detail.go?type=gene&acc=6596,,,6596.0,HLTF,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine results in decreased expression of HLTF mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
803,817644,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,646962,HRCT1,https://ctdbase.org/detail.go?type=gene&acc=646962,,,646962.0,HRCT1,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine results in increased expression of HRCT1 mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
804,817645,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,11255,HRH3,https://ctdbase.org/detail.go?type=gene&acc=11255,,,11255.0,HRH3,9541.0,Macaca fascicularis (crab-eating macaque),Methamphetamine results in decreased expression of HRH3 mRNA,,,PMID:29802913,https://www.ncbi.nlm.nih.gov/pubmed/29802913,29802913,,
805,806971,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,256471,MFSD8,https://ctdbase.org/detail.go?type=gene&acc=256471,,,256471.0,MFSD8,10116.0,Rattus norvegicus (Norway rat),1-naphthylisothiocyanate results in decreased expression of MFSD8 mRNA,,,PMID:30723492,https://www.ncbi.nlm.nih.gov/pubmed/30723492,30723492,,
806,807158,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,100124496,MIR743B,https://ctdbase.org/detail.go?type=gene&acc=100124496,,,100124496.0,Mir743b,10116.0,Rattus norvegicus (Norway rat),1-naphthylisothiocyanate results in decreased expression of MIR743B mRNA,,,PMID:22363424,https://www.ncbi.nlm.nih.gov/pubmed/22363424,22363424,,
807,807159,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,100126309,MIR875,https://ctdbase.org/detail.go?type=gene&acc=100126309,,,100126309.0,MIR875,10116.0,Rattus norvegicus (Norway rat),1-naphthylisothiocyanate results in decreased expression of MIR875 mRNA,,,PMID:22363424,https://www.ncbi.nlm.nih.gov/pubmed/22363424,22363424,,
808,807160,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,55320,MIS18BP1,https://ctdbase.org/detail.go?type=gene&acc=55320,,,55320.0,MIS18BP1,10116.0,Rattus norvegicus (Norway rat),1-naphthylisothiocyanate results in increased expression of MIS18BP1 mRNA,,,PMID:30723492,https://www.ncbi.nlm.nih.gov/pubmed/30723492,30723492,,
809,807352,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,221938,MMD2,https://ctdbase.org/detail.go?type=gene&acc=221938,,,221938.0,MMD2,10116.0,Rattus norvegicus (Norway rat),1-naphthylisothiocyanate results in decreased expression of MMD2 mRNA,,,PMID:30723492,https://www.ncbi.nlm.nih.gov/pubmed/30723492,30723492,,
810,807353,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,4311,MME,https://ctdbase.org/detail.go?type=gene&acc=4311,,,4311.0,MME,10116.0,Rattus norvegicus (Norway rat),1-naphthylisothiocyanate results in decreased expression of MME mRNA,,,PMID:30723492,https://www.ncbi.nlm.nih.gov/pubmed/30723492,30723492,,
811,807354,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,4323,MMP14,https://ctdbase.org/detail.go?type=gene&acc=4323,,,4323.0,MMP14,10090.0,Mus musculus (house mouse),"1-naphthylisothiocyanate results in increased expression of MMP14 mrna|o(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-naphthylisothiocyanate results in increased expression of MMP14 mrna]",,,PMID:15913567,https://www.ncbi.nlm.nih.gov/pubmed/15913567,15913567,,
812,807355,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,4324,MMP15,https://ctdbase.org/detail.go?type=gene&acc=4324,,,4324.0,MMP15,10116.0,Rattus norvegicus (Norway rat),1-naphthylisothiocyanate results in increased expression of MMP15 mRNA,,,PMID:25380136|PMID:30723492,https://www.ncbi.nlm.nih.gov/pubmed/25380136|https://www.ncbi.nlm.nih.gov/pubmed/30723492,25380136|30723492,,
813,807356,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,9313,MMP20,https://ctdbase.org/detail.go?type=gene&acc=9313,,,9313.0,MMP20,10116.0,Rattus norvegicus (Norway rat),1-naphthylisothiocyanate results in increased expression of MMP20 mRNA,,,PMID:30723492,https://www.ncbi.nlm.nih.gov/pubmed/30723492,30723492,,
814,902697,11442,Comparative Toxicogenomics Database (CTD),Allethrin,D000487,Allethrins,https://ctdbase.org/detail.go?type=chem&acc=D000487,8653,DDX3Y,https://ctdbase.org/detail.go?type=gene&acc=8653,,,8653.0,DDX3Y,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of DDX3Y mRNA,,,PMID:33396045|PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/33396045|https://www.ncbi.nlm.nih.gov/pubmed/34896426,33396045|34896426,,
815,810830,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,26002,MOXD1,https://ctdbase.org/detail.go?type=gene&acc=26002,,,26002.0,MOXD1,10090.0,Mus musculus (house mouse),Bisphenol F results in increased expression of MOXD1 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
816,810831,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,25874,MPC2,https://ctdbase.org/detail.go?type=gene&acc=25874,,,25874.0,MPC2,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of MPC2 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
817,810832,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,9526,MPDU1,https://ctdbase.org/detail.go?type=gene&acc=9526,,,9526.0,MPDU1,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of MPDU1 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
818,810833,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,8777,MPDZ,https://ctdbase.org/detail.go?type=gene&acc=8777,,,8777.0,MPDZ,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of MPDZ mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
819,810834,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,219972,MPEG1,https://ctdbase.org/detail.go?type=gene&acc=219972,,,219972.0,MPEG1,10090.0,Mus musculus (house mouse),Bisphenol F results in increased expression of MPEG1 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
820,810835,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,4351,MPI,https://ctdbase.org/detail.go?type=gene&acc=4351,,,4351.0,MPI,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of MPI mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
821,810836,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,80739,MPIG6B,https://ctdbase.org/detail.go?type=gene&acc=80739,,,80739.0,MPIG6B,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of MPIG6B mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
822,810992,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,4358,MPV17,https://ctdbase.org/detail.go?type=gene&acc=4358,,,4358.0,MPV17,9606.0,Homo sapiens (human),[bisphenol F co-treated with fulvestrant] results in increased methylation of MPV17 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
823,810993,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,337514,MPX,https://ctdbase.org/detail.go?type=gene&acc=337514,,,337514.0,mpx,7955.0,Danio rerio (zebrafish),[poly I-C co-treated with bisphenol F] results in decreased expression of MPX mrna|[pam(3)csk(4) peptide co-treated with bisphenol F] results in decreased expression of MPX mrna|bisphenol F results in decreased expression of MPX mRNA,,,PMID:28806546,https://www.ncbi.nlm.nih.gov/pubmed/28806546,28806546,,
824,812645,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,9961,MVP,https://ctdbase.org/detail.go?type=gene&acc=9961,,,9961.0,MVP,10090.0,Mus musculus (house mouse),Bisphenol F results in increased expression of MVP mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
825,812802,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,360142,MXA,https://ctdbase.org/detail.go?type=gene&acc=360142,,,360142.0,mxa,7955.0,Danio rerio (zebrafish),[poly I-C co-treated with bisphenol F] results in decreased expression of MXA mrna|bisphenol F results in decreased expression of MXA mrna|[pam(3)csk(4) peptide co-treated with bisphenol F] results in decreased expression of MXA mRNA,,,PMID:28806546,https://www.ncbi.nlm.nih.gov/pubmed/28806546,28806546,,
826,812803,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,25878,MXRA5,https://ctdbase.org/detail.go?type=gene&acc=25878,,,25878.0,MXRA5,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of MXRA5 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
827,814189,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,26509,MYOF,https://ctdbase.org/detail.go?type=gene&acc=26509,,,26509.0,MYOF,10090.0,Mus musculus (house mouse),Bisphenol F results in increased expression of MYOF mrna|[bisphenol F co-treated with tretinoin] results in decreased expression of MYOF mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
828,814190,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,4656,MYOG,https://ctdbase.org/detail.go?type=gene&acc=4656,,,4656.0,MYOG,10090.0,Mus musculus (house mouse),Bisphenol F results in increased expression of MYOG mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
829,814191,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,8736,MYOM1,https://ctdbase.org/detail.go?type=gene&acc=8736,,,8736.0,MYOM1,10090.0,Mus musculus (house mouse),Bisphenol F affects the expression of MYOM1 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
830,816190,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,4723,NDUFV1,https://ctdbase.org/detail.go?type=gene&acc=4723,,,4723.0,NDUFV1,9606.0,Homo sapiens (human),Bisphenol F results in increased expression of NDUFV1 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
831,816191,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,4723,NDUFV1,https://ctdbase.org/detail.go?type=gene&acc=4723,,,4723.0,NDUFV1,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of NDUFV1 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
832,816192,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,4731,NDUFV3,https://ctdbase.org/detail.go?type=gene&acc=4731,,,4731.0,NDUFV3,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of NDUFV3 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
833,816193,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,283131,NEAT1,https://ctdbase.org/detail.go?type=gene&acc=283131,,,283131.0,NEAT1,10090.0,Mus musculus (house mouse),[bisphenol F co-treated with LIF protein] results in increased expression of NEAT1 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
834,819315,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,4884,NPTX1,https://ctdbase.org/detail.go?type=gene&acc=4884,,,4884.0,NPTX1,10090.0,Mus musculus (house mouse),Bisphenol F results in increased expression of NPTX1 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
835,819316,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,4885,NPTX2,https://ctdbase.org/detail.go?type=gene&acc=4885,,,4885.0,NPTX2,10090.0,Mus musculus (house mouse),Bisphenol F results in increased expression of NPTX2 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
836,819317,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,4885,NPTX2,https://ctdbase.org/detail.go?type=gene&acc=4885,,,4885.0,NPTX2,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of NPTX2 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
837,819318,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,23467,NPTXR,https://ctdbase.org/detail.go?type=gene&acc=23467,,,23467.0,NPTXR,10090.0,Mus musculus (house mouse),[bisphenol F co-treated with tretinoin] results in decreased expression of NPTXR mrna|bisphenol F results in decreased expression of NPTXR mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
838,819319,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,64111,NPVF,https://ctdbase.org/detail.go?type=gene&acc=64111,,,64111.0,NPVF,10090.0,Mus musculus (house mouse),Bisphenol F results in increased expression of NPVF mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
839,819320,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,4852,NPY,https://ctdbase.org/detail.go?type=gene&acc=4852,,,4852.0,NPY,10090.0,Mus musculus (house mouse),Bisphenol F results in decreased expression of NPY mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
840,820144,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,55695,NSUN5,https://ctdbase.org/detail.go?type=gene&acc=55695,,,55695.0,NSUN5,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of NSUN5 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
841,820145,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,155400,NSUN5P1,https://ctdbase.org/detail.go?type=gene&acc=155400,,,155400.0,NSUN5P1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of NSUN5P1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
842,820146,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,221294,NT5DC1,https://ctdbase.org/detail.go?type=gene&acc=221294,,,221294.0,NT5DC1,9606.0,Homo sapiens (human),Bisphenol F results in increased expression of NT5DC1 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
843,820517,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,4916,NTRK3,https://ctdbase.org/detail.go?type=gene&acc=4916,,,4916.0,NTRK3,10090.0,Mus musculus (house mouse),Bisphenol F results in decreased expression of NTRK3 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
844,820518,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,4916,NTRK3,https://ctdbase.org/detail.go?type=gene&acc=4916,,,4916.0,NTRK3,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of NTRK3 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
845,820519,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,4923,NTSR1,https://ctdbase.org/detail.go?type=gene&acc=4923,,,4923.0,NTSR1,10090.0,Mus musculus (house mouse),Bisphenol F results in decreased expression of NTSR1 mRNA,,,PMID:36706583,https://www.ncbi.nlm.nih.gov/pubmed/36706583,36706583,,
846,820520,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,23620,NTSR2,https://ctdbase.org/detail.go?type=gene&acc=23620,,,23620.0,NTSR2,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of NTSR2 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
847,831499,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,5536,PPP5C,https://ctdbase.org/detail.go?type=gene&acc=5536,,,5536.0,PPP5C,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of PPP5C mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
848,806074,12699,Comparative Toxicogenomics Database (CTD),N-Nitroso-N-methylurea,D008770,Methylnitrosourea,https://ctdbase.org/detail.go?type=chem&acc=D008770,3845,KRAS,https://ctdbase.org/detail.go?type=gene&acc=3845,,,3845.0,KRAS,10116.0,Rattus norvegicus (Norway rat),KRAS protein results in decreased susceptibility to methylnitrosourea,,,PMID:11973638,https://www.ncbi.nlm.nih.gov/pubmed/11973638,11973638,,
849,806075,12699,Comparative Toxicogenomics Database (CTD),N-Nitroso-N-methylurea,D008770,Methylnitrosourea,https://ctdbase.org/detail.go?type=chem&acc=D008770,3934,LCN2,https://ctdbase.org/detail.go?type=gene&acc=3934,,,3934.0,LCN2,10116.0,Rattus norvegicus (Norway rat),Methylnitrosourea results in increased expression of LCN2 mRNA,,,PMID:17412507,https://www.ncbi.nlm.nih.gov/pubmed/17412507,17412507,,
850,806076,12699,Comparative Toxicogenomics Database (CTD),N-Nitroso-N-methylurea,D008770,Methylnitrosourea,https://ctdbase.org/detail.go?type=chem&acc=D008770,3952,LEP,https://ctdbase.org/detail.go?type=gene&acc=3952,,,3952.0,LEP,10090.0,Mus musculus (house mouse),Freund's adjuvant inhibits the reaction [methylnitrosourea results in increased expression of LEP protein]|ifng protein inhibits the reaction [methylnitrosourea results in increased expression of LEP protein]|methylnitrosourea results in increased expression of LEP protein|butylated hydroxytoluene inhibits the reaction [methylnitrosourea results in increased expression of LEP protein],,,PMID:16822543,https://www.ncbi.nlm.nih.gov/pubmed/16822543,16822543,,
851,808171,12699,Comparative Toxicogenomics Database (CTD),N-Nitroso-N-methylurea,D008770,Methylnitrosourea,https://ctdbase.org/detail.go?type=chem&acc=D008770,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116.0,Rattus norvegicus (Norway rat),Methylnitrosourea results in increased expression of PTGS2,,,PMID:28688903,https://www.ncbi.nlm.nih.gov/pubmed/28688903,28688903,,
852,808172,12699,Comparative Toxicogenomics Database (CTD),N-Nitroso-N-methylurea,D008770,Methylnitrosourea,https://ctdbase.org/detail.go?type=chem&acc=D008770,5784,PTPN14,https://ctdbase.org/detail.go?type=gene&acc=5784,,,5784.0,PTPN14,10090.0,Mus musculus (house mouse),Methylnitrosourea results in increased expression of PTPN14 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
853,808173,12699,Comparative Toxicogenomics Database (CTD),N-Nitroso-N-methylurea,D008770,Methylnitrosourea,https://ctdbase.org/detail.go?type=chem&acc=D008770,5914,RARA,https://ctdbase.org/detail.go?type=gene&acc=5914,,,5914.0,RARA,10090.0,Mus musculus (house mouse),Methylnitrosourea results in increased mutagenesis of RARA gene,,,PMID:16868089,https://www.ncbi.nlm.nih.gov/pubmed/16868089,16868089,,
854,808174,12699,Comparative Toxicogenomics Database (CTD),N-Nitroso-N-methylurea,D008770,Methylnitrosourea,https://ctdbase.org/detail.go?type=chem&acc=D008770,5914,RARA,https://ctdbase.org/detail.go?type=gene&acc=5914,,,5914.0,RARA,10116.0,Rattus norvegicus (Norway rat),Cholecalciferol inhibits the reaction [methylnitrosourea results in increased expression of RARA mrna]|methylnitrosourea results in increased expression of RARA mRNA,,,PMID:21843606,https://www.ncbi.nlm.nih.gov/pubmed/21843606,21843606,,
855,808175,12699,Comparative Toxicogenomics Database (CTD),N-Nitroso-N-methylurea,D008770,Methylnitrosourea,https://ctdbase.org/detail.go?type=chem&acc=D008770,5925,RB1,https://ctdbase.org/detail.go?type=gene&acc=5925,,,5925.0,RB1,10116.0,Rattus norvegicus (Norway rat),Methylnitrosourea results in increased phosphorylation of RB1 protein,,,PMID:15581186,https://www.ncbi.nlm.nih.gov/pubmed/15581186,15581186,,
856,809338,12699,Comparative Toxicogenomics Database (CTD),N-Nitroso-N-methylurea,D008770,Methylnitrosourea,https://ctdbase.org/detail.go?type=chem&acc=D008770,7068,THRB,https://ctdbase.org/detail.go?type=gene&acc=7068,,,7068.0,THRB,10116.0,Rattus norvegicus (Norway rat),Methylnitrosourea affects the expression of THRB mRNA,,,PMID:21843606,https://www.ncbi.nlm.nih.gov/pubmed/21843606,21843606,,
857,809339,12699,Comparative Toxicogenomics Database (CTD),N-Nitroso-N-methylurea,D008770,Methylnitrosourea,https://ctdbase.org/detail.go?type=chem&acc=D008770,7069,THRSP,https://ctdbase.org/detail.go?type=gene&acc=7069,,,7069.0,THRSP,10116.0,Rattus norvegicus (Norway rat),Methylnitrosourea results in decreased expression of THRSP mRNA,,,PMID:17341692,https://www.ncbi.nlm.nih.gov/pubmed/17341692,17341692,,
858,809340,12699,Comparative Toxicogenomics Database (CTD),N-Nitroso-N-methylurea,D008770,Methylnitrosourea,https://ctdbase.org/detail.go?type=chem&acc=D008770,7069,THRSP,https://ctdbase.org/detail.go?type=gene&acc=7069,,,7069.0,THRSP,10116.0,Rattus norvegicus (Norway rat),Methylnitrosourea results in increased expression of THRSP mRNA,,,PMID:16525678,https://www.ncbi.nlm.nih.gov/pubmed/16525678,16525678,,
859,809341,12699,Comparative Toxicogenomics Database (CTD),N-Nitroso-N-methylurea,D008770,Methylnitrosourea,https://ctdbase.org/detail.go?type=chem&acc=D008770,25917,THUMPD3,https://ctdbase.org/detail.go?type=gene&acc=25917,,,25917.0,THUMPD3,10090.0,Mus musculus (house mouse),Methylnitrosourea results in decreased expression of THUMPD3 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
860,809342,12699,Comparative Toxicogenomics Database (CTD),N-Nitroso-N-methylurea,D008770,Methylnitrosourea,https://ctdbase.org/detail.go?type=chem&acc=D008770,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076.0,TIMP1,10116.0,Rattus norvegicus (Norway rat),Methylnitrosourea results in increased expression of TIMP1 mRNA,,,PMID:17412507,https://www.ncbi.nlm.nih.gov/pubmed/17412507,17412507,,
861,810661,13462,Comparative Toxicogenomics Database (CTD),3-Nitrofluoranthene,C033643,3-nitrofluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C033643,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,9606.0,Homo sapiens (human),3-nitrofluoranthene binds to and results in increased activity of AHR protein,,,PMID:28186253,https://www.ncbi.nlm.nih.gov/pubmed/28186253,28186253,,
862,810662,13462,Comparative Toxicogenomics Database (CTD),3-Nitrofluoranthene,C033643,3-nitrofluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C033643,246224,AHR1A,https://ctdbase.org/detail.go?type=gene&acc=246224,,,246224.0,ahr1a,7955.0,Danio rerio (zebrafish),3-nitrofluoranthene binds to and results in increased activity of AHR1A protein,,,PMID:28186253,https://www.ncbi.nlm.nih.gov/pubmed/28186253,28186253,,
863,810663,13462,Comparative Toxicogenomics Database (CTD),3-Nitrofluoranthene,C033643,3-nitrofluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C033643,554265,AHR1B,https://ctdbase.org/detail.go?type=gene&acc=554265,,,554265.0,ahr1b,7955.0,Danio rerio (zebrafish),3-nitrofluoranthene binds to and results in increased activity of AHR1B protein,,,PMID:28186253,https://www.ncbi.nlm.nih.gov/pubmed/28186253,28186253,,
864,810664,13462,Comparative Toxicogenomics Database (CTD),3-Nitrofluoranthene,C033643,3-nitrofluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C033643,30517,AHR2,https://ctdbase.org/detail.go?type=gene&acc=30517,,,30517.0,ahr2,7955.0,Danio rerio (zebrafish),3-nitrofluoranthene binds to and results in increased activity of AHR2 protein,,,PMID:28186253,https://www.ncbi.nlm.nih.gov/pubmed/28186253,28186253,,
865,810665,13462,Comparative Toxicogenomics Database (CTD),3-Nitrofluoranthene,C033643,3-nitrofluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C033643,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10090.0,Mus musculus (house mouse),3-nitrofluoranthene results in increased phosphorylation of AKT1 protein,,,PMID:19041363,https://www.ncbi.nlm.nih.gov/pubmed/19041363,19041363,,
866,810666,13462,Comparative Toxicogenomics Database (CTD),3-Nitrofluoranthene,C033643,3-nitrofluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C033643,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090.0,Mus musculus (house mouse),3-nitrofluoranthene results in increased activity of CASP3 protein,,,PMID:19041363,https://www.ncbi.nlm.nih.gov/pubmed/19041363,19041363,,
867,810667,13462,Comparative Toxicogenomics Database (CTD),3-Nitrofluoranthene,C033643,3-nitrofluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C033643,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,10090.0,Mus musculus (house mouse),3-nitrofluoranthene results in increased activity of CASP8 protein,,,PMID:19041363,https://www.ncbi.nlm.nih.gov/pubmed/19041363,19041363,,
868,810826,13462,Comparative Toxicogenomics Database (CTD),3-Nitrofluoranthene,C033643,3-nitrofluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C033643,140634,CYP1A,https://ctdbase.org/detail.go?type=gene&acc=140634,,,140634.0,cyp1a,7955.0,Danio rerio (zebrafish),3-nitrofluoranthene results in increased expression of CYP1A mRNA,,,PMID:28186253,https://www.ncbi.nlm.nih.gov/pubmed/28186253,28186253,,
869,810827,13462,Comparative Toxicogenomics Database (CTD),3-Nitrofluoranthene,C033643,3-nitrofluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C033643,140634,CYP1A,https://ctdbase.org/detail.go?type=gene&acc=140634,,,140634.0,cyp1a,7955.0,Danio rerio (zebrafish),3-nitrofluoranthene results in increased expression of CYP1A protein,,,PMID:29094189,https://www.ncbi.nlm.nih.gov/pubmed/29094189,29094189,,
870,810828,13462,Comparative Toxicogenomics Database (CTD),3-Nitrofluoranthene,C033643,3-nitrofluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C033643,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),3-nitrofluoranthene results in increased expression of CYP1A1 mRNA,,,PMID:12107646,https://www.ncbi.nlm.nih.gov/pubmed/12107646,12107646,,
871,810829,13462,Comparative Toxicogenomics Database (CTD),3-Nitrofluoranthene,C033643,3-nitrofluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C033643,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10090.0,Mus musculus (house mouse),3-nitrofluoranthene results in increased expression of CYP1A1 protein,,,PMID:19041363,https://www.ncbi.nlm.nih.gov/pubmed/19041363,19041363,,
872,811993,13709,Comparative Toxicogenomics Database (CTD),Methidathion,C005828,methidathion,https://ctdbase.org/detail.go?type=chem&acc=C005828,10526,IPO8,https://ctdbase.org/detail.go?type=gene&acc=10526,,,10526.0,IPO8,10090.0,Mus musculus (house mouse),Methidathion results in decreased expression of IPO8 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
873,811994,13709,Comparative Toxicogenomics Database (CTD),Methidathion,C005828,methidathion,https://ctdbase.org/detail.go?type=chem&acc=C005828,55705,IPO9,https://ctdbase.org/detail.go?type=gene&acc=55705,,,55705.0,IPO9,10090.0,Mus musculus (house mouse),Methidathion results in decreased expression of IPO9 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
874,811995,13709,Comparative Toxicogenomics Database (CTD),Methidathion,C005828,methidathion,https://ctdbase.org/detail.go?type=chem&acc=C005828,10788,IQGAP2,https://ctdbase.org/detail.go?type=gene&acc=10788,,,10788.0,IQGAP2,10090.0,Mus musculus (house mouse),Methidathion results in increased expression of IQGAP2 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
875,811996,13709,Comparative Toxicogenomics Database (CTD),Methidathion,C005828,methidathion,https://ctdbase.org/detail.go?type=chem&acc=C005828,3654,IRAK1,https://ctdbase.org/detail.go?type=gene&acc=3654,,,3654.0,IRAK1,10090.0,Mus musculus (house mouse),Methidathion affects the expression of IRAK1 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
876,811997,13709,Comparative Toxicogenomics Database (CTD),Methidathion,C005828,methidathion,https://ctdbase.org/detail.go?type=chem&acc=C005828,3660,IRF2,https://ctdbase.org/detail.go?type=gene&acc=3660,,,3660.0,IRF2,10090.0,Mus musculus (house mouse),Methidathion results in increased expression of IRF2 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
877,811998,13709,Comparative Toxicogenomics Database (CTD),Methidathion,C005828,methidathion,https://ctdbase.org/detail.go?type=chem&acc=C005828,54396,IRGM2,https://ctdbase.org/detail.go?type=gene&acc=54396,,,54396.0,Irgm2,10090.0,Mus musculus (house mouse),Methidathion results in decreased expression of IRGM2 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
878,811999,13709,Comparative Toxicogenomics Database (CTD),Methidathion,C005828,methidathion,https://ctdbase.org/detail.go?type=chem&acc=C005828,23479,ISCU,https://ctdbase.org/detail.go?type=gene&acc=23479,,,23479.0,ISCU,10090.0,Mus musculus (house mouse),Methidathion results in increased expression of ISCU mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
879,814843,13709,Comparative Toxicogenomics Database (CTD),Methidathion,C005828,methidathion,https://ctdbase.org/detail.go?type=chem&acc=C005828,9553,MRPL33,https://ctdbase.org/detail.go?type=gene&acc=9553,,,9553.0,MRPL33,10090.0,Mus musculus (house mouse),Methidathion results in increased expression of MRPL33 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
880,814844,13709,Comparative Toxicogenomics Database (CTD),Methidathion,C005828,methidathion,https://ctdbase.org/detail.go?type=chem&acc=C005828,51073,MRPL4,https://ctdbase.org/detail.go?type=gene&acc=51073,,,51073.0,MRPL4,10090.0,Mus musculus (house mouse),Methidathion results in increased expression of MRPL4 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
881,814845,13709,Comparative Toxicogenomics Database (CTD),Methidathion,C005828,methidathion,https://ctdbase.org/detail.go?type=chem&acc=C005828,64976,MRPL40,https://ctdbase.org/detail.go?type=gene&acc=64976,,,64976.0,MRPL40,10090.0,Mus musculus (house mouse),Methidathion results in increased expression of MRPL40 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
882,814846,13709,Comparative Toxicogenomics Database (CTD),Methidathion,C005828,methidathion,https://ctdbase.org/detail.go?type=chem&acc=C005828,26589,MRPL46,https://ctdbase.org/detail.go?type=gene&acc=26589,,,26589.0,MRPL46,10090.0,Mus musculus (house mouse),Methidathion results in decreased expression of MRPL46 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
883,814847,13709,Comparative Toxicogenomics Database (CTD),Methidathion,C005828,methidathion,https://ctdbase.org/detail.go?type=chem&acc=C005828,51258,MRPL51,https://ctdbase.org/detail.go?type=gene&acc=51258,,,51258.0,MRPL51,10090.0,Mus musculus (house mouse),Methidathion results in increased expression of MRPL51 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
884,814848,13709,Comparative Toxicogenomics Database (CTD),Methidathion,C005828,methidathion,https://ctdbase.org/detail.go?type=chem&acc=C005828,116540,MRPL53,https://ctdbase.org/detail.go?type=gene&acc=116540,,,116540.0,MRPL53,10090.0,Mus musculus (house mouse),Methidathion results in increased expression of MRPL53 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
885,814849,13709,Comparative Toxicogenomics Database (CTD),Methidathion,C005828,methidathion,https://ctdbase.org/detail.go?type=chem&acc=C005828,116541,MRPL54,https://ctdbase.org/detail.go?type=gene&acc=116541,,,116541.0,MRPL54,10090.0,Mus musculus (house mouse),Methidathion results in increased expression of MRPL54 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
886,816038,13709,Comparative Toxicogenomics Database (CTD),Methidathion,C005828,methidathion,https://ctdbase.org/detail.go?type=chem&acc=C005828,4718,NDUFC2,https://ctdbase.org/detail.go?type=gene&acc=4718,,,4718.0,NDUFC2,10090.0,Mus musculus (house mouse),Methidathion affects the expression of NDUFC2 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
887,816989,14017,Comparative Toxicogenomics Database (CTD),(Aminomethyl)phosphonic acid,C000710227,aminomethylphosphonic acid (AMPA),https://ctdbase.org/detail.go?type=chem&acc=C000710227,1647,GADD45A,https://ctdbase.org/detail.go?type=gene&acc=1647,,,1647.0,GADD45A,9606.0,Homo sapiens (human),Aminomethylphosphonic acid (AMPA) results in increased expression of GADD45A mRNA,,,PMID:31295307,https://www.ncbi.nlm.nih.gov/pubmed/31295307,31295307,,
888,816990,14017,Comparative Toxicogenomics Database (CTD),(Aminomethyl)phosphonic acid,C000710227,aminomethylphosphonic acid (AMPA),https://ctdbase.org/detail.go?type=chem&acc=C000710227,2596,GAP43,https://ctdbase.org/detail.go?type=gene&acc=2596,,,2596.0,GAP43,9606.0,Homo sapiens (human),Aminomethylphosphonic acid (AMPA) results in decreased expression of GAP43 mRNA,,,PMID:31874349,https://www.ncbi.nlm.nih.gov/pubmed/31874349,31874349,,
889,816991,14017,Comparative Toxicogenomics Database (CTD),(Aminomethyl)phosphonic acid,C000710227,aminomethylphosphonic acid (AMPA),https://ctdbase.org/detail.go?type=chem&acc=C000710227,60674,GAS5,https://ctdbase.org/detail.go?type=gene&acc=60674,,,60674.0,GAS5,9606.0,Homo sapiens (human),Aminomethylphosphonic acid (AMPA) results in increased expression of GAS5 mRNA,,,PMID:37047296,https://www.ncbi.nlm.nih.gov/pubmed/37047296,37047296,,
890,816992,14017,Comparative Toxicogenomics Database (CTD),(Aminomethyl)phosphonic acid,C000710227,aminomethylphosphonic acid (AMPA),https://ctdbase.org/detail.go?type=chem&acc=C000710227,2805,GOT1,https://ctdbase.org/detail.go?type=gene&acc=2805,,,2805.0,GOT1,9606.0,Homo sapiens (human),[glyphosate results in increased abundance of aminomethylphosphonic acid (AMPA)] which results in increased activity of GOT1 protein,,,PMID:36856429,https://www.ncbi.nlm.nih.gov/pubmed/36856429,36856429,,
891,816993,14017,Comparative Toxicogenomics Database (CTD),(Aminomethyl)phosphonic acid,C000710227,aminomethylphosphonic acid (AMPA),https://ctdbase.org/detail.go?type=chem&acc=C000710227,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,9606.0,Homo sapiens (human),[glyphosate results in increased abundance of aminomethylphosphonic acid (AMPA)] which results in increased activity of GPT protein,,,PMID:36856429,https://www.ncbi.nlm.nih.gov/pubmed/36856429,36856429,,
892,816994,14017,Comparative Toxicogenomics Database (CTD),(Aminomethyl)phosphonic acid,C000710227,aminomethylphosphonic acid (AMPA),https://ctdbase.org/detail.go?type=chem&acc=C000710227,2947,GSTM3,https://ctdbase.org/detail.go?type=gene&acc=2947,,,2947.0,GSTM3,9606.0,Homo sapiens (human),Aminomethylphosphonic acid (AMPA) results in increased expression of GSTM3 mrna|aminomethylphosphonic acid (AMPA) affects the expression of GSTM3 protein,,,PMID:37047296,https://www.ncbi.nlm.nih.gov/pubmed/37047296,37047296,,
893,816995,14017,Comparative Toxicogenomics Database (CTD),(Aminomethyl)phosphonic acid,C000710227,aminomethylphosphonic acid (AMPA),https://ctdbase.org/detail.go?type=chem&acc=C000710227,3033,HADH,https://ctdbase.org/detail.go?type=gene&acc=3033,,,3033.0,HADH,7955.0,Danio rerio (zebrafish),Aminomethylphosphonic acid (AMPA) results in increased expression of HADH mRNA,,,PMID:35504511,https://www.ncbi.nlm.nih.gov/pubmed/35504511,35504511,,
894,819157,14457,Comparative Toxicogenomics Database (CTD),Ammonium iron(III) citrate,C013531,ferric ammonium citrate,https://ctdbase.org/detail.go?type=chem&acc=C013531,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,10090.0,Mus musculus (house mouse),Ferric ammonium citrate results in decreased expression of RUNX2 protein|silybin inhibits the reaction [ferric ammonium citrate results in decreased expression of RUNX2 protein],,,PMID:36087815,https://www.ncbi.nlm.nih.gov/pubmed/36087815,36087815,,
895,807357,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,2899,GRIK3,https://ctdbase.org/detail.go?type=gene&acc=2899,,,2899.0,GRIK3,10116.0,Rattus norvegicus (Norway rat),Paraquat results in decreased expression of GRIK3 mRNA,,,PMID:18198484,https://www.ncbi.nlm.nih.gov/pubmed/18198484,18198484,,
896,807358,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,2902,GRIN1,https://ctdbase.org/detail.go?type=gene&acc=2902,,,2902.0,GRIN1,10116.0,Rattus norvegicus (Norway rat),Paraquat results in decreased expression of GRIN1 mRNA,,,PMID:19146868|PMID:28916328,https://www.ncbi.nlm.nih.gov/pubmed/19146868|https://www.ncbi.nlm.nih.gov/pubmed/28916328,19146868|28916328,,
897,807359,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,2903,GRIN2A,https://ctdbase.org/detail.go?type=gene&acc=2903,,,2903.0,GRIN2A,10090.0,Mus musculus (house mouse),Paraquat results in increased expression of GRIN2A mRNA,,,PMID:22563483,https://www.ncbi.nlm.nih.gov/pubmed/22563483,22563483,,
898,807360,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,2903,GRIN2A,https://ctdbase.org/detail.go?type=gene&acc=2903,,,2903.0,GRIN2A,10116.0,Rattus norvegicus (Norway rat),Paraquat results in increased expression of GRIN2A mRNA,,,PMID:18198484,https://www.ncbi.nlm.nih.gov/pubmed/18198484,18198484,,
899,807361,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,2904,GRIN2B,https://ctdbase.org/detail.go?type=gene&acc=2904,,,2904.0,GRIN2B,10090.0,Mus musculus (house mouse),Paraquat results in increased expression of GRIN2B mRNA,,,PMID:22563483,https://www.ncbi.nlm.nih.gov/pubmed/22563483,22563483,,
900,807362,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,2904,GRIN2B,https://ctdbase.org/detail.go?type=gene&acc=2904,,,2904.0,GRIN2B,10116.0,Rattus norvegicus (Norway rat),Paraquat affects the expression of GRIN2B mRNA,,,PMID:15206577,https://www.ncbi.nlm.nih.gov/pubmed/15206577,15206577,,
901,807678,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10090.0,Mus musculus (house mouse),Paraquat results in increased expression of and results in increased phosphorylation of GSK3B protein,,,PMID:22292029,https://www.ncbi.nlm.nih.gov/pubmed/22292029,22292029,,
902,807679,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10090.0,Mus musculus (house mouse),Paraquat results in increased phosphorylation of GSK3B protein,,,PMID:24634145,https://www.ncbi.nlm.nih.gov/pubmed/24634145,24634145,,
903,807680,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10116.0,Rattus norvegicus (Norway rat),Paraquat results in decreased phosphorylation of GSK3B protein,,,PMID:34048864|PMID:36394833,https://www.ncbi.nlm.nih.gov/pubmed/34048864|https://www.ncbi.nlm.nih.gov/pubmed/36394833,34048864|36394833,,
904,807681,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,2935,GSPT1,https://ctdbase.org/detail.go?type=gene&acc=2935,,,2935.0,GSPT1,10116.0,Rattus norvegicus (Norway rat),Paraquat results in increased expression of GSPT1 mRNA,,,PMID:32680482,https://www.ncbi.nlm.nih.gov/pubmed/32680482,32680482,,
905,807682,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,23708,GSPT2,https://ctdbase.org/detail.go?type=gene&acc=23708,,,23708.0,GSPT2,10090.0,Mus musculus (house mouse),[maneb co-treated with paraquat] results in decreased expression of GSPT2 mRNA,,,PMID:36117858,https://www.ncbi.nlm.nih.gov/pubmed/36117858,36117858,,
906,807683,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,7955.0,Danio rerio (zebrafish),Paraquat affects the expression of GSR mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
907,807684,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9606.0,Homo sapiens (human),"Paraquat results in decreased activity of GSR protein|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [paraquat results in decreased activity of GSR protein]",,,PMID:30185695,https://www.ncbi.nlm.nih.gov/pubmed/30185695,30185695,,
908,807685,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9606.0,Homo sapiens (human),Paraquat inhibits the reaction [naringenin results in increased expression of GSR mrna],,,PMID:24561720,https://www.ncbi.nlm.nih.gov/pubmed/24561720,24561720,,
909,807686,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9606.0,Homo sapiens (human),[plant extracts co-treated with paraquat] results in increased expression of GSR mRNA,,,PMID:24141985,https://www.ncbi.nlm.nih.gov/pubmed/24141985,24141985,,
910,807855,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10090.0,Mus musculus (house mouse),Paraquat results in decreased expression of GSR mRNA,,,PMID:16797015,https://www.ncbi.nlm.nih.gov/pubmed/16797015,16797015,,
911,807856,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10090.0,Mus musculus (house mouse),Paraquat results in increased expression of GSR mRNA,,,PMID:12954614|PMID:17215068|PMID:21765237,https://www.ncbi.nlm.nih.gov/pubmed/12954614|https://www.ncbi.nlm.nih.gov/pubmed/17215068|https://www.ncbi.nlm.nih.gov/pubmed/21765237,12954614|17215068|21765237,,
912,807857,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,8022.0,Oncorhynchus mykiss (rainbow trout),Paraquat results in increased activity of GSR protein,,,PMID:12379427|PMID:12453665,https://www.ncbi.nlm.nih.gov/pubmed/12379427|https://www.ncbi.nlm.nih.gov/pubmed/12453665,12379427|12453665,,
913,808657,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,37113,GSTE8,https://ctdbase.org/detail.go?type=gene&acc=37113,,,37113.0,GstE8,7227.0,Drosophila melanogaster (fruit fly),Paraquat results in increased expression of GSTE8 mRNA,,,PMID:31481676,https://www.ncbi.nlm.nih.gov/pubmed/31481676,31481676,,
914,808658,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,246581,GSTE9,https://ctdbase.org/detail.go?type=gene&acc=246581,,,246581.0,GstE9,7227.0,Drosophila melanogaster (fruit fly),Paraquat results in decreased expression of GSTE9 protein,,,PMID:17907271,https://www.ncbi.nlm.nih.gov/pubmed/17907271,17907271,,
915,808659,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,2944,GSTM1,https://ctdbase.org/detail.go?type=gene&acc=2944,,,2944.0,GSTM1,10090.0,Mus musculus (house mouse),Paraquat results in increased expression of GSTM1 mRNA,,,PMID:16128001,https://www.ncbi.nlm.nih.gov/pubmed/16128001,16128001,,
916,808660,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,2946,GSTM2,https://ctdbase.org/detail.go?type=gene&acc=2946,,,2946.0,GSTM2,10090.0,Mus musculus (house mouse),Paraquat results in increased expression of GSTM2 mRNA,,,PMID:16128001|PMID:21371552,https://www.ncbi.nlm.nih.gov/pubmed/16128001|https://www.ncbi.nlm.nih.gov/pubmed/21371552,16128001|21371552,,
917,808661,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,2946,GSTM2,https://ctdbase.org/detail.go?type=gene&acc=2946,,,2946.0,GSTM2,10116.0,Rattus norvegicus (Norway rat),Paraquat results in decreased expression of GSTM2 mRNA,,,PMID:17935786,https://www.ncbi.nlm.nih.gov/pubmed/17935786,17935786,,
918,808662,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,2946,GSTM2,https://ctdbase.org/detail.go?type=gene&acc=2946,,,2946.0,GSTM2,10116.0,Rattus norvegicus (Norway rat),Paraquat results in increased expression of GSTM2 mRNA,,,PMID:16555045,https://www.ncbi.nlm.nih.gov/pubmed/16555045,16555045,,
919,816194,16078,Comparative Toxicogenomics Database (CTD),Dronabinol,D013759,Dronabinol,https://ctdbase.org/detail.go?type=chem&acc=D013759,252884,ZNF396,https://ctdbase.org/detail.go?type=gene&acc=252884,,,252884.0,ZNF396,9606.0,Homo sapiens (human),[dronabinol results in decreased susceptibility to potassium chloride] which results in decreased expression of ZNF396 mRNA,,,PMID:29691375,https://www.ncbi.nlm.nih.gov/pubmed/29691375,29691375,,
920,816195,16078,Comparative Toxicogenomics Database (CTD),Dronabinol,D013759,Dronabinol,https://ctdbase.org/detail.go?type=chem&acc=D013759,84307,ZNF397,https://ctdbase.org/detail.go?type=gene&acc=84307,,,84307.0,ZNF397,9606.0,Homo sapiens (human),[dronabinol results in decreased susceptibility to potassium chloride] which results in decreased expression of ZNF397 mRNA,,,PMID:29691375,https://www.ncbi.nlm.nih.gov/pubmed/29691375,29691375,,
921,816196,16078,Comparative Toxicogenomics Database (CTD),Dronabinol,D013759,Dronabinol,https://ctdbase.org/detail.go?type=chem&acc=D013759,220929,ZNF438,https://ctdbase.org/detail.go?type=gene&acc=220929,,,220929.0,ZNF438,9606.0,Homo sapiens (human),Dronabinol results in decreased expression of ZNF438 mRNA,,,PMID:16597638,https://www.ncbi.nlm.nih.gov/pubmed/16597638,16597638,,
922,816197,16078,Comparative Toxicogenomics Database (CTD),Dronabinol,D013759,Dronabinol,https://ctdbase.org/detail.go?type=chem&acc=D013759,26036,ZNF451,https://ctdbase.org/detail.go?type=gene&acc=26036,,,26036.0,ZNF451,9606.0,Homo sapiens (human),Dronabinol results in increased expression of ZNF451 mRNA,,,PMID:18454173,https://www.ncbi.nlm.nih.gov/pubmed/18454173,18454173,,
923,816198,16078,Comparative Toxicogenomics Database (CTD),Dronabinol,D013759,Dronabinol,https://ctdbase.org/detail.go?type=chem&acc=D013759,58499,ZNF462,https://ctdbase.org/detail.go?type=gene&acc=58499,,,58499.0,ZNF462,9606.0,Homo sapiens (human),Dronabinol results in increased expression of ZNF462 mRNA,,,PMID:29691375,https://www.ncbi.nlm.nih.gov/pubmed/29691375,29691375,,
924,816199,16078,Comparative Toxicogenomics Database (CTD),Dronabinol,D013759,Dronabinol,https://ctdbase.org/detail.go?type=chem&acc=D013759,90333,ZNF468,https://ctdbase.org/detail.go?type=gene&acc=90333,,,90333.0,ZNF468,9606.0,Homo sapiens (human),Dronabinol results in decreased expression of ZNF468 mRNA,,,PMID:29691375,https://www.ncbi.nlm.nih.gov/pubmed/29691375,29691375,,
925,816200,16078,Comparative Toxicogenomics Database (CTD),Dronabinol,D013759,Dronabinol,https://ctdbase.org/detail.go?type=chem&acc=D013759,440515,ZNF506,https://ctdbase.org/detail.go?type=gene&acc=440515,,,440515.0,ZNF506,9606.0,Homo sapiens (human),Dronabinol results in decreased expression of ZNF506 mRNA,,,PMID:16597638,https://www.ncbi.nlm.nih.gov/pubmed/16597638,16597638,,
926,819310,18728,Comparative Toxicogenomics Database (CTD),"1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane",C517232,"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517232,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9031.0,Gallus gallus (chicken),"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane results in increased expression of PTGS2 mRNA",,,PMID:24375616,https://www.ncbi.nlm.nih.gov/pubmed/24375616,24375616,,
927,819311,18728,Comparative Toxicogenomics Database (CTD),"1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane",C517232,"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517232,246227,PTGS2A,https://ctdbase.org/detail.go?type=gene&acc=246227,,,246227.0,ptgs2a,7955.0,Danio rerio (zebrafish),"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane results in increased expression of PTGS2A mRNA",,,PMID:23958786,https://www.ncbi.nlm.nih.gov/pubmed/23958786,23958786,,
928,819312,18728,Comparative Toxicogenomics Database (CTD),"1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane",C517232,"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517232,5831,PYCR1,https://ctdbase.org/detail.go?type=gene&acc=5831,,,5831.0,PYCR1,10090.0,Mus musculus (house mouse),"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [testosterone deficiency results in decreased expression of PYCR1 mrna]",,,PMID:33848595,https://www.ncbi.nlm.nih.gov/pubmed/33848595,33848595,,
929,819313,18728,Comparative Toxicogenomics Database (CTD),"1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane",C517232,"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517232,5834,PYGB,https://ctdbase.org/detail.go?type=gene&acc=5834,,,5834.0,PYGB,10090.0,Mus musculus (house mouse),"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [testosterone deficiency results in increased expression of PYGB mrna]",,,PMID:33848595,https://www.ncbi.nlm.nih.gov/pubmed/33848595,33848595,,
930,819314,18728,Comparative Toxicogenomics Database (CTD),"1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane",C517232,"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517232,10981,RAB32,https://ctdbase.org/detail.go?type=gene&acc=10981,,,10981.0,RAB32,10090.0,Mus musculus (house mouse),"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [testosterone deficiency results in increased expression of RAB32 mrna]",,,PMID:33848595,https://www.ncbi.nlm.nih.gov/pubmed/33848595,33848595,,
931,819492,18728,Comparative Toxicogenomics Database (CTD),"1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane",C517232,"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517232,116442,RAB39B,https://ctdbase.org/detail.go?type=gene&acc=116442,,,116442.0,RAB39B,10090.0,Mus musculus (house mouse),"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [testosterone deficiency results in decreased expression of RAB39B mrna]",,,PMID:33848595,https://www.ncbi.nlm.nih.gov/pubmed/33848595,33848595,,
932,819493,18728,Comparative Toxicogenomics Database (CTD),"1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane",C517232,"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517232,5888,RAD51,https://ctdbase.org/detail.go?type=gene&acc=5888,,,5888.0,RAD51,7955.0,Danio rerio (zebrafish),"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane results in increased expression of RAD51 mRNA",,,PMID:23958786,https://www.ncbi.nlm.nih.gov/pubmed/23958786,23958786,,
933,819494,18728,Comparative Toxicogenomics Database (CTD),"1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane",C517232,"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517232,5922,RASA2,https://ctdbase.org/detail.go?type=gene&acc=5922,,,5922.0,RASA2,10090.0,Mus musculus (house mouse),"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [testosterone deficiency results in increased expression of RASA2 mrna]",,,PMID:33848595,https://www.ncbi.nlm.nih.gov/pubmed/33848595,33848595,,
934,819495,18728,Comparative Toxicogenomics Database (CTD),"1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane",C517232,"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517232,8045,RASSF7,https://ctdbase.org/detail.go?type=gene&acc=8045,,,8045.0,RASSF7,10090.0,Mus musculus (house mouse),"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [testosterone deficiency results in increased expression of RASSF7 mrna]",,,PMID:33848595,https://www.ncbi.nlm.nih.gov/pubmed/33848595,33848595,,
935,819496,18728,Comparative Toxicogenomics Database (CTD),"1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane",C517232,"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517232,221035,REEP3,https://ctdbase.org/detail.go?type=gene&acc=221035,,,221035.0,REEP3,10090.0,Mus musculus (house mouse),"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [testosterone deficiency results in increased expression of REEP3 mrna]",,,PMID:33848595,https://www.ncbi.nlm.nih.gov/pubmed/33848595,33848595,,
936,819497,18728,Comparative Toxicogenomics Database (CTD),"1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane",C517232,"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517232,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,7955.0,Danio rerio (zebrafish),"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane results in increased expression of RELA mRNA",,,PMID:23958786,https://www.ncbi.nlm.nih.gov/pubmed/23958786,23958786,,
937,819498,18728,Comparative Toxicogenomics Database (CTD),"1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane",C517232,"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517232,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9031.0,Gallus gallus (chicken),"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane results in decreased expression of RELA mRNA",,,PMID:24375616,https://www.ncbi.nlm.nih.gov/pubmed/24375616,24375616,,
938,819499,18728,Comparative Toxicogenomics Database (CTD),"1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane",C517232,"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517232,25807,RHBDD3,https://ctdbase.org/detail.go?type=gene&acc=25807,,,25807.0,RHBDD3,10090.0,Mus musculus (house mouse),"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [testosterone deficiency results in decreased expression of RHBDD3 mrna]",,,PMID:33848595,https://www.ncbi.nlm.nih.gov/pubmed/33848595,33848595,,
939,819500,18728,Comparative Toxicogenomics Database (CTD),"1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane",C517232,"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517232,54453,RIN2,https://ctdbase.org/detail.go?type=gene&acc=54453,,,54453.0,RIN2,10090.0,Mus musculus (house mouse),"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [testosterone deficiency results in increased expression of RIN2 mrna]",,,PMID:33848595,https://www.ncbi.nlm.nih.gov/pubmed/33848595,33848595,,
940,906178,23964,Comparative Toxicogenomics Database (CTD),Tungsten,D014414,Tungsten,https://ctdbase.org/detail.go?type=chem&acc=D014414,9780,PIEZO1,https://ctdbase.org/detail.go?type=gene&acc=9780,,,9780.0,PIEZO1,10090.0,Mus musculus (house mouse),Tungsten results in decreased expression of PIEZO1 mRNA,,,PMID:30912803,https://www.ncbi.nlm.nih.gov/pubmed/30912803,30912803,,
941,1760232,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,79075,DSCC1,https://ctdbase.org/detail.go?type=gene&acc=79075,,,79075.0,DSCC1,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of DSCC1 mRNA,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
942,1760233,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,29940,DSE,https://ctdbase.org/detail.go?type=gene&acc=29940,,,29940.0,DSE,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of DSE mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
943,1760234,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,92126,DSEL,https://ctdbase.org/detail.go?type=gene&acc=92126,,,92126.0,DSEL,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of DSEL mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
944,1760235,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1829,DSG2,https://ctdbase.org/detail.go?type=gene&acc=1829,,,1829.0,DSG2,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of DSG2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
945,1760236,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1829,DSG2,https://ctdbase.org/detail.go?type=gene&acc=1829,,,1829.0,DSG2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of DSG2 mRNA,,,PMID:23411599|PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/23411599|https://www.ncbi.nlm.nih.gov/pubmed/34492290,23411599|34492290,,
946,1760237,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,147409,DSG4,https://ctdbase.org/detail.go?type=gene&acc=147409,,,147409.0,DSG4,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of DSG4 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
947,1760238,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,79980,DSN1,https://ctdbase.org/detail.go?type=gene&acc=79980,,,79980.0,DSN1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide affects the expression of DSN1 mrna|thioacetamide results in increased expression of DSN1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
948,1760239,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1832,DSP,https://ctdbase.org/detail.go?type=gene&acc=1832,,,1832.0,DSP,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of DSP mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
949,1760240,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1832,DSP,https://ctdbase.org/detail.go?type=gene&acc=1832,,,1832.0,DSP,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of DSP mRNA,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
950,1760241,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,667,DST,https://ctdbase.org/detail.go?type=gene&acc=667,,,667.0,DST,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of DST mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
951,1761479,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,124454,EARS2,https://ctdbase.org/detail.go?type=gene&acc=124454,,,124454.0,EARS2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide affects the expression of EARS2 mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
952,1761480,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,57593,EBF4,https://ctdbase.org/detail.go?type=gene&acc=57593,,,57593.0,EBF4,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of EBF4 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
953,1761481,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,10148,EBI3,https://ctdbase.org/detail.go?type=gene&acc=10148,,,10148.0,EBI3,7955.0,Danio rerio (zebrafish),Thioacetamide affects the expression of EBI3 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
954,1761482,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,10148,EBI3,https://ctdbase.org/detail.go?type=gene&acc=10148,,,10148.0,EBI3,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of EBI3 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
955,1761483,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,10969,EBNA1BP2,https://ctdbase.org/detail.go?type=gene&acc=10969,,,10969.0,EBNA1BP2,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of EBNA1BP2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
956,1761802,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,10455,ECI2,https://ctdbase.org/detail.go?type=gene&acc=10455,,,10455.0,ECI2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide affects the expression of ECI2 mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
957,1761803,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,69123,ECI3,https://ctdbase.org/detail.go?type=gene&acc=69123,,,69123.0,Eci3,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of ECI3 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
958,1761804,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1893,ECM1,https://ctdbase.org/detail.go?type=gene&acc=1893,,,1893.0,ECM1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of ECM1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
959,1761805,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1842,ECM2,https://ctdbase.org/detail.go?type=gene&acc=1842,,,1842.0,ECM2,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of ECM2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
960,1761806,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,84417,ECRG4,https://ctdbase.org/detail.go?type=gene&acc=84417,,,84417.0,ECRG4,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of ECRG4 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
961,1761807,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,641700,ECSCR,https://ctdbase.org/detail.go?type=gene&acc=641700,,,641700.0,ECSCR,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of ECSCR mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
962,1761808,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,51295,ECSIT,https://ctdbase.org/detail.go?type=gene&acc=51295,,,51295.0,ECSIT,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of ECSIT mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
963,1761809,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1894,ECT2,https://ctdbase.org/detail.go?type=gene&acc=1894,,,1894.0,ECT2,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of ECT2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
964,1762662,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,10278,EFS,https://ctdbase.org/detail.go?type=gene&acc=10278,,,10278.0,EFS,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide affects the expression of EFS mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
965,1762663,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1950,EGF,https://ctdbase.org/detail.go?type=gene&acc=1950,,,1950.0,EGF,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of EGF mRNA,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
966,1762664,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,51162,EGFL7,https://ctdbase.org/detail.go?type=gene&acc=51162,,,51162.0,EGFL7,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of EGFL7 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
967,1762665,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of EGFR mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
968,1762666,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with thioacetamide] results in decreased expression of EGFR mRNA,,,PMID:28943392,https://www.ncbi.nlm.nih.gov/pubmed/28943392,28943392,,
969,1762667,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of EGFR mRNA,,,PMID:23411599|PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/23411599|https://www.ncbi.nlm.nih.gov/pubmed/34492290,23411599|34492290,,
970,1762668,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,54583,EGLN1,https://ctdbase.org/detail.go?type=gene&acc=54583,,,54583.0,EGLN1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of EGLN1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
971,1762669,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,112398,EGLN2,https://ctdbase.org/detail.go?type=gene&acc=112398,,,112398.0,EGLN2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of EGLN2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
972,1762670,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,112399,EGLN3,https://ctdbase.org/detail.go?type=gene&acc=112399,,,112399.0,EGLN3,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of EGLN3 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
973,1762794,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1958,EGR1,https://ctdbase.org/detail.go?type=gene&acc=1958,,,1958.0,EGR1,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of EGR1 mRNA,,,PMID:23411599|PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/23411599|https://www.ncbi.nlm.nih.gov/pubmed/34492290,23411599|34492290,,
974,1762795,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1959,EGR2,https://ctdbase.org/detail.go?type=gene&acc=1959,,,1959.0,EGR2,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of EGR2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
975,1762796,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1960,EGR3,https://ctdbase.org/detail.go?type=gene&acc=1960,,,1960.0,EGR3,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of EGR3 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
976,1762797,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,23301,EHBP1,https://ctdbase.org/detail.go?type=gene&acc=23301,,,23301.0,EHBP1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of EHBP1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
977,1763271,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1965,EIF2S1,https://ctdbase.org/detail.go?type=gene&acc=1965,,,1965.0,EIF2S1,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of EIF2S1 mRNA,,,PMID:23411599|PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/23411599|https://www.ncbi.nlm.nih.gov/pubmed/34492290,23411599|34492290,,
978,1763272,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1968,EIF2S3,https://ctdbase.org/detail.go?type=gene&acc=1968,,,1968.0,EIF2S3,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of EIF2S3 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
979,1763273,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,8661,EIF3A,https://ctdbase.org/detail.go?type=gene&acc=8661,,,8661.0,EIF3A,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of EIF3A mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
980,1763274,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,8662,EIF3B,https://ctdbase.org/detail.go?type=gene&acc=8662,,,8662.0,EIF3B,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of EIF3B mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
981,1763275,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,8662,EIF3B,https://ctdbase.org/detail.go?type=gene&acc=8662,,,8662.0,EIF3B,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of EIF3B mRNA,,,PMID:23411599|PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/23411599|https://www.ncbi.nlm.nih.gov/pubmed/34492290,23411599|34492290,,
982,1763455,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1973,EIF4A1,https://ctdbase.org/detail.go?type=gene&acc=1973,,,1973.0,EIF4A1,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of EIF4A1 mRNA,,,PMID:23411599|PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/23411599|https://www.ncbi.nlm.nih.gov/pubmed/34492290,23411599|34492290,,
983,1763456,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1974,EIF4A2,https://ctdbase.org/detail.go?type=gene&acc=1974,,,1974.0,EIF4A2,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of EIF4A2 mrna|thioacetamide results in decreased expression of EIF4A2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
984,1763457,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1974,EIF4A2,https://ctdbase.org/detail.go?type=gene&acc=1974,,,1974.0,EIF4A2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide affects the expression of EIF4A2 mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
985,1763458,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,9775,EIF4A3,https://ctdbase.org/detail.go?type=gene&acc=9775,,,9775.0,EIF4A3,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of EIF4A3 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
986,1763459,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1977,EIF4E,https://ctdbase.org/detail.go?type=gene&acc=1977,,,1977.0,EIF4E,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of EIF4E mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
987,1763460,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,9470,EIF4E2,https://ctdbase.org/detail.go?type=gene&acc=9470,,,9470.0,EIF4E2,7955.0,Danio rerio (zebrafish),Thioacetamide affects the expression of EIF4E2 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
988,1763461,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,317649,EIF4E3,https://ctdbase.org/detail.go?type=gene&acc=317649,,,317649.0,EIF4E3,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of EIF4E3 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
989,1764413,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,83460,EMC6,https://ctdbase.org/detail.go?type=gene&acc=83460,,,83460.0,EMC6,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of EMC6 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
990,1764414,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,10328,EMC8,https://ctdbase.org/detail.go?type=gene&acc=10328,,,10328.0,EMC8,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of EMC8 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
991,1764415,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,51016,EMC9,https://ctdbase.org/detail.go?type=gene&acc=51016,,,51016.0,EMC9,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of EMC9 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
992,1764416,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,146956,EME1,https://ctdbase.org/detail.go?type=gene&acc=146956,,,146956.0,EME1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of EME1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
993,1764417,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,197342,EME2,https://ctdbase.org/detail.go?type=gene&acc=197342,,,197342.0,EME2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of EME2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
994,1765211,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,5167,ENPP1,https://ctdbase.org/detail.go?type=gene&acc=5167,,,5167.0,ENPP1,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of ENPP1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
995,1765212,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,5168,ENPP2,https://ctdbase.org/detail.go?type=gene&acc=5168,,,5168.0,ENPP2,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of ENPP2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
996,1765213,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,5168,ENPP2,https://ctdbase.org/detail.go?type=gene&acc=5168,,,5168.0,ENPP2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased activity of ENPP2 protein,,,PMID:20957682,https://www.ncbi.nlm.nih.gov/pubmed/20957682,20957682,,
997,1765214,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,5169,ENPP3,https://ctdbase.org/detail.go?type=gene&acc=5169,,,5169.0,ENPP3,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of ENPP3 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
998,1765420,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,954,ENTPD2,https://ctdbase.org/detail.go?type=gene&acc=954,,,954.0,ENTPD2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of ENTPD2 mRNA,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
999,1765421,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,956,ENTPD3,https://ctdbase.org/detail.go?type=gene&acc=956,,,956.0,ENTPD3,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of ENTPD3 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1000,1764934,2733487,Comparative Toxicogenomics Database (CTD),Fumonisin b1,C056933,fumonisin B1,https://ctdbase.org/detail.go?type=chem&acc=C056933,7036,TFR2,https://ctdbase.org/detail.go?type=gene&acc=7036,,,7036.0,TFR2,10090.0,Mus musculus (house mouse),Fumonisin B1 results in decreased expression of TFR2 mRNA,,,PMID:16221962,https://www.ncbi.nlm.nih.gov/pubmed/16221962,16221962,,
1001,1764935,2733487,Comparative Toxicogenomics Database (CTD),Fumonisin b1,C056933,fumonisin B1,https://ctdbase.org/detail.go?type=chem&acc=C056933,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10090.0,Mus musculus (house mouse),Fumonisin B1 results in increased expression of TGFB1 mRNA,,,PMID:15590129,https://www.ncbi.nlm.nih.gov/pubmed/15590129,15590129,,
1002,1764936,2733487,Comparative Toxicogenomics Database (CTD),Fumonisin b1,C056933,fumonisin B1,https://ctdbase.org/detail.go?type=chem&acc=C056933,7069,THRSP,https://ctdbase.org/detail.go?type=gene&acc=7069,,,7069.0,THRSP,10090.0,Mus musculus (house mouse),Fumonisin B1 results in decreased expression of THRSP mRNA,,,PMID:16221962,https://www.ncbi.nlm.nih.gov/pubmed/16221962,16221962,,
1003,1764937,2733487,Comparative Toxicogenomics Database (CTD),Fumonisin b1,C056933,fumonisin B1,https://ctdbase.org/detail.go?type=chem&acc=C056933,7082,TJP1,https://ctdbase.org/detail.go?type=gene&acc=7082,,,7082.0,TJP1,9823.0,Sus scrofa (pig),Fumonisin B1 results in decreased expression of TJP1 protein|fumonisin B1 results in decreased expression of TJP1 mRNA,,,PMID:31557363,https://www.ncbi.nlm.nih.gov/pubmed/31557363,31557363,,
1004,1764938,2733487,Comparative Toxicogenomics Database (CTD),Fumonisin b1,C056933,fumonisin B1,https://ctdbase.org/detail.go?type=chem&acc=C056933,7108,TM7SF2,https://ctdbase.org/detail.go?type=gene&acc=7108,,,7108.0,TM7SF2,10090.0,Mus musculus (house mouse),[NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of TM7SF2 mrna|[nr1h3 protein affects the susceptibility to fumonisin B1] which affects the expression of TM7SF2 mRNA,,,PMID:30448865,https://www.ncbi.nlm.nih.gov/pubmed/30448865,30448865,,
1005,1764939,2733487,Comparative Toxicogenomics Database (CTD),Fumonisin b1,C056933,fumonisin B1,https://ctdbase.org/detail.go?type=chem&acc=C056933,28959,TMEM176B,https://ctdbase.org/detail.go?type=gene&acc=28959,,,28959.0,TMEM176B,10090.0,Mus musculus (house mouse),Fumonisin B1 results in increased expression of TMEM176B mRNA,,,PMID:16221962,https://www.ncbi.nlm.nih.gov/pubmed/16221962,16221962,,
1006,1764940,2733487,Comparative Toxicogenomics Database (CTD),Fumonisin b1,C056933,fumonisin B1,https://ctdbase.org/detail.go?type=chem&acc=C056933,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Fumonisin B1 results in decreased expression of TNF protein|fumonisin B1 results in decreased expression of TNF mRNA,,,PMID:35697133,https://www.ncbi.nlm.nih.gov/pubmed/35697133,35697133,,
1007,1764941,2733487,Comparative Toxicogenomics Database (CTD),Fumonisin b1,C056933,fumonisin B1,https://ctdbase.org/detail.go?type=chem&acc=C056933,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Fumonisin B1 results in increased expression of TNF mRNA,,,PMID:15590129|PMID:17080400,https://www.ncbi.nlm.nih.gov/pubmed/15590129|https://www.ncbi.nlm.nih.gov/pubmed/17080400,15590129|17080400,,
1008,1764942,2733487,Comparative Toxicogenomics Database (CTD),Fumonisin b1,C056933,fumonisin B1,https://ctdbase.org/detail.go?type=chem&acc=C056933,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9823.0,Sus scrofa (pig),[deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of TNF mrna|[zearalenone co-treated with fumonisin B1] results in increased expression of TNF mrna|[nivalenol co-treated with fumonisin B1] results in increased expression of TNF mrna|[deoxynivalenol co-treated with zearalenone co-treated with fumonisin B1] results in increased expression of TNF mrna|[deoxynivalenol co-treated with nivalenol co-treated with zearalenone co-treated with fumonisin B1] results in increased expression of TNF mrna|[nivalenol co-treated with zearalenone co-treated with fumonisin B1] results in increased expression of TNF mrna|[deoxynivalenol co-treated with fumonisin B1] results in increased expression of TNF mRNA,,,PMID:23688591,https://www.ncbi.nlm.nih.gov/pubmed/23688591,23688591,,
1009,1765950,2734231,Comparative Toxicogenomics Database (CTD),1-Hexadecyl-3-methylimidazolium chloride,C540044,1-hexadecyl-3-methylimidazolium chloride,https://ctdbase.org/detail.go?type=chem&acc=C540044,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),1-hexadecyl-3-methylimidazolium chloride results in increased expression of BAX mRNA,,,PMID:29842889,https://www.ncbi.nlm.nih.gov/pubmed/29842889,29842889,,
1010,1765951,2734231,Comparative Toxicogenomics Database (CTD),1-Hexadecyl-3-methylimidazolium chloride,C540044,1-hexadecyl-3-methylimidazolium chloride,https://ctdbase.org/detail.go?type=chem&acc=C540044,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),1-hexadecyl-3-methylimidazolium chloride results in decreased expression of BCL2 mRNA,,,PMID:29842889,https://www.ncbi.nlm.nih.gov/pubmed/29842889,29842889,,
1011,1765952,2734231,Comparative Toxicogenomics Database (CTD),1-Hexadecyl-3-methylimidazolium chloride,C540044,1-hexadecyl-3-methylimidazolium chloride,https://ctdbase.org/detail.go?type=chem&acc=C540044,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),1-hexadecyl-3-methylimidazolium chloride results in increased expression of TP53 mRNA,,,PMID:29842889,https://www.ncbi.nlm.nih.gov/pubmed/29842889,29842889,,
1012,1765953,2734315,BindingDB,3-Biphenylboronic acid,26126,(3-phenylphenyl)boranediol,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26126,2965,Monoglyceride lipase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2965,Q99685,Monoglyceride lipase,11343.0,MGLL,9606.0,Homo sapiens (human),,IC50 (nM),71000,PMID:18983140|DOI:10.1021/jm801051t,https://www.ncbi.nlm.nih.gov/pubmed/18983140|https://doi.org/10.1021/jm801051t,18983140,10.1021/jm801051t,
1013,1765954,2734315,BindingDB,3-Biphenylboronic acid,26126,(3-phenylphenyl)boranediol,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26126,999,Fatty-acid amide hydrolase 1 [30-579],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=999,P97612,Fatty-acid amide hydrolase 1,,,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),130,PMID:18983140|DOI:10.1021/jm801051t,https://www.ncbi.nlm.nih.gov/pubmed/18983140|https://doi.org/10.1021/jm801051t,18983140,10.1021/jm801051t,
1014,1765955,2734325,BindingDB,3-Cyanophenylboronic acid,26125,3-(dihydroxyboranyl)benzonitrile,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26125,999,Fatty-acid amide hydrolase 1 [30-579],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=999,P97612,Fatty-acid amide hydrolase 1,,,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),1600,PMID:18983140|DOI:10.1021/jm801051t,https://www.ncbi.nlm.nih.gov/pubmed/18983140|https://doi.org/10.1021/jm801051t,18983140,10.1021/jm801051t,
1015,1765956,2734325,BindingDB,3-Cyanophenylboronic acid,26125,3-(dihydroxyboranyl)benzonitrile,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26125,2965,Monoglyceride lipase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2965,Q99685,Monoglyceride lipase,11343.0,MGLL,9606.0,Homo sapiens (human),,,,PMID:18983140|DOI:10.1021/jm801051t,https://www.ncbi.nlm.nih.gov/pubmed/18983140|https://doi.org/10.1021/jm801051t,18983140,10.1021/jm801051t,
1016,1765957,2734326,BindingDB,4-Cyanophenylboronic acid,26131,4-(dihydroxyboranyl)benzonitrile,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26131,999,Fatty-acid amide hydrolase 1 [30-579],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=999,P97612,Fatty-acid amide hydrolase 1,,,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),290,PMID:18983140|DOI:10.1021/jm801051t,https://www.ncbi.nlm.nih.gov/pubmed/18983140|https://doi.org/10.1021/jm801051t,18983140,10.1021/jm801051t,
1017,1765958,2734326,BindingDB,4-Cyanophenylboronic acid,26131,4-(dihydroxyboranyl)benzonitrile,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26131,2965,Monoglyceride lipase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2965,Q99685,Monoglyceride lipase,11343.0,MGLL,9606.0,Homo sapiens (human),,,,PMID:18983140|DOI:10.1021/jm801051t,https://www.ncbi.nlm.nih.gov/pubmed/18983140|https://doi.org/10.1021/jm801051t,18983140,10.1021/jm801051t,
1018,1768344,2827646,Comparative Toxicogenomics Database (CTD),Sirtinol,C439060,sirtinol,https://ctdbase.org/detail.go?type=chem&acc=C439060,653361,NCF1,https://ctdbase.org/detail.go?type=gene&acc=653361,,,653361.0,NCF1,9913.0,Bos taurus (cattle),Sirtinol promotes the reaction [glucose results in increased expression of NCF1 protein],,,PMID:22284404,https://www.ncbi.nlm.nih.gov/pubmed/22284404,22284404,,
1019,1768345,2827646,Comparative Toxicogenomics Database (CTD),Sirtinol,C439060,sirtinol,https://ctdbase.org/detail.go?type=chem&acc=C439060,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116.0,Rattus norvegicus (Norway rat),Sirtinol inhibits the reaction [resveratrol results in increased expression of NFE2L2 protein],,,PMID:24395567,https://www.ncbi.nlm.nih.gov/pubmed/24395567,24395567,,
1020,1768346,2827646,Comparative Toxicogenomics Database (CTD),Sirtinol,C439060,sirtinol,https://ctdbase.org/detail.go?type=chem&acc=C439060,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606.0,Homo sapiens (human),Sirtinol results in increased degradation of NFKBIA protein,,,PMID:21745208,https://www.ncbi.nlm.nih.gov/pubmed/21745208,21745208,,
1021,1768347,2827646,Comparative Toxicogenomics Database (CTD),Sirtinol,C439060,sirtinol,https://ctdbase.org/detail.go?type=chem&acc=C439060,4824,NKX3-1,https://ctdbase.org/detail.go?type=gene&acc=4824,,,4824.0,NKX3-1,9606.0,Homo sapiens (human),Sirtinol results in decreased expression of NKX3-1 mRNA,,,PMID:22495798,https://www.ncbi.nlm.nih.gov/pubmed/22495798,22495798,,
1022,1768348,2827646,Comparative Toxicogenomics Database (CTD),Sirtinol,C439060,sirtinol,https://ctdbase.org/detail.go?type=chem&acc=C439060,4842,NOS1,https://ctdbase.org/detail.go?type=gene&acc=4842,,,4842.0,NOS1,10116.0,Rattus norvegicus (Norway rat),Sirtinol affects the reaction [MIR141 mRNA affects the reaction [1-methyl-4-phenylpyridinium results in decreased expression of NOS1 protein]],,,PMID:33204711,https://www.ncbi.nlm.nih.gov/pubmed/33204711,33204711,,
1023,1768349,2827646,Comparative Toxicogenomics Database (CTD),Sirtinol,C439060,sirtinol,https://ctdbase.org/detail.go?type=chem&acc=C439060,50507,NOX4,https://ctdbase.org/detail.go?type=gene&acc=50507,,,50507.0,NOX4,10116.0,Rattus norvegicus (Norway rat),Sirtinol results in increased expression of NOX4 mrna|resveratrol inhibits the reaction [sirtinol results in increased expression of NOX4 mrna],,,PMID:23422569,https://www.ncbi.nlm.nih.gov/pubmed/23422569,23422569,,
1024,1768350,2827646,Comparative Toxicogenomics Database (CTD),Sirtinol,C439060,sirtinol,https://ctdbase.org/detail.go?type=chem&acc=C439060,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606.0,Homo sapiens (human),AHR mutant form inhibits the reaction [sirtinol results in increased expression of NQO1 mrna]|sirtinol results in increased expression of NQO1 mRNA,,,PMID:22495798,https://www.ncbi.nlm.nih.gov/pubmed/22495798,22495798,,
1025,1768351,2827646,Comparative Toxicogenomics Database (CTD),Sirtinol,C439060,sirtinol,https://ctdbase.org/detail.go?type=chem&acc=C439060,8431,NR0B2,https://ctdbase.org/detail.go?type=gene&acc=8431,,,8431.0,NR0B2,9606.0,Homo sapiens (human),Sirtinol inhibits the reaction [resveratrol results in increased expression of NR0B2 mrna],,,PMID:26044878,https://www.ncbi.nlm.nih.gov/pubmed/26044878,26044878,,
1026,1760499,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,55274,PHF10,https://ctdbase.org/detail.go?type=gene&acc=55274,,,55274.0,PHF10,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of PHF10 mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
1027,1760500,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,9678,PHF14,https://ctdbase.org/detail.go?type=gene&acc=9678,,,9678.0,PHF14,9606.0,Homo sapiens (human),Cobaltous chloride affects the expression of PHF14 mRNA alternative form|cobaltous chloride results in decreased expression of PHF14 mRNA,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,
1028,1760501,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,26147,PHF19,https://ctdbase.org/detail.go?type=gene&acc=26147,,,26147.0,PHF19,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of PHF19 mRNA,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,
1029,1760502,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,26147,PHF19,https://ctdbase.org/detail.go?type=gene&acc=26147,,,26147.0,PHF19,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in decreased expression of PHF19 mRNA,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
1030,1760503,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,51230,PHF20,https://ctdbase.org/detail.go?type=gene&acc=51230,,,51230.0,PHF20,9606.0,Homo sapiens (human),Cobaltous chloride results in increased expression of PHF20 mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
1031,1760919,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,23612,PHLDA3,https://ctdbase.org/detail.go?type=gene&acc=23612,,,23612.0,PHLDA3,7955.0,Danio rerio (zebrafish),Cobaltous chloride results in increased expression of PHLDA3 mRNA,,,PMID:24612858,https://www.ncbi.nlm.nih.gov/pubmed/24612858,24612858,,
1032,1760920,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,23612,PHLDA3,https://ctdbase.org/detail.go?type=gene&acc=23612,,,23612.0,PHLDA3,9606.0,Homo sapiens (human),Cobaltous chloride results in increased expression of PHLDA3 mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
1033,1760921,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,23187,PHLDB1,https://ctdbase.org/detail.go?type=gene&acc=23187,,,23187.0,PHLDB1,9606.0,Homo sapiens (human),Cobaltous chloride affects the expression of PHLDB1 mRNA alternative form|cobaltous chloride results in decreased expression of PHLDB1 mRNA,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,
1034,1760922,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,23187,PHLDB1,https://ctdbase.org/detail.go?type=gene&acc=23187,,,23187.0,PHLDB1,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in decreased expression of PHLDB1 mRNA,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
1035,1760923,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,90102,PHLDB2,https://ctdbase.org/detail.go?type=gene&acc=90102,,,90102.0,PHLDB2,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of PHLDB2 mRNA,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,
1036,1760924,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,10745,PHTF1,https://ctdbase.org/detail.go?type=gene&acc=10745,,,10745.0,PHTF1,9606.0,Homo sapiens (human),Cobaltous chloride results in increased expression of PHTF1 mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
1037,1760925,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,57157,PHTF2,https://ctdbase.org/detail.go?type=gene&acc=57157,,,57157.0,PHTF2,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of PHTF2 mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
1038,1760926,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5264,PHYH,https://ctdbase.org/detail.go?type=gene&acc=5264,,,5264.0,PHYH,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in decreased expression of PHYH mRNA,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
1039,1760927,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,254295,PHYHD1,https://ctdbase.org/detail.go?type=gene&acc=254295,,,254295.0,PHYHD1,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in decreased expression of PHYHD1 mRNA,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
1040,1763054,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5366,PMAIP1,https://ctdbase.org/detail.go?type=gene&acc=5366,,,5366.0,PMAIP1,9606.0,Homo sapiens (human),Cobaltous chloride results in increased expression of PMAIP1 mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
1041,1763055,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,56937,PMEPA1,https://ctdbase.org/detail.go?type=gene&acc=56937,,,56937.0,PMEPA1,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of PMEPA1 mRNA,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,
1042,1763056,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,11243,PMF1,https://ctdbase.org/detail.go?type=gene&acc=11243,,,11243.0,PMF1,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of PMF1 mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
1043,1763057,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5371,PML,https://ctdbase.org/detail.go?type=gene&acc=5371,,,5371.0,PML,9606.0,Homo sapiens (human),Cobaltous chloride promotes the reaction [arsenic trioxide results in increased degradation of PML protein mutant form],,,PMID:16330433,https://www.ncbi.nlm.nih.gov/pubmed/16330433,16330433,,
1044,1763058,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5372,PMM1,https://ctdbase.org/detail.go?type=gene&acc=5372,,,5372.0,PMM1,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in increased expression of PMM1 mRNA,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
1045,1763059,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5373,PMM2,https://ctdbase.org/detail.go?type=gene&acc=5373,,,5373.0,PMM2,7955.0,Danio rerio (zebrafish),Cobaltous chloride results in increased expression of PMM2 mRNA,,,PMID:24612858,https://www.ncbi.nlm.nih.gov/pubmed/24612858,24612858,,
1046,1763060,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,23203,PMPCA,https://ctdbase.org/detail.go?type=gene&acc=23203,,,23203.0,PMPCA,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of PMPCA mRNA,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,
1047,1763890,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5439,POLR2J,https://ctdbase.org/detail.go?type=gene&acc=5439,,,5439.0,POLR2J,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of POLR2J mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
1048,1763891,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,246721,POLR2J2,https://ctdbase.org/detail.go?type=gene&acc=246721,,,246721.0,POLR2J2,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of POLR2J2 mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
1049,1763892,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5440,POLR2K,https://ctdbase.org/detail.go?type=gene&acc=5440,,,5440.0,POLR2K,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of POLR2K mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
1050,1764122,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,55718,POLR3E,https://ctdbase.org/detail.go?type=gene&acc=55718,,,55718.0,POLR3E,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in increased expression of POLR3E mRNA,,,PMID:24619124,https://www.ncbi.nlm.nih.gov/pubmed/24619124,24619124,,
1051,1764123,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,10621,POLR3F,https://ctdbase.org/detail.go?type=gene&acc=10621,,,10621.0,POLR3F,9606.0,Homo sapiens (human),Cobaltous chloride results in increased expression of POLR3F mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
1052,1764124,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,447901,POLR3GLA,https://ctdbase.org/detail.go?type=gene&acc=447901,,,447901.0,polr3gla,7955.0,Danio rerio (zebrafish),Cobaltous chloride results in increased expression of POLR3GLA mRNA,,,PMID:24612858,https://www.ncbi.nlm.nih.gov/pubmed/24612858,24612858,,
1053,1764125,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,51728,POLR3K,https://ctdbase.org/detail.go?type=gene&acc=51728,,,51728.0,POLR3K,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of POLR3K mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
1054,1764126,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of PPARA mRNA,,,PMID:15708366,https://www.ncbi.nlm.nih.gov/pubmed/15708366,15708366,,
1055,1764127,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5443,POMC,https://ctdbase.org/detail.go?type=gene&acc=5443,,,5443.0,POMC,10090.0,Mus musculus (house mouse),Acetylcysteine inhibits the reaction [POMC protein promotes the reaction [cobaltous chloride results in increased activity of CASP3 protein]]|pomc protein modified form inhibits the reaction [cobaltous chloride results in decreased expression of NOX4 protein]|pomc protein promotes the reaction [cobaltous chloride results in increased activity of CASP3 protein]|pomc protein modified form inhibits the reaction [cobaltous chloride results in decreased expression of NOX4 mrna],,,PMID:24412703,https://www.ncbi.nlm.nih.gov/pubmed/24412703,24412703,,
1056,1764128,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,84197,POMK,https://ctdbase.org/detail.go?type=gene&acc=84197,,,84197.0,POMK,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in decreased expression of POMK mRNA,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
1057,1764755,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),Cobaltous chloride results in decreased expression of PPARG mRNA,,,PMID:20594416,https://www.ncbi.nlm.nih.gov/pubmed/20594416,20594416,,
1058,1764756,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in increased expression of PPARGC1A protein,,,PMID:22982409,https://www.ncbi.nlm.nih.gov/pubmed/22982409,22982409,,
1059,1766488,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,55170,PRMT6,https://ctdbase.org/detail.go?type=gene&acc=55170,,,55170.0,PRMT6,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in increased expression of PRMT6 mRNA,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
1060,1766489,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,54496,PRMT7,https://ctdbase.org/detail.go?type=gene&acc=54496,,,54496.0,PRMT7,7955.0,Danio rerio (zebrafish),Cobaltous chloride results in increased expression of PRMT7 mRNA,,,PMID:24612858,https://www.ncbi.nlm.nih.gov/pubmed/24612858,24612858,,
1061,1767084,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5664,PSEN2,https://ctdbase.org/detail.go?type=gene&acc=5664,,,5664.0,PSEN2,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of PSEN2 mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
1062,1767085,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,55851,PSENEN,https://ctdbase.org/detail.go?type=gene&acc=55851,,,55851.0,PSENEN,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of PSENEN mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
1063,1767086,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,11168,PSIP1,https://ctdbase.org/detail.go?type=gene&acc=11168,,,11168.0,PSIP1,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of PSIP1 mRNA,,,PMID:19320972|PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19320972|https://www.ncbi.nlm.nih.gov/pubmed/19376846,19320972|19376846,,
1064,1767087,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,11168,PSIP1,https://ctdbase.org/detail.go?type=gene&acc=11168,,,11168.0,PSIP1,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in decreased expression of PSIP1 protein,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
1065,1767088,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5683,PSMA2,https://ctdbase.org/detail.go?type=gene&acc=5683,,,5683.0,PSMA2,9606.0,Homo sapiens (human),Cobaltous chloride results in increased expression of PSMA2 mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
1066,1767089,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,408248,PSMA3L,https://ctdbase.org/detail.go?type=gene&acc=408248,,,408248.0,Psma3l,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in increased expression of PSMA3L mRNA,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
1067,1767090,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5686,PSMA5,https://ctdbase.org/detail.go?type=gene&acc=5686,,,5686.0,PSMA5,7955.0,Danio rerio (zebrafish),Cobaltous chloride results in increased expression of PSMA5 mRNA,,,PMID:24612858,https://www.ncbi.nlm.nih.gov/pubmed/24612858,24612858,,
1068,1767091,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,83917,PSMA6L,https://ctdbase.org/detail.go?type=gene&acc=83917,,,83917.0,psma6l,7955.0,Danio rerio (zebrafish),Cobaltous chloride results in increased expression of PSMA6L mRNA,,,PMID:24612858,https://www.ncbi.nlm.nih.gov/pubmed/24612858,24612858,,
1069,1767092,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5699,PSMB10,https://ctdbase.org/detail.go?type=gene&acc=5699,,,5699.0,PSMB10,7955.0,Danio rerio (zebrafish),Cobaltous chloride results in decreased expression of PSMB10 mRNA,,,PMID:24612858,https://www.ncbi.nlm.nih.gov/pubmed/24612858,24612858,,
1070,1767093,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5690,PSMB2,https://ctdbase.org/detail.go?type=gene&acc=5690,,,5690.0,PSMB2,9606.0,Homo sapiens (human),Cobaltous chloride results in increased expression of PSMB2 mRNA,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,
1071,1767290,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5690,PSMB2,https://ctdbase.org/detail.go?type=gene&acc=5690,,,5690.0,PSMB2,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in increased expression of PSMB2 protein,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
1072,1767291,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5691,PSMB3,https://ctdbase.org/detail.go?type=gene&acc=5691,,,5691.0,PSMB3,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in increased expression of PSMB3 mRNA,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
1073,1767292,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5692,PSMB4,https://ctdbase.org/detail.go?type=gene&acc=5692,,,5692.0,PSMB4,9606.0,Homo sapiens (human),Cobaltous chloride results in increased expression of PSMB4 mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
1074,1767468,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5704,PSMC4,https://ctdbase.org/detail.go?type=gene&acc=5704,,,5704.0,PSMC4,9606.0,Homo sapiens (human),Cobaltous chloride results in increased expression of PSMC4 mRNA,,,PMID:19320972|PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19320972|https://www.ncbi.nlm.nih.gov/pubmed/19376846,19320972|19376846,,
1075,1767469,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5704,PSMC4,https://ctdbase.org/detail.go?type=gene&acc=5704,,,5704.0,PSMC4,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in increased expression of PSMC4 mRNA,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
1076,1767470,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5706,PSMC6,https://ctdbase.org/detail.go?type=gene&acc=5706,,,5706.0,PSMC6,7955.0,Danio rerio (zebrafish),Cobaltous chloride results in increased expression of PSMC6 mRNA,,,PMID:24612858,https://www.ncbi.nlm.nih.gov/pubmed/24612858,24612858,,
1077,1767471,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5706,PSMC6,https://ctdbase.org/detail.go?type=gene&acc=5706,,,5706.0,PSMC6,9606.0,Homo sapiens (human),Cobaltous chloride results in increased expression of PSMC6 mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
1078,1767472,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5706,PSMC6,https://ctdbase.org/detail.go?type=gene&acc=5706,,,5706.0,PSMC6,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in increased expression of PSMC6 mRNA,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
1079,1767473,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5707,PSMD1,https://ctdbase.org/detail.go?type=gene&acc=5707,,,5707.0,PSMD1,7955.0,Danio rerio (zebrafish),Cobaltous chloride results in increased expression of PSMD1 mRNA,,,PMID:24612858,https://www.ncbi.nlm.nih.gov/pubmed/24612858,24612858,,
1080,1767474,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5707,PSMD1,https://ctdbase.org/detail.go?type=gene&acc=5707,,,5707.0,PSMD1,9606.0,Homo sapiens (human),Cobaltous chloride results in increased expression of PSMD1 mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
1081,1767475,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5707,PSMD1,https://ctdbase.org/detail.go?type=gene&acc=5707,,,5707.0,PSMD1,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in increased expression of PSMD1 mRNA,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
1082,1767476,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5716,PSMD10,https://ctdbase.org/detail.go?type=gene&acc=5716,,,5716.0,PSMD10,7955.0,Danio rerio (zebrafish),Cobaltous chloride results in increased expression of PSMD10 mRNA,,,PMID:24612858,https://www.ncbi.nlm.nih.gov/pubmed/24612858,24612858,,
1083,1767477,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5717,PSMD11,https://ctdbase.org/detail.go?type=gene&acc=5717,,,5717.0,PSMD11,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in increased expression of PSMD11 mRNA,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
1084,1768500,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),Acetylcysteine inhibits the reaction [PLD2 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]]|acetylcysteine inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]]|pld2 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]|reactive oxygen species affects the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]]|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]]|rottlerin inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]]|pld1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]|2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]]|2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [PLD2 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]]|1-butanol inhibits the reaction [cobaltous chloride results in increased expression of PTGS2 protein],,,PMID:17640750,https://www.ncbi.nlm.nih.gov/pubmed/17640750,17640750,,
1085,1768501,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,9232,PTTG1,https://ctdbase.org/detail.go?type=gene&acc=9232,,,9232.0,PTTG1,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of PTTG1 mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
1086,1768709,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),Cobaltous chloride results in increased expression of PTGS2 protein,,,PMID:17640750|PMID:21533553|PMID:21779360|PMID:21882223|PMID:28624453,https://www.ncbi.nlm.nih.gov/pubmed/17640750|https://www.ncbi.nlm.nih.gov/pubmed/21533553|https://www.ncbi.nlm.nih.gov/pubmed/21779360|https://www.ncbi.nlm.nih.gov/pubmed/21882223|https://www.ncbi.nlm.nih.gov/pubmed/28624453,17640750|21533553|21779360|21882223|28624453,,
1087,1768710,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),Indomethacin promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]|sulindac promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein],,,PMID:21882223,https://www.ncbi.nlm.nih.gov/pubmed/21882223,21882223,,
1088,1768859,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),RELA protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]|[n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [cobaltous chloride results in increased secretion of IL6 protein]|[n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [cobaltous chloride results in increased secretion of CXCL8 protein],,,PMID:21533553,https://www.ncbi.nlm.nih.gov/pubmed/21533553,21533553,,
1089,1768860,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in increased expression of PTGS2 mRNA,,,PMID:22349312,https://www.ncbi.nlm.nih.gov/pubmed/22349312,22349312,,
1090,1768861,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in increased expression of PTGS2 protein,,,PMID:28303633|PMID:30596275,https://www.ncbi.nlm.nih.gov/pubmed/28303633|https://www.ncbi.nlm.nih.gov/pubmed/30596275,28303633|30596275,,
1091,1768862,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,559020,PTGS2B,https://ctdbase.org/detail.go?type=gene&acc=559020,,,559020.0,ptgs2b,7955.0,Danio rerio (zebrafish),Cobaltous chloride results in increased expression of PTGS2B mRNA,,,PMID:24612858,https://www.ncbi.nlm.nih.gov/pubmed/24612858,24612858,,
1092,1768863,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5757,PTMA,https://ctdbase.org/detail.go?type=gene&acc=5757,,,5757.0,PTMA,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of PTMA mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
1093,1687648,3081361,Drug Gene Interaction database (DGIdb),Vandetanib,,VANDETANIB,https://www.dgidb.org/drugs/rxcui:1098413,,ABL1,https://www.dgidb.org/genes/hgnc:76,,,25.0,ABL1,9606.0,Homo sapiens (human),,,,,,,,
1094,1760770,4398380,BindingDB,"tetrahydrobenzothiophene (THBT), 21",31647,"tetrahydrobenzothiophene (THBT), 21",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31647,6551,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6551,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",5144.0,PDE4D,9606.0,Homo sapiens (human),,IC50 (nM),126,PMID:19525117|DOI:10.1016/j.bmc.2009.03.061,https://www.ncbi.nlm.nih.gov/pubmed/19525117|https://doi.org/10.1016/j.bmc.2009.03.061,19525117,10.1016/j.bmc.2009.03.061,
1095,1761567,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,84295,PHF6,https://ctdbase.org/detail.go?type=gene&acc=84295,,,84295.0,PHF6,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF6 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1096,1762894,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,5179,PENK,https://ctdbase.org/detail.go?type=gene&acc=5179,,,5179.0,PENK,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PENK mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1097,1762895,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,5144,PDE4D,https://ctdbase.org/detail.go?type=gene&acc=5144,,,5144.0,PDE4D,9606.0,Homo sapiens (human),"[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDE4D mrna|[nog protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDE4D mrna|[nog protein co-treated with panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDE4D mrna|[nog protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDE4D mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDE4D mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1098,1762896,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,9659,PDE4DIP,https://ctdbase.org/detail.go?type=gene&acc=9659,,,9659.0,PDE4DIP,9606.0,Homo sapiens (human),"[NOG protein co-treated with vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDE4DIP mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDE4DIP mrna|[nog protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDE4DIP mrna|[nog protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDE4DIP mrna|[nog protein co-treated with panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDE4DIP mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1099,1762897,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,8654,PDE5A,https://ctdbase.org/detail.go?type=gene&acc=8654,,,8654.0,PDE5A,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDE5A mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1100,1762898,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,5158,PDE6B,https://ctdbase.org/detail.go?type=gene&acc=5158,,,5158.0,PDE6B,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDE6B mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1101,1763893,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,375033,PEAR1,https://ctdbase.org/detail.go?type=gene&acc=375033,,,375033.0,PEAR1,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PEAR1 mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PEAR1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1102,1763894,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,5175,PECAM1,https://ctdbase.org/detail.go?type=gene&acc=5175,,,5175.0,PECAM1,9606.0,Homo sapiens (human),"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of PECAM1 mRNA",,,PMID:25670856,https://www.ncbi.nlm.nih.gov/pubmed/25670856,25670856,,
1103,1763895,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,23089,PEG10,https://ctdbase.org/detail.go?type=gene&acc=23089,,,23089.0,PEG10,9606.0,Homo sapiens (human),"[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PEG10 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1104,1763896,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,57162,PELI1,https://ctdbase.org/detail.go?type=gene&acc=57162,,,57162.0,PELI1,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PELI1 mrna|[nog protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PELI1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1105,1763897,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,53918,PELO,https://ctdbase.org/detail.go?type=gene&acc=53918,,,53918.0,PELO,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PELO mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PELO mrna|[nog protein co-treated with p-chloromercuribenzoic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PELO mrna|[nog protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PELO mrna|[nog protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PELO mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1106,1763898,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,27043,PELP1,https://ctdbase.org/detail.go?type=gene&acc=27043,,,27043.0,PELP1,9606.0,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of PELP1 protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
1107,1765682,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,5451,POU2F1,https://ctdbase.org/detail.go?type=gene&acc=5451,,,5451.0,POU2F1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POU2F1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1108,1765683,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,25833,POU2F3,https://ctdbase.org/detail.go?type=gene&acc=25833,,,25833.0,POU2F3,9606.0,Homo sapiens (human),"[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POU2F3 mrna|[nog protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POU2F3 mrna|[nog protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POU2F3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1109,1765684,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,5453,POU3F1,https://ctdbase.org/detail.go?type=gene&acc=5453,,,5453.0,POU3F1,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POU3F1 mrna|[nog protein co-treated with panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POU3F1 mrna|[nog protein co-treated with p-chloromercuribenzoic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POU3F1 mrna|[nog protein co-treated with vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POU3F1 mrna|[nog protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POU3F1 mrna|[nog protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POU3F1 mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POU3F1 mrna|[nog protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POU3F1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1110,1765685,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,5454,POU3F2,https://ctdbase.org/detail.go?type=gene&acc=5454,,,5454.0,POU3F2,9606.0,Homo sapiens (human),"[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POU3F2 mrna|[nog protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POU3F2 mrna|[nog protein co-treated with p-chloromercuribenzoic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POU3F2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1111,1765686,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,10105,PPIF,https://ctdbase.org/detail.go?type=gene&acc=10105,,,10105.0,PPIF,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIF mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1112,1766402,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,130271,PLEKHH2,https://ctdbase.org/detail.go?type=gene&acc=130271,,,130271.0,PLEKHH2,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLEKHH2 mrna|[nog protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHH2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1113,1766403,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,389072,PLEKHM3,https://ctdbase.org/detail.go?type=gene&acc=389072,,,389072.0,PLEKHM3,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHM3 mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHM3 mrna|[nog protein co-treated with panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHM3 mrna|[nog protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHM3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1114,1767283,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,10450,PPIE,https://ctdbase.org/detail.go?type=gene&acc=10450,,,10450.0,PPIE,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPIE mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1115,1767284,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,9360,PPIG,https://ctdbase.org/detail.go?type=gene&acc=9360,,,9360.0,PPIG,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPIG mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1116,1767285,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,51645,PPIL1,https://ctdbase.org/detail.go?type=gene&acc=51645,,,51645.0,PPIL1,9606.0,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of PPIL1 protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
1117,1767286,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,23759,PPIL2,https://ctdbase.org/detail.go?type=gene&acc=23759,,,23759.0,PPIL2,9606.0,Homo sapiens (human),"[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPIL2 mrna|[nog protein co-treated with p-chloromercuribenzoic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPIL2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1118,1767287,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,285755,PPIL6,https://ctdbase.org/detail.go?type=gene&acc=285755,,,285755.0,PPIL6,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPIL6 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1119,1767288,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,5493,PPL,https://ctdbase.org/detail.go?type=gene&acc=5493,,,5493.0,PPL,9606.0,Homo sapiens (human),"[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mrna|[nog protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mrna|[nog protein co-treated with panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mrna|[nog protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1120,1767289,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,5494,PPM1A,https://ctdbase.org/detail.go?type=gene&acc=5494,,,5494.0,PPM1A,9606.0,Homo sapiens (human),"[NOG protein co-treated with panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPM1A mrna|[nog protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPM1A mrna|[nog protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPM1A mrna|[nog protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPM1A mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPM1A mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1121,1767478,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,5495,PPM1B,https://ctdbase.org/detail.go?type=gene&acc=5495,,,5495.0,PPM1B,9606.0,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of PPM1B protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
1122,1768494,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,5502,PPP1R1A,https://ctdbase.org/detail.go?type=gene&acc=5502,,,5502.0,PPP1R1A,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP1R1A mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R1A mrna|[nog protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R1A mrna|[nog protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP1R1A mrna|[nog protein co-treated with panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R1A mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1123,1768495,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,84152,PPP1R1B,https://ctdbase.org/detail.go?type=gene&acc=84152,,,84152.0,PPP1R1B,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R1B mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1124,1768496,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,151242,PPP1R1C,https://ctdbase.org/detail.go?type=gene&acc=151242,,,151242.0,PPP1R1C,9606.0,Homo sapiens (human),"[NOG protein co-treated with p-chloromercuribenzoic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP1R1C mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1125,1768497,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,5504,PPP1R2,https://ctdbase.org/detail.go?type=gene&acc=5504,,,5504.0,PPP1R2,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1126,1768498,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,9858,PPP1R26,https://ctdbase.org/detail.go?type=gene&acc=9858,,,9858.0,PPP1R26,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP1R26 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1127,1768499,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,79660,PPP1R3B,https://ctdbase.org/detail.go?type=gene&acc=79660,,,79660.0,PPP1R3B,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3B mrna|[nog protein co-treated with vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3B mrna|[nog protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3B mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3B mrna|[nog protein co-treated with panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3B mrna|[nog protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3B mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1128,1814191,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,2317,FLNB,https://ctdbase.org/detail.go?type=gene&acc=2317,,,2317.0,FLNB,9606.0,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of FLNB protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
1129,1814192,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,2317,FLNB,https://ctdbase.org/detail.go?type=gene&acc=2317,,,2317.0,FLNB,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLNB mrna|[nog protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLNB mrna|[nog protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLNB mrna|[nog protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLNB mrna|[nog protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLNB mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1130,1814193,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,2318,FLNC,https://ctdbase.org/detail.go?type=gene&acc=2318,,,2318.0,FLNC,9606.0,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of FLNC protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
1131,1814194,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,2318,FLNC,https://ctdbase.org/detail.go?type=gene&acc=2318,,,2318.0,FLNC,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLNC mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1132,1762266,4659569,Drug Gene Interaction database (DGIdb),Tolcapone,,TOLCAPONE,https://www.dgidb.org/drugs/rxcui:72937,,COMT,https://www.dgidb.org/genes/hgnc:2228,,,1312.0,COMT,9606.0,Homo sapiens (human),,,,,,,,
1133,1762267,4663984,BindingDB,2-[[2-(3-Carboxyanilino)pyrimidin-4-yl]amino]benzoic acid,92802,"Bisanilinopyrimidine, 3q",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=92802,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),18.3,PMID:22803810|DOI:10.1021/jm300334d,https://www.ncbi.nlm.nih.gov/pubmed/22803810|https://doi.org/10.1021/jm300334d,22803810,10.1021/jm300334d,
1134,1762268,4685764,Therapeutic Target Database (TTD),3-(4-Chlorophenyl)propanoate,D0O6LW,3-phenyl propanoic derivative 1,https://idrblab.net/ttd/data/drug/details/D0O6LW,T88505,Nuclear factor erythroid 2-related factor 2 (Nrf2),https://idrblab.net/ttd/data/target/details/T88505,Q16236,Nuclear factor erythroid 2-related factor 2,4780.0,NFE2L2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1135,1762269,4787937,IUPHAR/BPS Guide to PHARMACOLOGY,N-(4-(2-benzoylhydrazinecarbonyl)benzyl)-3-chloro-4-fluorobenzenesulfonamide,7846,TCN-201,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7846,456,GluN2A,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=456,Q12879,"Glutamate receptor ionotropic, NMDA 2A",2903.0,GRIN2A,9606.0,Homo sapiens (human),Negative,pIC50,7,PMID:22553026,https://www.ncbi.nlm.nih.gov/pubmed/22553026,22553026,,
1136,1766758,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [cypermethrin results in increased expression of TNF mrna],,,PMID:35876585,https://www.ncbi.nlm.nih.gov/pubmed/35876585,35876585,,
1137,1766759,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [dehydroepiandrosterone results in increased expression of TNF protein],,,PMID:27634381,https://www.ncbi.nlm.nih.gov/pubmed/27634381,27634381,,
1138,1766760,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [doxorubicin results in increased expression of TNF mrna]|quercetin results in increased expression of TNF mRNA,,,PMID:25411067,https://www.ncbi.nlm.nih.gov/pubmed/25411067,25411067,,
1139,1767701,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,8743,TNFSF10,https://ctdbase.org/detail.go?type=gene&acc=8743,,,8743.0,TNFSF10,9606.0,Homo sapiens (human),Quercetin promotes the reaction [TNFSF10 protein results in increased activity of CASP3 protein],,,PMID:18377872|PMID:23711929,https://www.ncbi.nlm.nih.gov/pubmed/18377872|https://www.ncbi.nlm.nih.gov/pubmed/23711929,18377872|23711929,,
1140,1767702,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,8743,TNFSF10,https://ctdbase.org/detail.go?type=gene&acc=8743,,,8743.0,TNFSF10,9606.0,Homo sapiens (human),Quercetin promotes the reaction [TNFSF10 protein results in increased cleavage of CASP8 protein],,,PMID:17548900|PMID:20096292,https://www.ncbi.nlm.nih.gov/pubmed/17548900|https://www.ncbi.nlm.nih.gov/pubmed/20096292,17548900|20096292,,
1141,1767703,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,8743,TNFSF10,https://ctdbase.org/detail.go?type=gene&acc=8743,,,8743.0,TNFSF10,9606.0,Homo sapiens (human),Quercetin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein],,,PMID:17548900|PMID:17876056|PMID:18377872|PMID:20096292,https://www.ncbi.nlm.nih.gov/pubmed/17548900|https://www.ncbi.nlm.nih.gov/pubmed/17876056|https://www.ncbi.nlm.nih.gov/pubmed/18377872|https://www.ncbi.nlm.nih.gov/pubmed/20096292,17548900|17876056|18377872|20096292,,
1142,1768240,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,56993,TOMM22,https://ctdbase.org/detail.go?type=gene&acc=56993,,,56993.0,TOMM22,9606.0,Homo sapiens (human),Quercetin results in decreased expression of TOMM22 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1143,1768241,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,4796,TONSL,https://ctdbase.org/detail.go?type=gene&acc=4796,,,4796.0,TONSL,9606.0,Homo sapiens (human),Quercetin results in increased expression of TONSL mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1144,1768242,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,7153,TOP2A,https://ctdbase.org/detail.go?type=gene&acc=7153,,,7153.0,TOP2A,9606.0,Homo sapiens (human),Quercetin results in decreased expression of TOP2A mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1145,1768243,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,7153,TOP2A,https://ctdbase.org/detail.go?type=gene&acc=7153,,,7153.0,TOP2A,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [oxygen deficiency results in increased expression of TOP2A mrna],,,PMID:26476374,https://www.ncbi.nlm.nih.gov/pubmed/26476374,26476374,,
1146,1768244,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,7155,TOP2B,https://ctdbase.org/detail.go?type=gene&acc=7155,,,7155.0,TOP2B,9606.0,Homo sapiens (human),Quercetin results in decreased expression of TOP2B mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1147,1768245,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,7155,TOP2B,https://ctdbase.org/detail.go?type=gene&acc=7155,,,7155.0,TOP2B,9606.0,Homo sapiens (human),Quercetin results in decreased phosphorylation of TOP2B protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
1148,1768246,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,7155,TOP2B,https://ctdbase.org/detail.go?type=gene&acc=7155,,,7155.0,TOP2B,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [oxygen deficiency results in increased expression of TOP2B mrna],,,PMID:26476374,https://www.ncbi.nlm.nih.gov/pubmed/26476374,26476374,,
1149,1769385,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,91107,TRIM47,https://ctdbase.org/detail.go?type=gene&acc=91107,,,91107.0,TRIM47,9606.0,Homo sapiens (human),Quercetin results in decreased expression of TRIM47 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1150,1769386,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,84851,TRIM52,https://ctdbase.org/detail.go?type=gene&acc=84851,,,84851.0,TRIM52,9606.0,Homo sapiens (human),Quercetin results in decreased expression of TRIM52 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1151,1769387,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,81844,TRIM56,https://ctdbase.org/detail.go?type=gene&acc=81844,,,81844.0,TRIM56,9606.0,Homo sapiens (human),Quercetin results in increased phosphorylation of TRIM56 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
1152,1763188,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,10116.0,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [[calcitriol co-treated with TGFB1 protein] results in increased secretion of VEGFA protein]|sb 203580 inhibits the reaction [calcitriol results in increased secretion of VEGFA protein]|calcitriol promotes the reaction [TGFB1 protein results in increased secretion of VEGFA protein],,,PMID:16598785,https://www.ncbi.nlm.nih.gov/pubmed/16598785,16598785,,
1153,1763189,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9606.0,Homo sapiens (human),Calcitriol results in increased expression of VEGFA,,,PMID:11886167,https://www.ncbi.nlm.nih.gov/pubmed/11886167,11886167,,
1154,1763197,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,7447,VSNL1,https://ctdbase.org/detail.go?type=gene&acc=7447,,,7447.0,VSNL1,9606.0,Homo sapiens (human),Calcitriol results in decreased expression of VSNL1 mRNA,,,PMID:16002434,https://www.ncbi.nlm.nih.gov/pubmed/16002434,16002434,,
1155,1763529,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,90,ACVR1,https://ctdbase.org/detail.go?type=gene&acc=90,,,90.0,ACVR1,10090.0,Mus musculus (house mouse),Cholecalciferol results in increased expression of ACVR1 mRNA,,,PMID:17170073,https://www.ncbi.nlm.nih.gov/pubmed/17170073,17170073,,
1156,1763530,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,100,ADA,https://ctdbase.org/detail.go?type=gene&acc=100,,,100.0,ADA,10090.0,Mus musculus (house mouse),Cholecalciferol results in decreased expression of ADA mRNA,,,PMID:16508948,https://www.ncbi.nlm.nih.gov/pubmed/16508948,16508948,,
1157,1763531,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,101,ADAM8,https://ctdbase.org/detail.go?type=gene&acc=101,,,101.0,ADAM8,10090.0,Mus musculus (house mouse),Cholecalciferol results in decreased expression of ADAM8 mRNA,,,PMID:16508948,https://www.ncbi.nlm.nih.gov/pubmed/16508948,16508948,,
1158,1763532,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,104,ADARB1,https://ctdbase.org/detail.go?type=gene&acc=104,,,104.0,ADARB1,10090.0,Mus musculus (house mouse),Cholecalciferol results in increased expression of ADARB1 mRNA,,,PMID:16508948,https://www.ncbi.nlm.nih.gov/pubmed/16508948,16508948,,
1159,1763533,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,79924,ADM2,https://ctdbase.org/detail.go?type=gene&acc=79924,,,79924.0,ADM2,10116.0,Rattus norvegicus (Norway rat),[cholecalciferol co-treated with nicotine] results in decreased expression of ADM2 protein,,,PMID:19910445,https://www.ncbi.nlm.nih.gov/pubmed/19910445,19910445,,
1160,1763534,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,174,AFP,https://ctdbase.org/detail.go?type=gene&acc=174,,,174.0,AFP,8022.0,Oncorhynchus mykiss (rainbow trout),[vitamin A co-treated with cholecalciferol co-treated with vitamin E co-treated with ascorbic acid] inhibits the reaction [[cyhalothrin co-treated with chlorantranilipole] results in increased expression of AFP protein],,,PMID:36813254,https://www.ncbi.nlm.nih.gov/pubmed/36813254,36813254,,
1161,1763535,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,10090.0,Mus musculus (house mouse),Cholecalciferol results in decreased expression of AGT mRNA,,,PMID:16508948,https://www.ncbi.nlm.nih.gov/pubmed/16508948,16508948,,
1162,1763536,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,26358,ALDH1A7,https://ctdbase.org/detail.go?type=gene&acc=26358,,,26358.0,Aldh1a7,10090.0,Mus musculus (house mouse),Cholecalciferol results in increased expression of ALDH1A7 mRNA,,,PMID:16508948,https://www.ncbi.nlm.nih.gov/pubmed/16508948,16508948,,
1163,1763537,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,218,ALDH3A1,https://ctdbase.org/detail.go?type=gene&acc=218,,,218.0,ALDH3A1,10090.0,Mus musculus (house mouse),Cholecalciferol results in increased expression of ALDH3A1 mRNA,,,PMID:17170073,https://www.ncbi.nlm.nih.gov/pubmed/17170073,17170073,,
1164,1763538,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,10090.0,Mus musculus (house mouse),Cholecalciferol results in decreased expression of AR mRNA,,,PMID:16508948,https://www.ncbi.nlm.nih.gov/pubmed/16508948,16508948,,
1165,1765016,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,13095,CYP2C29,https://ctdbase.org/detail.go?type=gene&acc=13095,,,13095.0,Cyp2c29,10090.0,Mus musculus (house mouse),Cholecalciferol results in decreased activity of CYP2C29 protein,,,PMID:18420780,https://www.ncbi.nlm.nih.gov/pubmed/18420780,18420780,,
1166,1765017,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,1559,CYP2C9,https://ctdbase.org/detail.go?type=gene&acc=1559,,,1559.0,CYP2C9,9606.0,Homo sapiens (human),Cholecalciferol metabolite results in increased expression of CYP2C9,,,PMID:11991950,https://www.ncbi.nlm.nih.gov/pubmed/11991950,11991950,,
1167,1765018,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,1559,CYP2C9,https://ctdbase.org/detail.go?type=gene&acc=1559,,,1559.0,CYP2C9,9606.0,Homo sapiens (human),Cholecalciferol results in decreased activity of CYP2C9 protein,,,PMID:18420780,https://www.ncbi.nlm.nih.gov/pubmed/18420780,18420780,,
1168,1765019,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,1565,CYP2D6,https://ctdbase.org/detail.go?type=gene&acc=1565,,,1565.0,CYP2D6,9606.0,Homo sapiens (human),Cholecalciferol results in decreased activity of CYP2D6 protein,,,PMID:18420780,https://www.ncbi.nlm.nih.gov/pubmed/18420780,18420780,,
1169,1765020,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,120227,CYP2R1,https://ctdbase.org/detail.go?type=gene&acc=120227,,,120227.0,CYP2R1,9606.0,Homo sapiens (human),CYP2R1 protein results in increased hydroxylation of cholecalciferol,,,PMID:26704532,https://www.ncbi.nlm.nih.gov/pubmed/26704532,26704532,,
1170,1765021,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,13112,CYP3A11,https://ctdbase.org/detail.go?type=gene&acc=13112,,,13112.0,Cyp3a11,10090.0,Mus musculus (house mouse),Cholecalciferol results in decreased activity of CYP3A11 protein,,,PMID:18420780,https://www.ncbi.nlm.nih.gov/pubmed/18420780,18420780,,
1171,1765022,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Cholecalciferol metabolite results in increased expression of CYP3A4,,,PMID:11991950,https://www.ncbi.nlm.nih.gov/pubmed/11991950,11991950,,
1172,1765023,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Troleandomycin inhibits the reaction [CYP3A4 protein results in increased hydroxylation of cholecalciferol]|cyp3a4 protein results in increased hydroxylation of cholecalciferol|ketoconazole inhibits the reaction [CYP3A4 protein results in increased hydroxylation of cholecalciferol]|cholecalciferol results in increased expression of CYP3A4 mrna|phenytoin promotes the reaction [CYP3A4 protein results in increased hydroxylation of cholecalciferol],,,PMID:16207822,https://www.ncbi.nlm.nih.gov/pubmed/16207822,16207822,,
1173,1767587,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,5914,RARA,https://ctdbase.org/detail.go?type=gene&acc=5914,,,5914.0,RARA,9606.0,Homo sapiens (human),Cholecalciferol promotes the reaction [RARA protein binds to VDR promoter]|cholecalciferol promotes the reaction [RARA protein binds to VDR enhancer],,,PMID:36066700,https://www.ncbi.nlm.nih.gov/pubmed/36066700,36066700,,
1174,1767588,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,5914,RARA,https://ctdbase.org/detail.go?type=gene&acc=5914,,,5914.0,RARA,9606.0,Homo sapiens (human),RARA protein mutant form inhibits the reaction [[cholecalciferol co-treated with TGFB1 protein] results in increased expression of CD14 mrna],,,PMID:15988048,https://www.ncbi.nlm.nih.gov/pubmed/15988048,15988048,,
1175,1767589,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,5914,RARA,https://ctdbase.org/detail.go?type=gene&acc=5914,,,5914.0,RARA,10116.0,Rattus norvegicus (Norway rat),Cholecalciferol inhibits the reaction [methylnitrosourea results in increased expression of RARA mrna],,,PMID:21843606,https://www.ncbi.nlm.nih.gov/pubmed/21843606,21843606,,
1176,1767862,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,91543,RSAD2,https://ctdbase.org/detail.go?type=gene&acc=91543,,,91543.0,RSAD2,10090.0,Mus musculus (house mouse),Cholecalciferol results in increased expression of RSAD2 mRNA,,,PMID:16508948,https://www.ncbi.nlm.nih.gov/pubmed/16508948,16508948,,
1177,1767863,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,862,RUNX1T1,https://ctdbase.org/detail.go?type=gene&acc=862,,,862.0,RUNX1T1,10090.0,Mus musculus (house mouse),Cholecalciferol results in increased expression of RUNX1T1 mRNA,,,PMID:17170073,https://www.ncbi.nlm.nih.gov/pubmed/17170073,17170073,,
1178,1767864,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,9606.0,Homo sapiens (human),[cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] results in increased expression of RUNX2 mRNA,,,PMID:17692823,https://www.ncbi.nlm.nih.gov/pubmed/17692823,17692823,,
1179,1767865,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,9606.0,Homo sapiens (human),PARP1 mRNA promotes the reaction [[dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid co-treated with cholecalciferol] results in increased expression of RUNX2 mrna]|parg mRNA promotes the reaction [[dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid co-treated with cholecalciferol] results in increased expression of RUNX2 mrna]|[dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid co-treated with cholecalciferol] results in increased expression of RUNX2 mRNA,,,PMID:22940495,https://www.ncbi.nlm.nih.gov/pubmed/22940495,22940495,,
1180,1761228,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,238673,ZFP367,https://ctdbase.org/detail.go?type=gene&acc=238673,,,238673.0,Zfp367,10116.0,Rattus norvegicus (Norway rat),Senecionine results in increased expression of ZFP367 mRNA,,,PMID:32419051,https://www.ncbi.nlm.nih.gov/pubmed/32419051,32419051,,
1181,1761229,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,677,ZFP36L1,https://ctdbase.org/detail.go?type=gene&acc=677,,,677.0,ZFP36L1,10090.0,Mus musculus (house mouse),Senecionine results in increased expression of ZFP36L1 protein,,,PMID:35357534,https://www.ncbi.nlm.nih.gov/pubmed/35357534,35357534,,
1182,1761230,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,653808,ZG16,https://ctdbase.org/detail.go?type=gene&acc=653808,,,653808.0,ZG16,10090.0,Mus musculus (house mouse),Senecionine results in decreased expression of ZG16 protein,,,PMID:35357534,https://www.ncbi.nlm.nih.gov/pubmed/35357534,35357534,,
1183,1761231,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,64397,ZNF106,https://ctdbase.org/detail.go?type=gene&acc=64397,,,64397.0,ZNF106,10090.0,Mus musculus (house mouse),Senecionine results in increased expression of ZNF106 protein,,,PMID:35357534,https://www.ncbi.nlm.nih.gov/pubmed/35357534,35357534,,
1184,1761232,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,55055,ZWILCH,https://ctdbase.org/detail.go?type=gene&acc=55055,,,55055.0,ZWILCH,10116.0,Rattus norvegicus (Norway rat),Senecionine results in increased expression of ZWILCH mRNA,,,PMID:32419051,https://www.ncbi.nlm.nih.gov/pubmed/32419051,32419051,,
1185,1760999,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7391,USF1,https://ctdbase.org/detail.go?type=gene&acc=7391,,,7391.0,USF1,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of USF1 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1186,1761000,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7391,USF1,https://ctdbase.org/detail.go?type=gene&acc=7391,,,7391.0,USF1,10090.0,Mus musculus (house mouse),Genistein results in increased expression of USF1 mRNA,,,PMID:22553218,https://www.ncbi.nlm.nih.gov/pubmed/22553218,22553218,,
1187,1761001,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,8237,USP11,https://ctdbase.org/detail.go?type=gene&acc=8237,,,8237.0,USP11,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of USP11 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1188,1761002,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,9958,USP15,https://ctdbase.org/detail.go?type=gene&acc=9958,,,9958.0,USP15,10090.0,Mus musculus (house mouse),Genistein results in increased expression of USP15 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1189,1761003,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,10868,USP20,https://ctdbase.org/detail.go?type=gene&acc=10868,,,10868.0,USP20,9606.0,Homo sapiens (human),Genistein results in decreased expression of USP20 mRNA,,,PMID:16705744,https://www.ncbi.nlm.nih.gov/pubmed/16705744,16705744,,
1190,1761004,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,29761,USP25,https://ctdbase.org/detail.go?type=gene&acc=29761,,,29761.0,USP25,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of USP25 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1191,1761005,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,494031,USP2A,https://ctdbase.org/detail.go?type=gene&acc=494031,,,494031.0,usp2a,7955.0,Danio rerio (zebrafish),Genistein results in increased expression of USP2A mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
1192,1761006,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,57695,USP37,https://ctdbase.org/detail.go?type=gene&acc=57695,,,57695.0,USP37,10116.0,Rattus norvegicus (Norway rat),Genistein results in increased expression of USP37 protein,,,PMID:24552547,https://www.ncbi.nlm.nih.gov/pubmed/24552547,24552547,,
1193,1761007,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,55031,USP47,https://ctdbase.org/detail.go?type=gene&acc=55031,,,55031.0,USP47,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of USP47 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1194,1761233,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,441376,AARD,https://ctdbase.org/detail.go?type=gene&acc=441376,,,441376.0,AARD,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of AARD mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1195,1761234,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,16,AARS1,https://ctdbase.org/detail.go?type=gene&acc=16,,,16.0,AARS1,9606.0,Homo sapiens (human),Genistein results in increased expression of AARS1 mRNA,,,PMID:26865667,https://www.ncbi.nlm.nih.gov/pubmed/26865667,26865667,,
1196,1761474,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,5349,FXYD3,https://ctdbase.org/detail.go?type=gene&acc=5349,,,5349.0,FXYD3,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of FXYD3 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1197,1761475,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,8321,FZD1,https://ctdbase.org/detail.go?type=gene&acc=8321,,,8321.0,FZD1,10116.0,Rattus norvegicus (Norway rat),Genistein results in decreased expression of FZD1 mRNA,,,PMID:12075121,https://www.ncbi.nlm.nih.gov/pubmed/12075121,12075121,,
1198,1761476,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7976,FZD3,https://ctdbase.org/detail.go?type=gene&acc=7976,,,7976.0,FZD3,9606.0,Homo sapiens (human),Genistein results in increased expression of FZD3 mRNA,,,PMID:18847459,https://www.ncbi.nlm.nih.gov/pubmed/18847459,18847459,,
1199,1761477,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7855,FZD5,https://ctdbase.org/detail.go?type=gene&acc=7855,,,7855.0,FZD5,9606.0,Homo sapiens (human),Genistein results in increased expression of FZD5 mRNA,,,PMID:23019147,https://www.ncbi.nlm.nih.gov/pubmed/23019147,23019147,,
1200,1761478,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,8323,FZD6,https://ctdbase.org/detail.go?type=gene&acc=8323,,,8323.0,FZD6,10090.0,Mus musculus (house mouse),Genistein results in increased expression of FZD6 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1201,1761558,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9606.0,Homo sapiens (human),Genistein results in decreased expression of VEGFA protein,,,PMID:19005980|PMID:21078540,https://www.ncbi.nlm.nih.gov/pubmed/19005980|https://www.ncbi.nlm.nih.gov/pubmed/21078540,19005980|21078540,,
1202,1761559,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,10090.0,Mus musculus (house mouse),Genistein inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of VEGFA mrna],,,PMID:19063610,https://www.ncbi.nlm.nih.gov/pubmed/19063610,19063610,,
1203,1761560,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of VEGFA mRNA,,,PMID:21048042,https://www.ncbi.nlm.nih.gov/pubmed/21048042,21048042,,
1204,1761561,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,10116.0,Rattus norvegicus (Norway rat),Genistein results in increased expression of VEGFA mRNA,,,PMID:29217487,https://www.ncbi.nlm.nih.gov/pubmed/29217487,29217487,,
1205,1761562,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,10116.0,Rattus norvegicus (Norway rat),Genistein results in increased methylation of VEGFA gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
1206,1761563,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7424,VEGFC,https://ctdbase.org/detail.go?type=gene&acc=7424,,,7424.0,VEGFC,9606.0,Homo sapiens (human),Genistein results in decreased expression of VEGFC mRNA,,,PMID:22228119,https://www.ncbi.nlm.nih.gov/pubmed/22228119,22228119,,
1207,1761564,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,94106,VEGP2,https://ctdbase.org/detail.go?type=gene&acc=94106,,,94106.0,Vegp2,10116.0,Rattus norvegicus (Norway rat),[genistein co-treated with methoxychlor] results in decreased expression of VEGP2 mRNA,,,PMID:21782745,https://www.ncbi.nlm.nih.gov/pubmed/21782745,21782745,,
1208,1761565,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7425,VGF,https://ctdbase.org/detail.go?type=gene&acc=7425,,,7425.0,VGF,10116.0,Rattus norvegicus (Norway rat),Genistein results in decreased expression of VGF protein,,,PMID:24552547,https://www.ncbi.nlm.nih.gov/pubmed/24552547,24552547,,
1209,1761566,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,389136,VGLL3,https://ctdbase.org/detail.go?type=gene&acc=389136,,,389136.0,VGLL3,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of VGLL3 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1210,1761649,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,11194,ABCB8,https://ctdbase.org/detail.go?type=gene&acc=11194,,,11194.0,ABCB8,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of ABCB8 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1211,1761650,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606.0,Homo sapiens (human),Genistein affects the activity of ABCC1 protein,,,PMID:9334814,https://www.ncbi.nlm.nih.gov/pubmed/9334814,9334814,,
1212,1761651,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606.0,Homo sapiens (human),Glutathione promotes the reaction [genistein affects the reaction [ABCC1 protein results in increased uptake of leukotriene c4]]|genistein affects the reaction [ABCC1 protein results in increased uptake of leukotriene C4],,,PMID:11306701,https://www.ncbi.nlm.nih.gov/pubmed/11306701,11306701,,
1213,1761652,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606.0,Homo sapiens (human),Genistein analog results in decreased activity of ABCC1 protein,,,PMID:15916776,https://www.ncbi.nlm.nih.gov/pubmed/15916776,15916776,,
1214,1762420,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1238,ACKR2,https://ctdbase.org/detail.go?type=gene&acc=1238,,,1238.0,ACKR2,9606.0,Homo sapiens (human),Genistein results in decreased expression of ACKR2 mRNA,,,PMID:19371625,https://www.ncbi.nlm.nih.gov/pubmed/19371625,19371625,,
1215,1762421,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,57007,ACKR3,https://ctdbase.org/detail.go?type=gene&acc=57007,,,57007.0,ACKR3,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of ACKR3 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1216,1762422,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,47,ACLY,https://ctdbase.org/detail.go?type=gene&acc=47,,,47.0,ACLY,9606.0,Homo sapiens (human),Genistein results in decreased expression of ACLY protein|esr2 promotes the reaction [genistein results in decreased expression of ACLY protein],,,PMID:20884965,https://www.ncbi.nlm.nih.gov/pubmed/20884965,20884965,,
1217,1762423,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,47,ACLY,https://ctdbase.org/detail.go?type=gene&acc=47,,,47.0,ACLY,9606.0,Homo sapiens (human),Genistein results in increased expression of ACLY mRNA,,,PMID:20706672,https://www.ncbi.nlm.nih.gov/pubmed/20706672,20706672,,
1218,1762424,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,209186,ACNAT2,https://ctdbase.org/detail.go?type=gene&acc=209186,,,209186.0,Acnat2,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of ACNAT2 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1219,1763780,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,414758,ZFP950,https://ctdbase.org/detail.go?type=gene&acc=414758,,,414758.0,Zfp950,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of ZFP950 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1220,1763781,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,233987,ZFP958,https://ctdbase.org/detail.go?type=gene&acc=233987,,,233987.0,Zfp958,10116.0,Rattus norvegicus (Norway rat),Genistein results in increased methylation of ZFP958 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
1221,1763973,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,23613,ZMYND8,https://ctdbase.org/detail.go?type=gene&acc=23613,,,23613.0,ZMYND8,10116.0,Rattus norvegicus (Norway rat),Genistein results in increased expression of ZMYND8 protein,,,PMID:24552547,https://www.ncbi.nlm.nih.gov/pubmed/24552547,24552547,,
1222,1763974,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,565722,ZNF1043,https://ctdbase.org/detail.go?type=gene&acc=565722,,,565722.0,znf1043,7955.0,Danio rerio (zebrafish),Genistein results in increased expression of ZNF1043 mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
1223,1763975,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,100126129,ZNF1065,https://ctdbase.org/detail.go?type=gene&acc=100126129,,,100126129.0,znf1065,7955.0,Danio rerio (zebrafish),Genistein results in increased expression of ZNF1065 mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
1224,1764285,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,26289,AK5,https://ctdbase.org/detail.go?type=gene&acc=26289,,,26289.0,AK5,9606.0,Homo sapiens (human),Genistein results in decreased expression of AK5 mRNA,,,PMID:22228119,https://www.ncbi.nlm.nih.gov/pubmed/22228119,22228119,,
1225,1764286,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,9590,AKAP12,https://ctdbase.org/detail.go?type=gene&acc=9590,,,9590.0,AKAP12,9606.0,Homo sapiens (human),Genistein results in decreased expression of AKAP12 mRNA,,,PMID:26865667,https://www.ncbi.nlm.nih.gov/pubmed/26865667,26865667,,
1226,1764929,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,9687,GREB1,https://ctdbase.org/detail.go?type=gene&acc=9687,,,9687.0,GREB1,9606.0,Homo sapiens (human),Genistein promotes the reaction [ESR1 protein binds to GREB1 promoter],,,PMID:23019147,https://www.ncbi.nlm.nih.gov/pubmed/23019147,23019147,,
1227,1764930,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,9687,GREB1,https://ctdbase.org/detail.go?type=gene&acc=9687,,,9687.0,GREB1,9606.0,Homo sapiens (human),Genistein results in increased expression of GREB1 mRNA,,,PMID:16474171|PMID:19371625|PMID:23019147|PMID:26865667|PMID:35307500,https://www.ncbi.nlm.nih.gov/pubmed/16474171|https://www.ncbi.nlm.nih.gov/pubmed/19371625|https://www.ncbi.nlm.nih.gov/pubmed/23019147|https://www.ncbi.nlm.nih.gov/pubmed/26865667|https://www.ncbi.nlm.nih.gov/pubmed/35307500,16474171|19371625|23019147|26865667|35307500,,
1228,1764931,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,80000,GREB1L,https://ctdbase.org/detail.go?type=gene&acc=80000,,,80000.0,GREB1L,10090.0,Mus musculus (house mouse),Genistein results in increased expression of GREB1L mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1229,1764932,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,64388,GREM2,https://ctdbase.org/detail.go?type=gene&acc=64388,,,64388.0,GREM2,10090.0,Mus musculus (house mouse),Genistein results in increased expression of GREM2 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1230,1764933,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,2890,GRIA1,https://ctdbase.org/detail.go?type=gene&acc=2890,,,2890.0,GRIA1,10090.0,Mus musculus (house mouse),Genistein results in increased expression of GRIA1 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1231,1766394,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,116519,APOA5,https://ctdbase.org/detail.go?type=gene&acc=116519,,,116519.0,APOA5,10090.0,Mus musculus (house mouse),Genistein results in increased expression of APOA5 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1232,1766395,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,338,APOB,https://ctdbase.org/detail.go?type=gene&acc=338,,,338.0,APOB,10116.0,Rattus norvegicus (Norway rat),Genistein results in increased expression of APOB mRNA,,,PMID:17010207,https://www.ncbi.nlm.nih.gov/pubmed/17010207,17010207,,
1233,1766396,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,338,APOB,https://ctdbase.org/detail.go?type=gene&acc=338,,,338.0,APOB,10116.0,Rattus norvegicus (Norway rat),Genistein results in increased expression of APOB protein,,,PMID:24552547,https://www.ncbi.nlm.nih.gov/pubmed/24552547,24552547,,
1234,1766397,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,566465,APOBA,https://ctdbase.org/detail.go?type=gene&acc=566465,,,566465.0,apoba,7955.0,Danio rerio (zebrafish),Genistein results in decreased expression of APOBA mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
1235,1766398,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,321166,APOBB.1,https://ctdbase.org/detail.go?type=gene&acc=321166,,,321166.0,apobb.1,7955.0,Danio rerio (zebrafish),Genistein results in decreased expression of APOBB.1 mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
1236,1766399,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,10930,APOBEC2,https://ctdbase.org/detail.go?type=gene&acc=10930,,,10930.0,APOBEC2,10090.0,Mus musculus (house mouse),Genistein results in increased expression of APOBEC2 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1237,1766400,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,9582,APOBEC3B,https://ctdbase.org/detail.go?type=gene&acc=9582,,,9582.0,APOBEC3B,9606.0,Homo sapiens (human),Genistein results in increased expression of APOBEC3B mRNA,,,PMID:16474171,https://www.ncbi.nlm.nih.gov/pubmed/16474171,16474171,,
1238,1766401,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,341,APOC1,https://ctdbase.org/detail.go?type=gene&acc=341,,,341.0,APOC1,10116.0,Rattus norvegicus (Norway rat),Genistein results in decreased expression of APOC1 mRNA,,,PMID:12075121,https://www.ncbi.nlm.nih.gov/pubmed/12075121,12075121,,
1239,1766641,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,348,APOE,https://ctdbase.org/detail.go?type=gene&acc=348,,,348.0,APOE,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of APOE mRNA,,,PMID:21048042,https://www.ncbi.nlm.nih.gov/pubmed/21048042,21048042,,
1240,1766642,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,328561,APOL10B,https://ctdbase.org/detail.go?type=gene&acc=328561,,,328561.0,Apol10b,10090.0,Mus musculus (house mouse),Genistein results in increased expression of APOL10B mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1241,1766643,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,80830,APOL6,https://ctdbase.org/detail.go?type=gene&acc=80830,,,80830.0,APOL6,10090.0,Mus musculus (house mouse),Genistein results in increased expression of APOL6 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1242,1766644,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,75761,APOL7A,https://ctdbase.org/detail.go?type=gene&acc=75761,,,75761.0,Apol7a,10090.0,Mus musculus (house mouse),Genistein results in increased expression of APOL7A mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1243,1766645,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,108956,APOL7C,https://ctdbase.org/detail.go?type=gene&acc=108956,,,108956.0,Apol7c,10090.0,Mus musculus (house mouse),Genistein results in increased expression of APOL7C mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1244,1766646,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,396476,APOV1,https://ctdbase.org/detail.go?type=gene&acc=396476,,,396476.0,APOV1,9031.0,Gallus gallus (chicken),Genistein inhibits the reaction [estradiol results in increased expression of APOV1 protein]|genistein inhibits the reaction [estradiol results in increased expression of APOV1 mrna]|genistein results in increased stability of APOV1 mRNA,,,PMID:26452509,https://www.ncbi.nlm.nih.gov/pubmed/26452509,26452509,,
1245,1766647,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,10090.0,Mus musculus (house mouse),Genistein results in increased expression of APP mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1246,1766648,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,10513,APPBP2,https://ctdbase.org/detail.go?type=gene&acc=10513,,,10513.0,APPBP2,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of APPBP2 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
1247,1766649,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,353,APRT,https://ctdbase.org/detail.go?type=gene&acc=353,,,353.0,APRT,9606.0,Homo sapiens (human),ESR2 promotes the reaction [genistein results in increased expression of APRT protein]|genistein results in increased expression of APRT protein,,,PMID:20884965,https://www.ncbi.nlm.nih.gov/pubmed/20884965,20884965,,
1248,1813924,5281168,Comparative Toxicogenomics Database (CTD),2-Hexenal,C051750,2-hexenal,https://ctdbase.org/detail.go?type=chem&acc=C051750,2950,GSTP1,https://ctdbase.org/detail.go?type=gene&acc=2950,,,2950.0,GSTP1,9606.0,Homo sapiens (human),2-hexenal binds to and results in decreased activity of GSTP1 protein,,,PMID:9463521,https://www.ncbi.nlm.nih.gov/pubmed/9463521,9463521,,
1249,1813925,5281168,Comparative Toxicogenomics Database (CTD),2-Hexenal,C051750,2-hexenal,https://ctdbase.org/detail.go?type=chem&acc=C051750,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),2-hexenal results in increased expression of HMOX1 mRNA,,,PMID:20491607,https://www.ncbi.nlm.nih.gov/pubmed/20491607,20491607,,
1250,1813926,5281168,Comparative Toxicogenomics Database (CTD),2-Hexenal,C051750,2-hexenal,https://ctdbase.org/detail.go?type=chem&acc=C051750,23764,MAFF,https://ctdbase.org/detail.go?type=gene&acc=23764,,,23764.0,MAFF,9606.0,Homo sapiens (human),2-hexenal results in increased expression of MAFF mRNA,,,PMID:20491607,https://www.ncbi.nlm.nih.gov/pubmed/20491607,20491607,,
1251,1813927,5281168,Comparative Toxicogenomics Database (CTD),2-Hexenal,C051750,2-hexenal,https://ctdbase.org/detail.go?type=chem&acc=C051750,5443,POMC,https://ctdbase.org/detail.go?type=gene&acc=5443,,,5443.0,POMC,10116.0,Rattus norvegicus (Norway rat),"[2,5-dihydro-2,4,5-trimethylthiazoline co-treated with 3-hexen-1-ol co-treated with 2-hexenal] results in decreased expression of POMC protein|[3-hexen-1-ol co-treated with 2-hexenal] inhibits the reaction [2,5-dihydro-2,4,5-trimethylthiazoline results in decreased expression of POMC protein]",,,PMID:21515296,https://www.ncbi.nlm.nih.gov/pubmed/21515296,21515296,,
1252,1813928,5281168,Comparative Toxicogenomics Database (CTD),2-Hexenal,C051750,2-hexenal,https://ctdbase.org/detail.go?type=chem&acc=C051750,5443,POMC,https://ctdbase.org/detail.go?type=gene&acc=5443,,,5443.0,POMC,10116.0,Rattus norvegicus (Norway rat),[3-hexen-1-ol co-treated with 2-hexenal] results in decreased expression of POMC,,,PMID:19103229,https://www.ncbi.nlm.nih.gov/pubmed/19103229,19103229,,
1253,1814105,5281224,Comparative Toxicogenomics Database (CTD),Astaxanthin,C005948,astaxanthine,https://ctdbase.org/detail.go?type=chem&acc=C005948,22863,ATG14,https://ctdbase.org/detail.go?type=gene&acc=22863,,,22863.0,ATG14,9606.0,Homo sapiens (human),Astaxanthine inhibits the reaction [bisphenol A results in increased expression of ATG14 mrna],,,PMID:34439521,https://www.ncbi.nlm.nih.gov/pubmed/34439521,34439521,,
1254,1814106,5281224,Comparative Toxicogenomics Database (CTD),Astaxanthin,C005948,astaxanthine,https://ctdbase.org/detail.go?type=chem&acc=C005948,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),Astaxanthine inhibits the reaction [hydrogen peroxide results in increased expression of BAX mrna],,,PMID:33212048,https://www.ncbi.nlm.nih.gov/pubmed/33212048,33212048,,
1255,1814107,5281224,Comparative Toxicogenomics Database (CTD),Astaxanthin,C005948,astaxanthine,https://ctdbase.org/detail.go?type=chem&acc=C005948,570772,BCL2A,https://ctdbase.org/detail.go?type=gene&acc=570772,,,570772.0,bcl2a,7955.0,Danio rerio (zebrafish),Astaxanthine inhibits the reaction [[oxadiazon co-treated with butachlor] results in decreased expression of BCL2A mrna],,,PMID:32504889,https://www.ncbi.nlm.nih.gov/pubmed/32504889,32504889,,
1256,1814108,5281224,Comparative Toxicogenomics Database (CTD),Astaxanthin,C005948,astaxanthine,https://ctdbase.org/detail.go?type=chem&acc=C005948,8678,BECN1,https://ctdbase.org/detail.go?type=gene&acc=8678,,,8678.0,BECN1,9606.0,Homo sapiens (human),Astaxanthine inhibits the reaction [bisphenol A results in increased expression of BECN1 protein]|astaxanthine inhibits the reaction [bisphenol A results in increased expression of BECN1 mrna],,,PMID:34439521,https://www.ncbi.nlm.nih.gov/pubmed/34439521,34439521,,
1257,1814109,5281224,Comparative Toxicogenomics Database (CTD),Astaxanthin,C005948,astaxanthine,https://ctdbase.org/detail.go?type=chem&acc=C005948,712,C1QA,https://ctdbase.org/detail.go?type=gene&acc=712,,,712.0,C1QA,10090.0,Mus musculus (house mouse),Astaxanthine results in decreased expression of C1QA mRNA,,,PMID:19555370,https://www.ncbi.nlm.nih.gov/pubmed/19555370,19555370,,
1258,1814110,5281224,Comparative Toxicogenomics Database (CTD),Astaxanthin,C005948,astaxanthine,https://ctdbase.org/detail.go?type=chem&acc=C005948,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Astaxanthine inhibits the reaction [hydrogen peroxide results in increased expression of CASP3 mrna],,,PMID:33212048,https://www.ncbi.nlm.nih.gov/pubmed/33212048,33212048,,
1259,1765823,5281232,Comparative Toxicogenomics Database (CTD),Crocetin,C487773,trans-sodium crocetinate,https://ctdbase.org/detail.go?type=chem&acc=C487773,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,10116.0,Rattus norvegicus (Norway rat),Trans-sodium crocetinate inhibits the reaction [norepinephrine results in increased expression of MMP2 mrna]|trans-sodium crocetinate inhibits the reaction [norepinephrine results in increased activity of MMP2 protein],,,PMID:16864425,https://www.ncbi.nlm.nih.gov/pubmed/16864425,16864425,,
1260,1765824,5281232,Comparative Toxicogenomics Database (CTD),Crocetin,C487773,trans-sodium crocetinate,https://ctdbase.org/detail.go?type=chem&acc=C487773,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,10116.0,Rattus norvegicus (Norway rat),Trans-sodium crocetinate inhibits the reaction [norepinephrine results in increased expression of MMP9 mrna],,,PMID:16864425,https://www.ncbi.nlm.nih.gov/pubmed/16864425,16864425,,
1261,1765825,5281232,Comparative Toxicogenomics Database (CTD),Crocetin,C487773,trans-sodium crocetinate,https://ctdbase.org/detail.go?type=chem&acc=C487773,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,10090.0,Mus musculus (house mouse),Trans-sodium crocetinate inhibits the reaction [lipopolysaccharides results in increased activity of MPO protein],,,PMID:21925167,https://www.ncbi.nlm.nih.gov/pubmed/21925167,21925167,,
1262,1765513,5281377,Comparative Toxicogenomics Database (CTD),Genistin,C040641,genistin,https://ctdbase.org/detail.go?type=chem&acc=C040641,84913,ATOH8,https://ctdbase.org/detail.go?type=gene&acc=84913,,,84913.0,ATOH8,9606.0,Homo sapiens (human),[daidzein co-treated with daidzin co-treated with genistin co-treated with genistein co-treated with glycitin co-treated with glycitein] results in increased expression of ATOH8 mRNA,,,PMID:27424125,https://www.ncbi.nlm.nih.gov/pubmed/27424125,27424125,,
1263,1765514,5281377,Comparative Toxicogenomics Database (CTD),Genistin,C040641,genistin,https://ctdbase.org/detail.go?type=chem&acc=C040641,10295,BCKDK,https://ctdbase.org/detail.go?type=gene&acc=10295,,,10295.0,BCKDK,9606.0,Homo sapiens (human),[daidzein co-treated with daidzin co-treated with genistin co-treated with genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of BCKDK mRNA,,,PMID:27424125,https://www.ncbi.nlm.nih.gov/pubmed/27424125,27424125,,
1264,1765515,5281377,Comparative Toxicogenomics Database (CTD),Genistin,C040641,genistin,https://ctdbase.org/detail.go?type=chem&acc=C040641,669,BPGM,https://ctdbase.org/detail.go?type=gene&acc=669,,,669.0,BPGM,9606.0,Homo sapiens (human),[daidzein co-treated with daidzin co-treated with genistin co-treated with genistein co-treated with glycitin co-treated with glycitein] affects the expression of BPGM mRNA,,,PMID:27424125,https://www.ncbi.nlm.nih.gov/pubmed/27424125,27424125,,
1265,1766650,5281612,BindingDB,Diosmetin,23414,"5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-chromen-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23414,1653,Mitogen-activated protein kinase 10,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1653,P53779,Mitogen-activated protein kinase 10,5602.0,MAPK10,9606.0,Homo sapiens (human),,IC50 (nM),2.86e+4,PMID:21108268|DOI:10.1002/cbic.201000487,https://www.ncbi.nlm.nih.gov/pubmed/21108268|https://doi.org/10.1002/cbic.201000487,21108268,10.1002/cbic.201000487,
1266,1766651,5281612,Comparative Toxicogenomics Database (CTD),Diosmetin,C039602,diosmetin,https://ctdbase.org/detail.go?type=chem&acc=C039602,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606.0,Homo sapiens (human),Diosmetin results in decreased activity of ABCC1 protein,,,PMID:15670588,https://www.ncbi.nlm.nih.gov/pubmed/15670588,15670588,,
1267,1767932,5281613,Comparative Toxicogenomics Database (CTD),Diosmin,D004145,Diosmin,https://ctdbase.org/detail.go?type=chem&acc=D004145,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116.0,Rattus norvegicus (Norway rat),Diosmin inhibits the reaction [2-acetylaminofluorene results in decreased expression of GSR protein],,,PMID:23665045,https://www.ncbi.nlm.nih.gov/pubmed/23665045,23665045,,
1268,1767933,5281613,Comparative Toxicogenomics Database (CTD),Diosmin,D004145,Diosmin,https://ctdbase.org/detail.go?type=chem&acc=D004145,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),Diosmin inhibits the reaction [benzo(a)pyrene results in increased expression of IL6 protein],,,PMID:32061149,https://www.ncbi.nlm.nih.gov/pubmed/32061149,32061149,,
1269,1767934,5281613,Comparative Toxicogenomics Database (CTD),Diosmin,D004145,Diosmin,https://ctdbase.org/detail.go?type=chem&acc=D004145,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288.0,MKI67,10116.0,Rattus norvegicus (Norway rat),Diosmin inhibits the reaction [2-acetylaminofluorene results in increased expression of MKI67 protein]|diosmin inhibits the reaction [[diethylnitrosamine co-treated with 2-acetylaminofluorene] results in increased expression of MKI67 protein],,,PMID:23665045,https://www.ncbi.nlm.nih.gov/pubmed/23665045,23665045,,
1270,1767935,5281613,Comparative Toxicogenomics Database (CTD),Diosmin,D004145,Diosmin,https://ctdbase.org/detail.go?type=chem&acc=D004145,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,10116.0,Rattus norvegicus (Norway rat),Diosmin inhibits the reaction [acetic acid results in increased activity of MPO protein],,,PMID:29187079,https://www.ncbi.nlm.nih.gov/pubmed/29187079,29187079,,
1271,1767936,5281613,Comparative Toxicogenomics Database (CTD),Diosmin,D004145,Diosmin,https://ctdbase.org/detail.go?type=chem&acc=D004145,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116.0,Rattus norvegicus (Norway rat),Diosmin inhibits the reaction [[diethylnitrosamine co-treated with 2-acetylaminofluorene] results in increased expression of NOS2 protein],,,PMID:23665045,https://www.ncbi.nlm.nih.gov/pubmed/23665045,23665045,,
1272,1767937,5281613,Comparative Toxicogenomics Database (CTD),Diosmin,D004145,Diosmin,https://ctdbase.org/detail.go?type=chem&acc=D004145,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,10090.0,Mus musculus (house mouse),Diosmin inhibits the reaction [benzo(a)pyrene results in increased cleavage of PARP1 protein],,,PMID:32061149,https://www.ncbi.nlm.nih.gov/pubmed/32061149,32061149,,
1273,1767938,5281613,Comparative Toxicogenomics Database (CTD),Diosmin,D004145,Diosmin,https://ctdbase.org/detail.go?type=chem&acc=D004145,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,10116.0,Rattus norvegicus (Norway rat),Diosmin inhibits the reaction [[diethylnitrosamine co-treated with 2-acetylaminofluorene] results in increased expression of PCNA protein]|diosmin inhibits the reaction [2-acetylaminofluorene results in increased expression of PCNA protein],,,PMID:23665045,https://www.ncbi.nlm.nih.gov/pubmed/23665045,23665045,,
1274,1767939,5281613,Comparative Toxicogenomics Database (CTD),Diosmin,D004145,Diosmin,https://ctdbase.org/detail.go?type=chem&acc=D004145,5732,PTGER2,https://ctdbase.org/detail.go?type=gene&acc=5732,,,5732.0,PTGER2,10090.0,Mus musculus (house mouse),Diosmin inhibits the reaction [benzo(a)pyrene results in increased expression of PTGER2 protein],,,PMID:35920545,https://www.ncbi.nlm.nih.gov/pubmed/35920545,35920545,,
1275,1767940,5281613,Comparative Toxicogenomics Database (CTD),Diosmin,D004145,Diosmin,https://ctdbase.org/detail.go?type=chem&acc=D004145,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),Diosmin inhibits the reaction [benzo(a)pyrene results in increased expression of PTGS2 protein],,,PMID:32061149|PMID:35920545,https://www.ncbi.nlm.nih.gov/pubmed/32061149|https://www.ncbi.nlm.nih.gov/pubmed/35920545,32061149|35920545,,
1276,1767941,5281617,Comparative Toxicogenomics Database (CTD),Genkwanin,C014568,genkwanin,https://ctdbase.org/detail.go?type=chem&acc=C014568,4615,MYD88,https://ctdbase.org/detail.go?type=gene&acc=4615,,,4615.0,MYD88,9606.0,Homo sapiens (human),Genkwanin inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of MYD88 protein]|tlr4 protein inhibits the reaction [genkwanin inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of MYD88 protein]],,,PMID:34481870,https://www.ncbi.nlm.nih.gov/pubmed/34481870,34481870,,
1277,1768341,5281643,Comparative Toxicogenomics Database (CTD),Hyperoside,C021304,hyperoside,https://ctdbase.org/detail.go?type=chem&acc=C021304,54205,CYCS,https://ctdbase.org/detail.go?type=gene&acc=54205,,,54205.0,CYCS,9606.0,Homo sapiens (human),Hyperoside inhibits the reaction [tert-butylhydroperoxide affects the localization of CYCS protein],,,PMID:18552516,https://www.ncbi.nlm.nih.gov/pubmed/18552516,18552516,,
1278,1768342,5281643,Comparative Toxicogenomics Database (CTD),Hyperoside,C021304,hyperoside,https://ctdbase.org/detail.go?type=chem&acc=C021304,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein]|hyperoside inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]|hyperoside inhibits the reaction [TNF protein results in increased expression of TNFRSF1A protein]|hyperoside inhibits the reaction [TNF protein results in increased expression of VCAM1 mrna]|hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein]|hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein]|hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein],,,PMID:30125551,https://www.ncbi.nlm.nih.gov/pubmed/30125551,30125551,,
1279,1768343,5281643,Comparative Toxicogenomics Database (CTD),Hyperoside,C021304,hyperoside,https://ctdbase.org/detail.go?type=chem&acc=C021304,7132,TNFRSF1A,https://ctdbase.org/detail.go?type=gene&acc=7132,,,7132.0,TNFRSF1A,10090.0,Mus musculus (house mouse),Hyperoside inhibits the reaction [TNF protein results in increased expression of TNFRSF1A protein],,,PMID:30125551,https://www.ncbi.nlm.nih.gov/pubmed/30125551,30125551,,
1280,1769193,5281643,Comparative Toxicogenomics Database (CTD),Hyperoside,C021304,hyperoside,https://ctdbase.org/detail.go?type=chem&acc=C021304,406991,MIR21,https://ctdbase.org/detail.go?type=gene&acc=406991,,,406991.0,MIR21,9606.0,Homo sapiens (human),MIR21 mRNA results in decreased susceptibility to [quercetin co-treated with hyperoside]|mir21 mRNA inhibits the reaction [[quercetin co-treated with hyperoside] results in increased expression of PDCD4 mrna]|[quercetin co-treated with hyperoside] results in decreased expression of MIR21 mrna|mir21 mRNA inhibits the reaction [[quercetin co-treated with hyperoside] results in increased expression of PDCD4 protein],,,PMID:25354548,https://www.ncbi.nlm.nih.gov/pubmed/25354548,25354548,,
1281,1769194,5281643,Comparative Toxicogenomics Database (CTD),Hyperoside,C021304,hyperoside,https://ctdbase.org/detail.go?type=chem&acc=C021304,407018,MIR27A,https://ctdbase.org/detail.go?type=gene&acc=407018,,,407018.0,MIR27A,9606.0,Homo sapiens (human),MIR27A mRNA inhibits the reaction [[quercetin co-treated with hyperoside] results in increased expression of ZBTB10 mrna]|[quercetin co-treated with hyperoside] inhibits the reaction [MIR27A mRNA results in decreased expression of ZBTB10 mrna]|[quercetin co-treated with hyperoside] results in decreased expression of MIR27A mrna|[quercetin co-treated with hyperoside] inhibits the reaction [MIR27A mRNA results in increased expression of SP1 mrna],,,PMID:24173369,https://www.ncbi.nlm.nih.gov/pubmed/24173369,24173369,,
1282,1769195,5281643,Comparative Toxicogenomics Database (CTD),Hyperoside,C021304,hyperoside,https://ctdbase.org/detail.go?type=chem&acc=C021304,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10090.0,Mus musculus (house mouse),Hyperoside affects the localization of NFE2L2 protein,,,PMID:26772156,https://www.ncbi.nlm.nih.gov/pubmed/26772156,26772156,,
1283,1769196,5281643,Comparative Toxicogenomics Database (CTD),Hyperoside,C021304,hyperoside,https://ctdbase.org/detail.go?type=chem&acc=C021304,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,10090.0,Mus musculus (house mouse),Hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein],,,PMID:30125551,https://www.ncbi.nlm.nih.gov/pubmed/30125551,30125551,,
1284,1769197,5281643,Comparative Toxicogenomics Database (CTD),Hyperoside,C021304,hyperoside,https://ctdbase.org/detail.go?type=chem&acc=C021304,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),[quercetin co-treated with hyperoside] results in increased cleavage of PARP1 protein,,,PMID:24173369|PMID:25354548,https://www.ncbi.nlm.nih.gov/pubmed/24173369|https://www.ncbi.nlm.nih.gov/pubmed/25354548,24173369|25354548,,
1285,1768148,5281670,BindingDB,Morin,26658,"2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-1-benzopyran-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26658,4981,Aurora kinase B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4981,Q96GD4,Aurora kinase B,9212.0,AURKB,9606.0,Homo sapiens (human),,IC50 (nM),4.71e+3,PMID:25298094|DOI:10.1111/cbdd.12445,https://www.ncbi.nlm.nih.gov/pubmed/25298094|https://doi.org/10.1111/cbdd.12445,25298094,10.1111/cbdd.12445,
1286,1768149,5281672,BindingDB,Myricetin,15236,"3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=15236,4981,Aurora kinase B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4981,Q96GD4,Aurora kinase B,9212.0,AURKB,9606.0,Homo sapiens (human),,IC50 (nM),3.98e+3,PMID:25298094|DOI:10.1111/cbdd.12445,https://www.ncbi.nlm.nih.gov/pubmed/25298094|https://doi.org/10.1111/cbdd.12445,25298094,10.1111/cbdd.12445,
1287,1768150,5281672,BindingDB,Myricetin,15236,"3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=15236,4735,1-deoxy-D-xylulose 5-phosphate reductoisomerase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4735,P45568,1-deoxy-D-xylulose 5-phosphate reductoisomerase,945019.0,dxr,83333.0,Escherichia coli K-12,,IC50 (nM),1.5e+3,PMID:25800132|DOI:10.1016/j.bioorg.2015.02.008,https://www.ncbi.nlm.nih.gov/pubmed/25800132|https://doi.org/10.1016/j.bioorg.2015.02.008,25800132,10.1016/j.bioorg.2015.02.008,
1288,1768151,5281673,BindingDB,Myricitrin,153266,"5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=153266,4981,Aurora kinase B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4981,Q96GD4,Aurora kinase B,9212.0,AURKB,9606.0,Homo sapiens (human),,IC50 (nM),3.89e+3,PMID:25298094|DOI:10.1111/cbdd.12445,https://www.ncbi.nlm.nih.gov/pubmed/25298094|https://doi.org/10.1111/cbdd.12445,25298094,10.1111/cbdd.12445,
1289,1768152,5281680,BindingDB,Quercetagetin,23408,"2-(3,4-dihydroxyphenyl)-3,5,6,7-tetrahydroxy-4H-chromen-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23408,4981,Aurora kinase B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4981,Q96GD4,Aurora kinase B,9212.0,AURKB,9606.0,Homo sapiens (human),,IC50 (nM),2.62e+3,PMID:25298094|DOI:10.1111/cbdd.12445,https://www.ncbi.nlm.nih.gov/pubmed/25298094|https://doi.org/10.1111/cbdd.12445,25298094,10.1111/cbdd.12445,
1290,1768153,5281692,Drug Gene Interaction database (DGIdb),Robinetin,,ROBINETIN,https://www.dgidb.org/drugs/chembl:CHEMBL170405,,APEX1,https://www.dgidb.org/genes/hgnc:587,,,328.0,APEX1,9606.0,Homo sapiens (human),,,,,,,,
1291,1768154,5281697,BindingDB,Scutellarein,23411,"5,6,7-trihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23411,4981,Aurora kinase B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4981,Q96GD4,Aurora kinase B,9212.0,AURKB,9606.0,Homo sapiens (human),,IC50 (nM),3.85e+3,PMID:25298094|DOI:10.1111/cbdd.12445,https://www.ncbi.nlm.nih.gov/pubmed/25298094|https://doi.org/10.1111/cbdd.12445,25298094,10.1111/cbdd.12445,
1292,1768155,5281699,BindingDB,Tamarixetin,50325674,"3,5,7-trihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-chromen-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50325674,4981,Aurora kinase B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4981,Q96GD4,Aurora kinase B,9212.0,AURKB,9606.0,Homo sapiens (human),,IC50 (nM),7.39e+3,PMID:25298094|DOI:10.1111/cbdd.12445,https://www.ncbi.nlm.nih.gov/pubmed/25298094|https://doi.org/10.1111/cbdd.12445,25298094,10.1111/cbdd.12445,
1293,1768156,5281699,Drug Gene Interaction database (DGIdb),Tamarixetin,,TAMARIXETIN,https://www.dgidb.org/drugs/chembl:CHEMBL226034,,NFKB1,https://www.dgidb.org/genes/hgnc:7794,,,4790.0,NFKB1,9606.0,Homo sapiens (human),,,,,,,,
1294,1760407,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,9606.0,Homo sapiens (human),Daidzein promotes the reaction [CDKN1A protein binds to CDK2 protein]|daidzein results in decreased activity of CDK2 protein,,,PMID:11322924,https://www.ncbi.nlm.nih.gov/pubmed/11322924,11322924,,
1295,1760408,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,9606.0,Homo sapiens (human),Daidzein results in decreased activity of CDK4 protein,,,PMID:21161820,https://www.ncbi.nlm.nih.gov/pubmed/21161820,21161820,,
1296,1760409,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),Daidzein promotes the reaction [CDKN1A protein binds to CDK2 protein],,,PMID:11322924,https://www.ncbi.nlm.nih.gov/pubmed/11322924,11322924,,
1297,1760410,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),Daidzein results in increased expression of CDKN1A|ESR2 affects the reaction [daidzein results in increased expression of CDKN1A],,,PMID:21161820,https://www.ncbi.nlm.nih.gov/pubmed/21161820,21161820,,
1298,1760411,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,144406,CFAP251,https://ctdbase.org/detail.go?type=gene&acc=144406,,,144406.0,CFAP251,9606.0,Homo sapiens (human),[daidzein co-treated with daidzin co-treated with genistin co-treated with genistein co-treated with glycitin co-treated with glycitein] affects the expression of CFAP251 mRNA,,,PMID:27424125,https://www.ncbi.nlm.nih.gov/pubmed/27424125,27424125,,
1299,1761819,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Estradiol affects the reaction [daidzein metabolite affects the activity of ESR1 protein],,,PMID:16965913,https://www.ncbi.nlm.nih.gov/pubmed/16965913,16965913,,
1300,1761820,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10090.0,Mus musculus (house mouse),Daidzein binds to ESR1 protein,,,PMID:19913605,https://www.ncbi.nlm.nih.gov/pubmed/19913605,19913605,,
1301,1761821,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10090.0,Mus musculus (house mouse),Daidzein results in increased activity of ESR1 protein,,,PMID:19495926,https://www.ncbi.nlm.nih.gov/pubmed/19495926,19495926,,
1302,1761822,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10116.0,Rattus norvegicus (Norway rat),ESR1 protein affects the susceptibility to daidzein,,,PMID:19400946,https://www.ncbi.nlm.nih.gov/pubmed/19400946,19400946,,
1303,1761823,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9823.0,Sus scrofa (pig),Daidzein results in increased expression of ESR1 mRNA,,,PMID:19617652,https://www.ncbi.nlm.nih.gov/pubmed/19617652,19617652,,
1304,1761824,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Daidzein promotes the reaction [ESR1 protein binds to ESR1 protein],,,PMID:34848279,https://www.ncbi.nlm.nih.gov/pubmed/34848279,34848279,,
1305,1761825,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Daidzein promotes the reaction [ESR1 protein binds to NCOA2 protein],,,PMID:23583298,https://www.ncbi.nlm.nih.gov/pubmed/23583298,23583298,,
1306,1761826,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Daidzein results in increased activity of ESR1 protein,,,PMID:11403899,https://www.ncbi.nlm.nih.gov/pubmed/11403899,11403899,,
1307,1761827,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,398734,ESR1.L,https://ctdbase.org/detail.go?type=gene&acc=398734,,,398734.0,esr1.L,8355.0,Xenopus laevis (African clawed frog),Daidzein binds to and results in increased activity of ESR1.L protein,,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
1308,1761828,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9031.0,Gallus gallus (chicken),Daidzein results in increased expression of ESR2 mrna|daidzein inhibits the reaction [estradiol results in increased expression of ESR2 mrna],,,PMID:20043933,https://www.ncbi.nlm.nih.gov/pubmed/20043933,20043933,,
1309,1761999,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Daidzein metabolite binds to and results in increased activity of ESR2 protein,,,PMID:15084758,https://www.ncbi.nlm.nih.gov/pubmed/15084758,15084758,,
1310,1762000,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Daidzein promotes the reaction [estradiol results in increased activity of ESR2 protein],,,PMID:16118406,https://www.ncbi.nlm.nih.gov/pubmed/16118406,16118406,,
1311,1762001,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Daidzein results in increased activity of ESR2 protein,,,PMID:16118406|PMID:18937077|PMID:19161236|PMID:24284790,https://www.ncbi.nlm.nih.gov/pubmed/16118406|https://www.ncbi.nlm.nih.gov/pubmed/18937077|https://www.ncbi.nlm.nih.gov/pubmed/19161236|https://www.ncbi.nlm.nih.gov/pubmed/24284790,16118406|18937077|19161236|24284790,,
1312,1762002,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Daidzein results in increased activity of ESR2 protein alternative form,,,PMID:17266178,https://www.ncbi.nlm.nih.gov/pubmed/17266178,17266178,,
1313,1762197,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Daidzein results in increased expression of ESR2 protein|daidzein results in increased expression of ESR2 mRNA,,,PMID:16033089|PMID:27576059,https://www.ncbi.nlm.nih.gov/pubmed/16033089|https://www.ncbi.nlm.nih.gov/pubmed/27576059,16033089|27576059,,
1314,1762198,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),ESR2 affects the susceptibility to daidzein|esr2 affects the reaction [daidzein results in increased expression of CDKN1A],,,PMID:21161820,https://www.ncbi.nlm.nih.gov/pubmed/21161820,21161820,,
1315,1762199,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),ESR2 gene polymorphism affects the susceptibility to [genistein co-treated with daidzein]|esr2 gene polymorphism affects the reaction [[genistein co-treated with daidzein] affects the expression of VCAM1 protein],,,PMID:16332659,https://www.ncbi.nlm.nih.gov/pubmed/16332659,16332659,,
1316,1762200,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Estradiol affects the reaction [daidzein metabolite affects the activity of ESR2 protein],,,PMID:16965913,https://www.ncbi.nlm.nih.gov/pubmed/16965913,16965913,,
1317,1762201,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10090.0,Mus musculus (house mouse),Daidzein binds to ESR2 protein,,,PMID:19913605,https://www.ncbi.nlm.nih.gov/pubmed/19913605,19913605,,
1318,1762202,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10090.0,Mus musculus (house mouse),Daidzein results in increased activity of ESR2 protein,,,PMID:19495926,https://www.ncbi.nlm.nih.gov/pubmed/19495926,19495926,,
1319,1762203,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10090.0,Mus musculus (house mouse),Daidzein results in increased expression of ESR2 protein,,,PMID:27634370,https://www.ncbi.nlm.nih.gov/pubmed/27634370,27634370,,
1320,1762204,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10116.0,Rattus norvegicus (Norway rat),Daidzein results in increased expression of ESR2 protein|daidzein results in increased expression of ESR2 mRNA,,,PMID:29217487,https://www.ncbi.nlm.nih.gov/pubmed/29217487,29217487,,
1321,1762205,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10116.0,Rattus norvegicus (Norway rat),[genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased expression of ESR2 mRNA,,,PMID:28964809,https://www.ncbi.nlm.nih.gov/pubmed/28964809,28964809,,
1322,1763384,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,9606.0,Homo sapiens (human),Daidzein results in increased expression of JUN mRNA,,,PMID:17266178,https://www.ncbi.nlm.nih.gov/pubmed/17266178,17266178,,
1323,1763385,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,10524,KAT5,https://ctdbase.org/detail.go?type=gene&acc=10524,,,10524.0,KAT5,9606.0,Homo sapiens (human),Daidzein inhibits the reaction [KAT5 protein results in increased activity of ESR2 protein],,,PMID:23857583,https://www.ncbi.nlm.nih.gov/pubmed/23857583,23857583,,
1324,1765315,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,9537,TP53I11,https://ctdbase.org/detail.go?type=gene&acc=9537,,,9537.0,TP53I11,9606.0,Homo sapiens (human),Daidzein results in decreased expression of TP53I11 mRNA,,,PMID:15757668,https://www.ncbi.nlm.nih.gov/pubmed/15757668,15757668,,
1325,1765316,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,11309,SLCO2B1,https://ctdbase.org/detail.go?type=gene&acc=11309,,,11309.0,SLCO2B1,9606.0,Homo sapiens (human),SLCO2B1 protein results in increased transport of daidzein metabolite|daidzein inhibits the reaction [SLCO2B1 protein results in increased transport of estrone sulfate]|estrone sulfate inhibits the reaction [SLCO2B1 protein results in increased transport of daidzein metabolite]|daidzein metabolite inhibits the reaction [SLCO2B1 protein results in increased transport of estrone sulfate],,,PMID:25319728,https://www.ncbi.nlm.nih.gov/pubmed/25319728,25319728,,
1326,1765516,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,401548,SNX30,https://ctdbase.org/detail.go?type=gene&acc=401548,,,401548.0,SNX30,9606.0,Homo sapiens (human),[daidzein co-treated with daidzin co-treated with genistin co-treated with genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of SNX30 mRNA,,,PMID:27424125,https://www.ncbi.nlm.nih.gov/pubmed/27424125,27424125,,
1327,1765517,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10090.0,Mus musculus (house mouse),SOD2 protein affects the susceptibility to daidzein|daidzein results in increased expression of SOD2 protein|fulvestrant inhibits the reaction [daidzein results in increased expression of SOD2 protein],,,PMID:23526725,https://www.ncbi.nlm.nih.gov/pubmed/23526725,23526725,,
1328,1765518,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,284297,SSC5D,https://ctdbase.org/detail.go?type=gene&acc=284297,,,284297.0,SSC5D,9606.0,Homo sapiens (human),[daidzein co-treated with daidzin co-treated with genistin co-treated with genistein co-treated with glycitin co-treated with glycitein] affects the expression of SSC5D mRNA,,,PMID:27424125,https://www.ncbi.nlm.nih.gov/pubmed/27424125,27424125,,
1329,1765519,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,10116.0,Rattus norvegicus (Norway rat),[genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in decreased expression of STAR protein|[genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in decreased expression of STAR mRNA,,,PMID:28964809,https://www.ncbi.nlm.nih.gov/pubmed/28964809,28964809,,
1330,1765520,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,6772,STAT1,https://ctdbase.org/detail.go?type=gene&acc=6772,,,6772.0,STAT1,10090.0,Mus musculus (house mouse),Daidzein inhibits the reaction [lipopolysaccharides affects the localization of and results in increased activity of STAT1 protein alternative form],,,PMID:18274639,https://www.ncbi.nlm.nih.gov/pubmed/18274639,18274639,,
1331,1765521,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,6772,STAT1,https://ctdbase.org/detail.go?type=gene&acc=6772,,,6772.0,STAT1,10090.0,Mus musculus (house mouse),Daidzein inhibits the reaction [lipopolysaccharides results in increased phosphorylation of STAT1 protein],,,PMID:21972936,https://www.ncbi.nlm.nih.gov/pubmed/21972936,21972936,,
1332,1765522,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,6781,STC1,https://ctdbase.org/detail.go?type=gene&acc=6781,,,6781.0,STC1,9606.0,Homo sapiens (human),[genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of STC1 mRNA,,,PMID:16963248,https://www.ncbi.nlm.nih.gov/pubmed/16963248,16963248,,
1333,1760320,5281727,Comparative Toxicogenomics Database (CTD),Pterostilbene,C107773,pterostilbene,https://ctdbase.org/detail.go?type=chem&acc=C107773,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606.0,Homo sapiens (human),Pterostilbene results in increased degradation of NFKBIA protein|pterostilbene inhibits the reaction [tetradecanoylphorbol acetate results in increased phosphorylation of NFKBIA protein],,,PMID:22842666,https://www.ncbi.nlm.nih.gov/pubmed/22842666,22842666,,
1334,1760750,5281727,Comparative Toxicogenomics Database (CTD),Pterostilbene,C107773,pterostilbene,https://ctdbase.org/detail.go?type=chem&acc=C107773,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606.0,Homo sapiens (human),Pterostilbene results in increased expression of NQO1 mrna|buthionine sulfoximine promotes the reaction [pterostilbene results in increased expression of NQO1 mrna]|acetylcysteine inhibits the reaction [pterostilbene results in increased expression of NQO1 mrna]|cat protein inhibits the reaction [pterostilbene results in increased expression of NQO1 mrna],,,PMID:25341683,https://www.ncbi.nlm.nih.gov/pubmed/25341683,25341683,,
1335,1760751,5281727,Comparative Toxicogenomics Database (CTD),Pterostilbene,C107773,pterostilbene,https://ctdbase.org/detail.go?type=chem&acc=C107773,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606.0,Homo sapiens (human),[pterostilbene co-treated with quercetin] results in increased expression of NQO1 protein|[pterostilbene co-treated with kaempferol] results in increased expression of NQO1 protein,,,PMID:25111660,https://www.ncbi.nlm.nih.gov/pubmed/25111660,25111660,,
1336,1760752,5281727,Comparative Toxicogenomics Database (CTD),Pterostilbene,C107773,pterostilbene,https://ctdbase.org/detail.go?type=chem&acc=C107773,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606.0,Homo sapiens (human),RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [ethanol results in decreased expression of NQO1 protein]]|pterostilbene inhibits the reaction [ethanol results in decreased expression of NQO1 protein],,,PMID:34474091,https://www.ncbi.nlm.nih.gov/pubmed/34474091,34474091,,
1337,1760753,5281727,Comparative Toxicogenomics Database (CTD),Pterostilbene,C107773,pterostilbene,https://ctdbase.org/detail.go?type=chem&acc=C107773,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606.0,Homo sapiens (human),Pterostilbene results in increased expression of NQO1 protein,,,PMID:31139082,https://www.ncbi.nlm.nih.gov/pubmed/31139082,31139082,,
1338,1760754,5281727,Comparative Toxicogenomics Database (CTD),Pterostilbene,C107773,pterostilbene,https://ctdbase.org/detail.go?type=chem&acc=C107773,4835,NQO2,https://ctdbase.org/detail.go?type=gene&acc=4835,,,4835.0,NQO2,9606.0,Homo sapiens (human),Pterostilbene results in increased expression of NQO2 protein|pterostilbene results in increased expression of NQO2 mRNA,,,PMID:24936659,https://www.ncbi.nlm.nih.gov/pubmed/24936659,24936659,,
1339,1760755,5281727,Comparative Toxicogenomics Database (CTD),Pterostilbene,C107773,pterostilbene,https://ctdbase.org/detail.go?type=chem&acc=C107773,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,9606.0,Homo sapiens (human),Pterostilbene binds to and results in increased activity of NR1I2 protein,,,PMID:20869355,https://www.ncbi.nlm.nih.gov/pubmed/20869355,20869355,,
1340,1760756,5281727,Comparative Toxicogenomics Database (CTD),Pterostilbene,C107773,pterostilbene,https://ctdbase.org/detail.go?type=chem&acc=C107773,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,9606.0,Homo sapiens (human),Pterostilbene binds to NR1I2 protein,,,PMID:30394306,https://www.ncbi.nlm.nih.gov/pubmed/30394306,30394306,,
1341,1760757,5281727,Comparative Toxicogenomics Database (CTD),Pterostilbene,C107773,pterostilbene,https://ctdbase.org/detail.go?type=chem&acc=C107773,9970,NR1I3,https://ctdbase.org/detail.go?type=gene&acc=9970,,,9970.0,NR1I3,9606.0,Homo sapiens (human),Pterostilbene binds to and results in increased activity of NR1I3 protein alternative form,,,PMID:20869355,https://www.ncbi.nlm.nih.gov/pubmed/20869355,20869355,,
1342,1760758,5281727,Comparative Toxicogenomics Database (CTD),Pterostilbene,C107773,pterostilbene,https://ctdbase.org/detail.go?type=chem&acc=C107773,3084,NRG1,https://ctdbase.org/detail.go?type=gene&acc=3084,,,3084.0,NRG1,9606.0,Homo sapiens (human),Pterostilbene inhibits the reaction [NRG1 protein alternative form results in increased expression of MMP9 mrna]|pterostilbene results in decreased susceptibility to NRG1 protein alternative form|pterostilbene inhibits the reaction [NRG1 protein alternative form results in increased expression of MMP9 protein],,,PMID:19617202,https://www.ncbi.nlm.nih.gov/pubmed/19617202,19617202,,
1343,1767170,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,388503,C3P1,https://ctdbase.org/detail.go?type=gene&acc=388503,,,388503.0,C3P1,9606.0,Homo sapiens (human),Lasiocarpine results in decreased expression of C3P1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1344,1767171,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,823,CAPN1,https://ctdbase.org/detail.go?type=gene&acc=823,,,823.0,CAPN1,9606.0,Homo sapiens (human),[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of CAPN1 mRNA,,,PMID:33884520,https://www.ncbi.nlm.nih.gov/pubmed/33884520,33884520,,
1345,1767172,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,197350,CASP16P,https://ctdbase.org/detail.go?type=gene&acc=197350,,,197350.0,CASP16P,9606.0,Homo sapiens (human),Lasiocarpine results in decreased expression of CASP16P mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1346,1767173,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,100129792,CCDC152,https://ctdbase.org/detail.go?type=gene&acc=100129792,,,100129792.0,CCDC152,9606.0,Homo sapiens (human),Lasiocarpine results in increased expression of CCDC152 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1347,1767174,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,891,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891.0,CCNB1,9606.0,Homo sapiens (human),[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CCNB1 mRNA,,,PMID:33884520,https://www.ncbi.nlm.nih.gov/pubmed/33884520,33884520,,
1348,1767175,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,9133,CCNB2,https://ctdbase.org/detail.go?type=gene&acc=9133,,,9133.0,CCNB2,9606.0,Homo sapiens (human),[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CCNB2 mRNA,,,PMID:33884520,https://www.ncbi.nlm.nih.gov/pubmed/33884520,33884520,,
1349,1767176,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,9134,CCNE2,https://ctdbase.org/detail.go?type=gene&acc=9134,,,9134.0,CCNE2,9606.0,Homo sapiens (human),Lasiocarpine results in increased expression of CCNE2 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1350,1767177,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,900,CCNG1,https://ctdbase.org/detail.go?type=gene&acc=900,,,900.0,CCNG1,10116.0,Rattus norvegicus (Norway rat),Lasiocarpine results in increased expression of CCNG1 mRNA,,,PMID:32419051,https://www.ncbi.nlm.nih.gov/pubmed/32419051,32419051,,
1351,1767178,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,9308,CD83,https://ctdbase.org/detail.go?type=gene&acc=9308,,,9308.0,CD83,9606.0,Homo sapiens (human),Lasiocarpine results in increased expression of CD83 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1352,1768073,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of AURKA mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of TOP2A mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of PTTG1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RFC1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDC25C mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in increased expression of E2F7 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CLSPN mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RFC2 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of E2F3 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of HLTF mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of PPP2R5D mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RFC5 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of POU2F1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of PRC1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RPA1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ARID1A mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RAD21 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of WEE1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of PLK4 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of TOPBP1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDC16 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in increased expression of PLK3 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RAD17 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of TLK1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of E2F8 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ATM mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDK1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of BRCA2 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ATRIP mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDC20 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ESPL1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RFC3 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in increased expression of PPP2CB mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in increased expression of CDKN1A mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of MSH2 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of SMC1A mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of BRIP1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of SMARCC1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RAD1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDC7 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of E2F5 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of FANCD2 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of PLK1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ANAPC1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in increased expression of STAT1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in increased expression of BABAM2 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in increased expression of PLK2 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of MRE11 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which affects the expression of KIF23 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ANAPC2 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CCNB1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of BRCA1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in increased expression of GADD45A mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of PHF10 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of MSH6 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in increased expression of CDC23 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of KIF11 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of SMC3 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ARID2 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of BARD1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of MLH1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in increased expression of CAPN1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RFC4 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of BRD7 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDC25A mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of SLC19A1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of BORA mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in increased expression of ANAPC11 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDK2 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CHEK1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RBBP8 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of STAG2 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of BLM mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of FANCA mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of FBXO5 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDC25B mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of E2F1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CCNB2 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RBL1 mrna|[cyp3a4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of FANCB mRNA,,,PMID:33884520,https://www.ncbi.nlm.nih.gov/pubmed/33884520,33884520,,
1353,1768074,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased phosphorylation of H2AX protein,,,PMID:31103741,https://www.ncbi.nlm.nih.gov/pubmed/31103741,31103741,,
1354,1768075,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),CYP3A4 protein results in increased susceptibility to lasiocarpine,,,PMID:32910235,https://www.ncbi.nlm.nih.gov/pubmed/32910235,32910235,,
1355,1768076,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Lasiocarpine results in increased expression of CYP3A4 mrna|lasiocarpine results in increased expression of and results in increased activity of CYP3A4 protein,,,PMID:29665350,https://www.ncbi.nlm.nih.gov/pubmed/29665350,29665350,,
1356,1768077,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,1577,CYP3A5,https://ctdbase.org/detail.go?type=gene&acc=1577,,,1577.0,CYP3A5,9606.0,Homo sapiens (human),CYP3A5 protein results in increased metabolism of lasiocarpine,,,PMID:31103741,https://www.ncbi.nlm.nih.gov/pubmed/31103741,31103741,,
1357,1768078,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,1579,CYP4A11,https://ctdbase.org/detail.go?type=gene&acc=1579,,,1579.0,CYP4A11,9606.0,Homo sapiens (human),Lasiocarpine results in decreased expression of CYP4A11 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1358,1768711,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,26271,FBXO5,https://ctdbase.org/detail.go?type=gene&acc=26271,,,26271.0,FBXO5,9606.0,Homo sapiens (human),[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of FBXO5 mRNA,,,PMID:33884520,https://www.ncbi.nlm.nih.gov/pubmed/33884520,33884520,,
1359,1768712,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,14133,FCNA,https://ctdbase.org/detail.go?type=gene&acc=14133,,,14133.0,Fcna,10116.0,Rattus norvegicus (Norway rat),Lasiocarpine results in decreased expression of FCNA mRNA,,,PMID:32419051,https://www.ncbi.nlm.nih.gov/pubmed/32419051,32419051,,
1360,1768713,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,400550,FENDRR,https://ctdbase.org/detail.go?type=gene&acc=400550,,,400550.0,FENDRR,9606.0,Homo sapiens (human),Lasiocarpine results in increased expression of FENDRR mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1361,1768714,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,2258,FGF13,https://ctdbase.org/detail.go?type=gene&acc=2258,,,2258.0,FGF13,9606.0,Homo sapiens (human),Lasiocarpine results in decreased expression of FGF13 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1362,1768715,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,2247,FGF2,https://ctdbase.org/detail.go?type=gene&acc=2247,,,2247.0,FGF2,9606.0,Homo sapiens (human),Lasiocarpine metabolite results in decreased expression of FGF2 mRNA,,,PMID:30465738,https://www.ncbi.nlm.nih.gov/pubmed/30465738,30465738,,
1363,1768716,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,2272,FHIT,https://ctdbase.org/detail.go?type=gene&acc=2272,,,2272.0,FHIT,9606.0,Homo sapiens (human),Lasiocarpine results in decreased expression of FHIT mRNA,,,PMID:32234424|PMID:35690182,https://www.ncbi.nlm.nih.gov/pubmed/32234424|https://www.ncbi.nlm.nih.gov/pubmed/35690182,32234424|35690182,,
1364,1768717,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,55732,FIRRM,https://ctdbase.org/detail.go?type=gene&acc=55732,,,55732.0,FIRRM,9606.0,Homo sapiens (human),Lasiocarpine results in increased expression of FIRRM mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1365,1768718,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,2335,FN1,https://ctdbase.org/detail.go?type=gene&acc=2335,,,2335.0,FN1,9606.0,Homo sapiens (human),Lasiocarpine metabolite results in decreased expression of FN1 mRNA,,,PMID:30465738,https://www.ncbi.nlm.nih.gov/pubmed/30465738,30465738,,
1366,1768719,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,219595,FOLH1B,https://ctdbase.org/detail.go?type=gene&acc=219595,,,219595.0,FOLH1B,9606.0,Homo sapiens (human),Lasiocarpine results in decreased expression of FOLH1B mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1367,1769129,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014.0,H2AX,10029.0,Cricetulus griseus (Chinese hamster),[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased phosphorylation of H2AX protein|lasiocarpine metabolite results in increased phosphorylation of H2AX protein,,,PMID:31103741,https://www.ncbi.nlm.nih.gov/pubmed/31103741,31103741,,
1368,1769130,5281735,Comparative Toxicogenomics Database (CTD),Lasiocarpine,C005136,lasiocarpine,https://ctdbase.org/detail.go?type=chem&acc=C005136,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014.0,H2AX,9606.0,Homo sapiens (human),Lasiocarpine results in increased expression of H2AX protein,,,PMID:31154085,https://www.ncbi.nlm.nih.gov/pubmed/31154085,31154085,,
1369,1768621,5281779,Comparative Toxicogenomics Database (CTD),Irilone,C530234,irilone,https://ctdbase.org/detail.go?type=chem&acc=C530234,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Irilone results in decreased activity of CYP3A4 protein,,,PMID:29753067,https://www.ncbi.nlm.nih.gov/pubmed/29753067,29753067,,
1370,1768622,5281779,Comparative Toxicogenomics Database (CTD),Irilone,C530234,irilone,https://ctdbase.org/detail.go?type=chem&acc=C530234,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Irilone results in increased expression of ESR2 mRNA,,,PMID:23982890,https://www.ncbi.nlm.nih.gov/pubmed/23982890,23982890,,
1371,1768623,5281779,Comparative Toxicogenomics Database (CTD),Irilone,C530234,irilone,https://ctdbase.org/detail.go?type=chem&acc=C530234,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,9606.0,Homo sapiens (human),Irilone results in increased expression of PGR mRNA,,,PMID:23982890,https://www.ncbi.nlm.nih.gov/pubmed/23982890,23982890,,
1372,1768624,5281811,Drug Gene Interaction database (DGIdb),Tectorigenin,,TECTORIGENIN,https://www.dgidb.org/drugs/ncit:C1205,,AKR1B1,https://www.dgidb.org/genes/hgnc:381,,,231.0,AKR1B1,9606.0,Homo sapiens (human),,,,,,,,
1373,1762071,5281929,Comparative Toxicogenomics Database (CTD),Methyl jasmonate,C072239,methyl jasmonate,https://ctdbase.org/detail.go?type=chem&acc=C072239,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,9606.0,Homo sapiens (human),Methyl jasmonate metabolite promotes the reaction [TNFSF10 protein results in decreased expression of BCL2L1 protein],,,PMID:22079975,https://www.ncbi.nlm.nih.gov/pubmed/22079975,22079975,,
1374,1762072,5281929,Comparative Toxicogenomics Database (CTD),Methyl jasmonate,C072239,methyl jasmonate,https://ctdbase.org/detail.go?type=chem&acc=C072239,637,BID,https://ctdbase.org/detail.go?type=gene&acc=637,,,637.0,BID,9606.0,Homo sapiens (human),Methyl jasmonate metabolite promotes the reaction [TNFSF10 protein results in increased cleavage of BID protein],,,PMID:22079975,https://www.ncbi.nlm.nih.gov/pubmed/22079975,22079975,,
1375,1762073,5281929,Comparative Toxicogenomics Database (CTD),Methyl jasmonate,C072239,methyl jasmonate,https://ctdbase.org/detail.go?type=chem&acc=C072239,329,BIRC2,https://ctdbase.org/detail.go?type=gene&acc=329,,,329.0,BIRC2,9606.0,Homo sapiens (human),Methyl jasmonate metabolite promotes the reaction [TNFSF10 protein results in decreased expression of BIRC2 protein],,,PMID:22079975,https://www.ncbi.nlm.nih.gov/pubmed/22079975,22079975,,
1376,1762074,5281929,Comparative Toxicogenomics Database (CTD),Methyl jasmonate,C072239,methyl jasmonate,https://ctdbase.org/detail.go?type=chem&acc=C072239,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Methyl jasmonate metabolite promotes the reaction [TNFSF10 protein results in decreased expression of CASP3 protein]|[benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone results in decreased activity of CASP3 protein] inhibits the reaction [methyl jasmonate metabolite results in increased susceptibility to TNFSF10 protein]|methyl jasmonate metabolite promotes the reaction [TNFSF10 protein results in increased activity of CASP3 protein],,,PMID:22079975,https://www.ncbi.nlm.nih.gov/pubmed/22079975,22079975,,
1377,1762075,5281929,Comparative Toxicogenomics Database (CTD),Methyl jasmonate,C072239,methyl jasmonate,https://ctdbase.org/detail.go?type=chem&acc=C072239,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606.0,Homo sapiens (human),[benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [methyl jasmonate metabolite results in increased susceptibility to TNFSF10 protein]|methyl jasmonate metabolite promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein]|methyl jasmonate metabolite promotes the reaction [TNFSF10 protein results in decreased expression of CASP8 protein],,,PMID:22079975,https://www.ncbi.nlm.nih.gov/pubmed/22079975,22079975,,
1378,1762076,5281929,Comparative Toxicogenomics Database (CTD),Methyl jasmonate,C072239,methyl jasmonate,https://ctdbase.org/detail.go?type=chem&acc=C072239,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),Methyl jasmonate metabolite promotes the reaction [TNFSF10 protein results in increased activity of CASP9 protein]|[benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein] inhibits the reaction [methyl jasmonate metabolite results in increased susceptibility to TNFSF10 protein]|methyl jasmonate metabolite promotes the reaction [TNFSF10 protein results in decreased expression of CASP9 protein],,,PMID:22079975,https://www.ncbi.nlm.nih.gov/pubmed/22079975,22079975,,
1379,1762077,5281929,Comparative Toxicogenomics Database (CTD),Methyl jasmonate,C072239,methyl jasmonate,https://ctdbase.org/detail.go?type=chem&acc=C072239,411768,HSTRPA,https://ctdbase.org/detail.go?type=gene&acc=411768,,,411768.0,,7460.0,Apis mellifera (honey bee),[methyl jasmonate results in increased activity of HSTRPA protein] which results in increased uptake of calcium|methyl jasmonate results in increased activity of HSTRPA protein,,,PMID:29445768,https://www.ncbi.nlm.nih.gov/pubmed/29445768,29445768,,
1380,1764129,5282102,Therapeutic Target Database (TTD),Astragalin,D08BFU,ASTRAGALIN,https://idrblab.net/ttd/data/drug/details/D08BFU,T82577,Angiotensin-converting enzyme (ACE),https://idrblab.net/ttd/data/target/details/T82577,P12821,Angiotensin-converting enzyme ,1636.0,ACE,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1381,1764130,5282102,Therapeutic Target Database (TTD),Astragalin,D08BFU,ASTRAGALIN,https://idrblab.net/ttd/data/drug/details/D08BFU,T26623,Aldose reductase (AKR1B1),https://idrblab.net/ttd/data/target/details/T26623,P15121,Aldo-keto reductase family 1 member B1,231.0,AKR1B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1382,1764131,5282164,Comparative Toxicogenomics Database (CTD),gamma-Oryzanol,C013172,gamma-oryzanol,https://ctdbase.org/detail.go?type=chem&acc=C013172,210,ALAD,https://ctdbase.org/detail.go?type=gene&acc=210,,,210.0,ALAD,10090.0,Mus musculus (house mouse),Gamma-oryzanol inhibits the reaction [cadmium chloride results in decreased activity of ALAD protein],,,PMID:23395783,https://www.ncbi.nlm.nih.gov/pubmed/23395783,23395783,,
1383,1764132,5282164,Comparative Toxicogenomics Database (CTD),gamma-Oryzanol,C013172,gamma-oryzanol,https://ctdbase.org/detail.go?type=chem&acc=C013172,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632.0,BGLAP,10116.0,Rattus norvegicus (Norway rat),Gamma-oryzanol affects the expression of BGLAP protein,,,PMID:24098073,https://www.ncbi.nlm.nih.gov/pubmed/24098073,24098073,,
1384,1764133,5282164,Comparative Toxicogenomics Database (CTD),gamma-Oryzanol,C013172,gamma-oryzanol,https://ctdbase.org/detail.go?type=chem&acc=C013172,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),[gamma-oryzanol co-treated with cadmium chloride] results in increased activity of CAT protein,,,PMID:23395783,https://www.ncbi.nlm.nih.gov/pubmed/23395783,23395783,,
1385,1764134,5282164,Comparative Toxicogenomics Database (CTD),gamma-Oryzanol,C013172,gamma-oryzanol,https://ctdbase.org/detail.go?type=chem&acc=C013172,1278,COL1A2,https://ctdbase.org/detail.go?type=gene&acc=1278,,,1278.0,COL1A2,10116.0,Rattus norvegicus (Norway rat),Gamma-oryzanol affects the expression of COL1A2 mRNA,,,PMID:24098073,https://www.ncbi.nlm.nih.gov/pubmed/24098073,24098073,,
1386,1764135,5282164,Comparative Toxicogenomics Database (CTD),gamma-Oryzanol,C013172,gamma-oryzanol,https://ctdbase.org/detail.go?type=chem&acc=C013172,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),Gamma-oryzanol affects the expression of IL6 protein,,,PMID:24098073,https://www.ncbi.nlm.nih.gov/pubmed/24098073,24098073,,
1387,1764136,5282164,Comparative Toxicogenomics Database (CTD),gamma-Oryzanol,C013172,gamma-oryzanol,https://ctdbase.org/detail.go?type=chem&acc=C013172,10631,POSTN,https://ctdbase.org/detail.go?type=gene&acc=10631,,,10631.0,POSTN,10116.0,Rattus norvegicus (Norway rat),Gamma-oryzanol affects the expression of POSTN mRNA,,,PMID:24098073,https://www.ncbi.nlm.nih.gov/pubmed/24098073,24098073,,
1388,1764137,5282164,Comparative Toxicogenomics Database (CTD),gamma-Oryzanol,C013172,gamma-oryzanol,https://ctdbase.org/detail.go?type=chem&acc=C013172,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,10116.0,Rattus norvegicus (Norway rat),Gamma-oryzanol affects the expression of RUNX2 mRNA,,,PMID:24098073,https://www.ncbi.nlm.nih.gov/pubmed/24098073,24098073,,
1389,1764138,5282164,Comparative Toxicogenomics Database (CTD),gamma-Oryzanol,C013172,gamma-oryzanol,https://ctdbase.org/detail.go?type=chem&acc=C013172,121340,SP7,https://ctdbase.org/detail.go?type=gene&acc=121340,,,121340.0,SP7,10116.0,Rattus norvegicus (Norway rat),Gamma-oryzanol affects the expression of SP7 mRNA,,,PMID:24098073,https://www.ncbi.nlm.nih.gov/pubmed/24098073,24098073,,
1390,1764139,5282164,Comparative Toxicogenomics Database (CTD),gamma-Oryzanol,C013172,gamma-oryzanol,https://ctdbase.org/detail.go?type=chem&acc=C013172,6678,SPARC,https://ctdbase.org/detail.go?type=gene&acc=6678,,,6678.0,SPARC,10116.0,Rattus norvegicus (Norway rat),Gamma-oryzanol affects the expression of SPARC mRNA,,,PMID:24098073,https://www.ncbi.nlm.nih.gov/pubmed/24098073,24098073,,
1391,1765400,5282411,Drug Gene Interaction database (DGIdb),Epoprostenol,,EPOPROSTENOL,https://www.dgidb.org/drugs/rxcui:8814,,PTGIR,https://www.dgidb.org/genes/hgnc:9602,,,5739.0,PTGIR,9606.0,Homo sapiens (human),,,,,,,,
1392,1765401,5282419,Drug Gene Interaction database (DGIdb),Sensorcaine,,BUPIVACAINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:267396,,SCN4A,https://www.dgidb.org/genes/hgnc:10591,,,6329.0,SCN4A,9606.0,Homo sapiens (human),Blocker,,,,,,,
1393,1765402,5282487,Drug Gene Interaction database (DGIdb),Paroxetine hydrochloride hemihydrate,,"PAROXETINE HYDROCHLORIDE, HEMIHYDRATE",https://www.dgidb.org/drugs/rxcui:1298842,,IDH1,https://www.dgidb.org/genes/hgnc:5382,,,3417.0,IDH1,9606.0,Homo sapiens (human),,,,,,,,
1394,1765403,5282800,Comparative Toxicogenomics Database (CTD),"(10E,12Z)-octadeca-10,12-dienoic acid",C496197,"trans-10,cis-12-conjugated linoleic acid",https://ctdbase.org/detail.go?type=chem&acc=C496197,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,9606.0,Homo sapiens (human),"Trans-10,cis-12-conjugated linoleic acid results in decreased expression of ABCA1 mRNA",,,PMID:17951470,https://www.ncbi.nlm.nih.gov/pubmed/17951470,17951470,,
1395,1765404,5282800,Comparative Toxicogenomics Database (CTD),"(10E,12Z)-octadeca-10,12-dienoic acid",C496197,"trans-10,cis-12-conjugated linoleic acid",https://ctdbase.org/detail.go?type=chem&acc=C496197,51,ACOX1,https://ctdbase.org/detail.go?type=gene&acc=51,,,51.0,ACOX1,10090.0,Mus musculus (house mouse),"Trans-10,cis-12-conjugated linoleic acid results in decreased expression of ACOX1 mRNA",,,PMID:17217560,https://www.ncbi.nlm.nih.gov/pubmed/17217560,17217560,,
1396,1765405,5282800,Comparative Toxicogenomics Database (CTD),"(10E,12Z)-octadeca-10,12-dienoic acid",C496197,"trans-10,cis-12-conjugated linoleic acid",https://ctdbase.org/detail.go?type=chem&acc=C496197,51094,ADIPOR1,https://ctdbase.org/detail.go?type=gene&acc=51094,,,51094.0,ADIPOR1,10116.0,Rattus norvegicus (Norway rat),"[trans-10,cis-12-conjugated linoleic acid co-treated with cis-9, trans-11-conjugated linoleic acid] results in increased expression of ADIPOR1 mRNA",,,PMID:17408517,https://www.ncbi.nlm.nih.gov/pubmed/17408517,17408517,,
1397,1765406,5282800,Comparative Toxicogenomics Database (CTD),"(10E,12Z)-octadeca-10,12-dienoic acid",C496197,"trans-10,cis-12-conjugated linoleic acid",https://ctdbase.org/detail.go?type=chem&acc=C496197,79602,ADIPOR2,https://ctdbase.org/detail.go?type=gene&acc=79602,,,79602.0,ADIPOR2,10116.0,Rattus norvegicus (Norway rat),"[trans-10,cis-12-conjugated linoleic acid co-treated with cis-9, trans-11-conjugated linoleic acid] results in increased expression of ADIPOR2 mRNA",,,PMID:17408517,https://www.ncbi.nlm.nih.gov/pubmed/17408517,17408517,,
1398,1765407,5282800,Comparative Toxicogenomics Database (CTD),"(10E,12Z)-octadeca-10,12-dienoic acid",C496197,"trans-10,cis-12-conjugated linoleic acid",https://ctdbase.org/detail.go?type=chem&acc=C496197,199,AIF1,https://ctdbase.org/detail.go?type=gene&acc=199,,,199.0,AIF1,9606.0,Homo sapiens (human),"Trans-10,cis-12-conjugated linoleic acid results in decreased expression of AIF1 mRNA",,,PMID:17951470,https://www.ncbi.nlm.nih.gov/pubmed/17951470,17951470,,
1399,1765408,5282800,Comparative Toxicogenomics Database (CTD),"(10E,12Z)-octadeca-10,12-dienoic acid",C496197,"trans-10,cis-12-conjugated linoleic acid",https://ctdbase.org/detail.go?type=chem&acc=C496197,54443,ANLN,https://ctdbase.org/detail.go?type=gene&acc=54443,,,54443.0,ANLN,9606.0,Homo sapiens (human),"Trans-10,cis-12-conjugated linoleic acid results in decreased expression of ANLN mRNA",,,PMID:17951470,https://www.ncbi.nlm.nih.gov/pubmed/17951470,17951470,,
1400,1766055,5282800,Comparative Toxicogenomics Database (CTD),"(10E,12Z)-octadeca-10,12-dienoic acid",C496197,"trans-10,cis-12-conjugated linoleic acid",https://ctdbase.org/detail.go?type=chem&acc=C496197,1028,CDKN1C,https://ctdbase.org/detail.go?type=gene&acc=1028,,,1028.0,CDKN1C,9606.0,Homo sapiens (human),"Trans-10,cis-12-conjugated linoleic acid results in increased expression of CDKN1C mRNA",,,PMID:17951470,https://www.ncbi.nlm.nih.gov/pubmed/17951470,17951470,,
1401,1766056,5282800,Comparative Toxicogenomics Database (CTD),"(10E,12Z)-octadeca-10,12-dienoic acid",C496197,"trans-10,cis-12-conjugated linoleic acid",https://ctdbase.org/detail.go?type=chem&acc=C496197,1030,CDKN2B,https://ctdbase.org/detail.go?type=gene&acc=1030,,,1030.0,CDKN2B,9606.0,Homo sapiens (human),"Trans-10,cis-12-conjugated linoleic acid results in increased expression of CDKN2B mRNA",,,PMID:17951470,https://www.ncbi.nlm.nih.gov/pubmed/17951470,17951470,,
1402,1766057,5282800,Comparative Toxicogenomics Database (CTD),"(10E,12Z)-octadeca-10,12-dienoic acid",C496197,"trans-10,cis-12-conjugated linoleic acid",https://ctdbase.org/detail.go?type=chem&acc=C496197,1031,CDKN2C,https://ctdbase.org/detail.go?type=gene&acc=1031,,,1031.0,CDKN2C,9606.0,Homo sapiens (human),"Trans-10,cis-12-conjugated linoleic acid results in decreased expression of CDKN2C mRNA",,,PMID:17951470,https://www.ncbi.nlm.nih.gov/pubmed/17951470,17951470,,
1403,1766058,5282800,Comparative Toxicogenomics Database (CTD),"(10E,12Z)-octadeca-10,12-dienoic acid",C496197,"trans-10,cis-12-conjugated linoleic acid",https://ctdbase.org/detail.go?type=chem&acc=C496197,1033,CDKN3,https://ctdbase.org/detail.go?type=gene&acc=1033,,,1033.0,CDKN3,9606.0,Homo sapiens (human),"Trans-10,cis-12-conjugated linoleic acid results in decreased expression of CDKN3 mRNA",,,PMID:17951470,https://www.ncbi.nlm.nih.gov/pubmed/17951470,17951470,,
1404,1766059,5282800,Comparative Toxicogenomics Database (CTD),"(10E,12Z)-octadeca-10,12-dienoic acid",C496197,"trans-10,cis-12-conjugated linoleic acid",https://ctdbase.org/detail.go?type=chem&acc=C496197,1058,CENPA,https://ctdbase.org/detail.go?type=gene&acc=1058,,,1058.0,CENPA,9606.0,Homo sapiens (human),"Trans-10,cis-12-conjugated linoleic acid results in decreased expression of CENPA mRNA",,,PMID:17951470,https://www.ncbi.nlm.nih.gov/pubmed/17951470,17951470,,
1405,1766060,5282800,Comparative Toxicogenomics Database (CTD),"(10E,12Z)-octadeca-10,12-dienoic acid",C496197,"trans-10,cis-12-conjugated linoleic acid",https://ctdbase.org/detail.go?type=chem&acc=C496197,1062,CENPE,https://ctdbase.org/detail.go?type=gene&acc=1062,,,1062.0,CENPE,9606.0,Homo sapiens (human),"Trans-10,cis-12-conjugated linoleic acid results in decreased expression of CENPE mRNA",,,PMID:17951470,https://www.ncbi.nlm.nih.gov/pubmed/17951470,17951470,,
1406,1766490,5282800,Comparative Toxicogenomics Database (CTD),"(10E,12Z)-octadeca-10,12-dienoic acid",C496197,"trans-10,cis-12-conjugated linoleic acid",https://ctdbase.org/detail.go?type=chem&acc=C496197,1663,DDX11,https://ctdbase.org/detail.go?type=gene&acc=1663,,,1663.0,DDX11,9606.0,Homo sapiens (human),"Trans-10,cis-12-conjugated linoleic acid results in decreased expression of DDX11 mRNA",,,PMID:17951470,https://www.ncbi.nlm.nih.gov/pubmed/17951470,17951470,,
1407,1766491,5282800,Comparative Toxicogenomics Database (CTD),"(10E,12Z)-octadeca-10,12-dienoic acid",C496197,"trans-10,cis-12-conjugated linoleic acid",https://ctdbase.org/detail.go?type=chem&acc=C496197,8847,DLEU2,https://ctdbase.org/detail.go?type=gene&acc=8847,,,8847.0,DLEU2,9606.0,Homo sapiens (human),"Trans-10,cis-12-conjugated linoleic acid results in decreased expression of DLEU2 mRNA",,,PMID:17951470,https://www.ncbi.nlm.nih.gov/pubmed/17951470,17951470,,
1408,1766492,5282800,Comparative Toxicogenomics Database (CTD),"(10E,12Z)-octadeca-10,12-dienoic acid",C496197,"trans-10,cis-12-conjugated linoleic acid",https://ctdbase.org/detail.go?type=chem&acc=C496197,1773,DNASE1,https://ctdbase.org/detail.go?type=gene&acc=1773,,,1773.0,DNASE1,9606.0,Homo sapiens (human),"Trans-10,cis-12-conjugated linoleic acid results in decreased expression of DNASE1 mRNA",,,PMID:17951470,https://www.ncbi.nlm.nih.gov/pubmed/17951470,17951470,,
1409,1766493,5282800,Comparative Toxicogenomics Database (CTD),"(10E,12Z)-octadeca-10,12-dienoic acid",C496197,"trans-10,cis-12-conjugated linoleic acid",https://ctdbase.org/detail.go?type=chem&acc=C496197,1843,DUSP1,https://ctdbase.org/detail.go?type=gene&acc=1843,,,1843.0,DUSP1,9606.0,Homo sapiens (human),"Trans-10,cis-12-conjugated linoleic acid results in increased expression of DUSP1 mRNA",,,PMID:17951470,https://www.ncbi.nlm.nih.gov/pubmed/17951470,17951470,,
1410,1766494,5282800,Comparative Toxicogenomics Database (CTD),"(10E,12Z)-octadeca-10,12-dienoic acid",C496197,"trans-10,cis-12-conjugated linoleic acid",https://ctdbase.org/detail.go?type=chem&acc=C496197,1848,DUSP6,https://ctdbase.org/detail.go?type=gene&acc=1848,,,1848.0,DUSP6,9606.0,Homo sapiens (human),"Trans-10,cis-12-conjugated linoleic acid results in increased expression of DUSP6 mRNA",,,PMID:17951470,https://www.ncbi.nlm.nih.gov/pubmed/17951470,17951470,,
1411,1766495,5282800,Comparative Toxicogenomics Database (CTD),"(10E,12Z)-octadeca-10,12-dienoic acid",C496197,"trans-10,cis-12-conjugated linoleic acid",https://ctdbase.org/detail.go?type=chem&acc=C496197,1778,DYNC1H1,https://ctdbase.org/detail.go?type=gene&acc=1778,,,1778.0,DYNC1H1,9606.0,Homo sapiens (human),"Trans-10,cis-12-conjugated linoleic acid results in increased expression of DYNC1H1 mRNA",,,PMID:17951470,https://www.ncbi.nlm.nih.gov/pubmed/17951470,17951470,,
1412,1766496,5282800,Comparative Toxicogenomics Database (CTD),"(10E,12Z)-octadeca-10,12-dienoic acid",C496197,"trans-10,cis-12-conjugated linoleic acid",https://ctdbase.org/detail.go?type=chem&acc=C496197,144455,E2F7,https://ctdbase.org/detail.go?type=gene&acc=144455,,,144455.0,E2F7,9606.0,Homo sapiens (human),"Trans-10,cis-12-conjugated linoleic acid results in decreased expression of E2F7 mRNA",,,PMID:17951470,https://www.ncbi.nlm.nih.gov/pubmed/17951470,17951470,,
1413,1766497,5282800,Comparative Toxicogenomics Database (CTD),"(10E,12Z)-octadeca-10,12-dienoic acid",C496197,"trans-10,cis-12-conjugated linoleic acid",https://ctdbase.org/detail.go?type=chem&acc=C496197,79733,E2F8,https://ctdbase.org/detail.go?type=gene&acc=79733,,,79733.0,E2F8,9606.0,Homo sapiens (human),"Trans-10,cis-12-conjugated linoleic acid results in decreased expression of E2F8 mRNA",,,PMID:17951470,https://www.ncbi.nlm.nih.gov/pubmed/17951470,17951470,,
1414,1766498,5282800,Comparative Toxicogenomics Database (CTD),"(10E,12Z)-octadeca-10,12-dienoic acid",C496197,"trans-10,cis-12-conjugated linoleic acid",https://ctdbase.org/detail.go?type=chem&acc=C496197,1950,EGF,https://ctdbase.org/detail.go?type=gene&acc=1950,,,1950.0,EGF,9606.0,Homo sapiens (human),"Trans-10,cis-12-conjugated linoleic acid results in increased expression of EGF mRNA",,,PMID:17951470,https://www.ncbi.nlm.nih.gov/pubmed/17951470,17951470,,
1415,1760616,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,10419,PRMT5,https://ctdbase.org/detail.go?type=gene&acc=10419,,,10419.0,PRMT5,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PRMT5 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1416,1760617,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,55170,PRMT6,https://ctdbase.org/detail.go?type=gene&acc=55170,,,55170.0,PRMT6,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PRMT6 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
1417,1760618,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,55170,PRMT6,https://ctdbase.org/detail.go?type=gene&acc=55170,,,55170.0,PRMT6,10090.0,Mus musculus (house mouse),Cyclosporine results in increased expression of PRMT6 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1418,1760619,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,54496,PRMT7,https://ctdbase.org/detail.go?type=gene&acc=54496,,,54496.0,PRMT7,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PRMT7 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1419,1760620,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5621,PRNP,https://ctdbase.org/detail.go?type=gene&acc=5621,,,5621.0,PRNP,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PRNP mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
1420,1760621,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5621,PRNP,https://ctdbase.org/detail.go?type=gene&acc=5621,,,5621.0,PRNP,10090.0,Mus musculus (house mouse),Cyclosporine results in increased expression of PRNP mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1421,1760622,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5624,PROC,https://ctdbase.org/detail.go?type=gene&acc=5624,,,5624.0,PROC,9606.0,Homo sapiens (human),Cyclosporine affects the expression of PROC mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1422,1760623,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5624,PROC,https://ctdbase.org/detail.go?type=gene&acc=5624,,,5624.0,PROC,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PROC mRNA,,,PMID:25562108|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/25562108|https://www.ncbi.nlm.nih.gov/pubmed/27989131,25562108|27989131,,
1423,1760624,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5624,PROC,https://ctdbase.org/detail.go?type=gene&acc=5624,,,5624.0,PROC,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PROC protein,,,PMID:2859508,https://www.ncbi.nlm.nih.gov/pubmed/2859508,2859508,,
1424,1760625,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,10544,PROCR,https://ctdbase.org/detail.go?type=gene&acc=10544,,,10544.0,PROCR,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PROCR mRNA,,,PMID:20106945|PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981,20106945|21632981,,
1425,1760626,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5625,PRODH,https://ctdbase.org/detail.go?type=gene&acc=5625,,,5625.0,PRODH,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PRODH mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1426,1760846,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,58510,PRODH2,https://ctdbase.org/detail.go?type=gene&acc=58510,,,58510.0,PRODH2,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PRODH2 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
1427,1760847,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,8842,PROM1,https://ctdbase.org/detail.go?type=gene&acc=8842,,,8842.0,PROM1,9606.0,Homo sapiens (human),Cyclosporine affects the expression of PROM1 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
1428,1760848,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,8842,PROM1,https://ctdbase.org/detail.go?type=gene&acc=8842,,,8842.0,PROM1,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PROM1 mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
1429,1760849,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,8842,PROM1,https://ctdbase.org/detail.go?type=gene&acc=8842,,,8842.0,PROM1,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PROM1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1430,1760850,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,8842,PROM1,https://ctdbase.org/detail.go?type=gene&acc=8842,,,8842.0,PROM1,10090.0,Mus musculus (house mouse),Cyclosporine results in decreased expression of PROM1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1431,1760997,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,6372,CXCL6,https://ctdbase.org/detail.go?type=gene&acc=6372,,,6372.0,CXCL6,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of CXCL6 mRNA,,,PMID:22147139|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/22147139|https://www.ncbi.nlm.nih.gov/pubmed/27989131,22147139|27989131,,
1432,1760998,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Cyclosporine inhibits the reaction [histamine results in increased expression of CXCL8 mrna],,,PMID:9609743,https://www.ncbi.nlm.nih.gov/pubmed/9609743,9609743,,
1433,1761408,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,222171,PRR15,https://ctdbase.org/detail.go?type=gene&acc=222171,,,222171.0,PRR15,10090.0,Mus musculus (house mouse),Cyclosporine results in increased expression of PRR15 protein,,,PMID:25047351,https://www.ncbi.nlm.nih.gov/pubmed/25047351,25047351,,
1434,1761409,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,51334,PRR16,https://ctdbase.org/detail.go?type=gene&acc=51334,,,51334.0,PRR16,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PRR16 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1435,1761410,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,150381,PRR34-AS1,https://ctdbase.org/detail.go?type=gene&acc=150381,,,150381.0,PRR34-AS1,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PRR34-AS1 mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
1436,1761411,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,146325,PRR35,https://ctdbase.org/detail.go?type=gene&acc=146325,,,146325.0,PRR35,9606.0,Homo sapiens (human),Cyclosporine results in decreased methylation of PRR35 promoter,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
1437,1761412,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,11272,PRR4,https://ctdbase.org/detail.go?type=gene&acc=11272,,,11272.0,PRR4,9606.0,Homo sapiens (human),Cyclosporine results in increased methylation of PRR4 promoter,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
1438,1761643,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,51450,PRRX2,https://ctdbase.org/detail.go?type=gene&acc=51450,,,51450.0,PRRX2,9606.0,Homo sapiens (human),Cyclosporine results in decreased methylation of PRRX2 promoter,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
1439,1761644,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,8492,PRSS12,https://ctdbase.org/detail.go?type=gene&acc=8492,,,8492.0,PRSS12,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PRSS12 mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
1440,1761645,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,10279,PRSS16,https://ctdbase.org/detail.go?type=gene&acc=10279,,,10279.0,PRSS16,7955.0,Danio rerio (zebrafish),Cyclosporine affects the expression of PRSS16 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
1441,1761646,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,11098,PRSS23,https://ctdbase.org/detail.go?type=gene&acc=11098,,,11098.0,PRSS23,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PRSS23 mRNA,,,PMID:20106945|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/27989131,20106945|27989131,,
1442,1761647,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5646,PRSS3,https://ctdbase.org/detail.go?type=gene&acc=5646,,,5646.0,PRSS3,9606.0,Homo sapiens (human),Cyclosporine results in decreased methylation of PRSS3 promoter|cyclosporine results in decreased expression of PRSS3 mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
1443,1761648,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,154754,PRSS3P2,https://ctdbase.org/detail.go?type=gene&acc=154754,,,154754.0,PRSS3P2,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PRSS3P2 mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
1444,1761829,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5652,PRSS8,https://ctdbase.org/detail.go?type=gene&acc=5652,,,5652.0,PRSS8,9606.0,Homo sapiens (human),Cyclosporine affects the expression of PRSS8 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
1445,1761916,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10116.0,Rattus norvegicus (Norway rat),Cyclosporine results in decreased expression of CYP1A1 mRNA,,,PMID:19224547,https://www.ncbi.nlm.nih.gov/pubmed/19224547,19224547,,
1446,1761917,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),[glycochenodeoxycholic acid co-treated with deoxycholic acid co-treated with chenodeoxycholic acid co-treated with glycodeoxycholic acid co-treated with glycocholic acid co-treated with cyclosporine] results in decreased expression of CYP1A2 mRNA,,,PMID:33819548,https://www.ncbi.nlm.nih.gov/pubmed/33819548,33819548,,
1447,1761918,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,10116.0,Rattus norvegicus (Norway rat),Cyclosporine results in decreased expression of CYP1A2 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
1448,1761919,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,7955.0,Danio rerio (zebrafish),Cyclosporine affects the expression of CYP1B1 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
1449,1761920,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of CYP1B1 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
1450,1761921,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of CYP1B1 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1451,1761922,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,57404,CYP20A1,https://ctdbase.org/detail.go?type=gene&acc=57404,,,57404.0,CYP20A1,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of CYP20A1 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
1452,1761923,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1589,CYP21A2,https://ctdbase.org/detail.go?type=gene&acc=1589,,,1589.0,CYP21A2,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of CYP21A2 mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
1453,1762003,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,29968,PSAT1,https://ctdbase.org/detail.go?type=gene&acc=29968,,,29968.0,PSAT1,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PSAT1 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
1454,1762004,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,29968,PSAT1,https://ctdbase.org/detail.go?type=gene&acc=29968,,,29968.0,PSAT1,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PSAT1 mRNA,,,PMID:20106945|PMID:21632981|PMID:22147139|PMID:25596134|PMID:27989131|PMID:33631201,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/22147139|https://www.ncbi.nlm.nih.gov/pubmed/25596134|https://www.ncbi.nlm.nih.gov/pubmed/27989131|https://www.ncbi.nlm.nih.gov/pubmed/33631201,20106945|21632981|22147139|25596134|27989131|33631201,,
1455,1762005,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,137133,PSAT1P1,https://ctdbase.org/detail.go?type=gene&acc=137133,,,137133.0,PSAT1P1,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PSAT1P1 mRNA,,,PMID:22147139,https://www.ncbi.nlm.nih.gov/pubmed/22147139,22147139,,
1456,1762006,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,8000,PSCA,https://ctdbase.org/detail.go?type=gene&acc=8000,,,8000.0,PSCA,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PSCA mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1457,1762007,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,23362,PSD3,https://ctdbase.org/detail.go?type=gene&acc=23362,,,23362.0,PSD3,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PSD3 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
1458,1762008,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,23550,PSD4,https://ctdbase.org/detail.go?type=gene&acc=23550,,,23550.0,PSD4,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PSD4 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1459,1762415,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5694,PSMB6,https://ctdbase.org/detail.go?type=gene&acc=5694,,,5694.0,PSMB6,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PSMB6 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1460,1762416,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5695,PSMB7,https://ctdbase.org/detail.go?type=gene&acc=5695,,,5695.0,PSMB7,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PSMB7 mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
1461,1762417,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5695,PSMB7,https://ctdbase.org/detail.go?type=gene&acc=5695,,,5695.0,PSMB7,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PSMB7 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1462,1762418,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5695,PSMB7,https://ctdbase.org/detail.go?type=gene&acc=5695,,,5695.0,PSMB7,10090.0,Mus musculus (house mouse),Cyclosporine results in increased expression of PSMB7 mRNA,,,PMID:25047351,https://www.ncbi.nlm.nih.gov/pubmed/25047351,25047351,,
1463,1762419,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5695,PSMB7,https://ctdbase.org/detail.go?type=gene&acc=5695,,,5695.0,PSMB7,10090.0,Mus musculus (house mouse),Cyclosporine results in increased expression of PSMB7 protein,,,PMID:23308384|PMID:25047351,https://www.ncbi.nlm.nih.gov/pubmed/23308384|https://www.ncbi.nlm.nih.gov/pubmed/25047351,23308384|25047351,,
1464,1766061,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of DDIT3 mRNA,,,PMID:19159671|PMID:20106945|PMID:21632981|PMID:22147139|PMID:24973091|PMID:25562108|PMID:25596134|PMID:27989131|PMID:30008028|PMID:32152650|PMID:33631201|PMID:34681664|PMID:35033536,https://www.ncbi.nlm.nih.gov/pubmed/19159671|https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/22147139|https://www.ncbi.nlm.nih.gov/pubmed/24973091|https://www.ncbi.nlm.nih.gov/pubmed/25562108|https://www.ncbi.nlm.nih.gov/pubmed/25596134|https://www.ncbi.nlm.nih.gov/pubmed/27989131|https://www.ncbi.nlm.nih.gov/pubmed/30008028|https://www.ncbi.nlm.nih.gov/pubmed/32152650|https://www.ncbi.nlm.nih.gov/pubmed/33631201|https://www.ncbi.nlm.nih.gov/pubmed/34681664|https://www.ncbi.nlm.nih.gov/pubmed/35033536,19159671|20106945|21632981|22147139|24973091|25562108|25596134|27989131|30008028|32152650|33631201|34681664|35033536,,
1465,1766062,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,10036.0,Mesocricetus auratus (golden hamster),Cyclosporine results in increased expression of DDIT3 protein,,,PMID:15494209,https://www.ncbi.nlm.nih.gov/pubmed/15494209,15494209,,
1466,1766063,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,10090.0,Mus musculus (house mouse),Cyclosporine results in increased expression of DDIT3 mRNA,,,PMID:19770486|PMID:23958496|PMID:25224403|PMID:27585667,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/23958496|https://www.ncbi.nlm.nih.gov/pubmed/25224403|https://www.ncbi.nlm.nih.gov/pubmed/27585667,19770486|23958496|25224403|27585667,,
1467,1766064,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,10090.0,Mus musculus (house mouse),Salubrinal promotes the reaction [cyclosporine results in increased expression of DDIT3 protein]|cyclosporine results in increased phosphorylation of DDIT3 protein,,,PMID:23958496,https://www.ncbi.nlm.nih.gov/pubmed/23958496,23958496,,
1468,1766281,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,54541,DDIT4,https://ctdbase.org/detail.go?type=gene&acc=54541,,,54541.0,DDIT4,10116.0,Rattus norvegicus (Norway rat),Cyclosporine results in increased expression of DDIT4 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
1469,1766282,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,115265,DDIT4L,https://ctdbase.org/detail.go?type=gene&acc=115265,,,115265.0,DDIT4L,10116.0,Rattus norvegicus (Norway rat),Cyclosporine results in decreased expression of DDIT4L mRNA,,,PMID:21865292,https://www.ncbi.nlm.nih.gov/pubmed/21865292,21865292,,
1470,1766283,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1650,DDOST,https://ctdbase.org/detail.go?type=gene&acc=1650,,,1650.0,DDOST,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of DDOST mRNA,,,PMID:20106945|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/27989131,20106945|27989131,,
1471,1766284,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1650,DDOST,https://ctdbase.org/detail.go?type=gene&acc=1650,,,1650.0,DDOST,10090.0,Mus musculus (house mouse),Cyclosporine results in increased expression of DDOST mRNA,,,PMID:19770486|PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/25270620,19770486|25270620,,
1472,1766285,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,780,DDR1,https://ctdbase.org/detail.go?type=gene&acc=780,,,780.0,DDR1,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of DDR1 mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
1473,1768157,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,406433,DHDH.1,https://ctdbase.org/detail.go?type=gene&acc=406433,,,406433.0,dhdh.1,7955.0,Danio rerio (zebrafish),Cyclosporine affects the expression of DHDH.1 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
1474,1769020,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,27122,DKK3,https://ctdbase.org/detail.go?type=gene&acc=27122,,,27122.0,DKK3,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of DKK3 mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
1475,1769021,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,27121,DKK4,https://ctdbase.org/detail.go?type=gene&acc=27121,,,27121.0,DKK4,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of DKK4 mRNA,,,PMID:21632981|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/25562108,21632981|25562108,,
1476,1769198,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,10395,DLC1,https://ctdbase.org/detail.go?type=gene&acc=10395,,,10395.0,DLC1,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of DLC1 mRNA,,,PMID:20106945|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/27989131,20106945|27989131,,
1477,1769199,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,10395,DLC1,https://ctdbase.org/detail.go?type=gene&acc=10395,,,10395.0,DLC1,10090.0,Mus musculus (house mouse),Cyclosporine results in decreased expression of DLC1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1478,1769200,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1738,DLD,https://ctdbase.org/detail.go?type=gene&acc=1738,,,1738.0,DLD,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of DLD mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1479,1769201,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,10301,DLEU1,https://ctdbase.org/detail.go?type=gene&acc=10301,,,10301.0,DLEU1,9606.0,Homo sapiens (human),Cyclosporine affects the expression of DLEU1 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1480,1769202,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,10301,DLEU1,https://ctdbase.org/detail.go?type=gene&acc=10301,,,10301.0,DLEU1,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of DLEU1 mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
1481,1769384,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,27109,DMAC2L,https://ctdbase.org/detail.go?type=gene&acc=27109,,,27109.0,DMAC2L,7955.0,Danio rerio (zebrafish),Cyclosporine affects the expression of DMAC2L mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
1482,1814111,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,64577,ALDH8A1,https://ctdbase.org/detail.go?type=gene&acc=64577,,,64577.0,ALDH8A1,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of ALDH8A1 mRNA,,,PMID:20106945|PMID:21632981|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/27989131,20106945|21632981|27989131,,
1483,1763179,5284474,Comparative Toxicogenomics Database (CTD),"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",C019132,"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",https://ctdbase.org/detail.go?type=chem&acc=C019132,6581,SLC22A3,https://ctdbase.org/detail.go?type=gene&acc=6581,,,6581.0,SLC22A3,9606.0,Homo sapiens (human),"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole inhibits the reaction [SLC22A3 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide]|3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole results in decreased activity of SLC22A3 protein",,,PMID:30189235,https://www.ncbi.nlm.nih.gov/pubmed/30189235,30189235,,
1484,1763180,5284474,Comparative Toxicogenomics Database (CTD),"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",C019132,"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",https://ctdbase.org/detail.go?type=chem&acc=C019132,55244,SLC47A1,https://ctdbase.org/detail.go?type=gene&acc=55244,,,55244.0,SLC47A1,9606.0,Homo sapiens (human),"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole results in decreased activity of SLC47A1 protein",,,PMID:30189235,https://www.ncbi.nlm.nih.gov/pubmed/30189235,30189235,,
1485,1763181,5284474,Comparative Toxicogenomics Database (CTD),"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",C019132,"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",https://ctdbase.org/detail.go?type=chem&acc=C019132,146802,SLC47A2,https://ctdbase.org/detail.go?type=gene&acc=146802,,,146802.0,SLC47A2,9606.0,Homo sapiens (human),"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole results in decreased activity of SLC47A2 protein",,,PMID:30189235,https://www.ncbi.nlm.nih.gov/pubmed/30189235,30189235,,
1486,1763182,5284474,Comparative Toxicogenomics Database (CTD),"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",C019132,"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",https://ctdbase.org/detail.go?type=chem&acc=C019132,10599,SLCO1B1,https://ctdbase.org/detail.go?type=gene&acc=10599,,,10599.0,SLCO1B1,9606.0,Homo sapiens (human),"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole results in decreased activity of SLCO1B1 protein",,,PMID:30189235,https://www.ncbi.nlm.nih.gov/pubmed/30189235,30189235,,
1487,1763183,5284474,Comparative Toxicogenomics Database (CTD),"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",C019132,"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",https://ctdbase.org/detail.go?type=chem&acc=C019132,7054,TH,https://ctdbase.org/detail.go?type=gene&acc=7054,,,7054.0,TH,10116.0,Rattus norvegicus (Norway rat),"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole results in decreased activity of TH protein",,,PMID:2904812|PMID:7931246,https://www.ncbi.nlm.nih.gov/pubmed/2904812|https://www.ncbi.nlm.nih.gov/pubmed/7931246,2904812|7931246,,
1488,1763184,5284474,Comparative Toxicogenomics Database (CTD),"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",C019132,"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",https://ctdbase.org/detail.go?type=chem&acc=C019132,7054,TH,https://ctdbase.org/detail.go?type=gene&acc=7054,,,7054.0,TH,10116.0,Rattus norvegicus (Norway rat),"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole results in decreased expression of TH mrna|3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole results in increased expression of TH mRNA",,,PMID:8103199,https://www.ncbi.nlm.nih.gov/pubmed/8103199,8103199,,
1489,1763185,5284474,Comparative Toxicogenomics Database (CTD),"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",C019132,"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",https://ctdbase.org/detail.go?type=chem&acc=C019132,7150,TOP1,https://ctdbase.org/detail.go?type=gene&acc=7150,,,7150.0,TOP1,9606.0,Homo sapiens (human),"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole results in decreased activity of TOP1 protein",,,PMID:8600349,https://www.ncbi.nlm.nih.gov/pubmed/8600349,8600349,,
1490,1763186,5284474,Comparative Toxicogenomics Database (CTD),"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",C019132,"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",https://ctdbase.org/detail.go?type=chem&acc=C019132,35225,TOP2,https://ctdbase.org/detail.go?type=gene&acc=35225,,,35225.0,Top2,7227.0,Drosophila melanogaster (fruit fly),"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole results in decreased activity of TOP2 protein",,,PMID:8600349,https://www.ncbi.nlm.nih.gov/pubmed/8600349,8600349,,
1491,1763187,5284474,Comparative Toxicogenomics Database (CTD),"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",C019132,"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",https://ctdbase.org/detail.go?type=chem&acc=C019132,7166,TPH1,https://ctdbase.org/detail.go?type=gene&acc=7166,,,7166.0,TPH1,10090.0,Mus musculus (house mouse),"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole results in decreased activity of TPH1 protein",,,PMID:1989631,https://www.ncbi.nlm.nih.gov/pubmed/1989631,1989631,,
1492,1764276,5284583,Comparative Toxicogenomics Database (CTD),Levetiracetam,D000077287,Levetiracetam,https://ctdbase.org/detail.go?type=chem&acc=D000077287,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10116.0,Rattus norvegicus (Norway rat),Levetiracetam results in decreased activity of GPX1 protein,,,PMID:37572749,https://www.ncbi.nlm.nih.gov/pubmed/37572749,37572749,,
1493,1764277,5284583,Comparative Toxicogenomics Database (CTD),Levetiracetam,D000077287,Levetiracetam,https://ctdbase.org/detail.go?type=chem&acc=D000077287,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [levetiracetam results in decreased expression of GPX1 protein]|levetiracetam results in decreased expression of GPX1 protein,,,PMID:37098359,https://www.ncbi.nlm.nih.gov/pubmed/37098359,37098359,,
1494,1764278,5284583,Comparative Toxicogenomics Database (CTD),Levetiracetam,D000077287,Levetiracetam,https://ctdbase.org/detail.go?type=chem&acc=D000077287,610,HCN2,https://ctdbase.org/detail.go?type=gene&acc=610,,,610.0,HCN2,10116.0,Rattus norvegicus (Norway rat),Levetiracetam results in decreased expression of HCN2 mRNA,,,PMID:20345932,https://www.ncbi.nlm.nih.gov/pubmed/20345932,20345932,,
1495,1764279,5284583,Comparative Toxicogenomics Database (CTD),Levetiracetam,D000077287,Levetiracetam,https://ctdbase.org/detail.go?type=chem&acc=D000077287,83933,HDAC10,https://ctdbase.org/detail.go?type=gene&acc=83933,,,83933.0,HDAC10,10116.0,Rattus norvegicus (Norway rat),Levetiracetam results in decreased expression of HDAC10 mRNA,,,PMID:20345932,https://www.ncbi.nlm.nih.gov/pubmed/20345932,20345932,,
1496,1764280,5284583,Comparative Toxicogenomics Database (CTD),Levetiracetam,D000077287,Levetiracetam,https://ctdbase.org/detail.go?type=chem&acc=D000077287,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116.0,Rattus norvegicus (Norway rat),Levetiracetam results in decreased expression of HMOX1 protein,,,PMID:37098359,https://www.ncbi.nlm.nih.gov/pubmed/37098359,37098359,,
1497,1764281,5284583,Comparative Toxicogenomics Database (CTD),Levetiracetam,D000077287,Levetiracetam,https://ctdbase.org/detail.go?type=chem&acc=D000077287,3163,HMOX2,https://ctdbase.org/detail.go?type=gene&acc=3163,,,3163.0,HMOX2,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [levetiracetam results in decreased expression of HMOX2 protein],,,PMID:37098359,https://www.ncbi.nlm.nih.gov/pubmed/37098359,37098359,,
1498,1764282,5284583,Comparative Toxicogenomics Database (CTD),Levetiracetam,D000077287,Levetiracetam,https://ctdbase.org/detail.go?type=chem&acc=D000077287,3284,HSD3B2,https://ctdbase.org/detail.go?type=gene&acc=3284,,,3284.0,HSD3B2,9606.0,Homo sapiens (human),Levetiracetam results in decreased expression of HSD3B2 mRNA,,,PMID:19566492,https://www.ncbi.nlm.nih.gov/pubmed/19566492,19566492,,
1499,1764283,5284583,Comparative Toxicogenomics Database (CTD),Levetiracetam,D000077287,Levetiracetam,https://ctdbase.org/detail.go?type=chem&acc=D000077287,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [levetiracetam results in increased activity of IL1B protein]|levetiracetam results in increased activity of IL1B protein,,,PMID:37098359,https://www.ncbi.nlm.nih.gov/pubmed/37098359,37098359,,
1500,1764284,5284583,Comparative Toxicogenomics Database (CTD),Levetiracetam,D000077287,Levetiracetam,https://ctdbase.org/detail.go?type=chem&acc=D000077287,3739,KCNA4,https://ctdbase.org/detail.go?type=gene&acc=3739,,,3739.0,KCNA4,10116.0,Rattus norvegicus (Norway rat),Levetiracetam results in increased expression of KCNA4 mRNA,,,PMID:20345932,https://www.ncbi.nlm.nih.gov/pubmed/20345932,20345932,,
1501,1765317,5284627,Drug Gene Interaction database (DGIdb),Topiramate,,TOPIRAMATE,https://www.dgidb.org/drugs/rxcui:38404,,SCN1A,https://www.dgidb.org/genes/hgnc:10585,,,6323.0,SCN1A,9606.0,Homo sapiens (human),,,,,,,,
1502,1765318,5284627,Drug Gene Interaction database (DGIdb),Topiramate,,TOPIRAMATE,https://www.dgidb.org/drugs/rxcui:38404,,GABRB1,https://www.dgidb.org/genes/hgnc:4081,,,2560.0,GABRB1,9606.0,Homo sapiens (human),Positive modulator,,,,,,,
1503,1765319,5284627,Drug Gene Interaction database (DGIdb),Topiramate,,TOPIRAMATE,https://www.dgidb.org/drugs/rxcui:38404,,GABRD,https://www.dgidb.org/genes/hgnc:4084,,,2563.0,GABRD,9606.0,Homo sapiens (human),Positive modulator,,,,,,,
1504,1765320,5284627,Drug Gene Interaction database (DGIdb),Topiramate,,TOPIRAMATE,https://www.dgidb.org/drugs/rxcui:38404,,GABRA3,https://www.dgidb.org/genes/hgnc:4077,,,2556.0,GABRA3,9606.0,Homo sapiens (human),Positive modulator,,,,,,,
1505,1765321,5284627,Drug Gene Interaction database (DGIdb),Topiramate,,TOPIRAMATE,https://www.dgidb.org/drugs/rxcui:38404,,SCN10A,https://www.dgidb.org/genes/hgnc:10582,,,6336.0,SCN10A,9606.0,Homo sapiens (human),Blocker,,,,,,,
1506,1765322,5284627,Drug Gene Interaction database (DGIdb),Topiramate,,TOPIRAMATE,https://www.dgidb.org/drugs/rxcui:38404,,SCN2A,https://www.dgidb.org/genes/hgnc:10588,,,6326.0,SCN2A,9606.0,Homo sapiens (human),Blocker,,,,,,,
1507,1765323,5284627,Drug Gene Interaction database (DGIdb),Topiramate,,TOPIRAMATE,https://www.dgidb.org/drugs/rxcui:38404,,AQP4,https://www.dgidb.org/genes/hgnc:637,,,361.0,AQP4,9606.0,Homo sapiens (human),,,,,,,,
1508,1765324,5284627,BindingDB,Topiramate,10887,Sulfamate 7,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10887,1194,CARBONIC ANHYDRASE,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1194,,,,,,,,Ki (nM),172,PMID:16539401|DOI:10.1021/jm0512600,https://www.ncbi.nlm.nih.gov/pubmed/16539401|https://doi.org/10.1021/jm0512600,16539401,10.1021/jm0512600,
1509,1760228,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,4291,MLF1,https://ctdbase.org/detail.go?type=gene&acc=4291,,,4291.0,MLF1,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of MLF1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1510,1760229,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,4300,MLLT3,https://ctdbase.org/detail.go?type=gene&acc=4300,,,4300.0,MLLT3,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of MLLT3 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1511,1760230,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,4302,MLLT6,https://ctdbase.org/detail.go?type=gene&acc=4302,,,4302.0,MLLT6,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of MLLT6 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1512,1760231,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,79083,MLPH,https://ctdbase.org/detail.go?type=gene&acc=79083,,,79083.0,MLPH,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of MLPH mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1513,1760401,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,133,ADM,https://ctdbase.org/detail.go?type=gene&acc=133,,,133.0,ADM,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of ADM mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1514,1760402,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,134,ADORA1,https://ctdbase.org/detail.go?type=gene&acc=134,,,134.0,ADORA1,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of ADORA1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1515,1760403,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,136,ADORA2B,https://ctdbase.org/detail.go?type=gene&acc=136,,,136.0,ADORA2B,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of ADORA2B mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1516,1760404,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,83440,ADPGK,https://ctdbase.org/detail.go?type=gene&acc=83440,,,83440.0,ADPGK,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of ADPGK mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1517,1760405,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,155,ADRB3,https://ctdbase.org/detail.go?type=gene&acc=155,,,155.0,ADRB3,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of ADRB3 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1518,1760406,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,122622,ADSS1,https://ctdbase.org/detail.go?type=gene&acc=122622,,,122622.0,ADSS1,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of ADSS1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1519,1760691,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,9019,MPZL1,https://ctdbase.org/detail.go?type=gene&acc=9019,,,9019.0,MPZL1,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of MPZL1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1520,1760692,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,10205,MPZL2,https://ctdbase.org/detail.go?type=gene&acc=10205,,,10205.0,MPZL2,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of MPZL2 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1521,1760693,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,4360,MRC1,https://ctdbase.org/detail.go?type=gene&acc=4360,,,4360.0,MRC1,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of MRC1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1522,1760694,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,116535,MRGPRF,https://ctdbase.org/detail.go?type=gene&acc=116535,,,116535.0,MRGPRF,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of MRGPRF mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1523,1760695,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,339766,MROH2A,https://ctdbase.org/detail.go?type=gene&acc=339766,,,339766.0,MROH2A,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of MROH2A mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1524,1760696,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,29088,MRPL15,https://ctdbase.org/detail.go?type=gene&acc=29088,,,29088.0,MRPL15,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of MRPL15 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1525,1760697,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,51318,MRPL35,https://ctdbase.org/detail.go?type=gene&acc=51318,,,51318.0,MRPL35,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of MRPL35 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1526,1760841,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,9242,MSC,https://ctdbase.org/detail.go?type=gene&acc=9242,,,9242.0,MSC,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of MSC mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1527,1760842,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,124540,MSI2,https://ctdbase.org/detail.go?type=gene&acc=124540,,,124540.0,MSI2,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of MSI2 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1528,1760843,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,10232,MSLN,https://ctdbase.org/detail.go?type=gene&acc=10232,,,10232.0,MSLN,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of MSLN mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1529,1760844,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,6307,MSMO1,https://ctdbase.org/detail.go?type=gene&acc=6307,,,6307.0,MSMO1,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of MSMO1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1530,1760845,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,4481,MSR1,https://ctdbase.org/detail.go?type=gene&acc=4481,,,4481.0,MSR1,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of MSR1 mrna|fenretinide results in increased expression of MSR1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1531,1761106,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,25902,MTHFD1L,https://ctdbase.org/detail.go?type=gene&acc=25902,,,25902.0,MTHFD1L,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of MTHFD1L mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1532,1761107,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,10797,MTHFD2,https://ctdbase.org/detail.go?type=gene&acc=10797,,,10797.0,MTHFD2,9606.0,Homo sapiens (human),Fenretinide affects the expression of MTHFD2 mRNA,,,PMID:16570282,https://www.ncbi.nlm.nih.gov/pubmed/16570282,16570282,,
1533,1761108,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,10797,MTHFD2,https://ctdbase.org/detail.go?type=gene&acc=10797,,,10797.0,MTHFD2,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of MTHFD2 mrna|fenretinide results in increased expression of MTHFD2 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1534,1761109,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,4534,MTM1,https://ctdbase.org/detail.go?type=gene&acc=4534,,,4534.0,MTM1,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of MTM1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1535,1761110,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,10903,MTMR11,https://ctdbase.org/detail.go?type=gene&acc=10903,,,10903.0,MTMR11,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of MTMR11 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1536,1761111,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,54545,MTMR12,https://ctdbase.org/detail.go?type=gene&acc=54545,,,54545.0,MTMR12,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of MTMR12 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1537,1761112,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,9788,MTSS1,https://ctdbase.org/detail.go?type=gene&acc=9788,,,9788.0,MTSS1,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of MTSS1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1538,1761113,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,4547,MTTP,https://ctdbase.org/detail.go?type=gene&acc=4547,,,4547.0,MTTP,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of MTTP mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1539,1761114,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,222166,MTURN,https://ctdbase.org/detail.go?type=gene&acc=222166,,,222166.0,MTURN,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of MTURN mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1540,1761115,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,94025,MUC16,https://ctdbase.org/detail.go?type=gene&acc=94025,,,94025.0,MUC16,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of MUC16 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1541,1761116,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,727897,MUC5B,https://ctdbase.org/detail.go?type=gene&acc=727897,,,727897.0,MUC5B,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of MUC5B mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1542,1761235,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,10000,AKT3,https://ctdbase.org/detail.go?type=gene&acc=10000,,,10000.0,AKT3,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of AKT3 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1543,1761236,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,64400,AKTIP,https://ctdbase.org/detail.go?type=gene&acc=64400,,,64400.0,AKTIP,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of AKTIP mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1544,1761237,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,210,ALAD,https://ctdbase.org/detail.go?type=gene&acc=210,,,210.0,ALAD,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of ALAD mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1545,1761238,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,212,ALAS2,https://ctdbase.org/detail.go?type=gene&acc=212,,,212.0,ALAS2,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of ALAS2 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1546,1761239,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of ALB protein,,,PMID:6226123,https://www.ncbi.nlm.nih.gov/pubmed/6226123,6226123,,
1547,1761240,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,214,ALCAM,https://ctdbase.org/detail.go?type=gene&acc=214,,,214.0,ALCAM,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of ALCAM mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1548,1761241,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,5832,ALDH18A1,https://ctdbase.org/detail.go?type=gene&acc=5832,,,5832.0,ALDH18A1,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of ALDH18A1 mrna|fenretinide results in increased expression of ALDH18A1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1549,1761242,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,26358,ALDH1A7,https://ctdbase.org/detail.go?type=gene&acc=26358,,,26358.0,Aldh1a7,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of ALDH1A7 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1550,1761243,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,10840,ALDH1L1,https://ctdbase.org/detail.go?type=gene&acc=10840,,,10840.0,ALDH1L1,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of ALDH1L1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1551,1761244,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,221,ALDH3B1,https://ctdbase.org/detail.go?type=gene&acc=221,,,221.0,ALDH3B1,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of ALDH3B1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1552,1761245,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,8659,ALDH4A1,https://ctdbase.org/detail.go?type=gene&acc=8659,,,8659.0,ALDH4A1,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of ALDH4A1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1553,1761413,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,7915,ALDH5A1,https://ctdbase.org/detail.go?type=gene&acc=7915,,,7915.0,ALDH5A1,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of ALDH5A1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1554,1761414,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,64577,ALDH8A1,https://ctdbase.org/detail.go?type=gene&acc=64577,,,64577.0,ALDH8A1,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of ALDH8A1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1555,1761415,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,229,ALDOB,https://ctdbase.org/detail.go?type=gene&acc=229,,,229.0,ALDOB,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of ALDOB mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1556,1761416,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,230,ALDOC,https://ctdbase.org/detail.go?type=gene&acc=230,,,230.0,ALDOC,9606.0,Homo sapiens (human),Fenretinide results in increased expression of ALDOC mRNA,,,PMID:16671099,https://www.ncbi.nlm.nih.gov/pubmed/16671099,16671099,,
1557,1761417,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,230,ALDOC,https://ctdbase.org/detail.go?type=gene&acc=230,,,230.0,ALDOC,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of ALDOC mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1558,1761799,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,80018,NAA25,https://ctdbase.org/detail.go?type=gene&acc=80018,,,80018.0,NAA25,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of NAA25 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1559,1761800,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,27163,NAAA,https://ctdbase.org/detail.go?type=gene&acc=27163,,,27163.0,NAAA,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of NAAA mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1560,1761801,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,64859,NABP1,https://ctdbase.org/detail.go?type=gene&acc=64859,,,64859.0,NABP1,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of NABP1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1561,1762482,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,341,APOC1,https://ctdbase.org/detail.go?type=gene&acc=341,,,341.0,APOC1,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of APOC1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1562,1762483,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,345,APOC3,https://ctdbase.org/detail.go?type=gene&acc=345,,,345.0,APOC3,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of APOC3 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1563,1762484,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,346,APOC4,https://ctdbase.org/detail.go?type=gene&acc=346,,,346.0,APOC4,9606.0,Homo sapiens (human),Fenretinide results in decreased expression of APOC4 mRNA,,,PMID:16671099,https://www.ncbi.nlm.nih.gov/pubmed/16671099,16671099,,
1564,1762485,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,347,APOD,https://ctdbase.org/detail.go?type=gene&acc=347,,,347.0,APOD,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of APOD mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1565,1762548,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,4702,NDUFA8,https://ctdbase.org/detail.go?type=gene&acc=4702,,,4702.0,NDUFA8,9606.0,Homo sapiens (human),Fenretinide affects the expression of NDUFA8 mRNA,,,PMID:16570282,https://www.ncbi.nlm.nih.gov/pubmed/16570282,16570282,,
1566,1762549,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,4704,NDUFA9,https://ctdbase.org/detail.go?type=gene&acc=4704,,,4704.0,NDUFA9,9606.0,Homo sapiens (human),Fenretinide affects the expression of NDUFA9 mRNA,,,PMID:16570282,https://www.ncbi.nlm.nih.gov/pubmed/16570282,16570282,,
1567,1762550,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,4706,NDUFAB1,https://ctdbase.org/detail.go?type=gene&acc=4706,,,4706.0,NDUFAB1,9606.0,Homo sapiens (human),Fenretinide affects the expression of NDUFAB1 mRNA,,,PMID:16570282,https://www.ncbi.nlm.nih.gov/pubmed/16570282,16570282,,
1568,1762551,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,4706,NDUFAB1,https://ctdbase.org/detail.go?type=gene&acc=4706,,,4706.0,NDUFAB1,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of NDUFAB1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1569,1762552,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,4708,NDUFB2,https://ctdbase.org/detail.go?type=gene&acc=4708,,,4708.0,NDUFB2,9606.0,Homo sapiens (human),Fenretinide affects the expression of NDUFB2 mRNA,,,PMID:16570282,https://www.ncbi.nlm.nih.gov/pubmed/16570282,16570282,,
1570,1762553,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,4709,NDUFB3,https://ctdbase.org/detail.go?type=gene&acc=4709,,,4709.0,NDUFB3,9606.0,Homo sapiens (human),Fenretinide affects the expression of NDUFB3 mRNA,,,PMID:16570282,https://www.ncbi.nlm.nih.gov/pubmed/16570282,16570282,,
1571,1764581,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,10678,B3GNT2,https://ctdbase.org/detail.go?type=gene&acc=10678,,,10678.0,B3GNT2,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of B3GNT2 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1572,1764582,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,93010,B3GNT7,https://ctdbase.org/detail.go?type=gene&acc=93010,,,93010.0,B3GNT7,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of B3GNT7 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1573,1764583,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,374907,B3GNT8,https://ctdbase.org/detail.go?type=gene&acc=374907,,,374907.0,B3GNT8,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of B3GNT8 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1574,1764584,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,84752,B3GNT9,https://ctdbase.org/detail.go?type=gene&acc=84752,,,84752.0,B3GNT9,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of B3GNT9 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1575,1764585,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,2583,B4GALNT1,https://ctdbase.org/detail.go?type=gene&acc=2583,,,2583.0,B4GALNT1,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of B4GALNT1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1576,1764586,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,124872,B4GALNT2,https://ctdbase.org/detail.go?type=gene&acc=124872,,,124872.0,B4GALNT2,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of B4GALNT2 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1577,1764587,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,283358,B4GALNT3,https://ctdbase.org/detail.go?type=gene&acc=283358,,,283358.0,B4GALNT3,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of B4GALNT3 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1578,1764588,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,8704,B4GALT2,https://ctdbase.org/detail.go?type=gene&acc=8704,,,8704.0,B4GALT2,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of B4GALT2 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1579,1764589,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,8703,B4GALT3,https://ctdbase.org/detail.go?type=gene&acc=8703,,,8703.0,B4GALT3,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of B4GALT3 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1580,1765031,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,10439,OLFM1,https://ctdbase.org/detail.go?type=gene&acc=10439,,,10439.0,OLFM1,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of OLFM1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1581,1765032,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,283298,OLFML1,https://ctdbase.org/detail.go?type=gene&acc=283298,,,283298.0,OLFML1,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of OLFML1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1582,1765033,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,56944,OLFML3,https://ctdbase.org/detail.go?type=gene&acc=56944,,,56944.0,OLFML3,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of OLFML3 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1583,1765034,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,4983,OPHN1,https://ctdbase.org/detail.go?type=gene&acc=4983,,,4983.0,OPHN1,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of OPHN1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1584,1765035,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,26873,OPLAH,https://ctdbase.org/detail.go?type=gene&acc=26873,,,26873.0,OPLAH,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of OPLAH mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1585,1765036,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,23596,OPN3,https://ctdbase.org/detail.go?type=gene&acc=23596,,,23596.0,OPN3,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of OPN3 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1586,1765037,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,4988,OPRM1,https://ctdbase.org/detail.go?type=gene&acc=4988,,,4988.0,OPRM1,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of OPRM1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1587,1765038,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,81285,OR51E2,https://ctdbase.org/detail.go?type=gene&acc=81285,,,81285.0,OR51E2,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of OR51E2 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1588,1765039,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,258566,OR5G25,https://ctdbase.org/detail.go?type=gene&acc=258566,,,258566.0,Or5g25,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of OR5G25 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1589,1765040,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,4999,ORC2,https://ctdbase.org/detail.go?type=gene&acc=4999,,,4999.0,ORC2,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of ORC2 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1590,1765041,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,5004,ORM1,https://ctdbase.org/detail.go?type=gene&acc=5004,,,5004.0,ORM1,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of ORM1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1591,1765200,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,585,BBS4,https://ctdbase.org/detail.go?type=gene&acc=585,,,585.0,BBS4,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of BBS4 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1592,1765201,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,10134,BCAP31,https://ctdbase.org/detail.go?type=gene&acc=10134,,,10134.0,BCAP31,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of BCAP31 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1593,1765202,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,54828,BCAS3,https://ctdbase.org/detail.go?type=gene&acc=54828,,,54828.0,BCAS3,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of BCAS3 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1594,1765203,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,586,BCAT1,https://ctdbase.org/detail.go?type=gene&acc=586,,,586.0,BCAT1,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of BCAT1 mrna|fenretinide results in increased expression of BCAT1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1595,1765204,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,587,BCAT2,https://ctdbase.org/detail.go?type=gene&acc=587,,,587.0,BCAT2,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of BCAT2 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1596,1765205,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,590,BCHE,https://ctdbase.org/detail.go?type=gene&acc=590,,,590.0,BCHE,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of BCHE mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1597,1765206,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,593,BCKDHA,https://ctdbase.org/detail.go?type=gene&acc=593,,,593.0,BCKDHA,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of BCKDHA mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1598,1765207,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,594,BCKDHB,https://ctdbase.org/detail.go?type=gene&acc=594,,,594.0,BCKDHB,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of BCKDHB mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1599,1765208,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Fenretinide results in decreased expression of BCL2 mrna|bcl2 protein affects the susceptibility to fenretinide,,,PMID:7811993,https://www.ncbi.nlm.nih.gov/pubmed/7811993,7811993,,
1600,1765209,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),[fenretinide co-treated with carmustine] results in decreased expression of BCL2 protein,,,PMID:16187019,https://www.ncbi.nlm.nih.gov/pubmed/16187019,16187019,,
1601,1765210,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Fenretinide inhibits the reaction [TNF protein results in increased expression of BCL2 protein],,,PMID:16230421,https://www.ncbi.nlm.nih.gov/pubmed/16230421,16230421,,
1602,1765815,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,152559,PAQR3,https://ctdbase.org/detail.go?type=gene&acc=152559,,,152559.0,PAQR3,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of PAQR3 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1603,1765816,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,124222,PAQR4,https://ctdbase.org/detail.go?type=gene&acc=124222,,,124222.0,PAQR4,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of PAQR4 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1604,1765817,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,164091,PAQR7,https://ctdbase.org/detail.go?type=gene&acc=164091,,,164091.0,PAQR7,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of PAQR7 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1605,1765818,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,117583,PARD3B,https://ctdbase.org/detail.go?type=gene&acc=117583,,,117583.0,PARD3B,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of PARD3B mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1606,1765819,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,84612,PARD6B,https://ctdbase.org/detail.go?type=gene&acc=84612,,,84612.0,PARD6B,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of PARD6B mrna|fenretinide results in increased expression of PARD6B mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1607,1765820,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein]|bisindolylmaleimide I inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein]|pyrazolanthrone inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein]|butylated hydroxyanisole inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein]|ascorbic acid inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein]|mapk8 protein promotes the reaction [fenretinide results in increased cleavage of PARP1 protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein],,,PMID:16407847,https://www.ncbi.nlm.nih.gov/pubmed/16407847,16407847,,
1608,1765821,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),Acetylcysteine inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein]|deoxyglucose inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein]|u 0126 inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein]|s-ethyl glutathione inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein]|bi D1870 inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein],,,PMID:25246272,https://www.ncbi.nlm.nih.gov/pubmed/25246272,25246272,,
1609,1765822,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),Fenretinide affects the expression of PARP1 mRNA,,,PMID:16570282,https://www.ncbi.nlm.nih.gov/pubmed/16570282,16570282,,
1610,1765948,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,55589,BMP2K,https://ctdbase.org/detail.go?type=gene&acc=55589,,,55589.0,BMP2K,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of BMP2K mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1611,1765949,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,652,BMP4,https://ctdbase.org/detail.go?type=gene&acc=652,,,652.0,BMP4,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of BMP4 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1612,1766873,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,729,C6,https://ctdbase.org/detail.go?type=gene&acc=729,,,729.0,C6,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of C6 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1613,1766874,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,30865,C78513,https://ctdbase.org/detail.go?type=gene&acc=30865,,,30865.0,C78513,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of C78513 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1614,1766875,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,732,C8B,https://ctdbase.org/detail.go?type=gene&acc=732,,,732.0,C8B,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of C8B mrna|fenretinide results in increased expression of C8B mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1615,1766876,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,733,C8G,https://ctdbase.org/detail.go?type=gene&acc=733,,,733.0,C8G,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of C8G mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1616,1766877,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,401546,C9ORF152,https://ctdbase.org/detail.go?type=gene&acc=401546,,,401546.0,C9orf152,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of C9ORF152 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1617,1767372,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,58986,PGAP6,https://ctdbase.org/detail.go?type=gene&acc=58986,,,58986.0,PGAP6,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of PGAP6 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1618,1767373,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,5226,PGD,https://ctdbase.org/detail.go?type=gene&acc=5226,,,5226.0,PGD,9606.0,Homo sapiens (human),Fenretinide results in increased expression of PGD mRNA,,,PMID:16671099,https://www.ncbi.nlm.nih.gov/pubmed/16671099,16671099,,
1619,1767374,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,5228,PGF,https://ctdbase.org/detail.go?type=gene&acc=5228,,,5228.0,PGF,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of PGF mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1620,1767375,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,5236,PGM1,https://ctdbase.org/detail.go?type=gene&acc=5236,,,5236.0,PGM1,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of PGM1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1621,1767376,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,5239,PGM5,https://ctdbase.org/detail.go?type=gene&acc=5239,,,5239.0,PGM5,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of PGM5 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1622,1767377,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,54858,PGPEP1,https://ctdbase.org/detail.go?type=gene&acc=54858,,,54858.0,PGPEP1,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of PGPEP1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1623,1768614,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,6354,CCL7,https://ctdbase.org/detail.go?type=gene&acc=6354,,,6354.0,CCL7,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of CCL7 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1624,1768615,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,6355,CCL8,https://ctdbase.org/detail.go?type=gene&acc=6355,,,6355.0,CCL8,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of CCL8 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1625,1768616,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,3491,CCN1,https://ctdbase.org/detail.go?type=gene&acc=3491,,,3491.0,CCN1,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of CCN1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1626,1768617,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,1490,CCN2,https://ctdbase.org/detail.go?type=gene&acc=1490,,,1490.0,CCN2,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of CCN2 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1627,1768618,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,4856,CCN3,https://ctdbase.org/detail.go?type=gene&acc=4856,,,4856.0,CCN3,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of CCN3 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1628,1768619,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,8839,CCN5,https://ctdbase.org/detail.go?type=gene&acc=8839,,,8839.0,CCN5,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of CCN5 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1629,1768620,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,890,CCNA2,https://ctdbase.org/detail.go?type=gene&acc=890,,,890.0,CCNA2,9606.0,Homo sapiens (human),Fenretinide results in decreased expression of CCNA2 protein,,,PMID:16540676,https://www.ncbi.nlm.nih.gov/pubmed/16540676,16540676,,
1630,1768940,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,57018,CCNL1,https://ctdbase.org/detail.go?type=gene&acc=57018,,,57018.0,CCNL1,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of CCNL1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1631,1768941,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,10309,CCNO,https://ctdbase.org/detail.go?type=gene&acc=10309,,,10309.0,CCNO,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of CCNO mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1632,1768942,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,219771,CCNY,https://ctdbase.org/detail.go?type=gene&acc=219771,,,219771.0,CCNY,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of CCNY mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1633,1768943,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,9738,CCP110,https://ctdbase.org/detail.go?type=gene&acc=9738,,,9738.0,CCP110,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of CCP110 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1634,1768944,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,1230,CCR1,https://ctdbase.org/detail.go?type=gene&acc=1230,,,1230.0,CCR1,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of CCR1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1635,1769120,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,69165,CD209B,https://ctdbase.org/detail.go?type=gene&acc=69165,,,69165.0,Cd209b,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of CD209B mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1636,1769121,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,170779,CD209D,https://ctdbase.org/detail.go?type=gene&acc=170779,,,170779.0,Cd209d,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of CD209D mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1637,1769122,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,69142,CD209F,https://ctdbase.org/detail.go?type=gene&acc=69142,,,69142.0,Cd209f,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of CD209F mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1638,1769123,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,70192,CD209G,https://ctdbase.org/detail.go?type=gene&acc=70192,,,70192.0,Cd209g,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of CD209G mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1639,1769124,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,933,CD22,https://ctdbase.org/detail.go?type=gene&acc=933,,,933.0,CD22,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of CD22 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1640,1769125,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,57124,CD248,https://ctdbase.org/detail.go?type=gene&acc=57124,,,57124.0,CD248,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of CD248 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1641,1769126,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,12484,CD24A,https://ctdbase.org/detail.go?type=gene&acc=12484,,,12484.0,Cd24a,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of CD24A mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1642,1769127,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,80381,CD276,https://ctdbase.org/detail.go?type=gene&acc=80381,,,80381.0,CD276,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of CD276 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1643,1769128,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,146894,CD300LG,https://ctdbase.org/detail.go?type=gene&acc=146894,,,146894.0,CD300LG,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of CD300LG mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1644,1769307,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,9936,CD302,https://ctdbase.org/detail.go?type=gene&acc=9936,,,9936.0,CD302,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of CD302 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1645,1769308,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,947,CD34,https://ctdbase.org/detail.go?type=gene&acc=947,,,947.0,CD34,9606.0,Homo sapiens (human),Fenretinide results in decreased expression of CD34 mRNA,,,PMID:15958647,https://www.ncbi.nlm.nih.gov/pubmed/15958647,15958647,,
1646,1769309,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,947,CD34,https://ctdbase.org/detail.go?type=gene&acc=947,,,947.0,CD34,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of CD34 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1647,1767704,5288382,Comparative Toxicogenomics Database (CTD),Geldanamycin,C001277,geldanamycin,https://ctdbase.org/detail.go?type=chem&acc=C001277,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,10090.0,Mus musculus (house mouse),Geldanamycin results in increased degradation of AHR protein,,,PMID:12606767|PMID:16226227,https://www.ncbi.nlm.nih.gov/pubmed/12606767|https://www.ncbi.nlm.nih.gov/pubmed/16226227,12606767|16226227,,
1648,1767705,5288382,Comparative Toxicogenomics Database (CTD),Geldanamycin,C001277,geldanamycin,https://ctdbase.org/detail.go?type=chem&acc=C001277,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,10090.0,Mus musculus (house mouse),Geldanamycin results in increased localization of AHR protein|geldanamycin results in increased degradation of AHR protein mutant form,,,PMID:12606767,https://www.ncbi.nlm.nih.gov/pubmed/12606767,12606767,,
1649,1767706,5288382,Comparative Toxicogenomics Database (CTD),Geldanamycin,C001277,geldanamycin,https://ctdbase.org/detail.go?type=chem&acc=C001277,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),[geldanamycin co-treated with bortezomib] results in decreased expression of AKT1 protein,,,PMID:15781649,https://www.ncbi.nlm.nih.gov/pubmed/15781649,15781649,,
1650,1767707,5288382,Comparative Toxicogenomics Database (CTD),Geldanamycin,C001277,geldanamycin,https://ctdbase.org/detail.go?type=chem&acc=C001277,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),Geldanamycin inhibits the reaction [tretinoin results in increased phosphorylation of AKT1 protein],,,PMID:17293044,https://www.ncbi.nlm.nih.gov/pubmed/17293044,17293044,,
1651,1767708,5288382,Comparative Toxicogenomics Database (CTD),Geldanamycin,C001277,geldanamycin,https://ctdbase.org/detail.go?type=chem&acc=C001277,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),Geldanamycin results in decreased expression of AKT1 protein,,,PMID:24211270,https://www.ncbi.nlm.nih.gov/pubmed/24211270,24211270,,
1652,1767709,5288382,Comparative Toxicogenomics Database (CTD),Geldanamycin,C001277,geldanamycin,https://ctdbase.org/detail.go?type=chem&acc=C001277,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),Geldanamycin results in decreased expression of and results in decreased phosphorylation of AKT1 protein,,,PMID:19167484,https://www.ncbi.nlm.nih.gov/pubmed/19167484,19167484,,
1653,1767710,5288382,Comparative Toxicogenomics Database (CTD),Geldanamycin,C001277,geldanamycin,https://ctdbase.org/detail.go?type=chem&acc=C001277,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),Geldanamycin results in decreased phosphorylation of AKT1 protein,,,PMID:17293044|PMID:24450340,https://www.ncbi.nlm.nih.gov/pubmed/17293044|https://www.ncbi.nlm.nih.gov/pubmed/24450340,17293044|24450340,,
1654,1767856,5288382,Comparative Toxicogenomics Database (CTD),Geldanamycin,C001277,geldanamycin,https://ctdbase.org/detail.go?type=chem&acc=C001277,83989,ARB2A,https://ctdbase.org/detail.go?type=gene&acc=83989,,,83989.0,ARB2A,9606.0,Homo sapiens (human),Geldanamycin results in increased expression of ARB2A mRNA,,,PMID:26705709,https://www.ncbi.nlm.nih.gov/pubmed/26705709,26705709,,
1655,1767857,5288382,Comparative Toxicogenomics Database (CTD),Geldanamycin,C001277,geldanamycin,https://ctdbase.org/detail.go?type=chem&acc=C001277,27236,ARFIP1,https://ctdbase.org/detail.go?type=gene&acc=27236,,,27236.0,ARFIP1,9606.0,Homo sapiens (human),Geldanamycin results in increased expression of ARFIP1 mRNA,,,PMID:26705709,https://www.ncbi.nlm.nih.gov/pubmed/26705709,26705709,,
1656,1767858,5288382,Comparative Toxicogenomics Database (CTD),Geldanamycin,C001277,geldanamycin,https://ctdbase.org/detail.go?type=chem&acc=C001277,259266,ASPM,https://ctdbase.org/detail.go?type=gene&acc=259266,,,259266.0,ASPM,9606.0,Homo sapiens (human),Geldanamycin results in increased expression of ASPM mRNA,,,PMID:26705709,https://www.ncbi.nlm.nih.gov/pubmed/26705709,26705709,,
1657,1767859,5288382,Comparative Toxicogenomics Database (CTD),Geldanamycin,C001277,geldanamycin,https://ctdbase.org/detail.go?type=chem&acc=C001277,23200,ATP11B,https://ctdbase.org/detail.go?type=gene&acc=23200,,,23200.0,ATP11B,9606.0,Homo sapiens (human),Geldanamycin results in increased expression of ATP11B mRNA,,,PMID:26705709,https://www.ncbi.nlm.nih.gov/pubmed/26705709,26705709,,
1658,1767860,5288382,Comparative Toxicogenomics Database (CTD),Geldanamycin,C001277,geldanamycin,https://ctdbase.org/detail.go?type=chem&acc=C001277,286410,ATP11C,https://ctdbase.org/detail.go?type=gene&acc=286410,,,286410.0,ATP11C,9606.0,Homo sapiens (human),Geldanamycin results in increased expression of ATP11C mRNA,,,PMID:26705709,https://www.ncbi.nlm.nih.gov/pubmed/26705709,26705709,,
1659,1767861,5288382,Comparative Toxicogenomics Database (CTD),Geldanamycin,C001277,geldanamycin,https://ctdbase.org/detail.go?type=chem&acc=C001277,79572,ATP13A3,https://ctdbase.org/detail.go?type=gene&acc=79572,,,79572.0,ATP13A3,9606.0,Homo sapiens (human),Geldanamycin results in increased expression of ATP13A3 mRNA,,,PMID:26705709,https://www.ncbi.nlm.nih.gov/pubmed/26705709,26705709,,
1660,1760698,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,3547,IGSF1,https://ctdbase.org/detail.go?type=gene&acc=3547,,,3547.0,IGSF1,10090.0,Mus musculus (house mouse),Morphine results in decreased expression of IGSF1 mRNA,,,PMID:21955143,https://www.ncbi.nlm.nih.gov/pubmed/21955143,21955143,,
1661,1760699,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,7962.0,Cyprinus carpio (common carp),Morphine affects the reaction [zymosan results in increased expression of IL10 mrna],,,PMID:18760300,https://www.ncbi.nlm.nih.gov/pubmed/18760300,18760300,,
1662,1760700,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,3592,IL12A,https://ctdbase.org/detail.go?type=gene&acc=3592,,,3592.0,IL12A,10090.0,Mus musculus (house mouse),Morphine affects the expression of [IL12A protein binds to IL12B protein],,,PMID:16299287,https://www.ncbi.nlm.nih.gov/pubmed/16299287,16299287,,
1663,1761246,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,3622,ING2,https://ctdbase.org/detail.go?type=gene&acc=3622,,,3622.0,ING2,10116.0,Rattus norvegicus (Norway rat),Morphine promotes the reaction [ING2 protein binds to BDNF promoter],,,PMID:25643298,https://www.ncbi.nlm.nih.gov/pubmed/25643298,25643298,,
1664,1761247,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,9606.0,Homo sapiens (human),Acetylcysteine inhibits the reaction [morphine results in increased phosphorylation of and results in increased activity of JUN protein]|pyrazolanthrone inhibits the reaction [morphine results in increased phosphorylation of and results in increased activity of JUN protein]|morphine results in increased phosphorylation of and results in increased activity of JUN protein,,,PMID:19292871,https://www.ncbi.nlm.nih.gov/pubmed/19292871,19292871,,
1665,1761248,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,3726,JUNB,https://ctdbase.org/detail.go?type=gene&acc=3726,,,3726.0,JUNB,10090.0,Mus musculus (house mouse),Morphine results in increased expression of JUNB mRNA,,,PMID:21955143,https://www.ncbi.nlm.nih.gov/pubmed/21955143,21955143,,
1666,1761249,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,8609,KLF7,https://ctdbase.org/detail.go?type=gene&acc=8609,,,8609.0,KLF7,9606.0,Homo sapiens (human),Morphine results in increased expression of KLF7 mrna|morphine results in increased expression of KLF7 protein|naloxone inhibits the reaction [morphine results in increased expression of KLF7 mrna],,,PMID:14644156,https://www.ncbi.nlm.nih.gov/pubmed/14644156,14644156,,
1667,1763061,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090.0,Mus musculus (house mouse),Morphine results in increased expression of NOS2 protein,,,PMID:15220775|PMID:24756886|PMID:37394652,https://www.ncbi.nlm.nih.gov/pubmed/15220775|https://www.ncbi.nlm.nih.gov/pubmed/24756886|https://www.ncbi.nlm.nih.gov/pubmed/37394652,15220775|24756886|37394652,,
1668,1763062,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090.0,Mus musculus (house mouse),NOS2 protein affects the susceptibility to morphine,,,PMID:19751225,https://www.ncbi.nlm.nih.gov/pubmed/19751225,19751225,,
1669,1763063,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090.0,Mus musculus (house mouse),NOS2 protein promotes the reaction [[morphine results in increased expression of PTGS2 protein] which results in increased abundance of dinoprostone]|nos2 protein promotes the reaction [[morphine results in increased expression of PTGS2 protein] which results in increased abundance of 6-ketoprostaglandin F1 alpha],,,PMID:16325209,https://www.ncbi.nlm.nih.gov/pubmed/16325209,16325209,,
1670,1763064,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,9606.0,Homo sapiens (human),Morphine results in increased expression of NOS2 mRNA,,,PMID:9469450,https://www.ncbi.nlm.nih.gov/pubmed/9469450,9469450,,
1671,1763198,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,51299,NRN1,https://ctdbase.org/detail.go?type=gene&acc=51299,,,51299.0,NRN1,10090.0,Mus musculus (house mouse),Morphine results in decreased expression of NRN1 mRNA,,,PMID:21955143,https://www.ncbi.nlm.nih.gov/pubmed/21955143,21955143,,
1672,1763199,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,9369,NRXN3,https://ctdbase.org/detail.go?type=gene&acc=9369,,,9369.0,NRXN3,10090.0,Mus musculus (house mouse),Morphine results in increased expression of NRXN3 mRNA,,,PMID:21955143,https://www.ncbi.nlm.nih.gov/pubmed/21955143,21955143,,
1673,1763200,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,22854,NTNG1,https://ctdbase.org/detail.go?type=gene&acc=22854,,,22854.0,NTNG1,10090.0,Mus musculus (house mouse),Morphine results in decreased expression of NTNG1 mRNA,,,PMID:21955143,https://www.ncbi.nlm.nih.gov/pubmed/21955143,21955143,,
1674,1763201,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,4923,NTSR1,https://ctdbase.org/detail.go?type=gene&acc=4923,,,4923.0,NTSR1,10090.0,Mus musculus (house mouse),NTSR1 protein affects the susceptibility to morphine,,,PMID:20727387,https://www.ncbi.nlm.nih.gov/pubmed/20727387,20727387,,
1675,1763202,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,93377,OPALIN,https://ctdbase.org/detail.go?type=gene&acc=93377,,,93377.0,OPALIN,10090.0,Mus musculus (house mouse),Morphine results in decreased expression of OPALIN mRNA,,,PMID:21955143,https://www.ncbi.nlm.nih.gov/pubmed/21955143,21955143,,
1676,1763203,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,4985,OPRD1,https://ctdbase.org/detail.go?type=gene&acc=4985,,,4985.0,OPRD1,9606.0,Homo sapiens (human),Benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [ARL6IP5 mutant form inhibits the reaction [morphine results in increased expression of OPRD1 protein]]|oprd1 mutant form inhibits the reaction [morphine results in increased phosphorylation of MAPK3 protein]|oprd1 mutant form inhibits the reaction [morphine results in increased phosphorylation of PPP1R1B protein]|oprd1 mutant form inhibits the reaction [morphine results in increased phosphorylation of MAPK1 protein]|morphine results in increased expression of OPRD1 protein|arl6ip5 mutant form inhibits the reaction [morphine results in increased expression of OPRD1 protein]|morphine promotes the reaction [ARL6IP5 protein binds to OPRD1 protein],,,PMID:21600884,https://www.ncbi.nlm.nih.gov/pubmed/21600884,21600884,,
1677,1763204,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,4985,OPRD1,https://ctdbase.org/detail.go?type=gene&acc=4985,,,4985.0,OPRD1,10116.0,Rattus norvegicus (Norway rat),Morphine binds to OPRD1 protein,,,PMID:35477798|PMID:7562497,https://www.ncbi.nlm.nih.gov/pubmed/35477798|https://www.ncbi.nlm.nih.gov/pubmed/7562497,35477798|7562497,,
1678,1763205,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,336529,OPRD1B,https://ctdbase.org/detail.go?type=gene&acc=336529,,,336529.0,oprd1b,7955.0,Danio rerio (zebrafish),Morphine promotes the reaction [pentylenetetrazole results in decreased expression of OPRD1B mrna],,,PMID:35866229,https://www.ncbi.nlm.nih.gov/pubmed/35866229,35866229,,
1679,1763206,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,4986,OPRK1,https://ctdbase.org/detail.go?type=gene&acc=4986,,,4986.0,OPRK1,9606.0,Homo sapiens (human),Morphine results in increased activity of OPRK1 protein,,,PMID:26476280,https://www.ncbi.nlm.nih.gov/pubmed/26476280,26476280,,
1680,1763376,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,4988,OPRM1,https://ctdbase.org/detail.go?type=gene&acc=4988,,,4988.0,OPRM1,9606.0,Homo sapiens (human),Morphine results in increased phosphorylation of OPRM1 protein|[oprm1 protein co-treated with morphine] results in increased activity of ARRB2 protein,,,PMID:23300227,https://www.ncbi.nlm.nih.gov/pubmed/23300227,23300227,,
1681,1763641,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,4988,OPRM1,https://ctdbase.org/detail.go?type=gene&acc=4988,,,4988.0,OPRM1,10090.0,Mus musculus (house mouse),Morphine binds to and results in increased activity of OPRM1 protein,,,PMID:11272841|PMID:12605406,https://www.ncbi.nlm.nih.gov/pubmed/11272841|https://www.ncbi.nlm.nih.gov/pubmed/12605406,11272841|12605406,,
1682,1763642,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,4988,OPRM1,https://ctdbase.org/detail.go?type=gene&acc=4988,,,4988.0,OPRM1,10090.0,Mus musculus (house mouse),Morphine promotes the reaction [OPRM1 protein binds to PRKCG protein],,,PMID:18652891|PMID:21235400,https://www.ncbi.nlm.nih.gov/pubmed/18652891|https://www.ncbi.nlm.nih.gov/pubmed/21235400,18652891|21235400,,
1683,1763643,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,4988,OPRM1,https://ctdbase.org/detail.go?type=gene&acc=4988,,,4988.0,OPRM1,10090.0,Mus musculus (house mouse),Morphine results in decreased expression of OPRM1 mRNA,,,PMID:26877219,https://www.ncbi.nlm.nih.gov/pubmed/26877219,26877219,,
1684,1763644,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,4988,OPRM1,https://ctdbase.org/detail.go?type=gene&acc=4988,,,4988.0,OPRM1,10090.0,Mus musculus (house mouse),Morphine results in increased activity of OPRM1 protein|[morphine results in increased activity of OPRM1 protein] which results in increased phosphorylation of GRIN1 protein|[phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to morphine,,,PMID:17996026,https://www.ncbi.nlm.nih.gov/pubmed/17996026,17996026,,
1685,1763645,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,4988,OPRM1,https://ctdbase.org/detail.go?type=gene&acc=4988,,,4988.0,OPRM1,10090.0,Mus musculus (house mouse),Morphine results in increased expression of OPRM1 protein|naloxone inhibits the reaction [morphine results in increased phosphorylation of OPRM1 protein],,,PMID:21957251,https://www.ncbi.nlm.nih.gov/pubmed/21957251,21957251,,
1686,1763976,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,4988,OPRM1,https://ctdbase.org/detail.go?type=gene&acc=4988,,,4988.0,OPRM1,9606.0,Homo sapiens (human),Morphine results in increased activity of OPRM1 protein,,,PMID:35072756,https://www.ncbi.nlm.nih.gov/pubmed/35072756,35072756,,
1687,1763977,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,5019,OXCT1,https://ctdbase.org/detail.go?type=gene&acc=5019,,,5019.0,OXCT1,10116.0,Rattus norvegicus (Norway rat),Morphine results in decreased expression of OXCT1 protein,,,PMID:23056601,https://www.ncbi.nlm.nih.gov/pubmed/23056601,23056601,,
1688,1763978,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,5187,PER1,https://ctdbase.org/detail.go?type=gene&acc=5187,,,5187.0,PER1,10116.0,Rattus norvegicus (Norway rat),Morphine affects the expression of PER1 mRNA,,,PMID:19383088,https://www.ncbi.nlm.nih.gov/pubmed/19383088,19383088,,
1689,1763979,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,5020,OXT,https://ctdbase.org/detail.go?type=gene&acc=5020,,,5020.0,OXT,9606.0,Homo sapiens (human),[morphine affects the activity of OPRM1 protein] which results in decreased susceptibility to OXT protein|morphine inhibits the reaction [OXT protein results in increased abundance of nitrites]|naloxone inhibits the reaction [morphine inhibits the reaction [OXT protein results in increased abundance of nitrates]]|morphine inhibits the reaction [OXT protein results in increased abundance of nitrates]|naloxone inhibits the reaction [morphine inhibits the reaction [OXT protein results in increased abundance of nitrites]],,,PMID:9151298,https://www.ncbi.nlm.nih.gov/pubmed/9151298,9151298,,
1690,1763980,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,5020,OXT,https://ctdbase.org/detail.go?type=gene&acc=5020,,,5020.0,OXT,9606.0,Homo sapiens (human),Naloxone inhibits the reaction [morphine results in decreased susceptibility to OXT protein]|morphine results in decreased susceptibility to OXT protein,,,PMID:1315136,https://www.ncbi.nlm.nih.gov/pubmed/1315136,1315136,,
1691,1763981,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,10207,PATJ,https://ctdbase.org/detail.go?type=gene&acc=10207,,,10207.0,PATJ,10090.0,Mus musculus (house mouse),Morphine results in decreased expression of PATJ mRNA,,,PMID:21955143,https://www.ncbi.nlm.nih.gov/pubmed/21955143,21955143,,
1692,1763982,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,27344,PCSK1N,https://ctdbase.org/detail.go?type=gene&acc=27344,,,27344.0,PCSK1N,10090.0,Mus musculus (house mouse),Morphine results in increased expression of PCSK1N mRNA,,,PMID:20144693,https://www.ncbi.nlm.nih.gov/pubmed/20144693,20144693,,
1693,1763983,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,9141,PDCD5,https://ctdbase.org/detail.go?type=gene&acc=9141,,,9141.0,PDCD5,10116.0,Rattus norvegicus (Norway rat),Morphine results in increased expression of PDCD5 protein,,,PMID:23056601,https://www.ncbi.nlm.nih.gov/pubmed/23056601,23056601,,
1694,1764407,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,84808,PERM1,https://ctdbase.org/detail.go?type=gene&acc=84808,,,84808.0,PERM1,10116.0,Rattus norvegicus (Norway rat),Morphine deficiency affects the reaction [morphine results in increased expression of PERM1 protein]|morphine results in increased expression of PERM1 protein,,,PMID:23056601,https://www.ncbi.nlm.nih.gov/pubmed/23056601,23056601,,
1695,1764408,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,23187,PHLDB1,https://ctdbase.org/detail.go?type=gene&acc=23187,,,23187.0,PHLDB1,10090.0,Mus musculus (house mouse),Morphine results in decreased expression of PHLDB1 mRNA,,,PMID:21955143,https://www.ncbi.nlm.nih.gov/pubmed/21955143,21955143,,
1696,1764409,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,5277,PIGA,https://ctdbase.org/detail.go?type=gene&acc=5277,,,5277.0,PIGA,10090.0,Mus musculus (house mouse),Morphine results in decreased expression of PIGA mRNA,,,PMID:21955143,https://www.ncbi.nlm.nih.gov/pubmed/21955143,21955143,,
1697,1764410,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,5316,PKNOX1,https://ctdbase.org/detail.go?type=gene&acc=5316,,,5316.0,PKNOX1,10090.0,Mus musculus (house mouse),Morphine results in increased expression of PKNOX1 mRNA,,,PMID:21178816,https://www.ncbi.nlm.nih.gov/pubmed/21178816,21178816,,
1698,1764411,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,5327,PLAT,https://ctdbase.org/detail.go?type=gene&acc=5327,,,5327.0,PLAT,10090.0,Mus musculus (house mouse),Naloxone affects the reaction [morphine results in increased expression of PLAT protein]|plat protein affects the susceptibility to morphine|plat protein promotes the reaction [morphine results in increased secretion of dopamine]|morphine results in increased expression of PLAT mrna|morphine results in increased expression of PLAT protein|naloxone affects the reaction [morphine results in increased expression of PLAT mrna],,,PMID:16619846,https://www.ncbi.nlm.nih.gov/pubmed/16619846,16619846,,
1699,1764412,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,23236,PLCB1,https://ctdbase.org/detail.go?type=gene&acc=23236,,,23236.0,PLCB1,10090.0,Mus musculus (house mouse),PLCB1 protein affects the susceptibility to morphine,,,PMID:16405873,https://www.ncbi.nlm.nih.gov/pubmed/16405873,16405873,,
1700,1764747,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,5443,POMC,https://ctdbase.org/detail.go?type=gene&acc=5443,,,5443.0,POMC,9606.0,Homo sapiens (human),POMC results in decreased susceptibility to morphine,,,PMID:3421781,https://www.ncbi.nlm.nih.gov/pubmed/3421781,3421781,,
1701,1764748,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,5478,PPIA,https://ctdbase.org/detail.go?type=gene&acc=5478,,,5478.0,PPIA,10116.0,Rattus norvegicus (Norway rat),Morphine results in increased expression of PPIA protein,,,PMID:23056601,https://www.ncbi.nlm.nih.gov/pubmed/23056601,23056601,,
1702,1764749,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,84152,PPP1R1B,https://ctdbase.org/detail.go?type=gene&acc=84152,,,84152.0,PPP1R1B,9606.0,Homo sapiens (human),Morphine results in increased phosphorylation of PPP1R1B protein|arl6ip5 mutant form inhibits the reaction [morphine results in increased phosphorylation of PPP1R1B protein]|oprd1 mutant form inhibits the reaction [morphine results in increased phosphorylation of PPP1R1B protein],,,PMID:21600884,https://www.ncbi.nlm.nih.gov/pubmed/21600884,21600884,,
1703,1764750,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,84152,PPP1R1B,https://ctdbase.org/detail.go?type=gene&acc=84152,,,84152.0,PPP1R1B,10116.0,Rattus norvegicus (Norway rat),Morphine affects the expression of PPP1R1B protein modified form,,,PMID:15287884,https://www.ncbi.nlm.nih.gov/pubmed/15287884,15287884,,
1704,1764751,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,5534,PPP3R1,https://ctdbase.org/detail.go?type=gene&acc=5534,,,5534.0,PPP3R1,10090.0,Mus musculus (house mouse),Morphine deficiency results in increased expression of PPP3R1 mRNA,,,PMID:27126842,https://www.ncbi.nlm.nih.gov/pubmed/27126842,27126842,,
1705,1764752,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,5534,PPP3R1,https://ctdbase.org/detail.go?type=gene&acc=5534,,,5534.0,PPP3R1,10090.0,Mus musculus (house mouse),Morphine results in increased expression of PPP3R1 mRNA,,,PMID:21955143,https://www.ncbi.nlm.nih.gov/pubmed/21955143,21955143,,
1706,1764753,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,5578,PRKCA,https://ctdbase.org/detail.go?type=gene&acc=5578,,,5578.0,PRKCA,10090.0,Mus musculus (house mouse),Morphine promotes the reaction [OPRM1 protein binds to PRKCA protein]|hint1 gene mutant form inhibits the reaction [morphine promotes the reaction [OPRM1 protein binds to PRKCA protein]]|dizocilpine maleate inhibits the reaction [morphine promotes the reaction [OPRM1 protein binds to PRKCA protein]],,,PMID:18652891,https://www.ncbi.nlm.nih.gov/pubmed/18652891,18652891,,
1707,1764754,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,5579,PRKCB,https://ctdbase.org/detail.go?type=gene&acc=5579,,,5579.0,PRKCB,10090.0,Mus musculus (house mouse),Morphine promotes the reaction [OPRM1 protein binds to PRKCB protein]|hint1 gene mutant form inhibits the reaction [morphine promotes the reaction [OPRM1 protein binds to PRKCB protein]],,,PMID:18652891,https://www.ncbi.nlm.nih.gov/pubmed/18652891,18652891,,
1708,1764943,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,10090.0,Mus musculus (house mouse),Morphine results in decreased expression of PRKCD mRNA,,,PMID:21955143,https://www.ncbi.nlm.nih.gov/pubmed/21955143,21955143,,
1709,1764944,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,5582,PRKCG,https://ctdbase.org/detail.go?type=gene&acc=5582,,,5582.0,PRKCG,10090.0,Mus musculus (house mouse),HINT1 gene mutant form inhibits the reaction [morphine promotes the reaction [OPRM1 protein binds to PRKCG protein]]|dizocilpine maleate inhibits the reaction [morphine promotes the reaction [OPRM1 protein binds to PRKCG protein]]|tetradecanoylphorbol acetate inhibits the reaction [morphine promotes the reaction [OPRM1 protein binds to PRKCG protein]],,,PMID:18652891,https://www.ncbi.nlm.nih.gov/pubmed/18652891,18652891,,
1710,1764945,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,5582,PRKCG,https://ctdbase.org/detail.go?type=gene&acc=5582,,,5582.0,PRKCG,10090.0,Mus musculus (house mouse),Morphine promotes the reaction [OPRM1 protein binds to PRKCG protein],,,PMID:18652891|PMID:21235400,https://www.ncbi.nlm.nih.gov/pubmed/18652891|https://www.ncbi.nlm.nih.gov/pubmed/21235400,18652891|21235400,,
1711,1764946,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,5582,PRKCG,https://ctdbase.org/detail.go?type=gene&acc=5582,,,5582.0,PRKCG,10090.0,Mus musculus (house mouse),Morphine results in increased expression of PRKCG protein modified form,,,PMID:20359526,https://www.ncbi.nlm.nih.gov/pubmed/20359526,20359526,,
1712,1764947,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,5582,PRKCG,https://ctdbase.org/detail.go?type=gene&acc=5582,,,5582.0,PRKCG,10116.0,Rattus norvegicus (Norway rat),Morphine results in increased expression of PRKCG protein|penk protein alternative form inhibits the reaction [morphine results in increased expression of PRKCG protein],,,PMID:20568289,https://www.ncbi.nlm.nih.gov/pubmed/20568289,20568289,,
1713,1764948,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,5582,PRKCG,https://ctdbase.org/detail.go?type=gene&acc=5582,,,5582.0,PRKCG,9606.0,Homo sapiens (human),Morphine promotes the reaction [HINT1 protein binds to PRKCG protein],,,PMID:21235400,https://www.ncbi.nlm.nih.gov/pubmed/21235400,21235400,,
1714,1764949,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,5592,PRKG1,https://ctdbase.org/detail.go?type=gene&acc=5592,,,5592.0,PRKG1,10116.0,Rattus norvegicus (Norway rat),Morphine inhibits the reaction [formaldehyde results in increased expression of PRKG1 protein],,,PMID:12620371,https://www.ncbi.nlm.nih.gov/pubmed/12620371,12620371,,
1715,1764950,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,5617,PRL,https://ctdbase.org/detail.go?type=gene&acc=5617,,,5617.0,PRL,10116.0,Rattus norvegicus (Norway rat),Morphine results in increased secretion of PRL protein,,,PMID:7201058,https://www.ncbi.nlm.nih.gov/pubmed/7201058,7201058,,
1716,1766276,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,57464,STRIP2,https://ctdbase.org/detail.go?type=gene&acc=57464,,,57464.0,STRIP2,10090.0,Mus musculus (house mouse),Morphine results in increased expression of STRIP2 mRNA,,,PMID:21955143,https://www.ncbi.nlm.nih.gov/pubmed/21955143,21955143,,
1717,1766277,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,23673,STX12,https://ctdbase.org/detail.go?type=gene&acc=23673,,,23673.0,STX12,10116.0,Rattus norvegicus (Norway rat),Morphine results in increased expression of STX12 mRNA,,,PMID:15183518,https://www.ncbi.nlm.nih.gov/pubmed/15183518,15183518,,
1718,1766278,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,56389,STX5A,https://ctdbase.org/detail.go?type=gene&acc=56389,,,56389.0,Stx5a,10116.0,Rattus norvegicus (Norway rat),Morphine results in increased expression of STX5A mRNA,,,PMID:15183518,https://www.ncbi.nlm.nih.gov/pubmed/15183518,15183518,,
1719,1766279,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,8802,SUCLG1,https://ctdbase.org/detail.go?type=gene&acc=8802,,,8802.0,SUCLG1,10116.0,Rattus norvegicus (Norway rat),Morphine results in decreased expression of SUCLG1 protein,,,PMID:23056601,https://www.ncbi.nlm.nih.gov/pubmed/23056601,23056601,,
1720,1766280,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,6817,SULT1A1,https://ctdbase.org/detail.go?type=gene&acc=6817,,,6817.0,SULT1A1,10090.0,Mus musculus (house mouse),Morphine results in increased expression of SULT1A1 mRNA,,,PMID:20144693,https://www.ncbi.nlm.nih.gov/pubmed/20144693,20144693,,
1721,1766761,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,7054,TH,https://ctdbase.org/detail.go?type=gene&acc=7054,,,7054.0,TH,10116.0,Rattus norvegicus (Norway rat),Morphine deficiency results in increased phosphorylation of TH protein|[cp 154526 binds to and results in decreased activity of CRHR1 protein] inhibits the reaction [morphine deficiency results in increased phosphorylation of TH protein],,,PMID:24398105,https://www.ncbi.nlm.nih.gov/pubmed/24398105,24398105,,
1722,1766762,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,7054,TH,https://ctdbase.org/detail.go?type=gene&acc=7054,,,7054.0,TH,10116.0,Rattus norvegicus (Norway rat),[morphine co-treated with naloxone] results in increased phosphorylation of TH protein,,,PMID:25308750,https://www.ncbi.nlm.nih.gov/pubmed/25308750,25308750,,
1723,1766763,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,7054,TH,https://ctdbase.org/detail.go?type=gene&acc=7054,,,7054.0,TH,10116.0,Rattus norvegicus (Norway rat),Morphine promotes the reaction [CREB1 protein modified form binds to TH promoter],,,PMID:25643298,https://www.ncbi.nlm.nih.gov/pubmed/25643298,25643298,,
1724,1766764,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,7054,TH,https://ctdbase.org/detail.go?type=gene&acc=7054,,,7054.0,TH,10116.0,Rattus norvegicus (Norway rat),Morphine results in decreased expression of TH protein,,,PMID:26386147,https://www.ncbi.nlm.nih.gov/pubmed/26386147,26386147,,
1725,1766765,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,7086,TKT,https://ctdbase.org/detail.go?type=gene&acc=7086,,,7086.0,TKT,10116.0,Rattus norvegicus (Norway rat),Morphine results in decreased expression of TKT protein,,,PMID:23056601,https://www.ncbi.nlm.nih.gov/pubmed/23056601,23056601,,
1726,1766766,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,9725,TMEM63A,https://ctdbase.org/detail.go?type=gene&acc=9725,,,9725.0,TMEM63A,10090.0,Mus musculus (house mouse),Morphine results in decreased expression of TMEM63A mRNA,,,PMID:21955143,https://www.ncbi.nlm.nih.gov/pubmed/21955143,21955143,,
1727,1766767,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),Naloxone inhibits the reaction [morphine inhibits the reaction [dactinomycin results in increased expression of TP53 protein modified form]]|morphine inhibits the reaction [dactinomycin results in increased expression of TP53 protein modified form],,,PMID:12927789,https://www.ncbi.nlm.nih.gov/pubmed/12927789,12927789,,
1728,1767590,5311211,Comparative Toxicogenomics Database (CTD),"15-Deoxy-delta-12,14-prostaglandin J2",C097240,"15-deoxy-delta(12,14)-prostaglandin J2",https://ctdbase.org/detail.go?type=chem&acc=C097240,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,10090.0,Mus musculus (house mouse),"T 0070907 inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [LIF protein results in increased phosphorylation of STAT3 protein]]|15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [LIF protein results in increased phosphorylation of STAT3 protein]|t 0070907 inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [LIF protein results in increased expression of STAT3 protein]]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [LIF protein results in increased phosphorylation of STAT3 protein]]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [LIF protein results in increased expression of STAT3 protein]]|15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [LIF protein results in increased expression of STAT3 protein]",,,PMID:19922793,https://www.ncbi.nlm.nih.gov/pubmed/19922793,19922793,,
1729,1767591,5311211,Comparative Toxicogenomics Database (CTD),"15-Deoxy-delta-12,14-prostaglandin J2",C477819,15-deoxyprostaglandin J2,https://ctdbase.org/detail.go?type=chem&acc=C477819,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9986.0,Oryctolagus cuniculus (rabbit),15-deoxyprostaglandin J2 affects the expression of BCL2 protein,,,PMID:16912651,https://www.ncbi.nlm.nih.gov/pubmed/16912651,16912651,,
1730,1767592,5311211,Comparative Toxicogenomics Database (CTD),"15-Deoxy-delta-12,14-prostaglandin J2",C097240,"15-deoxy-delta(12,14)-prostaglandin J2",https://ctdbase.org/detail.go?type=chem&acc=C097240,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,10116.0,Rattus norvegicus (Norway rat),"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [AGT protein results in increased expression of SERPINE1 mrna]]|2-chloro-5-nitrobenzanilide inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [AGT protein results in increased expression of and results in increased secretion of SERPINE1 protein]]|2-chloro-5-nitrobenzanilide inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [AGT protein results in increased expression of SERPINE1 mrna]]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [AGT protein results in increased expression of and results in increased secretion of SERPINE1 protein]]|15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [AGT protein results in increased expression of SERPINE1 mrna]|15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [AGT protein results in increased expression of and results in increased secretion of SERPINE1 protein]",,,PMID:18278065,https://www.ncbi.nlm.nih.gov/pubmed/18278065,18278065,,
1731,1767593,5311211,Comparative Toxicogenomics Database (CTD),"15-Deoxy-delta-12,14-prostaglandin J2",C097240,"15-deoxy-delta(12,14)-prostaglandin J2",https://ctdbase.org/detail.go?type=chem&acc=C097240,4087,SMAD2,https://ctdbase.org/detail.go?type=gene&acc=4087,,,4087.0,SMAD2,9606.0,Homo sapiens (human),"15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD2 protein]|smad2 protein modified form affects the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [TGFB1 protein results in increased expression of CCN2]]",,,PMID:19429239,https://www.ncbi.nlm.nih.gov/pubmed/19429239,19429239,,
1732,1767594,5311211,Comparative Toxicogenomics Database (CTD),"15-Deoxy-delta-12,14-prostaglandin J2",C097240,"15-deoxy-delta(12,14)-prostaglandin J2",https://ctdbase.org/detail.go?type=chem&acc=C097240,8651,SOCS1,https://ctdbase.org/detail.go?type=gene&acc=8651,,,8651.0,SOCS1,10116.0,Rattus norvegicus (Norway rat),"15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of SOCS1 mRNA",,,PMID:12584205,https://www.ncbi.nlm.nih.gov/pubmed/12584205,12584205,,
1733,1767595,5311211,Comparative Toxicogenomics Database (CTD),"15-Deoxy-delta-12,14-prostaglandin J2",C097240,"15-deoxy-delta(12,14)-prostaglandin J2",https://ctdbase.org/detail.go?type=chem&acc=C097240,9021,SOCS3,https://ctdbase.org/detail.go?type=gene&acc=9021,,,9021.0,SOCS3,10116.0,Rattus norvegicus (Norway rat),"15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of SOCS3 mRNA",,,PMID:12584205,https://www.ncbi.nlm.nih.gov/pubmed/12584205,12584205,,
1734,1768934,5311264,Comparative Toxicogenomics Database (CTD),Lysophosphatidylcholine,D008244,Lysophosphatidylcholines,https://ctdbase.org/detail.go?type=chem&acc=D008244,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116.0,Rattus norvegicus (Norway rat),Lysophosphatidylcholines results in increased phosphorylation of MAPK1 protein|resveratrol inhibits the reaction [lysophosphatidylcholines results in increased phosphorylation of MAPK1 protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lysophosphatidylcholines results in increased phosphorylation of MAPK1 protein],,,PMID:20564508,https://www.ncbi.nlm.nih.gov/pubmed/20564508,20564508,,
1735,1768935,5311264,Comparative Toxicogenomics Database (CTD),Lysophosphatidylcholine,D008244,Lysophosphatidylcholines,https://ctdbase.org/detail.go?type=chem&acc=D008244,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [lysophosphatidylcholines results in increased phosphorylation of MAPK3 protein]|lysophosphatidylcholines results in increased phosphorylation of MAPK3 protein|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lysophosphatidylcholines results in increased phosphorylation of MAPK3 protein],,,PMID:20564508,https://www.ncbi.nlm.nih.gov/pubmed/20564508,20564508,,
1736,1768936,5311264,Comparative Toxicogenomics Database (CTD),Lysophosphatidylcholine,D008244,Lysophosphatidylcholines,https://ctdbase.org/detail.go?type=chem&acc=D008244,84879,MFSD2A,https://ctdbase.org/detail.go?type=gene&acc=84879,,,84879.0,MFSD2A,9606.0,Homo sapiens (human),MFSD2A results in increased transport of lysophosphatidylcholines,,,PMID:26005865,https://www.ncbi.nlm.nih.gov/pubmed/26005865,26005865,,
1737,1768937,5311264,Comparative Toxicogenomics Database (CTD),Lysophosphatidylcholine,D008244,Lysophosphatidylcholines,https://ctdbase.org/detail.go?type=chem&acc=D008244,114548,NLRP3,https://ctdbase.org/detail.go?type=gene&acc=114548,,,114548.0,NLRP3,9606.0,Homo sapiens (human),Lysophosphatidylcholines results in increased expression of NLRP3 protein|gpr4 protein promotes the reaction [lysophosphatidylcholines results in increased expression of NLRP3 protein],,,PMID:34293432,https://www.ncbi.nlm.nih.gov/pubmed/34293432,34293432,,
1738,1768938,5311264,Comparative Toxicogenomics Database (CTD),Lysophosphatidylcholine,D008244,Lysophosphatidylcholines,https://ctdbase.org/detail.go?type=chem&acc=D008244,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116.0,Rattus norvegicus (Norway rat),Lysophosphatidylcholines results in increased expression of NOS2 mrna|resveratrol inhibits the reaction [lysophosphatidylcholines results in increased expression of NOS2 mrna]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lysophosphatidylcholines results in increased expression of NOS2 mrna],,,PMID:20564508,https://www.ncbi.nlm.nih.gov/pubmed/20564508,20564508,,
1739,1768939,5311264,Comparative Toxicogenomics Database (CTD),Lysophosphatidylcholine,D008244,Lysophosphatidylcholines,https://ctdbase.org/detail.go?type=chem&acc=D008244,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,10116.0,Rattus norvegicus (Norway rat),Lysophosphatidylcholines results in decreased expression of NOS3 mrna|resveratrol inhibits the reaction [lysophosphatidylcholines results in decreased expression of NOS3 mrna]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lysophosphatidylcholines results in decreased expression of NOS3 mrna],,,PMID:20564508,https://www.ncbi.nlm.nih.gov/pubmed/20564508,20564508,,
1740,1768853,5318650,Comparative Toxicogenomics Database (CTD),Isorhapontigenin,C432307,isorhapontigenin,https://ctdbase.org/detail.go?type=chem&acc=C432307,3551,IKBKB,https://ctdbase.org/detail.go?type=gene&acc=3551,,,3551.0,IKBKB,10116.0,Rattus norvegicus (Norway rat),Isorhapontigenin affects the activity of IKBKB protein,,,PMID:15607907,https://www.ncbi.nlm.nih.gov/pubmed/15607907,15607907,,
1741,1768854,5318650,Comparative Toxicogenomics Database (CTD),Isorhapontigenin,C432307,isorhapontigenin,https://ctdbase.org/detail.go?type=chem&acc=C432307,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,10116.0,Rattus norvegicus (Norway rat),Isorhapontigenin affects the expression of JUN protein,,,PMID:15607907,https://www.ncbi.nlm.nih.gov/pubmed/15607907,15607907,,
1742,1768855,5318650,Comparative Toxicogenomics Database (CTD),Isorhapontigenin,C432307,isorhapontigenin,https://ctdbase.org/detail.go?type=chem&acc=C432307,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116.0,Rattus norvegicus (Norway rat),Isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein],,,PMID:15607907,https://www.ncbi.nlm.nih.gov/pubmed/15607907,15607907,,
1743,1768856,5318650,Comparative Toxicogenomics Database (CTD),Isorhapontigenin,C432307,isorhapontigenin,https://ctdbase.org/detail.go?type=chem&acc=C432307,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116.0,Rattus norvegicus (Norway rat),Isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein],,,PMID:15607907,https://www.ncbi.nlm.nih.gov/pubmed/15607907,15607907,,
1744,1768857,5318650,Comparative Toxicogenomics Database (CTD),Isorhapontigenin,C432307,isorhapontigenin,https://ctdbase.org/detail.go?type=chem&acc=C432307,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,10116.0,Rattus norvegicus (Norway rat),Isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK8 protein],,,PMID:15607907,https://www.ncbi.nlm.nih.gov/pubmed/15607907,15607907,,
1745,1768858,5318650,Comparative Toxicogenomics Database (CTD),Isorhapontigenin,C432307,isorhapontigenin,https://ctdbase.org/detail.go?type=chem&acc=C432307,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,10116.0,Rattus norvegicus (Norway rat),Isorhapontigenin affects the degradation of and affects the phosphorylation of NFKBIA protein,,,PMID:15607907,https://www.ncbi.nlm.nih.gov/pubmed/15607907,15607907,,
1746,1769022,5318659,Comparative Toxicogenomics Database (CTD),Isosalipurposide,C027321,isosalipurposide,https://ctdbase.org/detail.go?type=chem&acc=C027321,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),Isosalipurposide results in increased expression of HMOX1 protein,,,PMID:26028482,https://www.ncbi.nlm.nih.gov/pubmed/26028482,26028482,,
1747,1769023,5318659,Comparative Toxicogenomics Database (CTD),Isosalipurposide,C027321,isosalipurposide,https://ctdbase.org/detail.go?type=chem&acc=C027321,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),MAPK1 protein affects the reaction [isosalipurposide affects the localization of NFE2L2 protein],,,PMID:26028482,https://www.ncbi.nlm.nih.gov/pubmed/26028482,26028482,,
1748,1769024,5318659,Comparative Toxicogenomics Database (CTD),Isosalipurposide,C027321,isosalipurposide,https://ctdbase.org/detail.go?type=chem&acc=C027321,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),MAPK3 protein affects the reaction [isosalipurposide affects the localization of NFE2L2 protein],,,PMID:26028482,https://www.ncbi.nlm.nih.gov/pubmed/26028482,26028482,,
1749,1769025,5318659,Comparative Toxicogenomics Database (CTD),Isosalipurposide,C027321,isosalipurposide,https://ctdbase.org/detail.go?type=chem&acc=C027321,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),MAPK3 protein affects the reaction [isosalipurposide affects the localization of NFE2L2 protein]|mapk1 protein affects the reaction [isosalipurposide affects the localization of NFE2L2 protein]|isosalipurposide affects the localization of NFE2L2 protein,,,PMID:26028482,https://www.ncbi.nlm.nih.gov/pubmed/26028482,26028482,,
1750,1769026,5319251,Comparative Toxicogenomics Database (CTD),"3,5-Bis(beta-D-glucopyranosyloxy)-7-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-1-benzopyrylium chloride",C502603,malvin,https://ctdbase.org/detail.go?type=chem&acc=C502603,760,CA2,https://ctdbase.org/detail.go?type=gene&acc=760,,,760.0,CA2,9606.0,Homo sapiens (human),Malvin results in decreased activity of CA2 protein,,,PMID:28445001,https://www.ncbi.nlm.nih.gov/pubmed/28445001,28445001,,
1751,1769027,5319251,Comparative Toxicogenomics Database (CTD),"3,5-Bis(beta-D-glucopyranosyloxy)-7-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-1-benzopyrylium chloride",C502603,malvin,https://ctdbase.org/detail.go?type=chem&acc=C502603,759,CA1,https://ctdbase.org/detail.go?type=gene&acc=759,,,759.0,CA1,9606.0,Homo sapiens (human),Malvin results in decreased activity of CA1 protein,,,PMID:28445001,https://www.ncbi.nlm.nih.gov/pubmed/28445001,28445001,,
1752,1769028,5322194,IUPHAR/BPS Guide to PHARMACOLOGY,"3-methyl-2-[(5Z)-5-(1-methyl-2-oxoindol-3-ylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoic acid",5827,group E 1682-2106 [PMID:16118363],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5827,222,FPR1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=222,P21462,fMet-Leu-Phe receptor,2357.0,FPR1,9606.0,Homo sapiens (human),Antagonist,pIC50,5.3,PMID:16118363,https://www.ncbi.nlm.nih.gov/pubmed/16118363,16118363,,
1753,1769029,5322399,IUPHAR/BPS Guide to PHARMACOLOGY,"1-(4-(6-Bromobenzo[1,3]dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl)-ethanone",1014,G-1,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1014,221,GPER,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=221,Q99527,G-protein coupled estrogen receptor 1,2852.0,GPER1,9606.0,Homo sapiens (human),Full agonist,pKi,8,PMID:16520733,https://www.ncbi.nlm.nih.gov/pubmed/16520733,16520733,,
1754,1769030,5322399,Comparative Toxicogenomics Database (CTD),"1-(4-(6-Bromobenzo[1,3]dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl)-ethanone",C517943,"1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone",https://ctdbase.org/detail.go?type=chem&acc=C517943,6194,RPS6,https://ctdbase.org/detail.go?type=gene&acc=6194,,,6194.0,RPS6,7955.0,Danio rerio (zebrafish),"1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone results in increased phosphorylation of RPS6 protein|gper1 protein affects the reaction [1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone results in increased phosphorylation of RPS6 protein]|mtor protein affects the reaction [1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone results in increased phosphorylation of RPS6 protein]",,,PMID:30641053,https://www.ncbi.nlm.nih.gov/pubmed/30641053,30641053,,
1755,1814004,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,3767,KCNJ11,https://ctdbase.org/detail.go?type=gene&acc=3767,,,3767.0,KCNJ11,9606.0,Homo sapiens (human),Sunitinib results in increased expression of KCNJ11 mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
1756,1814005,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,3759,KCNJ2,https://ctdbase.org/detail.go?type=gene&acc=3759,,,3759.0,KCNJ2,9606.0,Homo sapiens (human),Sunitinib results in increased expression of KCNJ2 mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
1757,1814006,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,400617,KCNJ2-AS1,https://ctdbase.org/detail.go?type=gene&acc=400617,,,400617.0,KCNJ2-AS1,9606.0,Homo sapiens (human),Sunitinib results in increased expression of KCNJ2-AS1 mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
1758,1814007,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,3760,KCNJ3,https://ctdbase.org/detail.go?type=gene&acc=3760,,,3760.0,KCNJ3,9606.0,Homo sapiens (human),Sunitinib results in increased expression of KCNJ3 mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
1759,1814008,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,3762,KCNJ5,https://ctdbase.org/detail.go?type=gene&acc=3762,,,3762.0,KCNJ5,9606.0,Homo sapiens (human),Sunitinib results in increased expression of KCNJ5 mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
1760,1814009,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,56659,KCNK13,https://ctdbase.org/detail.go?type=gene&acc=56659,,,56659.0,KCNK13,9606.0,Homo sapiens (human),Sunitinib results in decreased expression of KCNK13 mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
1761,1814010,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,3777,KCNK3,https://ctdbase.org/detail.go?type=gene&acc=3777,,,3777.0,KCNK3,9606.0,Homo sapiens (human),Sunitinib results in increased expression of KCNK3 mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
1762,1814189,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,83892,KCTD10,https://ctdbase.org/detail.go?type=gene&acc=83892,,,83892.0,KCTD10,9606.0,Homo sapiens (human),Sunitinib results in decreased expression of KCTD10 mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
1763,1814190,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,115207,KCTD12,https://ctdbase.org/detail.go?type=gene&acc=115207,,,115207.0,KCTD12,9606.0,Homo sapiens (human),Sunitinib results in decreased expression of KCTD12 mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
1764,1760321,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,120237,DBX1,https://ctdbase.org/detail.go?type=gene&acc=120237,,,120237.0,DBX1,9606.0,Homo sapiens (human),Arsenic affects the methylation of DBX1 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1765,1760322,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,10238,DCAF7,https://ctdbase.org/detail.go?type=gene&acc=10238,,,10238.0,DCAF7,9606.0,Homo sapiens (human),Arsenic affects the expression of DCAF7 mRNA,,,PMID:18414638,https://www.ncbi.nlm.nih.gov/pubmed/18414638,18414638,,
1766,1760323,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,10238,DCAF7,https://ctdbase.org/detail.go?type=gene&acc=10238,,,10238.0,DCAF7,9606.0,Homo sapiens (human),Arsenic affects the methylation of DCAF7 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1767,1760324,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,347442,DCAF8L2,https://ctdbase.org/detail.go?type=gene&acc=347442,,,347442.0,DCAF8L2,9606.0,Homo sapiens (human),Arsenic affects the methylation of DCAF8L2 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1768,1760325,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,79877,DCAKD,https://ctdbase.org/detail.go?type=gene&acc=79877,,,79877.0,DCAKD,9606.0,Homo sapiens (human),Arsenic results in increased methylation of DCAKD promoter,,,PMID:21291286,https://www.ncbi.nlm.nih.gov/pubmed/21291286,21291286,,
1769,1760326,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,140947,DCANP1,https://ctdbase.org/detail.go?type=gene&acc=140947,,,140947.0,DCANP1,9606.0,Homo sapiens (human),Arsenic affects the methylation of DCANP1 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1770,1760327,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,131566,DCBLD2,https://ctdbase.org/detail.go?type=gene&acc=131566,,,131566.0,DCBLD2,9606.0,Homo sapiens (human),[sodium arsenate results in increased abundance of arsenic] which results in increased expression of DCBLD2 mRNA,,,PMID:32525701,https://www.ncbi.nlm.nih.gov/pubmed/32525701,32525701,,
1771,1760328,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,166614,DCLK2,https://ctdbase.org/detail.go?type=gene&acc=166614,,,166614.0,DCLK2,9606.0,Homo sapiens (human),Arsenic affects the methylation of DCLK2 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1772,1760329,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,64858,DCLRE1B,https://ctdbase.org/detail.go?type=gene&acc=64858,,,64858.0,DCLRE1B,9606.0,Homo sapiens (human),Arsenic affects the methylation of DCLRE1B gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1773,1760330,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,28960,DCPS,https://ctdbase.org/detail.go?type=gene&acc=28960,,,28960.0,DCPS,9606.0,Homo sapiens (human),Arsenic affects the methylation of DCPS gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1774,1760759,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,54541,DDIT4,https://ctdbase.org/detail.go?type=gene&acc=54541,,,54541.0,DDIT4,9606.0,Homo sapiens (human),Arsenic results in decreased ubiquitination of DDIT4 protein,,,PMID:35994080,https://www.ncbi.nlm.nih.gov/pubmed/35994080,35994080,,
1775,1760760,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,1662,DDX10,https://ctdbase.org/detail.go?type=gene&acc=1662,,,1662.0,DDX10,9606.0,Homo sapiens (human),Arsenic affects the methylation of DDX10 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1776,1760761,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,1663,DDX11,https://ctdbase.org/detail.go?type=gene&acc=1663,,,1663.0,DDX11,9606.0,Homo sapiens (human),Arsenic affects the methylation of DDX11 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1777,1760762,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,10521,DDX17,https://ctdbase.org/detail.go?type=gene&acc=10521,,,10521.0,DDX17,9606.0,Homo sapiens (human),DDX17 mRNA results in decreased susceptibility to arsenic,,,PMID:17976673,https://www.ncbi.nlm.nih.gov/pubmed/17976673,17976673,,
1778,1760763,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,11269,DDX19B,https://ctdbase.org/detail.go?type=gene&acc=11269,,,11269.0,DDX19B,9606.0,Homo sapiens (human),Arsenic affects the methylation of DDX19B gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1779,1760764,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,55661,DDX27,https://ctdbase.org/detail.go?type=gene&acc=55661,,,55661.0,DDX27,9606.0,Homo sapiens (human),Arsenic affects the methylation of DDX27 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1780,1760765,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,64794,DDX31,https://ctdbase.org/detail.go?type=gene&acc=64794,,,64794.0,DDX31,9606.0,Homo sapiens (human),Arsenic affects the methylation of DDX31 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1781,1760766,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,7919,DDX39B,https://ctdbase.org/detail.go?type=gene&acc=7919,,,7919.0,DDX39B,9606.0,Homo sapiens (human),Arsenic affects the methylation of DDX39B gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1782,1760767,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,11325,DDX42,https://ctdbase.org/detail.go?type=gene&acc=11325,,,11325.0,DDX42,9606.0,Homo sapiens (human),[sodium arsenite results in increased abundance of arsenic] which results in increased expression of DDX42 protein,,,PMID:35072517,https://www.ncbi.nlm.nih.gov/pubmed/35072517,35072517,,
1783,1760768,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,55510,DDX43,https://ctdbase.org/detail.go?type=gene&acc=55510,,,55510.0,DDX43,9606.0,Homo sapiens (human),Arsenic affects the methylation of DDX43 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1784,1760769,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,11056,DDX52,https://ctdbase.org/detail.go?type=gene&acc=11056,,,11056.0,DDX52,9606.0,Homo sapiens (human),Arsenic affects the methylation of DDX52 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1785,1761914,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,1762,DMWD,https://ctdbase.org/detail.go?type=gene&acc=1762,,,1762.0,DMWD,9606.0,Homo sapiens (human),[sodium arsenate results in increased abundance of arsenic] which results in increased expression of DMWD mRNA,,,PMID:32525701,https://www.ncbi.nlm.nih.gov/pubmed/32525701,32525701,,
1786,1761915,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,1763,DNA2,https://ctdbase.org/detail.go?type=gene&acc=1763,,,1763.0,DNA2,9606.0,Homo sapiens (human),Arsenic affects the methylation of DNA2 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1787,1762554,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,1786,DNMT1,https://ctdbase.org/detail.go?type=gene&acc=1786,,,1786.0,DNMT1,9606.0,Homo sapiens (human),Arsenic affects the methylation of DNMT1 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1788,1762555,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,1786,DNMT1,https://ctdbase.org/detail.go?type=gene&acc=1786,,,1786.0,DNMT1,9606.0,Homo sapiens (human),Arsenic results in decreased expression of DNMT1 mrna|folic acid inhibits the reaction [arsenic results in decreased expression of DNMT1 mrna],,,PMID:35490796,https://www.ncbi.nlm.nih.gov/pubmed/35490796,35490796,,
1789,1762556,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,1786,DNMT1,https://ctdbase.org/detail.go?type=gene&acc=1786,,,1786.0,DNMT1,9606.0,Homo sapiens (human),Arsenic results in increased expression of DNMT1 mRNA,,,PMID:27838757,https://www.ncbi.nlm.nih.gov/pubmed/27838757,27838757,,
1790,1762557,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,1786,DNMT1,https://ctdbase.org/detail.go?type=gene&acc=1786,,,1786.0,DNMT1,9606.0,Homo sapiens (human),DNMT1 gene SNP affects the susceptibility to arsenic,,,PMID:27292127|PMID:31864032,https://www.ncbi.nlm.nih.gov/pubmed/27292127|https://www.ncbi.nlm.nih.gov/pubmed/31864032,27292127|31864032,,
1791,1764579,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,1958,EGR1,https://ctdbase.org/detail.go?type=gene&acc=1958,,,1958.0,EGR1,9606.0,Homo sapiens (human),[S-adenosylmethionine inhibits the reaction [arsenic results in decreased methylation of EGR1 promoter]] which results in decreased expression of EGR1 mRNA,,,PMID:35490796,https://www.ncbi.nlm.nih.gov/pubmed/35490796,35490796|35490796,,
1792,1764580,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,1959,EGR2,https://ctdbase.org/detail.go?type=gene&acc=1959,,,1959.0,EGR2,9606.0,Homo sapiens (human),Arsenic affects the methylation of EGR2 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1793,1765687,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,2023,ENO1,https://ctdbase.org/detail.go?type=gene&acc=2023,,,2023.0,ENO1,10116.0,Rattus norvegicus (Norway rat),Arsenic results in decreased expression of ENO1 mRNA,,,PMID:18315880,https://www.ncbi.nlm.nih.gov/pubmed/18315880,18315880,,
1794,1765688,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,2026,ENO2,https://ctdbase.org/detail.go?type=gene&acc=2026,,,2026.0,ENO2,9606.0,Homo sapiens (human),[sodium arsenate results in increased abundance of arsenic] which results in increased expression of ENO2 mRNA,,,PMID:32525701,https://www.ncbi.nlm.nih.gov/pubmed/32525701,32525701,,
1795,1765689,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,2027,ENO3,https://ctdbase.org/detail.go?type=gene&acc=2027,,,2027.0,ENO3,10090.0,Mus musculus (house mouse),Arsenic results in decreased expression of ENO3 protein,,,PMID:22552367,https://www.ncbi.nlm.nih.gov/pubmed/22552367,22552367,,
1796,1765690,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,5168,ENPP2,https://ctdbase.org/detail.go?type=gene&acc=5168,,,5168.0,ENPP2,9606.0,Homo sapiens (human),Arsenic affects the expression of ENPP2 mRNA,,,PMID:23866971,https://www.ncbi.nlm.nih.gov/pubmed/23866971,23866971,,
1797,1767787,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,54536,EXOC6,https://ctdbase.org/detail.go?type=gene&acc=54536,,,54536.0,EXOC6,9606.0,Homo sapiens (human),Arsenic affects the methylation of EXOC6 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1798,1767788,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,149371,EXOC8,https://ctdbase.org/detail.go?type=gene&acc=149371,,,149371.0,EXOC8,9606.0,Homo sapiens (human),Arsenic affects the expression of EXOC8 mRNA,,,PMID:18414638,https://www.ncbi.nlm.nih.gov/pubmed/18414638,18414638,,
1799,1767789,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,56915,EXOSC5,https://ctdbase.org/detail.go?type=gene&acc=56915,,,56915.0,EXOSC5,9606.0,Homo sapiens (human),Arsenic affects the methylation of EXOSC5 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1800,1767790,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,2131,EXT1,https://ctdbase.org/detail.go?type=gene&acc=2131,,,2131.0,EXT1,9606.0,Homo sapiens (human),Arsenic affects the methylation of EXT1 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1801,1767791,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,2134,EXTL1,https://ctdbase.org/detail.go?type=gene&acc=2134,,,2134.0,EXTL1,9606.0,Homo sapiens (human),Arsenic affects the methylation of EXTL1 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1802,1767792,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,2137,EXTL3,https://ctdbase.org/detail.go?type=gene&acc=2137,,,2137.0,EXTL3,7955.0,Danio rerio (zebrafish),[sodium arsenite results in increased abundance of arsenic] which results in decreased expression of EXTL3 mRNA,,,PMID:33147493,https://www.ncbi.nlm.nih.gov/pubmed/33147493,33147493,,
1803,1767793,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,2140,EYA3,https://ctdbase.org/detail.go?type=gene&acc=2140,,,2140.0,EYA3,9606.0,Homo sapiens (human),Arsenic affects the methylation of EYA3 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1804,1767794,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,2070,EYA4,https://ctdbase.org/detail.go?type=gene&acc=2070,,,2070.0,EYA4,9606.0,Homo sapiens (human),Arsenic affects the methylation of EYA4 gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1805,1767795,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,346007,EYS,https://ctdbase.org/detail.go?type=gene&acc=346007,,,346007.0,EYS,9606.0,Homo sapiens (human),Arsenic affects the methylation of EYS gene,,,PMID:25304211,https://www.ncbi.nlm.nih.gov/pubmed/25304211,25304211,,
1806,1767796,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,2146,EZH2,https://ctdbase.org/detail.go?type=gene&acc=2146,,,2146.0,EZH2,9606.0,Homo sapiens (human),Arsenic analog results in increased phosphorylation of and affects the localization of EZH2 protein|acetylcysteine inhibits the reaction [arsenic analog results in increased phosphorylation of EZH2 protein],,,PMID:24582688,https://www.ncbi.nlm.nih.gov/pubmed/24582688,24582688,,
1807,1760504,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,64073,C19ORF33,https://ctdbase.org/detail.go?type=gene&acc=64073,,,64073.0,C19orf33,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of C19ORF33 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1808,1760505,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,126526,C19ORF47,https://ctdbase.org/detail.go?type=gene&acc=126526,,,126526.0,C19orf47,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of C19ORF47 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1809,1760506,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,56913,C1GALT1,https://ctdbase.org/detail.go?type=gene&acc=56913,,,56913.0,C1GALT1,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of C1GALT1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1810,1760507,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,29071,C1GALT1C1,https://ctdbase.org/detail.go?type=gene&acc=29071,,,29071.0,C1GALT1C1,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of C1GALT1C1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1811,1760508,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,728819,C1GALT1C1L,https://ctdbase.org/detail.go?type=gene&acc=728819,,,728819.0,C1GALT1C1L,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of C1GALT1C1L mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1812,1760509,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,128061,C1ORF131,https://ctdbase.org/detail.go?type=gene&acc=128061,,,128061.0,C1orf131,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of C1ORF131 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1813,1761316,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,23473,CAPN7,https://ctdbase.org/detail.go?type=gene&acc=23473,,,23473.0,CAPN7,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CAPN7 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1814,1761317,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,829,CAPZA1,https://ctdbase.org/detail.go?type=gene&acc=829,,,829.0,CAPZA1,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CAPZA1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1815,1761318,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,830,CAPZA2,https://ctdbase.org/detail.go?type=gene&acc=830,,,830.0,CAPZA2,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CAPZA2 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1816,1761319,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,22794,CASC3,https://ctdbase.org/detail.go?type=gene&acc=22794,,,22794.0,CASC3,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of CASC3 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1817,1761320,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,64921,CASD1,https://ctdbase.org/detail.go?type=gene&acc=64921,,,64921.0,CASD1,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CASD1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1818,1761321,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,57513,CASKIN2,https://ctdbase.org/detail.go?type=gene&acc=57513,,,57513.0,CASKIN2,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of CASKIN2 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1819,1761322,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,834,CASP1,https://ctdbase.org/detail.go?type=gene&acc=834,,,834.0,CASP1,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CASP1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1820,1761323,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,835,CASP2,https://ctdbase.org/detail.go?type=gene&acc=835,,,835.0,CASP2,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of CASP2 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1821,1761324,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CASP3 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1822,1761325,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,837,CASP4,https://ctdbase.org/detail.go?type=gene&acc=837,,,837.0,CASP4,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CASP4 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1823,1762067,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,57820,CCNB1IP1,https://ctdbase.org/detail.go?type=gene&acc=57820,,,57820.0,CCNB1IP1,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CCNB1IP1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1824,1762068,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,892,CCNC,https://ctdbase.org/detail.go?type=gene&acc=892,,,892.0,CCNC,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CCNC mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1825,1762069,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,23582,CCNDBP1,https://ctdbase.org/detail.go?type=gene&acc=23582,,,23582.0,CCNDBP1,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CCNDBP1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1826,1762070,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,899,CCNF,https://ctdbase.org/detail.go?type=gene&acc=899,,,899.0,CCNF,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of CCNF mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1827,1762270,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,900,CCNG1,https://ctdbase.org/detail.go?type=gene&acc=900,,,900.0,CCNG1,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CCNG1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1828,1762271,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,901,CCNG2,https://ctdbase.org/detail.go?type=gene&acc=901,,,901.0,CCNG2,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CCNG2 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1829,1762272,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,902,CCNH,https://ctdbase.org/detail.go?type=gene&acc=902,,,902.0,CCNH,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CCNH mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1830,1762273,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,8812,CCNK,https://ctdbase.org/detail.go?type=gene&acc=8812,,,8812.0,CCNK,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of CCNK mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1831,1762274,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,905,CCNT2,https://ctdbase.org/detail.go?type=gene&acc=905,,,905.0,CCNT2,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CCNT2 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1832,1762275,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,9236,CCPG1,https://ctdbase.org/detail.go?type=gene&acc=9236,,,9236.0,CCPG1,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CCPG1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1833,1762899,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,51755,CDK12,https://ctdbase.org/detail.go?type=gene&acc=51755,,,51755.0,CDK12,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of CDK12 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1834,1762900,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,5129,CDK18,https://ctdbase.org/detail.go?type=gene&acc=5129,,,5129.0,CDK18,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of CDK18 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1835,1762901,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,10263,CDK2AP2,https://ctdbase.org/detail.go?type=gene&acc=10263,,,10263.0,CDK2AP2,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of CDK2AP2 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1836,1762902,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,80279,CDK5RAP3,https://ctdbase.org/detail.go?type=gene&acc=80279,,,80279.0,CDK5RAP3,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CDK5RAP3 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1837,1762903,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,1022,CDK7,https://ctdbase.org/detail.go?type=gene&acc=1022,,,1022.0,CDK7,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CDK7 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1838,1762904,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,55602,CDKN2AIP,https://ctdbase.org/detail.go?type=gene&acc=55602,,,55602.0,CDKN2AIP,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CDKN2AIP mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1839,1764140,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,148046,CIRBP-AS1,https://ctdbase.org/detail.go?type=gene&acc=148046,,,148046.0,CIRBP-AS1,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of CIRBP-AS1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1840,1764141,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,55847,CISD1,https://ctdbase.org/detail.go?type=gene&acc=55847,,,55847.0,CISD1,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CISD1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1841,1764142,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,493856,CISD2,https://ctdbase.org/detail.go?type=gene&acc=493856,,,493856.0,CISD2,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CISD2 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1842,1765193,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,23412,COMMD3,https://ctdbase.org/detail.go?type=gene&acc=23412,,,23412.0,COMMD3,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of COMMD3 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1843,1765194,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,170622,COMMD6,https://ctdbase.org/detail.go?type=gene&acc=170622,,,170622.0,COMMD6,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of COMMD6 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1844,1765195,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,54951,COMMD8,https://ctdbase.org/detail.go?type=gene&acc=54951,,,54951.0,COMMD8,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of COMMD8 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1845,1765196,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,118881,COMTD1,https://ctdbase.org/detail.go?type=gene&acc=118881,,,118881.0,COMTD1,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of COMTD1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1846,1765197,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,1315,COPB1,https://ctdbase.org/detail.go?type=gene&acc=1315,,,1315.0,COPB1,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of COPB1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1847,1765198,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,9276,COPB2,https://ctdbase.org/detail.go?type=gene&acc=9276,,,9276.0,COPB2,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of COPB2 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1848,1765199,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,22820,COPG1,https://ctdbase.org/detail.go?type=gene&acc=22820,,,22820.0,COPG1,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of COPG1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1849,1765409,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,9318,COPS2,https://ctdbase.org/detail.go?type=gene&acc=9318,,,9318.0,COPS2,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of COPS2 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1850,1765410,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,8533,COPS3,https://ctdbase.org/detail.go?type=gene&acc=8533,,,8533.0,COPS3,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of COPS3 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1851,1765411,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,51138,COPS4,https://ctdbase.org/detail.go?type=gene&acc=51138,,,51138.0,COPS4,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of COPS4 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1852,1765412,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,10987,COPS5,https://ctdbase.org/detail.go?type=gene&acc=10987,,,10987.0,COPS5,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of COPS5 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1853,1765413,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,64708,COPS7B,https://ctdbase.org/detail.go?type=gene&acc=64708,,,64708.0,COPS7B,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of COPS7B mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1854,1765414,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,80219,COQ10B,https://ctdbase.org/detail.go?type=gene&acc=80219,,,80219.0,COQ10B,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of COQ10B mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1855,1765415,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,51805,COQ3,https://ctdbase.org/detail.go?type=gene&acc=51805,,,51805.0,COQ3,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of COQ3 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1856,1765416,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,84274,COQ5,https://ctdbase.org/detail.go?type=gene&acc=84274,,,84274.0,COQ5,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of COQ5 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1857,1765417,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,1352,COX10,https://ctdbase.org/detail.go?type=gene&acc=1352,,,1352.0,COX10,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of COX10 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1858,1765418,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,84987,COX14,https://ctdbase.org/detail.go?type=gene&acc=84987,,,84987.0,COX14,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of COX14 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1859,1765419,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,51241,COX16,https://ctdbase.org/detail.go?type=gene&acc=51241,,,51241.0,COX16,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of COX16 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1860,1765681,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,10814,CPLX2,https://ctdbase.org/detail.go?type=gene&acc=10814,,,10814.0,CPLX2,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of CPLX2 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1861,1766141,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,54675,CRLS1,https://ctdbase.org/detail.go?type=gene&acc=54675,,,54675.0,CRLS1,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CRLS1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1862,1766142,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,51340,CRNKL1,https://ctdbase.org/detail.go?type=gene&acc=51340,,,51340.0,CRNKL1,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CRNKL1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1863,1766143,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,23373,CRTC1,https://ctdbase.org/detail.go?type=gene&acc=23373,,,23373.0,CRTC1,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of CRTC1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1864,1766144,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,64784,CRTC3,https://ctdbase.org/detail.go?type=gene&acc=64784,,,64784.0,CRTC3,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of CRTC3 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1865,1766145,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,1409,CRYAA,https://ctdbase.org/detail.go?type=gene&acc=1409,,,1409.0,CRYAA,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of CRYAA mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1866,1766146,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,55057,CRYBG2,https://ctdbase.org/detail.go?type=gene&acc=55057,,,55057.0,CRYBG2,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of CRYBG2 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1867,1766147,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,1429,CRYZ,https://ctdbase.org/detail.go?type=gene&acc=1429,,,1429.0,CRYZ,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CRYZ mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1868,1766148,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,9946,CRYZL1,https://ctdbase.org/detail.go?type=gene&acc=9946,,,9946.0,CRYZL1,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CRYZL1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1869,1766149,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,1431,CS,https://ctdbase.org/detail.go?type=gene&acc=1431,,,1431.0,CS,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of CS mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1870,1766150,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,7812,CSDE1,https://ctdbase.org/detail.go?type=gene&acc=7812,,,7812.0,CSDE1,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of CSDE1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1871,1767169,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,54165,DCUN1D1,https://ctdbase.org/detail.go?type=gene&acc=54165,,,54165.0,DCUN1D1,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of DCUN1D1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1872,1768068,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,1733,DIO1,https://ctdbase.org/detail.go?type=gene&acc=1733,,,1733.0,DIO1,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of DIO1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1873,1768069,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,23181,DIP2A,https://ctdbase.org/detail.go?type=gene&acc=23181,,,23181.0,DIP2A,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of DIP2A mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1874,1768070,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,57609,DIP2B,https://ctdbase.org/detail.go?type=gene&acc=57609,,,57609.0,DIP2B,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of DIP2B mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1875,1768071,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,22894,DIS3,https://ctdbase.org/detail.go?type=gene&acc=22894,,,22894.0,DIS3,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of DIS3 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1876,1768072,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,129563,DIS3L2,https://ctdbase.org/detail.go?type=gene&acc=129563,,,129563.0,DIS3L2,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of DIS3L2 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1877,1768492,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,27000,DNAJC2,https://ctdbase.org/detail.go?type=gene&acc=27000,,,27000.0,DNAJC2,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of DNAJC2 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1878,1768493,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,120526,DNAJC24,https://ctdbase.org/detail.go?type=gene&acc=120526,,,120526.0,DNAJC24,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of DNAJC24 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1879,1769299,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,1778,DYNC1H1,https://ctdbase.org/detail.go?type=gene&acc=1778,,,1778.0,DYNC1H1,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of DYNC1H1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1880,1769300,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,1781,DYNC1I2,https://ctdbase.org/detail.go?type=gene&acc=1781,,,1781.0,DYNC1I2,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of DYNC1I2 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1881,1769301,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,51626,DYNC2LI1,https://ctdbase.org/detail.go?type=gene&acc=51626,,,51626.0,DYNC2LI1,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of DYNC2LI1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1882,1769302,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,83658,DYNLRB1,https://ctdbase.org/detail.go?type=gene&acc=83658,,,83658.0,DYNLRB1,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of DYNLRB1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1883,1769303,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,6990,DYNLT3,https://ctdbase.org/detail.go?type=gene&acc=6990,,,6990.0,DYNLT3,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of DYNLT3 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1884,1769304,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,144455,E2F7,https://ctdbase.org/detail.go?type=gene&acc=144455,,,144455.0,E2F7,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of E2F7 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1885,1769305,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,79733,E2F8,https://ctdbase.org/detail.go?type=gene&acc=79733,,,79733.0,E2F8,9606.0,Homo sapiens (human),Dicrotophos results in increased expression of E2F8 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1886,1769306,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,55837,EAPP,https://ctdbase.org/detail.go?type=gene&acc=55837,,,55837.0,EAPP,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of EAPP mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1887,1762352,6326417,BindingDB,N-(4-chlorophenyl)-4-(pyridin-2-ylmethyl)phthalazin-1-amine,4856,1-(4-Chloroanilino)-4-(2-pyridylmethyl)phthalazine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4856,692,Vascular endothelial growth factor receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=692,P35968,Vascular endothelial growth factor receptor 2,3791.0,KDR,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:10882357|DOI:10.1021/jm9909443,https://www.ncbi.nlm.nih.gov/pubmed/10882357|https://doi.org/10.1021/jm9909443,10882357,10.1021/jm9909443,
1888,1762353,6326418,BindingDB,N-(4-chlorophenyl)-4-(pyrimidin-4-ylmethyl)phthalazin-1-amine,4857,1-(4-Chloroanilino)-4-(4-pyrimidylmethyl)phthalazine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4857,692,Vascular endothelial growth factor receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=692,P35968,Vascular endothelial growth factor receptor 2,3791.0,KDR,9606.0,Homo sapiens (human),,IC50 (nM),410,PMID:10882357|DOI:10.1021/jm9909443,https://www.ncbi.nlm.nih.gov/pubmed/10882357|https://doi.org/10.1021/jm9909443,10882357,10.1021/jm9909443,
1889,1762354,6326418,BindingDB,N-(4-chlorophenyl)-4-(pyrimidin-4-ylmethyl)phthalazin-1-amine,4857,1-(4-Chloroanilino)-4-(4-pyrimidylmethyl)phthalazine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4857,690,Vascular endothelial growth factor receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=690,P17948,Vascular endothelial growth factor receptor 1 ,2321.0,FLT1,9606.0,Homo sapiens (human),,IC50 (nM),760,PMID:10882357|DOI:10.1021/jm9909443,https://www.ncbi.nlm.nih.gov/pubmed/10882357|https://doi.org/10.1021/jm9909443,10882357,10.1021/jm9909443,
1890,1762355,6326419,BindingDB,N-(4-chlorophenyl)-4-[(2-methylpyridin-4-yl)methyl]phthalazin-1-amine,4858,1-(4-Chloroanilino)-4-[2-methylpyridin-4-ylmethyl]-phthalazine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4858,690,Vascular endothelial growth factor receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=690,P17948,Vascular endothelial growth factor receptor 1 ,2321.0,FLT1,9606.0,Homo sapiens (human),,IC50 (nM),620,PMID:10882357|DOI:10.1021/jm9909443,https://www.ncbi.nlm.nih.gov/pubmed/10882357|https://doi.org/10.1021/jm9909443,10882357,10.1021/jm9909443,
1891,1762356,6326419,BindingDB,N-(4-chlorophenyl)-4-[(2-methylpyridin-4-yl)methyl]phthalazin-1-amine,4858,1-(4-Chloroanilino)-4-[2-methylpyridin-4-ylmethyl]-phthalazine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4858,692,Vascular endothelial growth factor receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=692,P35968,Vascular endothelial growth factor receptor 2,3791.0,KDR,9606.0,Homo sapiens (human),,IC50 (nM),240,PMID:10882357|DOI:10.1021/jm9909443,https://www.ncbi.nlm.nih.gov/pubmed/10882357|https://doi.org/10.1021/jm9909443,10882357,10.1021/jm9909443,
1892,1762475,6326422,BindingDB,rac-1-(4-Chloroanilino)-4-[1-(4-pyridyl)ethyl]phthalazine,4861,CGP79787 Analog 52,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4861,690,Vascular endothelial growth factor receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=690,P17948,Vascular endothelial growth factor receptor 1 ,2321.0,FLT1,9606.0,Homo sapiens (human),,IC50 (nM),420,PMID:10882357|DOI:10.1021/jm9909443,https://www.ncbi.nlm.nih.gov/pubmed/10882357|https://doi.org/10.1021/jm9909443,10882357,10.1021/jm9909443,
1893,1762476,6326668,Comparative Toxicogenomics Database (CTD),Apratoxin A,C442201,apratoxin A,https://ctdbase.org/detail.go?type=chem&acc=C442201,3297,HSF1,https://ctdbase.org/detail.go?type=gene&acc=3297,,,3297.0,HSF1,9606.0,Homo sapiens (human),Apratoxin A results in increased activity of HSF1 protein,,,PMID:34170685,https://www.ncbi.nlm.nih.gov/pubmed/34170685,34170685,,
1894,1762477,6326970,Drug Gene Interaction database (DGIdb),Selenium,,SELENIUM,https://www.dgidb.org/drugs/rxcui:9641,,ADA,https://www.dgidb.org/genes/hgnc:186,,,100.0,ADA,9606.0,Homo sapiens (human),,,,,,,,
1895,1762478,6326970,Drug Gene Interaction database (DGIdb),Selenium,,SELENIUM,https://www.dgidb.org/drugs/rxcui:9641,,MAPK3,https://www.dgidb.org/genes/hgnc:6877,,,5595.0,MAPK3,9606.0,Homo sapiens (human),,,,,,,,
1896,1762479,6326970,Drug Gene Interaction database (DGIdb),Selenium,,SELENIUM,https://www.dgidb.org/drugs/rxcui:9641,,FASN,https://www.dgidb.org/genes/hgnc:3594,,,2194.0,FASN,9606.0,Homo sapiens (human),,,,,,,,
1897,1762480,6327182,Therapeutic Target Database (TTD),Tellurium,D0A1QJ,Tellurium,https://idrblab.net/ttd/data/drug/details/D0A1QJ,T93344,Squalene monooxygenase (SQLE),https://idrblab.net/ttd/data/target/details/T93344,Q14534,Squalene monooxygenase,6713.0,SQLE,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1898,1762481,6327657,Comparative Toxicogenomics Database (CTD),Triphenyltin hydroxide,C007567,triphenyltin hydroxide,https://ctdbase.org/detail.go?type=chem&acc=C007567,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632.0,BGLAP,10090.0,Mus musculus (house mouse),Triphenyltin hydroxide inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna],,,PMID:32473317,https://www.ncbi.nlm.nih.gov/pubmed/32473317,32473317,,
1899,1762660,6327657,Comparative Toxicogenomics Database (CTD),Triphenyltin hydroxide,C007567,triphenyltin hydroxide,https://ctdbase.org/detail.go?type=chem&acc=C007567,373598,KLF9.L,https://ctdbase.org/detail.go?type=gene&acc=373598,,,373598.0,klf9.L,8355.0,Xenopus laevis (African clawed frog),Triphenyltin hydroxide results in decreased expression of KLF9.L mRNA,,,PMID:31476497,https://www.ncbi.nlm.nih.gov/pubmed/31476497,31476497,,
1900,1762661,6327657,Comparative Toxicogenomics Database (CTD),Triphenyltin hydroxide,C007567,triphenyltin hydroxide,https://ctdbase.org/detail.go?type=chem&acc=C007567,5346,PLIN1,https://ctdbase.org/detail.go?type=gene&acc=5346,,,5346.0,PLIN1,10090.0,Mus musculus (house mouse),Triphenyltin hydroxide promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna],,,PMID:32473317,https://www.ncbi.nlm.nih.gov/pubmed/32473317,32473317,,
1901,1762787,6327657,Comparative Toxicogenomics Database (CTD),Triphenyltin hydroxide,C007567,triphenyltin hydroxide,https://ctdbase.org/detail.go?type=chem&acc=C007567,6257,RXRB,https://ctdbase.org/detail.go?type=gene&acc=6257,,,6257.0,RXRB,9606.0,Homo sapiens (human),Triphenyltin hydroxide binds to and affects the activity of RXRB protein,,,PMID:15941851,https://www.ncbi.nlm.nih.gov/pubmed/15941851,15941851,,
1902,1762788,6327657,Comparative Toxicogenomics Database (CTD),Triphenyltin hydroxide,C007567,triphenyltin hydroxide,https://ctdbase.org/detail.go?type=chem&acc=C007567,6258,RXRG,https://ctdbase.org/detail.go?type=gene&acc=6258,,,6258.0,RXRG,9606.0,Homo sapiens (human),Triphenyltin hydroxide binds to and affects the activity of RXRG protein,,,PMID:15941851,https://www.ncbi.nlm.nih.gov/pubmed/15941851,15941851,,
1903,1762789,6327657,Comparative Toxicogenomics Database (CTD),Triphenyltin hydroxide,C007567,triphenyltin hydroxide,https://ctdbase.org/detail.go?type=chem&acc=C007567,446726,SLC5A5.L,https://ctdbase.org/detail.go?type=gene&acc=446726,,,446726.0,slc5a5.L,8355.0,Xenopus laevis (African clawed frog),Triphenyltin hydroxide results in increased expression of SLC5A5.L mRNA,,,PMID:31476497,https://www.ncbi.nlm.nih.gov/pubmed/31476497,31476497,,
1904,1762790,6327657,Comparative Toxicogenomics Database (CTD),Triphenyltin hydroxide,C007567,triphenyltin hydroxide,https://ctdbase.org/detail.go?type=chem&acc=C007567,121340,SP7,https://ctdbase.org/detail.go?type=gene&acc=121340,,,121340.0,SP7,10090.0,Mus musculus (house mouse),Triphenyltin hydroxide inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna],,,PMID:32473317,https://www.ncbi.nlm.nih.gov/pubmed/32473317,32473317,,
1905,1762791,6327657,Comparative Toxicogenomics Database (CTD),Triphenyltin hydroxide,C007567,triphenyltin hydroxide,https://ctdbase.org/detail.go?type=chem&acc=C007567,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,9606.0,Homo sapiens (human),Triphenyltin hydroxide results in decreased activity of TGFB1 protein,,,PMID:31652400,https://www.ncbi.nlm.nih.gov/pubmed/31652400,31652400,,
1906,1762792,6327657,Comparative Toxicogenomics Database (CTD),Triphenyltin hydroxide,C007567,triphenyltin hydroxide,https://ctdbase.org/detail.go?type=chem&acc=C007567,7068,THRB,https://ctdbase.org/detail.go?type=gene&acc=7068,,,7068.0,THRB,9606.0,Homo sapiens (human),Triphenyltin hydroxide binds to THRB protein,,,PMID:31476497,https://www.ncbi.nlm.nih.gov/pubmed/31476497,31476497,,
1907,1762793,6327657,Comparative Toxicogenomics Database (CTD),Triphenyltin hydroxide,C007567,triphenyltin hydroxide,https://ctdbase.org/detail.go?type=chem&acc=C007567,779054,THRB.L,https://ctdbase.org/detail.go?type=gene&acc=779054,,,779054.0,thrb.L,8355.0,Xenopus laevis (African clawed frog),Triphenyltin hydroxide results in decreased expression of THRB.L mRNA,,,PMID:31476497,https://www.ncbi.nlm.nih.gov/pubmed/31476497,31476497,,
1908,1763377,6336539,Toxin and Toxin Target Database (T3DB),Barium cadmium tetrastearate,T3D1097,Barium cadmium stearate,http://www.t3db.ca/toxins/T3D1097,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,P48048,ATP-sensitive inward rectifier potassium channel 1,3758.0,KCNJ1,9606.0,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
1909,1763378,6336539,Toxin and Toxin Target Database (T3DB),Barium cadmium tetrastearate,T3D1097,Barium cadmium stearate,http://www.t3db.ca/toxins/T3D1097,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,P78508,ATP-sensitive inward rectifier potassium channel 10,3766.0,KCNJ10,9606.0,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
1910,1763379,6336539,Toxin and Toxin Target Database (T3DB),Barium cadmium tetrastearate,T3D1097,Barium cadmium stearate,http://www.t3db.ca/toxins/T3D1097,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,Q14654,ATP-sensitive inward rectifier potassium channel 11,3767.0,KCNJ11,9606.0,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
1911,1763380,6336539,Toxin and Toxin Target Database (T3DB),Barium cadmium tetrastearate,T3D1097,Barium cadmium stearate,http://www.t3db.ca/toxins/T3D1097,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,Q14500,ATP-sensitive inward rectifier potassium channel 12,3768.0,KCNJ12,9606.0,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
1912,1763381,6336539,Toxin and Toxin Target Database (T3DB),Barium cadmium tetrastearate,T3D1097,Barium cadmium stearate,http://www.t3db.ca/toxins/T3D1097,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,Q9UNX9,ATP-sensitive inward rectifier potassium channel 14,3770.0,KCNJ14,9606.0,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
1913,1763382,6336539,Toxin and Toxin Target Database (T3DB),Barium cadmium tetrastearate,T3D1097,Barium cadmium stearate,http://www.t3db.ca/toxins/T3D1097,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,Q99712,ATP-sensitive inward rectifier potassium channel 15,3772.0,KCNJ15,9606.0,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
1914,1763383,6336539,Toxin and Toxin Target Database (T3DB),Barium cadmium tetrastearate,T3D1097,Barium cadmium stearate,http://www.t3db.ca/toxins/T3D1097,BE0000644,ATP-sensitive inward rectifier potassium channel 1,http://www.t3db.ca/biodb/bio_entities/BE0000644,P48048,ATP-sensitive inward rectifier potassium channel 1,3758.0,KCNJ1,9606.0,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
1915,1763899,6336539,Toxin and Toxin Target Database (T3DB),Barium cadmium tetrastearate,T3D1097,Barium cadmium stearate,http://www.t3db.ca/toxins/T3D1097,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,P78508,ATP-sensitive inward rectifier potassium channel 10,3766.0,KCNJ10,9606.0,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
1916,1763900,6336539,Toxin and Toxin Target Database (T3DB),Barium cadmium tetrastearate,T3D1097,Barium cadmium stearate,http://www.t3db.ca/toxins/T3D1097,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,Q14654,ATP-sensitive inward rectifier potassium channel 11,3767.0,KCNJ11,9606.0,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
1917,1765024,6419390,BindingDB,1-(3-Methoxyanilino)-4-(4-pyridylmethyl)phthalazine,4874,1-(3-Methoxyanilino)-4-(4-pyridylmethyl)phthalazine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4874,690,Vascular endothelial growth factor receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=690,P17948,Vascular endothelial growth factor receptor 1 ,2321.0,FLT1,9606.0,Homo sapiens (human),,IC50 (nM),330,PMID:10882357|DOI:10.1021/jm9909443,https://www.ncbi.nlm.nih.gov/pubmed/10882357|https://doi.org/10.1021/jm9909443,10882357,10.1021/jm9909443,
1918,1765025,6419390,BindingDB,1-(3-Methoxyanilino)-4-(4-pyridylmethyl)phthalazine,4874,1-(3-Methoxyanilino)-4-(4-pyridylmethyl)phthalazine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4874,359,Mast/stem cell growth factor receptor Kit,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=359,P10721,Mast/stem cell growth factor receptor Kit,3815.0,KIT,9606.0,Homo sapiens (human),,IC50 (nM),3000,PMID:10882357|DOI:10.1021/jm9909443,https://www.ncbi.nlm.nih.gov/pubmed/10882357|https://doi.org/10.1021/jm9909443,10882357,10.1021/jm9909443,
1919,1765026,6419390,BindingDB,1-(3-Methoxyanilino)-4-(4-pyridylmethyl)phthalazine,4874,1-(3-Methoxyanilino)-4-(4-pyridylmethyl)phthalazine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4874,692,Vascular endothelial growth factor receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=692,P35968,Vascular endothelial growth factor receptor 2,3791.0,KDR,9606.0,Homo sapiens (human),,IC50 (nM),240,PMID:10882357|DOI:10.1021/jm9909443,https://www.ncbi.nlm.nih.gov/pubmed/10882357|https://doi.org/10.1021/jm9909443,10882357,10.1021/jm9909443,
1920,1765027,6419390,BindingDB,1-(3-Methoxyanilino)-4-(4-pyridylmethyl)phthalazine,4874,1-(3-Methoxyanilino)-4-(4-pyridylmethyl)phthalazine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4874,575,Platelet-derived growth factor receptor beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=575,P09619,Platelet-derived growth factor receptor beta,5159.0,PDGFRB,9606.0,Homo sapiens (human),,IC50 (nM),800,PMID:10882357|DOI:10.1021/jm9909443,https://www.ncbi.nlm.nih.gov/pubmed/10882357|https://doi.org/10.1021/jm9909443,10882357,10.1021/jm9909443,
1921,1765028,6419391,BindingDB,1-(3-Hydroxyanilino)-4-(4-pyridylmethyl)phthalazine,4875,1-(3-Hydroxyanilino)-4-(4-pyridylmethyl)phthalazine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4875,575,Platelet-derived growth factor receptor beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=575,P09619,Platelet-derived growth factor receptor beta,5159.0,PDGFRB,9606.0,Homo sapiens (human),,IC50 (nM),4000,PMID:10882357|DOI:10.1021/jm9909443,https://www.ncbi.nlm.nih.gov/pubmed/10882357|https://doi.org/10.1021/jm9909443,10882357,10.1021/jm9909443,
1922,1765029,6419391,BindingDB,1-(3-Hydroxyanilino)-4-(4-pyridylmethyl)phthalazine,4875,1-(3-Hydroxyanilino)-4-(4-pyridylmethyl)phthalazine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4875,692,Vascular endothelial growth factor receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=692,P35968,Vascular endothelial growth factor receptor 2,3791.0,KDR,9606.0,Homo sapiens (human),,IC50 (nM),670,PMID:10882357|DOI:10.1021/jm9909443,https://www.ncbi.nlm.nih.gov/pubmed/10882357|https://doi.org/10.1021/jm9909443,10882357,10.1021/jm9909443,
1923,1765030,6419391,BindingDB,1-(3-Hydroxyanilino)-4-(4-pyridylmethyl)phthalazine,4875,1-(3-Hydroxyanilino)-4-(4-pyridylmethyl)phthalazine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4875,359,Mast/stem cell growth factor receptor Kit,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=359,P10721,Mast/stem cell growth factor receptor Kit,3815.0,KIT,9606.0,Homo sapiens (human),,IC50 (nM),7900,PMID:10882357|DOI:10.1021/jm9909443,https://www.ncbi.nlm.nih.gov/pubmed/10882357|https://doi.org/10.1021/jm9909443,10882357,10.1021/jm9909443,
1924,1762347,6433205,Comparative Toxicogenomics Database (CTD),Methylazoxymethanol,C030667,methylazoxymethanol,https://ctdbase.org/detail.go?type=chem&acc=C030667,84967,LSM10,https://ctdbase.org/detail.go?type=gene&acc=84967,,,84967.0,LSM10,10090.0,Mus musculus (house mouse),Methylazoxymethanol results in increased expression of LSM10 mRNA,,,PMID:17107856,https://www.ncbi.nlm.nih.gov/pubmed/17107856,17107856,,
1925,1762348,6433205,Comparative Toxicogenomics Database (CTD),Methylazoxymethanol,C030667,methylazoxymethanol,https://ctdbase.org/detail.go?type=chem&acc=C030667,10982,MAPRE2,https://ctdbase.org/detail.go?type=gene&acc=10982,,,10982.0,MAPRE2,10090.0,Mus musculus (house mouse),Methylazoxymethanol results in increased expression of MAPRE2 mRNA,,,PMID:17107856,https://www.ncbi.nlm.nih.gov/pubmed/17107856,17107856,,
1926,1762349,6433205,Comparative Toxicogenomics Database (CTD),Methylazoxymethanol,C030667,methylazoxymethanol,https://ctdbase.org/detail.go?type=chem&acc=C030667,4245,MGAT1,https://ctdbase.org/detail.go?type=gene&acc=4245,,,4245.0,MGAT1,10090.0,Mus musculus (house mouse),Methylazoxymethanol results in increased expression of MGAT1 mRNA,,,PMID:17107856,https://www.ncbi.nlm.nih.gov/pubmed/17107856,17107856,,
1927,1762350,6433205,Comparative Toxicogenomics Database (CTD),Methylazoxymethanol,C030667,methylazoxymethanol,https://ctdbase.org/detail.go?type=chem&acc=C030667,23154,NCDN,https://ctdbase.org/detail.go?type=gene&acc=23154,,,23154.0,NCDN,10090.0,Mus musculus (house mouse),Methylazoxymethanol results in increased expression of NCDN mRNA,,,PMID:17107856,https://www.ncbi.nlm.nih.gov/pubmed/17107856,17107856,,
1928,1762351,6433205,Comparative Toxicogenomics Database (CTD),Methylazoxymethanol,C030667,methylazoxymethanol,https://ctdbase.org/detail.go?type=chem&acc=C030667,5049,PAFAH1B2,https://ctdbase.org/detail.go?type=gene&acc=5049,,,5049.0,PAFAH1B2,10090.0,Mus musculus (house mouse),Methylazoxymethanol results in increased expression of PAFAH1B2 mRNA,,,PMID:17107856,https://www.ncbi.nlm.nih.gov/pubmed/17107856,17107856,,
1929,1763266,6435378,IUPHAR/BPS Guide to PHARMACOLOGY,"(5E)-5-[(3aS,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid",1895,iloprost,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1895,345,IP receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=345,P43252,Prostacyclin receptor ,19222.0,Ptgir,10090.0,Mus musculus (house mouse),Full agonist,pKi,8,PMID:9313928,https://www.ncbi.nlm.nih.gov/pubmed/9313928,9313928,,
1930,1763267,6435378,IUPHAR/BPS Guide to PHARMACOLOGY,"(5E)-5-[(3aS,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid",1895,iloprost,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1895,346,TP receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=346,P21731,Thromboxane A2 receptor ,6915.0,TBXA2R,9606.0,Homo sapiens (human),Full agonist,pKi,5.2,PMID:10634944,https://www.ncbi.nlm.nih.gov/pubmed/10634944,10634944,,
1931,1763268,6435378,IUPHAR/BPS Guide to PHARMACOLOGY,"(5E)-5-[(3aS,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid",1895,iloprost,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1895,340,EP1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=340,P34995,Prostaglandin E2 receptor EP1 subtype,5731.0,PTGER1,9606.0,Homo sapiens (human),Full agonist,pKi,5.6 - 8,PMID:10634944|PMID:11999132,https://www.ncbi.nlm.nih.gov/pubmed/10634944|https://www.ncbi.nlm.nih.gov/pubmed/11999132,10634944|11999132,,
1932,1763269,6435378,IUPHAR/BPS Guide to PHARMACOLOGY,"(5E)-5-[(3aS,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid",1895,iloprost,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1895,338,DP1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=338,Q13258,Prostaglandin D2 receptor,5729.0,PTGDR,9606.0,Homo sapiens (human),Full agonist,pKi,6 - 6.6,PMID:9579725|PMID:10634944|PMID:22480736,https://www.ncbi.nlm.nih.gov/pubmed/9579725|https://www.ncbi.nlm.nih.gov/pubmed/10634944|https://www.ncbi.nlm.nih.gov/pubmed/22480736,9579725|10634944|22480736,,
1933,1763270,6435402,IUPHAR/BPS Guide to PHARMACOLOGY,(E)-7-[2-morpholin-4-yl-3-oxo-5-[(4-phenylphenyl)methoxy]cyclopentyl]hept-4-enoic acid,1950,AH23848 (racemic),https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1950,343,EP4 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=343,P43114,Prostaglandin E2 receptor EP4 subtype,84023.0,Ptger4,10116.0,Rattus norvegicus (Norway rat),Antagonist,pKi,5,PMID:9537820,https://www.ncbi.nlm.nih.gov/pubmed/9537820,9537820,,
1934,1763452,6436143,Toxin and Toxin Target Database (T3DB),Adenosylcobalamin,T3D0672,Adenosylcobalamin,http://www.t3db.ca/toxins/T3D0672,BE0005051,DNA repair protein complementing XP-A cells,http://www.t3db.ca/biodb/bio_entities/BE0005051,P23025,DNA repair protein complementing XP-A cells,7507.0,XPA,9606.0,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,
1935,1763453,6436143,Toxin and Toxin Target Database (T3DB),Adenosylcobalamin,T3D0672,Adenosylcobalamin,http://www.t3db.ca/toxins/T3D0672,BE0005097,Ig alpha-1 chain C region,http://www.t3db.ca/biodb/bio_entities/BE0005097,P01876,Immunoglobulin heavy constant alpha 1,,,9606.0,Homo sapiens (human),"Cobalt interacts with specific iga antibodies, resulting in immunosensitization. (A102)",,,PMID:6663071,https://www.ncbi.nlm.nih.gov/pubmed/6663071,6663071,,
1936,1763454,6436143,Toxin and Toxin Target Database (T3DB),Adenosylcobalamin,T3D0672,Adenosylcobalamin,http://www.t3db.ca/toxins/T3D0672,BE0004610,Ig alpha-2 chain C region,http://www.t3db.ca/biodb/bio_entities/BE0004610,P01877,Immunoglobulin heavy constant alpha 2,,,9606.0,Homo sapiens (human),"Cobalt interacts with specific iga antibodies, resulting in immunosensitization. (A102)",,,PMID:6663071,https://www.ncbi.nlm.nih.gov/pubmed/6663071,6663071,,
1937,1763636,6436143,Toxin and Toxin Target Database (T3DB),Adenosylcobalamin,T3D0672,Adenosylcobalamin,http://www.t3db.ca/toxins/T3D0672,BE0002357,Voltage-dependent L-type calcium channel subunit alpha-1F,http://www.t3db.ca/biodb/bio_entities/BE0002357,O60840,Voltage-dependent L-type calcium channel subunit alpha-1F,778.0,CACNA1F,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
1938,1763637,6436143,Toxin and Toxin Target Database (T3DB),Adenosylcobalamin,T3D0672,Adenosylcobalamin,http://www.t3db.ca/toxins/T3D0672,BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,http://www.t3db.ca/biodb/bio_entities/BE0002355,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,779.0,CACNA1S,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
1939,1763638,6436143,Toxin and Toxin Target Database (T3DB),Adenosylcobalamin,T3D0672,Adenosylcobalamin,http://www.t3db.ca/toxins/T3D0672,BE0000303,Voltage-dependent L-type calcium channel subunit beta-1,http://www.t3db.ca/biodb/bio_entities/BE0000303,Q02641,Voltage-dependent L-type calcium channel subunit beta-1,782.0,CACNB1,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
1940,1763639,6436143,Toxin and Toxin Target Database (T3DB),Adenosylcobalamin,T3D0672,Adenosylcobalamin,http://www.t3db.ca/toxins/T3D0672,BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,http://www.t3db.ca/biodb/bio_entities/BE0002354,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,783.0,CACNB2,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
1941,1763640,6436143,Toxin and Toxin Target Database (T3DB),Adenosylcobalamin,T3D0672,Adenosylcobalamin,http://www.t3db.ca/toxins/T3D0672,BE0002358,Voltage-dependent L-type calcium channel subunit beta-3,http://www.t3db.ca/biodb/bio_entities/BE0002358,P54284,Voltage-dependent L-type calcium channel subunit beta-3,784.0,CACNB3,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
1942,1763782,6436143,Toxin and Toxin Target Database (T3DB),Adenosylcobalamin,T3D0672,Adenosylcobalamin,http://www.t3db.ca/toxins/T3D0672,BE0002356,Voltage-dependent L-type calcium channel subunit beta-4,http://www.t3db.ca/biodb/bio_entities/BE0002356,O00305,Voltage-dependent L-type calcium channel subunit beta-4,785.0,CACNB4,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
1943,1763783,6436143,Toxin and Toxin Target Database (T3DB),Adenosylcobalamin,T3D0672,Adenosylcobalamin,http://www.t3db.ca/toxins/T3D0672,BE0002226,Voltage-dependent N-type calcium channel subunit alpha-1B,http://www.t3db.ca/biodb/bio_entities/BE0002226,Q00975,Voltage-dependent N-type calcium channel subunit alpha-1B,774.0,CACNA1B,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
1944,1763784,6436143,Toxin and Toxin Target Database (T3DB),Adenosylcobalamin,T3D0672,Adenosylcobalamin,http://www.t3db.ca/toxins/T3D0672,BE0000356,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,http://www.t3db.ca/biodb/bio_entities/BE0000356,O00555,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,773.0,CACNA1A,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
1945,1763785,6436143,Toxin and Toxin Target Database (T3DB),Adenosylcobalamin,T3D0672,Adenosylcobalamin,http://www.t3db.ca/toxins/T3D0672,BE0005099,Voltage-dependent R-type calcium channel subunit alpha-1E,http://www.t3db.ca/biodb/bio_entities/BE0005099,Q15878,Voltage-dependent R-type calcium channel subunit alpha-1E,777.0,CACNA1E,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
1946,1763786,6436143,Toxin and Toxin Target Database (T3DB),Adenosylcobalamin,T3D0672,Adenosylcobalamin,http://www.t3db.ca/toxins/T3D0672,BE0000679,Voltage-dependent calcium channel gamma-1 subunit,http://www.t3db.ca/biodb/bio_entities/BE0000679,Q06432,Voltage-dependent calcium channel gamma-1 subunit,786.0,CACNG1,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
1947,1763787,6436143,Toxin and Toxin Target Database (T3DB),Adenosylcobalamin,T3D0672,Adenosylcobalamin,http://www.t3db.ca/toxins/T3D0672,BE0005108,Voltage-dependent calcium channel gamma-2 subunit,http://www.t3db.ca/biodb/bio_entities/BE0005108,Q9Y698,Voltage-dependent calcium channel gamma-2 subunit,10369.0,CACNG2,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
1948,1763788,6436143,Toxin and Toxin Target Database (T3DB),Adenosylcobalamin,T3D0672,Adenosylcobalamin,http://www.t3db.ca/toxins/T3D0672,BE0005105,Voltage-dependent calcium channel gamma-3 subunit,http://www.t3db.ca/biodb/bio_entities/BE0005105,O60359,Voltage-dependent calcium channel gamma-3 subunit,10368.0,CACNG3,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
1949,1763789,6436143,Toxin and Toxin Target Database (T3DB),Adenosylcobalamin,T3D0672,Adenosylcobalamin,http://www.t3db.ca/toxins/T3D0672,BE0005110,Voltage-dependent calcium channel gamma-4 subunit,http://www.t3db.ca/biodb/bio_entities/BE0005110,Q9UBN1,Voltage-dependent calcium channel gamma-4 subunit,27092.0,CACNG4,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
1950,1765042,6441562,Drug Gene Interaction database (DGIdb),1-Stearoyl-2-linoleoyl-sn-glycerol,,(+/-)-ERIODICTYOL,https://www.dgidb.org/drugs/iuphar.ligand:12442,,ALPL,https://www.dgidb.org/genes/hgnc:438,,,249.0,ALPL,9606.0,Homo sapiens (human),,,,,,,,
1951,1765043,6441562,Drug Gene Interaction database (DGIdb),1-Stearoyl-2-linoleoyl-sn-glycerol,,(+/-)-ERIODICTYOL,https://www.dgidb.org/drugs/iuphar.ligand:12442,,ALOX15,https://www.dgidb.org/genes/hgnc:433,,,246.0,ALOX15,9606.0,Homo sapiens (human),,,,,,,,
1952,1765044,6441562,Drug Gene Interaction database (DGIdb),1-Stearoyl-2-linoleoyl-sn-glycerol,,(+/-)-ERIODICTYOL,https://www.dgidb.org/drugs/iuphar.ligand:12442,,ALPI,https://www.dgidb.org/genes/hgnc:437,,,248.0,ALPI,9606.0,Homo sapiens (human),,,,,,,,
1953,1765045,6441562,Drug Gene Interaction database (DGIdb),1-Stearoyl-2-linoleoyl-sn-glycerol,,(+/-)-ERIODICTYOL,https://www.dgidb.org/drugs/iuphar.ligand:12442,,CYP3A4,https://www.dgidb.org/genes/hgnc:2637,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),,,,,,,,
1954,1765046,6441636,IUPHAR/BPS Guide to PHARMACOLOGY,Latanoprost acid,1960,latanoprost (free acid form),https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1960,344,FP receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=344,P43088,Prostaglandin F2-alpha receptor,5737.0,PTGFR,9606.0,Homo sapiens (human),Full agonist,pKi,8.6,PMID:10634944,https://www.ncbi.nlm.nih.gov/pubmed/10634944,10634944,,
1955,1765047,6442177,Drug Gene Interaction database (DGIdb),Everolimus,,EVEROLIMUS,https://www.dgidb.org/drugs/rxcui:141704,,MTOR,https://www.dgidb.org/genes/hgnc:3942,,,2475.0,MTOR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1956,1768237,6442177,Drug Gene Interaction database (DGIdb),Everolimus,,EVEROLIMUS,https://www.dgidb.org/drugs/rxcui:141704,,PIK3CA,https://www.dgidb.org/genes/hgnc:8975,,,5290.0,PIK3CA,9606.0,Homo sapiens (human),,,,,,,,
1957,1768238,6442177,Drug Gene Interaction database (DGIdb),Everolimus,,EVEROLIMUS,https://www.dgidb.org/drugs/rxcui:141704,,AR,https://www.dgidb.org/genes/hgnc:644,,,367.0,AR,9606.0,Homo sapiens (human),,,,,,,,
1958,1768239,6442273,Comparative Toxicogenomics Database (CTD),N-(2-(1-azabicyclo(3.3.0)octan-5-yl)ethyl)-2-nitroaniline,C107666,N-(2-(1-azabicyclo(3.3.0)octan-5-yl)ethyl)-2-nitroaniline,https://ctdbase.org/detail.go?type=chem&acc=C107666,1128,CHRM1,https://ctdbase.org/detail.go?type=gene&acc=1128,,,1128.0,CHRM1,10116.0,Rattus norvegicus (Norway rat),N-(2-(1-azabicyclo(3.3.0)octan-5-yl)ethyl)-2-nitroaniline binds to and results in increased activity of CHRM1 protein,,,PMID:9987823,https://www.ncbi.nlm.nih.gov/pubmed/9987823,9987823,,
1959,1765048,6445562,Drug Gene Interaction database (DGIdb),Pelitinib,,PELITINIB,https://www.dgidb.org/drugs/ncit:C2713,,ERBB2,https://www.dgidb.org/genes/hgnc:3430,,,2064.0,ERBB2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1960,1765959,6451142,Comparative Toxicogenomics Database (CTD),Prothioconazole,C550005,prothioconazole,https://ctdbase.org/detail.go?type=chem&acc=C550005,7439,BEST1,https://ctdbase.org/detail.go?type=gene&acc=7439,,,7439.0,BEST1,9606.0,Homo sapiens (human),Prothioconazole results in increased expression of BEST1 mRNA,,,PMID:35048155,https://www.ncbi.nlm.nih.gov/pubmed/35048155,35048155,,
1961,1765960,6451142,Comparative Toxicogenomics Database (CTD),Prothioconazole,C550005,prothioconazole,https://ctdbase.org/detail.go?type=chem&acc=C550005,64170,CARD9,https://ctdbase.org/detail.go?type=gene&acc=64170,,,64170.0,CARD9,9606.0,Homo sapiens (human),Prothioconazole results in increased expression of CARD9 mRNA,,,PMID:35048155,https://www.ncbi.nlm.nih.gov/pubmed/35048155,35048155,,
1962,1765961,6451142,Comparative Toxicogenomics Database (CTD),Prothioconazole,C550005,prothioconazole,https://ctdbase.org/detail.go?type=chem&acc=C550005,124093,CCDC78,https://ctdbase.org/detail.go?type=gene&acc=124093,,,124093.0,CCDC78,9606.0,Homo sapiens (human),Prothioconazole results in decreased expression of CCDC78 mRNA,,,PMID:35048155,https://www.ncbi.nlm.nih.gov/pubmed/35048155,35048155,,
1963,1765962,6451142,Comparative Toxicogenomics Database (CTD),Prothioconazole,C550005,prothioconazole,https://ctdbase.org/detail.go?type=chem&acc=C550005,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606.0,Homo sapiens (human),Prothioconazole results in decreased expression of CCND1 protein|prothioconazole results in decreased expression of CCND1 mrna|eif4ebp1 protein affects the reaction [prothioconazole results in decreased expression of CCND1 mrna]|eif4ebp1 protein affects the reaction [prothioconazole results in decreased expression of CCND1 protein],,,PMID:35048155,https://www.ncbi.nlm.nih.gov/pubmed/35048155,35048155,,
1964,1765963,6451142,Comparative Toxicogenomics Database (CTD),Prothioconazole,C550005,prothioconazole,https://ctdbase.org/detail.go?type=chem&acc=C550005,951,CD37,https://ctdbase.org/detail.go?type=gene&acc=951,,,951.0,CD37,9606.0,Homo sapiens (human),Prothioconazole results in decreased expression of CD37 mRNA,,,PMID:35048155,https://www.ncbi.nlm.nih.gov/pubmed/35048155,35048155,,
1965,1765964,6451142,Comparative Toxicogenomics Database (CTD),Prothioconazole,C550005,prothioconazole,https://ctdbase.org/detail.go?type=chem&acc=C550005,9076,CLDN1,https://ctdbase.org/detail.go?type=gene&acc=9076,,,9076.0,CLDN1,10090.0,Mus musculus (house mouse),Prothioconazole results in decreased expression of CLDN1 mRNA,,,PMID:36007749,https://www.ncbi.nlm.nih.gov/pubmed/36007749,36007749,,
1966,1765965,6451142,Comparative Toxicogenomics Database (CTD),Prothioconazole,C550005,prothioconazole,https://ctdbase.org/detail.go?type=chem&acc=C550005,1491,CTH,https://ctdbase.org/detail.go?type=gene&acc=1491,,,1491.0,CTH,9606.0,Homo sapiens (human),Prothioconazole results in increased expression of CTH mRNA,,,PMID:35048155,https://www.ncbi.nlm.nih.gov/pubmed/35048155,35048155,,
1967,1765966,6451142,Comparative Toxicogenomics Database (CTD),Prothioconazole,C550005,prothioconazole,https://ctdbase.org/detail.go?type=chem&acc=C550005,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,10090.0,Mus musculus (house mouse),Prothioconazole results in increased expression of CYP27A1 mRNA,,,PMID:36007749,https://www.ncbi.nlm.nih.gov/pubmed/36007749,36007749,,
1968,1765967,6451142,Comparative Toxicogenomics Database (CTD),Prothioconazole,C550005,prothioconazole,https://ctdbase.org/detail.go?type=chem&acc=C550005,13121,CYP51,https://ctdbase.org/detail.go?type=gene&acc=13121,,,13121.0,Cyp51,7955.0,Danio rerio (zebrafish),Prothioconazole results in decreased expression of CYP51 mRNA,,,PMID:31574395,https://www.ncbi.nlm.nih.gov/pubmed/31574395,31574395,,
1969,1765968,6451142,Comparative Toxicogenomics Database (CTD),Prothioconazole,C550005,prothioconazole,https://ctdbase.org/detail.go?type=chem&acc=C550005,13121,CYP51,https://ctdbase.org/detail.go?type=gene&acc=13121,,,13121.0,Cyp51,10090.0,Mus musculus (house mouse),Prothioconazole results in increased expression of CYP51 mRNA,,,PMID:29337257,https://www.ncbi.nlm.nih.gov/pubmed/29337257,29337257,,
1970,1766878,6451142,Comparative Toxicogenomics Database (CTD),Prothioconazole,C550005,prothioconazole,https://ctdbase.org/detail.go?type=chem&acc=C550005,5260,PHKG1,https://ctdbase.org/detail.go?type=gene&acc=5260,,,5260.0,PHKG1,9606.0,Homo sapiens (human),Prothioconazole results in increased expression of PHKG1 mRNA,,,PMID:35048155,https://www.ncbi.nlm.nih.gov/pubmed/35048155,35048155,,
1971,1766879,6451142,Comparative Toxicogenomics Database (CTD),Prothioconazole,C550005,prothioconazole,https://ctdbase.org/detail.go?type=chem&acc=C550005,5320,PLA2G2A,https://ctdbase.org/detail.go?type=gene&acc=5320,,,5320.0,PLA2G2A,10090.0,Mus musculus (house mouse),Prothioconazole results in increased expression of PLA2G2A mRNA,,,PMID:36007749,https://www.ncbi.nlm.nih.gov/pubmed/36007749,36007749,,
1972,1766880,6451142,Comparative Toxicogenomics Database (CTD),Prothioconazole,C550005,prothioconazole,https://ctdbase.org/detail.go?type=chem&acc=C550005,5480,PPIC,https://ctdbase.org/detail.go?type=gene&acc=5480,,,5480.0,PPIC,9606.0,Homo sapiens (human),Prothioconazole results in increased expression of PPIC mRNA,,,PMID:35048155,https://www.ncbi.nlm.nih.gov/pubmed/35048155,35048155,,
1973,1766881,6451142,Comparative Toxicogenomics Database (CTD),Prothioconazole,C550005,prothioconazole,https://ctdbase.org/detail.go?type=chem&acc=C550005,29968,PSAT1,https://ctdbase.org/detail.go?type=gene&acc=29968,,,29968.0,PSAT1,9606.0,Homo sapiens (human),Prothioconazole results in increased expression of PSAT1 mRNA,,,PMID:35048155,https://www.ncbi.nlm.nih.gov/pubmed/35048155,35048155,,
1974,1766882,6451142,Comparative Toxicogenomics Database (CTD),Prothioconazole,C550005,prothioconazole,https://ctdbase.org/detail.go?type=chem&acc=C550005,388,RHOB,https://ctdbase.org/detail.go?type=gene&acc=388,,,388.0,RHOB,9606.0,Homo sapiens (human),Prothioconazole results in decreased expression of RHOB mRNA,,,PMID:35048155,https://www.ncbi.nlm.nih.gov/pubmed/35048155,35048155,,
1975,1767368,6451142,Comparative Toxicogenomics Database (CTD),Prothioconazole,C550005,prothioconazole,https://ctdbase.org/detail.go?type=chem&acc=C550005,7695,ZNF136,https://ctdbase.org/detail.go?type=gene&acc=7695,,,7695.0,ZNF136,9606.0,Homo sapiens (human),Prothioconazole results in decreased expression of ZNF136 mRNA,,,PMID:35048155,https://www.ncbi.nlm.nih.gov/pubmed/35048155,35048155,,
1976,1767369,6451142,Comparative Toxicogenomics Database (CTD),Prothioconazole,C550005,prothioconazole,https://ctdbase.org/detail.go?type=chem&acc=C550005,80139,ZNF703,https://ctdbase.org/detail.go?type=gene&acc=80139,,,80139.0,ZNF703,9606.0,Homo sapiens (human),Prothioconazole results in decreased expression of ZNF703 mRNA,,,PMID:35048155,https://www.ncbi.nlm.nih.gov/pubmed/35048155,35048155,,
1977,1767370,6451142,Comparative Toxicogenomics Database (CTD),Prothioconazole,C550005,prothioconazole,https://ctdbase.org/detail.go?type=chem&acc=C550005,29965,CDIP1,https://ctdbase.org/detail.go?type=gene&acc=29965,,,29965.0,CDIP1,9606.0,Homo sapiens (human),Prothioconazole results in decreased expression of CDIP1 mRNA,,,PMID:35048155,https://www.ncbi.nlm.nih.gov/pubmed/35048155,35048155,,
1978,1767371,6451142,Comparative Toxicogenomics Database (CTD),Prothioconazole,C550005,prothioconazole,https://ctdbase.org/detail.go?type=chem&acc=C550005,1080,CFTR,https://ctdbase.org/detail.go?type=gene&acc=1080,,,1080.0,CFTR,10090.0,Mus musculus (house mouse),Prothioconazole results in increased expression of CFTR mRNA,,,PMID:36007749,https://www.ncbi.nlm.nih.gov/pubmed/36007749,36007749,,
1979,1813921,6918837,Comparative Toxicogenomics Database (CTD),Panobinostat,D000077767,Panobinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077767,1380,CR2,https://ctdbase.org/detail.go?type=gene&acc=1380,,,1380.0,CR2,9606.0,Homo sapiens (human),"[NOG protein co-treated with panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CR2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1980,1813922,6918837,Comparative Toxicogenomics Database (CTD),Panobinostat,D000077767,Panobinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077767,1380,CR2,https://ctdbase.org/detail.go?type=gene&acc=1380,,,1380.0,CR2,9606.0,Homo sapiens (human),Panobinostat results in increased expression of CR2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
1981,1813923,6918837,Comparative Toxicogenomics Database (CTD),Panobinostat,D000077767,Panobinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077767,1381,CRABP1,https://ctdbase.org/detail.go?type=gene&acc=1381,,,1381.0,CRABP1,9606.0,Homo sapiens (human),"[NOG protein co-treated with panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CRABP1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
